[["Gut microbiota", "psychological ED", "IS LINKED TO"], ["defensins", "antimicrobial proteins", "PART OF"], ["striatal homovanillic acid", "substantia nigra pars compacta", "LOCATED IN"], ["Parkinson's disease", "rats", "TARGET"], ["<i>Lachnospiraceae</i> family", "Parkinson's disease", "INFLUENCE"], ["Hoehn and Yahr disease", "urolithin non-producers", "TARGET"], ["intestine microbiota", "Parkinson's disease", "IS LINKED TO"], ["gut microbiota", "SGS-3W group", "LOCATED IN"], ["obesity", "SZ patients", "TARGET"], ["CT-26", "Escherichia-Shigella", "IMPACT"], ["PS128", "gut microbiota", "IMPACT"], ["Subdoligranulum", "PTGS2", "CHANGE EXPRESSION"], ["c_Clostridia", "IBS", "INFLUENCE"], ["gut microbiota", "depressive and anxiety disorders", "IS LINKED TO"], ["anxiety", "Psychiatric comorbidities", "IS A"], ["social avoidance effects", "male mice", "TARGET"], ["Irritable bowel syndrome", "depression", "AFFECT"], ["LPS plus MPTP-induced neurotoxicity", "mice", "TARGET"], ["short-chain fatty acids", "bacteria", "IMPACT"], ["fiber intake", "non-depressed groups", "ADMINISTERED"], ["risk of depression", "offspring", "TARGET"], ["neurodegeneration", "disease subpopulations", "TARGET"], ["gut microbiota", "16S RNA gene sequencing", "USED BY"], ["Anaerostipes", "SCFAs", "INTERACT"], ["psychological stress", "medical students", "TARGET"], ["PD", "Occidental Patients", "TARGET"], ["cecum", "Male and female Sprague-Dawley rats", "LOCATED IN"], ["Yaniella", "anxiety", "INFLUENCE"], ["cortisol", "PMAD", "INFLUENCE"], ["dysbiosis", "PIPO patients", "TARGET"], ["curcumin", "cell wrinkling", "INFLUENCE"], ["Hua-Feng-Dan", "behavioral dysfunction", "CHANGE EFFECT"], ["lipid", "gastrointestinal tract", "LOCATED IN"], ["MA", "Clostridia_vadinBB60_group", "IMPACT"], ["PD-dementia conversion", "TMAO", "INTERACT"], ["increased production of neurotransmitters", "depression", "AFFECT"], ["probiotics", "CNS disorders", "INFLUENCE"], ["gut microbiota", "mental health-related disorders", "IS LINKED TO"], ["tyrosine decarboxylating (TDC) bacteria", "levodopa", "INTERACT"], ["Paracasei 37", "ASD", "INFLUENCE"], ["CsgA protein", "amyloid-related diseases", "INFLUENCE"], ["GMB", "mice", "LOCATED IN"], ["probiotics", "neurological and psychological changes", "INFLUENCE"], ["PD", "GAPDH", "INTERACT"], ["depression", "RA patients", "TARGET"], ["Gut microbiota", "inflammaging", "IS LINKED TO"], ["Hoehn and Yahr disease", "metabotype-0", "TARGET"], ["Rifaximin", "gut microbiota", "IMPACT"], ["Gut microbial-derived metabolites", "Parkinson's disease", "INFLUENCE"], ["oral drugs", "symbiotic gut microbiota", "IMPACT"], ["probiotic", "MDD", "INFLUENCE"], ["neuropsychiatric disorders", "animals", "TARGET"], ["Bacteroides vulgatus", "Gut microbiota", "PART OF"], ["bacterial species", "gut microbiota", "PART OF"], ["Maternal Microbiota", "Neurodevelopmental Disorders", "IS LINKED TO"], ["Bacteroides thetaiotaomicron", "MCI", "INFLUENCE"], ["BHB", "butyrate", "INTERACT"], ["Adult specific pathogen free (SPF) Sprague-Dawley rats", "SPT", "USED BY"], ["excess body weight", "type 2 diabetes", "AFFECT"], ["Prevotella", "Dry eye discomfort", "INFLUENCE"], ["Fisetin", "stroke (both ischemic and hemorrhagic)", "INFLUENCE"], ["Exposure to stressors", "bacteria", "CHANGE ABUNDANCE"], ["slowness of movement", "KO mice", "TARGET"], ["depression and fatigue symptoms", "Patients", "TARGET"], ["GMB composition changes", "metabolic perturbations", "IS LINKED TO"], ["CA", "proinflammatory cytokines", "INTERACT"], ["ketogenic diet", "AD", "INFLUENCE"], ["Flavonifractor", "microbial genera", "PART OF"], ["gastrointestinal microbiota", "Alzheimer's disease", "IS LINKED TO"], ["multi-ingredient supplements", "gut health-related markers", "INFLUENCE"], ["Lipopolysaccharide", "Verrucomicrobiaceae", "IMPACT"], ["individuals", "fecal metagenome-wide sequencing", "USED BY"], ["Parabacteroides", "gut microbiota", "PART OF"], ["low FODMAP diet", "IBS", "INFLUENCE"], ["anxiety/depression", "offspring", "TARGET"], ["gut microbiota", "epigenetic processes", "IS LINKED TO"], ["impaired GBB", "patients", "TARGET"], ["gut microbiota", "motor deficits", "IS LINKED TO"], ["HPHP", "peroxisome proliferator-activated receptor gamma (PPARg)\u00a0genes", "CHANGE EXPRESSION"], ["Fusicatenibacter", "PD", "INFLUENCE"], ["TCE", "Parkinsonian pathology", "INFLUENCE"], ["highest Th1 inflammatory response", "Sprague-Dawley (SD) rats", "TARGET"], ["curcumin", "cell survival", "INFLUENCE"], ["Lachnospiraceae", "Parkinson's disease pathophysiology", "INFLUENCE"], ["probiotic bacteria", "mental health-related disorders", "INFLUENCE"], ["stable allergenic proteins", "amyloid-related diseases", "INFLUENCE"], ["Gut microbiota", "depression", "IS LINKED TO"], ["lead", "late onset neuropathology", "INFLUENCE"], ["RA patients", "FMT", "USED BY"], ["Gastrointestinal Dysfunction", "Neurological and Neurodegenerative Disorders", "AFFECT"], ["Firmicutes phylum", "gut microbiota", "PART OF"], ["Gut microbes", "mental health disorders", "IS LINKED TO"], ["gut microbiota", "neurocognitive and mental health disorders", "IS LINKED TO"], ["MDD patients", "Comparative taxonomic analysis", "USED BY"], ["MND", "patients", "TARGET"], ["MPTP", "Staphylococcus", "IMPACT"], ["celiac disease", "inactive adults", "TARGET"], ["H. suis", "neurological disorders", "INFLUENCE"], ["non-tremor dominant", "PD patients", "TARGET"], ["NLRP3 inflammasome", "atherosclerosis", "INFLUENCE"], ["gut microbiota", "SND", "USED BY"], ["anti-inflammatory bacteria, genes and pathways", "PD", "IS LINKED TO"], ["kidneys", "humans", "LOCATED IN"], ["dysbiosis", "intestinal microbiome", "CHANGE ABUNDANCE"], ["Lactobacillus plantarum CCFM8661", "oleic acid-induced acne", "INFLUENCE"], ["Parabacteroides", "controls", "LOCATED IN"], ["gut microbiome", "United States (US) military Veterans", "LOCATED IN"], ["rotenone", "Enterobacteeriaceae", "IMPACT"], ["Mercury sulfide-containing Hua-Feng-Dan", "disturbance of gut microbiota", "CHANGE EFFECT"], ["gut microbiota", "16S rRNA gene amplicon sequencing", "USED BY"], ["neurodegenerative diseases", "unhealthy nutrition", "AFFECT"], ["probiotic", "host energy metabolism", "INFLUENCE"], ["Olanzapine", "Mild Metabolic Disorders", "CHANGE EFFECT"], ["alterations in reproductive function", "host", "TARGET"], ["Gut microbes", "irritable bowel syndrome", "INFLUENCE"], ["IL-6", "gut microbiota", "IMPACT"], ["d-form glutamate", "gut bacteria", "IMPACT"], ["CSDS", "gut microbiota", "CHANGE ABUNDANCE"], ["behavioral dysfunction", "Proteobacteria", "CHANGE ABUNDANCE"], ["Neurological disorders", "disability", "AFFECT"], ["LD", "LD group", "ADMINISTERED"], ["intestinal site", "bird", "LOCATED IN"], ["human microbiota", "Neurodegenerative diseases", "IS LINKED TO"], ["Listeria monocytogenes", "ASD children", "LOCATED IN"], ["zonula occludens", "increased gut permeability", "INFLUENCE"], ["neurodegenerative diseases", "rats", "TARGET"], ["Synbiotics", "Neurodegenerative Disease", "INFLUENCE"], ["gut microbiota", "16S ribosomal RNA (16S rRNA) gene sequencing", "USED BY"], ["erectile dysfunction", "men", "TARGET"], ["gut microbiome", "\u03b1-synuclein overexpressing (ASO) mice", "LOCATED IN"], ["gastrointestinal comorbidities", "Parkinson's disease", "AFFECT"], ["Gut microbial-derived metabolites", "Alzheimer's disease", "INFLUENCE"], ["gut microbiota", "Illumina sequencing", "USED BY"], ["gut flora", "autism spectrum disorder", "IS LINKED TO"], ["family Bifidobacteriaceae", "CCL2", "CHANGE EXPRESSION"], ["CUMS", "depression-like phenotypes", "AFFECT"], ["207-1", "probiotics groups", "IMPACT"], ["BAs", "inflammation", "INFLUENCE"], ["general paresis", "NS patients", "TARGET"], ["human microbiota", "Neurodegenerative Diseases", "IS LINKED TO"], ["(R)-ketamine", "neurological disorders", "CHANGE EFFECT"], ["F. rodentium", "anhedonia-like behavior", "INFLUENCE"], ["psychiatric comorbidities", "patients", "TARGET"], ["F4", "neurometabolic alterations", "INFLUENCE"], ["pro-inflammatory bacteria, genes and pathways", "PD", "IS LINKED TO"], ["AGE breaker compounds", "diabetes", "CHANGE EFFECT"], ["gut microbiome dysbiosis", "Parkinson's disease patients", "TARGET"], ["malnutrition", "Patients", "TARGET"], ["gut microbiota", "immunological response", "IS LINKED TO"], ["melanin", "brain", "LOCATED IN"], ["gut microbiota", "cholecystectomy", "USED BY"], ["PD", "PD groups", "TARGET"], ["short chain fatty acids", "Parkinson's disease", "INFLUENCE"], ["overweight", "generations", "TARGET"], ["Psychobiotics", "neurological disorders", "INFLUENCE"], ["gut", "PD individuals", "LOCATED IN"], ["vancomycin pretreatment", "inflammation", "CHANGE EFFECT"], ["metabolites", "neurological disorders", "INFLUENCE"], ["biomarker", "schizophrenia", "INFLUENCE"], ["live L. plantarum CCFM8661", "non-esterified free fatty acids", "INTERACT"], ["polymannuronic acid", "Gut microbiota", "IMPACT"], ["probiotics", "gut microbial flora", "IMPACT"], ["Bacteroides", "gut microbiota", "PART OF"], ["sleep disturbances", "gut bacteria", "CHANGE ABUNDANCE"], ["LPHP", "adipogenesis", "CHANGE EXPRESSION"], ["PD-related injuries", "PD mice", "TARGET"], ["Rannasangpei", "Pronicromonosporaceae", "IMPACT"], ["3-Methylindole", "microbiota", "PRODUCED BY"], ["carbohydrate", "Depression", "INFLUENCE"], ["Gut microbiota", "schizophrenia", "IS LINKED TO"], ["early PD", "Eggerthella lenta", "CHANGE ABUNDANCE"], ["dysfunction", "vulnerable brain regions", "STRIKE"], ["p-Hydroxyphenylacetic acid", "intestine microbiota", "PRODUCED BY"], ["individuals", "OMM-sequence", "USED BY"], ["gut microbiota", "healthy women", "LOCATED IN"], ["gut microbial diversity", "Academic stress", "IS LINKED TO"], ["pre- or probiotics", "gut microbiota", "IMPACT"], ["anti-infective agents", "oxidative stress", "CHANGE EFFECT"], ["irritable bowel syndrome", "individuals", "TARGET"], ["Acetobacter", "AD-induced <i>Drosophila</i>", "LOCATED IN"], ["NAPEs", "6-OHDA", "LOCATED IN"], ["L. brevis", "stress-related sleep disturbances", "INFLUENCE"], ["24 drug-na\u00efve MDD patients", "MRI scanning", "USED BY"], ["antibiotic therapy", "gut microbiome", "IMPACT"], ["schizophrenia", "remission group (patients with schizophrenia in remission)", "TARGET"], ["gut microbes", "disease conditions", "IS LINKED TO"], ["GM", "MCI", "IS LINKED TO"], ["Gastrointestinal disturbances", "PD patients", "TARGET"], ["Bacteroides", "PD patients", "LOCATED IN"], ["gut microbiota", "constipation", "IS LINKED TO"], ["vancomycin pretreatment", "Blautia", "IMPACT"], ["K01626", "MDD group", "LOCATED IN"], ["Piperine", "PKC\u03b1/ERK1/2", "INTERACT"], ["polysaccharides", "GM", "IMPACT"], ["TCE", "nigrostriatal neurodegeneration", "INFLUENCE"], ["food bioactive compounds", "Parkinson's disease", "INFLUENCE"], ["ASD", "young men", "TARGET"], ["motor deficits", "\u03b1-synuclein overexpressing mice", "TARGET"], ["Lachnospira", "Gut Microbiota", "PART OF"], ["chronic and selective process of neuron cell death", "diseases of the central nervous system", "AFFECT"], ["MCC950", "gut microbiota", "IMPACT"], ["adequate protein", "PD", "INFLUENCE"], ["ROS", "cell danger response", "INFLUENCE"], ["Gut microbes", "complex and long-term psychiatric disorder", "IS LINKED TO"], ["probiotic AP-32 and A-RM supplementations", "energy metabolism", "INFLUENCE"], ["PIPO patients", "next generation sequencing (NGS) of the V3-V4 region of the bacterial RNA 16\u00a0S", "USED BY"], ["SCFAs", "colon", "LOCATED IN"], ["gut microbiota", "affective disorders", "IS LINKED TO"], ["BAs", "Alzheimer's disease", "INFLUENCE"], ["Parkinson disease", "Akkermansia", "CHANGE ABUNDANCE"], ["genera", "AD", "INFLUENCE"], ["Schizophrenia", "People", "TARGET"], ["mice", "spleen nerve denervation", "USED BY"], ["gut microbiota", "human gastrointestinal tract", "LOCATED IN"], ["stage-specific gut-microbiome-derived metabolites", "intracranial aneurysms", "INFLUENCE"], ["depression", "Fusicatenibacter saccharivorans", "CHANGE ABUNDANCE"], ["chronic and selective process of neuron cell death", "Parkinson's disease", "AFFECT"], ["Gut Microbiome", "behavioural and psychological symptoms of dementia", "IS LINKED TO"], ["controls", "Bile acid analysis", "USED BY"], ["loss of dopaminergic neurons", "control/6-OHDA groups", "TARGET"], ["GI issues", "NGI", "TARGET"], ["Streptococcus", "gut microbiota", "PART OF"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "cleaved caspase-3", "INTERACT"], ["HCD", "Akkermansia_muciniphila", "CHANGE ABUNDANCE"], ["neurodegenerative diseases", "host liver metabolism", "AFFECT"], ["bacteroides", "patients", "LOCATED IN"], ["probiotic applications", "depression", "INFLUENCE"], ["Male Sprague-Dawley rats", "16S rRNA sequencing", "USED BY"], ["major depressive disorder", "hippuric acid", "INTERACT"], ["Depressive Symptoms", "Chinese and Korean Immigrants", "TARGET"], ["prebiotics", "gut health", "INFLUENCE"], ["KD", "depression", "INFLUENCE"], ["intestinal microenvironment", "chronic unpredictable mild stress-induced depression", "IS LINKED TO"], ["reduced BMD", "ovariectomized (OVX) mice", "TARGET"], ["Shigella", "Women with high perceived stress", "LOCATED IN"], ["ocular Alzheimer's disease", "neurodegenerative central nervous system disorders", "IS A"], ["microbes-derived compounds", "neurodegenerative disorders", "INFLUENCE"], ["Psychobiotics", "Parkinson's disease", "INFLUENCE"], ["Lactobacillus", "infant gut microbiota", "PART OF"], ["gut microbiota", "TAO", "IS LINKED TO"], ["metabolites", "Parkinson's disease", "INFLUENCE"], ["Metformin", "depression-Like behaviors", "CHANGE EFFECT"], ["gut microbiota", "shared gut dysbiosis", "IS LINKED TO"], ["late onset neuropathology", "autoimmune diseases", "AFFECT"], ["\u03b1-synuclein pathology", "PD", "AFFECT"], ["CS", "adolescents", "TARGET"], ["neurodegenerative diseases", "aging population", "TARGET"], ["healthy donor", "FMT", "USED BY"], ["oxygen", "cell danger response", "INFLUENCE"], ["low carbohydrate", "gut microbiota", "IMPACT"], ["\u03b1-synuclein pathology", "human case-control studies", "TARGET"], ["gut microbiota", "autism spectrum disorder", "IS LINKED TO"], ["microbial dysbiosis", "mental health and neurocognitive disorders", "AFFECT"], ["chronic human diseases", "humans", "TARGET"], ["Lachnospiraceae", "Gut Microbiota", "PART OF"], ["Roseburia intestinalis", "GM", "PART OF"], ["Short-chain fatty acids", "PD", "INFLUENCE"], ["functional foods containing psychotropic strains", "mental health", "INFLUENCE"], ["acetate", "anxiety", "INFLUENCE"], ["Di-(2-ethylhexyl) phthalate", "obesity", "INFLUENCE"], ["specific SCFA-producing bacteria", "gut microbiota", "PART OF"], ["PHP", "low-density lipoprotein cholesterol", "INTERACT"], ["metabotropic glutamate receptor 8", "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "INTERACT"], ["GM", "gut microbiota disorders", "IS LINKED TO"], ["gut bacterial dysbiosis", "acetate", "INTERACT"], ["Thyroid cancer", "humans", "TARGET"], ["synaptic proteins", "medial prefrontal cortex", "LOCATED IN"], ["narcolepsy type 1", "patients", "TARGET"], ["Verrucomicrobiaceae", "PD", "INFLUENCE"], ["GM", "16S rRNA sequencing", "USED BY"], ["reduced anxiety-like behavior", "Transgenic mice", "TARGET"], ["UCG009", "OSA onset", "INFLUENCE"], ["microbial community", "mice", "LOCATED IN"], ["organophosphate pesticides", "Parkinson's disease", "INFLUENCE"], ["novel pharmaceutical approaches", "depressive symptoms", "CHANGE EFFECT"], ["interleukin (IL)-1\u03b2", "chronic social defeat", "INFLUENCE"], ["dopaminergic (DA) neurons", "substantia nigra", "LOCATED IN"], ["Alistipes", "faecal gut microbiota", "PART OF"], ["SBF", "depressive behaviors", "INFLUENCE"], ["mood", "athletes", "TARGET"], ["non-nutrient bioactive compounds", "mammalian gut microbiota", "IMPACT"], ["bovine milk", "type 1 diabetes", "INFLUENCE"], ["MS", "young adults", "TARGET"], ["non-TD", "Serratia", "CHANGE ABUNDANCE"], ["IL-6", "AI", "INFLUENCE"], ["schizophrenia", "Ruminococcus", "CHANGE ABUNDANCE"], ["Rannasangpei", "Verrucomicrobiaceae", "IMPACT"], ["kefir", "genus <i>Holdemania</i>", "IMPACT"], ["SZ patients", "Fecal metabolome analysis", "USED BY"], ["depression-like phenotypes", "mice", "TARGET"], ["microbes", "central nervous system (CNS) disorders", "INFLUENCE"], ["gut microbiota", "wild-type littermates", "LOCATED IN"], ["GM", "sequencing analyses", "USED BY"], ["psychiatric diagnoses", "young women", "TARGET"], ["gastrointestinal dysfunction", "PD", "AFFECT"], ["Autism Spectrum Disorder", "restricted and repetitive patterns of behavior", "AFFECT"], ["Cinnabar", "gut microbiota", "IMPACT"], ["HgS-containing traditional medicines", "gut microbiomes", "IMPACT"], ["Weissella_cibaria", "gut microbiota", "PART OF"], ["antibiotics", "Parkinson's disease", "CHANGE EFFECT"], ["IBS", "patients", "TARGET"], ["MPTP", "Verrucomicrobiaceae", "IMPACT"], ["Eggerthellaceae", "gut microbiome", "PART OF"], ["lasting effects", "susceptibility to psychiatric disorders", "AFFECT"], ["Bioactive Nutraceuticals", "Chronic Kidney Disease Progression", "INFLUENCE"], ["gut microbiota", "mental health", "IS LINKED TO"], ["Parkinson's disease", "independent group of 78 patients", "TARGET"], ["neurosyphilis", "patients", "TARGET"], ["Firmicutes", "gut microbiota", "PART OF"], ["healthy controls", "Full-length bacterial 16S rRNA gene sequencing", "USED BY"], ["L. helveticus NS8", "chronic restraint stress-induced behavioral", "INFLUENCE"], ["microbial community", "Parkinson's disease", "IS LINKED TO"], ["beneficial bacteria", "gut microbiota", "PART OF"], ["Inflammatory bowel disease", "IBD patients", "TARGET"], ["Gut microbiota", "insomnia", "IS LINKED TO"], ["microbiota-derived short-chain fatty acids", "amyotrophic lateral sclerosis", "INFLUENCE"], ["colonic microbiome", "neuromyelitis optica", "IS LINKED TO"], ["Gut microbiota", "16S ribosomal RNA (16S rRNA) gene sequencing", "USED BY"], ["L-3,4-dihydroxyphenylalanine (L-DOPA)", "Parkinson's disease", "CHANGE EFFECT"], ["modified gut microbiome composition", "rats", "TARGET"], ["bacterial flora", "human gut", "LOCATED IN"], ["\u03b2-HgS-containing 70 Wei-Zhen-Zhu-Wan", "Methanobacteriaceae", "IMPACT"], ["ileum", "age-/sex-matched healthy controls", "LOCATED IN"], ["microbiota-derived metabolites", "older individuals", "LOCATED IN"], ["neuronal stem cell degradation", "neurodegeneration", "AFFECT"], ["metabolite supplementation", "ASD", "INFLUENCE"], ["enteric inflammation", "Parkinson's disease (PD) patients", "TARGET"], ["Parkinson's disease", "motor and non-motor manifestations", "AFFECT"], ["Odoribacter", "pSS", "INFLUENCE"], ["prebiotics", "MDD", "INFLUENCE"], ["Prevotella7", "insomnia", "INFLUENCE"], ["gut microbiome", "Parkinson's disease patients", "LOCATED IN"], ["damage to different tissues", "rodent", "TARGET"], ["polyphenols", "PD incidence and progression", "INFLUENCE"], ["microbiota-derived metabolites", "stress", "INFLUENCE"], ["dietary sources", "protein misfolding", "INFLUENCE"], ["brain tissue", "<i>H. suis</i>-infected 6-OHDA mice", "LOCATED IN"], ["peripheral vascular disease", "severe depression", "AFFECT"], ["gut microbiota", "Liquid chromatography-mass spectrometry", "USED BY"], ["metabolites", "anxiety", "INFLUENCE"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "Parkinson's disease", "INFLUENCE"], ["impaired glycemic control", "F0 males", "TARGET"], ["Zn2+", "novel coronavirus infection", "INFLUENCE"], ["migraine headache", "depression", "AFFECT"], ["gut", "people", "LOCATED IN"], ["prebiotics", "psychiatric patients", "ADMINISTERED"], ["intestinal microbiota", "Parkinson's patients", "LOCATED IN"], ["gut microbiome", "veterans", "LOCATED IN"], ["GMB", "depression", "IS LINKED TO"], ["antibiotic-treated animals", "paw-rearing measurements", "USED BY"], ["Gut microbes", "neurological diseases", "IS LINKED TO"], ["prebiotic PM", "Gut microbiota", "IMPACT"], ["synucleinopathy", "young and aging animals", "TARGET"], ["Gut Microbiome", "Neurodegenerative Diseases", "IS LINKED TO"], ["molecular biomarkers", "ASD", "INFLUENCE"], ["5-HT", "Gut microbiota", "IMPACT"], ["mitochondrial dysfunction", "PD pathophysiology", "AFFECT"], ["schizophrenia", "mental health and neurocognitive disorders", "IS A"], ["gut microbiota", "GI", "IS LINKED TO"], ["neurometabolic alterations", "healthy mice", "TARGET"], ["comorbid patients", "multiomics study", "USED BY"], ["polyphenols", "brain health", "INFLUENCE"], ["Parkinson's Disease", "patients", "TARGET"], ["gut microbiome", "eating disorders", "IS LINKED TO"], ["Antipsychotics", "metabolic perturbations", "CHANGE EFFECT"], ["gut microbiota", "intracranial aneurysms", "IS LINKED TO"], ["NaB", "autophagy", "INFLUENCE"], ["gut microbiota", "gastroenteritis", "IS LINKED TO"], ["Bifidobacterium", "Parkinson's disease patients", "LOCATED IN"], ["neurological symptoms", "COVID-19 recovered patients", "TARGET"], ["inflammation", "maternal microbiota", "CHANGE ABUNDANCE"], ["intestinal microbe", "schizophrenia", "IS LINKED TO"], ["Methanobacteriaceae", "gut microbiomes", "PART OF"], ["oxaliplatin", "Parabacteroides", "IMPACT"], ["Fisetin", "amyotrophic lateral sclerosis", "INFLUENCE"], ["Phascolarctobacterium", "ET", "INFLUENCE"], ["psychotic disorders", "Firmicutes", "CHANGE ABUNDANCE"], ["gut microbiota", "Major depressive disorder", "IS LINKED TO"], ["SIBO", "bacteria", "CHANGE ABUNDANCE"], ["migraine medication", "Migraine", "CHANGE EFFECT"], ["IBS symptoms", "gut microbiota", "CHANGE ABUNDANCE"], ["Probiotics", "neurological disorders", "INFLUENCE"], ["Gut microbiota", "psychiatric disorders", "IS LINKED TO"], ["\"depression-related\" microbiome", "rodents", "LOCATED IN"], ["anthocyanins", "chronic human diseases", "INFLUENCE"], ["nasal and oral microbiota", "PD pathology", "IS LINKED TO"], ["metals", "gut microbiome", "IMPACT"], ["pro-inflammatory cytokines", "SNpc", "LOCATED IN"], ["d-glutamate", "Alzheimer's Disease", "INFLUENCE"], ["gut microbiota", "central nervous system inflammation", "IS LINKED TO"], ["established schizophrenia", "patients", "TARGET"], ["Polycystic ovary syndrome", "women of childbearing age", "TARGET"], ["human gut microbiome", "neuropsychiatric disorders", "IS LINKED TO"], ["NRTN", "neurodegenerative diseases", "INFLUENCE"], ["probiotic supplementation", "children", "ADMINISTERED"], ["posttraumatic stress disorder", "Turicibacter sanguinis", "CHANGE ABUNDANCE"], ["(S)-ketamine", "CSDS-susceptible mice", "ADMINISTERED"], ["mitochondrial dysfunction", "A53T transgenic monkeys", "TARGET"], ["MPTP", "Clostridaceae species", "IMPACT"], ["gut microbiota", "serious mental illness", "IS LINKED TO"], ["PD", "Bifidobacterium", "CHANGE ABUNDANCE"], ["uncultured_bacterium_g_Bacillus", "MPTP group gut microbiota", "PART OF"], ["GV-971", "isoleucine", "INTERACT"], ["genus Roseburia", "gut microbiome", "PART OF"], ["Gut Microbiota", "Retinal Diseases", "IS LINKED TO"], ["gut microbiota metabolites", "neuromyelitis optica spectrum disorders", "INFLUENCE"], ["Probiotics", "metabolic", "INFLUENCE"], ["LPB145", "antidepressive-like behaviour", "INFLUENCE"], ["IBS", "GM", "CHANGE ABUNDANCE"], ["taurocholic acid", "primary open-angle glaucoma", "INFLUENCE"], ["malnutrition", "Older adults", "TARGET"], ["anti-inflammatory bacteria", "stress response", "INFLUENCE"], ["levodopa", "tyrosine decarboxylase enzymes", "CHANGE EXPRESSION"], ["Major depressive disorder", "persistent depression", "AFFECT"], ["Neurodegenerative diseases", "ND patients", "TARGET"], ["MedDiet", "neurodegenerative diseases", "INFLUENCE"], ["inflammatory cytokines", "neuroinflammation", "INFLUENCE"], ["prenatal maternal stress", "maternal and offspring microbiota", "CHANGE ABUNDANCE"], ["patients", "WMT", "USED BY"], ["commensal gut microbiota", "necrotizing enterocolitis", "IS LINKED TO"], ["abnormal composition", "adult mice", "TARGET"], ["SCI", "intestinal dysfunction", "AFFECT"], ["gut microbiota", "nervous system disturbances", "IS LINKED TO"], ["Parkinson's disease", "female and male mice", "TARGET"], ["major depression", "Women", "TARGET"], ["neurodegenerative, inflammatory, metabolic, and cardiovascular diseases", "age-associated diseases", "AFFECT"], ["Parkinson's disease", "colonic FMT group", "TARGET"], ["gut microbiota", "Microbial diversity analysis", "USED BY"], ["bovine milk", "cardiovascular diseases", "INFLUENCE"], ["GABA", "controls", "LOCATED IN"], ["piperine", "activation transcription factor-2", "INTERACT"], ["anxiety-related physical symptoms", "exclusion group", "TARGET"], ["levodopa", "Enterococcus faecalis", "IMPACT"], ["IL-22", "gut microbiota", "IMPACT"], ["SZ", "people with the major psychiatric disorders", "TARGET"], ["Psychobiotics", "autism spectrum disorders", "INFLUENCE"], ["miR-149", "LPS-induced depression-like behavior", "INFLUENCE"], ["Affective disorders", "Christensenellaceae", "CHANGE ABUNDANCE"], ["butyrate", "stroke", "INFLUENCE"], ["gut microbiome", "schizophrenia", "IS LINKED TO"], ["gut microbiota", "HD", "IS LINKED TO"], ["Lactobacillus", "Alzheimer's", "INFLUENCE"], ["GM", "participants", "LOCATED IN"], ["CKD", "gut microbiota", "CHANGE ABUNDANCE"], ["phytochemicals", "TGFB1&2", "CHANGE EXPRESSION"], ["sleep and circadian rhythm disruption", "A\u03b2", "INTERACT"], ["gut microbiota", "ASD patients", "LOCATED IN"], ["XPro1595", "inflammation", "CHANGE EFFECT"], ["<i>Lactobacillus</i> probiotics", "alleviated neurodegeneration", "INFLUENCE"], ["levodopa", "Clostridium sporogenes", "IMPACT"], ["L. helveticus", "treatment-resistant depression", "INFLUENCE"], ["antibiotics", "dopamine neuron loss", "CHANGE EFFECT"], ["Nail", "cisgender-heterosexuals", "LOCATED IN"], ["ursodeoxycholic acid", "DLB", "INFLUENCE"], ["misfolded protein alpha-synuclein", "olfactory bulb", "LOCATED IN"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "PD-related injuries", "CHANGE EFFECT"], ["Parkinson's disease", "A53T monkeys", "TARGET"], ["Lipopolysaccharide", "progressive neurodegeneration", "INFLUENCE"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "neuroinflammation", "CHANGE EFFECT"], ["bile acids", "gut microbiota", "PRODUCED BY"], ["PD", "Mollicutes", "CHANGE ABUNDANCE"], ["SN", "mice", "LOCATED IN"], ["Sodium oligomannate", "Alzheimer's disease progression", "INFLUENCE"], ["fatigue", "patients", "TARGET"], ["PD-like degeneration", "non-human primates", "TARGET"], ["SGS", "stress-related psychiatric disorders", "INFLUENCE"], ["gut microbiota composition", "stress-related", "IS LINKED TO"], ["Bifidobacterium longum", "ADHD", "INFLUENCE"], ["altered gut microbiota", "human PD cases", "LOCATED IN"], ["antibiotics", "altered gut barrier function, activation of the hypothalamic-pituitary-adrenal axis, reducing levels of brain-derived neurotrophic factor or oxytocin and alteration of vagal tone", "CHANGE EFFECT"], ["sugar intake", "metabolic disease", "INFLUENCE"], ["prebiotics", "neurodegenerative diseases", "INFLUENCE"], ["Sj\u00f6gren's syndrome", "patients", "TARGET"], ["psychoses", "people", "TARGET"], ["gut microbiota", "metagenomics", "USED BY"], ["Probiotics", "Parkinson's disease", "INFLUENCE"], ["immune system dysfunction", "risk of depression", "AFFECT"], ["anxiety", "SCI patients", "TARGET"], ["Butyricimonas", "PD-MCI group", "LOCATED IN"], ["substantia nigra", "ASO mice", "LOCATED IN"], ["Faecalibacterium", "PD-associated microbiota", "PART OF"], ["unhealthy nutrition", "Neurodegenerative Diseases", "AFFECT"], ["gut microbes", "Schizophrenia", "IS LINKED TO"], ["Lachnospiraceae", "PD patients", "LOCATED IN"], ["Gut microbiome", "major depressive disorder", "IS LINKED TO"], ["ketamine enantiomers", "Butyricimonas", "IMPACT"], ["swollen tyrosine hydroxylase-positive varicosities", "Parkinson's disease pathophysiology", "AFFECT"], ["gut microbiota", "Neurodegenerative Diseases", "IS LINKED TO"], ["systemic exposure", "bacterial endotoxin lipopolysaccharide", "INTERACT"], ["FCR", "Bacteroidetes", "CHANGE ABUNDANCE"], ["SCFAs", "PD patient group", "LOCATED IN"], ["Ruminococcus-2", "SCFAs", "INTERACT"], ["Parkinson's Disease", "Ruminococcaceae", "CHANGE ABUNDANCE"], ["ketogenic diet", "microbiota", "IMPACT"], ["Lactulose", "human gut microbiota", "IMPACT"], ["gut microbiome", "autism spectrum disorders", "IS LINKED TO"], ["malnutrition", "gut-microbiota-brain axis dysfunction", "AFFECT"], ["Escherichia coli", "euthyroid thyroid cancer", "INFLUENCE"], ["gut microbiome", "MS", "IS LINKED TO"], ["COVID-19", "patients", "TARGET"], ["zinc", "children", "LOCATED IN"], ["Irritable bowel syndrome", "patients", "TARGET"], ["PM", "Verrucomicrobia", "IMPACT"], ["MAM", "DNA extraction", "USED BY"], ["Citrobacter rodentium", "PD-like pathology", "INFLUENCE"], ["stress", "rodents", "TARGET"], ["gut microbiota", "AN", "IS LINKED TO"], ["\u03bc-opioid receptors", "gut inflammation", "INFLUENCE"], ["CA", "inflammation", "INFLUENCE"], ["anxiety/depression", "irritable bowel syndrome", "AFFECT"], ["gut peptides", "gut microbiota", "PRODUCED BY"], ["Probiotics", "Neurodegenerative Disease", "INFLUENCE"], ["Firmicutes", "altered gut microbiota", "PART OF"], ["BMAA", "cyanobacteria", "IMPACT"], ["HFD", "Lactobacteriaceae", "IMPACT"], ["depression", "Veillonellaceae", "CHANGE ABUNDANCE"], ["psychobiotics", "anxiety disorders", "INFLUENCE"], ["pathogenic proteins", "central inflammation", "INFLUENCE"], ["CCRA", "colon cancer", "AFFECT"], ["ICH", "Enterobacter", "CHANGE ABUNDANCE"], ["IBS/FD", "human participants", "TARGET"], ["Gut microbiota", "neurodegenerative and neuropsychiatric disorders", "IS LINKED TO"], ["prebiotic supplementation", "bifidobacterial populations", "IMPACT"], ["Bacteroidetes", "gut microbiota", "PART OF"], ["phytochemicals", "age-related brain diseases", "INFLUENCE"], ["Ruminococcus torques group", "MDD", "INFLUENCE"], ["Lacticaseibacillus rhamnosus GG", "brain-derived neurotrophic factor", "INTERACT"], ["gut dysbiosis", "long-term neurological disorders", "AFFECT"], ["acetate", "schizophrenia", "INFLUENCE"], ["Cannabidiol", "potential therapeutic effects", "CHANGE EFFECT"], ["PD and healthy controls", "mass spectrometry", "USED BY"], ["5-hydroxytryptamine", "colon", "LOCATED IN"], ["6-n-propylthiouracil", "39 PD patients", "LOCATED IN"], ["gut microbiota", "psoriatic arthritis", "IS LINKED TO"], ["PD-like symptoms and pathology", "\u03b1-synuclein overexpressing (ASO) mice", "TARGET"], ["PD", "Rikenellaceae_RC9_gut_group", "CHANGE ABUNDANCE"], ["betaine", "stress-related psychiatric disorders", "INFLUENCE"], ["healthy control subjects", "liquid and gas chromatography mass spectrometry", "USED BY"], ["Enterobacteeriaceae", "gut microbiota", "PART OF"], ["gut microbiome", "ulcerative colitis", "IS LINKED TO"], ["L. plantarum CCFM8661", "skin inflammation", "INFLUENCE"], ["Bifidobacterium adolescentis", "fecal metagenomes", "PART OF"], ["Symprove\u2122", "gastrointestinal diseases", "INFLUENCE"], ["Gut microbiota", "ED", "IS LINKED TO"], ["MPTP-Induced Motor Deficits", "Mice", "TARGET"], ["PD", "PD", "TARGET"], ["age-/sex-matched healthy controls", "DNA extraction", "USED BY"], ["adequate protein", "neurological diseases", "INFLUENCE"], ["gut microbiota diversity", "psychological/emotional risk", "IS LINKED TO"], ["Probiotics", "Alzheimer's disease", "INFLUENCE"], ["commensal gut microbiota", "Type-II diabetes", "IS LINKED TO"], ["dietary fiber", "inflammatory and depressive disorders", "INFLUENCE"], ["microbiota", "Cancers", "IS LINKED TO"], ["Wolbachia", "neurodegenerative disorders", "INFLUENCE"], ["gut microbiota", "neurodegeneration and mental health conditions", "IS LINKED TO"], ["Flavobacterium spp.", "Social avoidance behaviors", "INFLUENCE"], ["amyloid", "dysbiosis", "INFLUENCE"], ["p-Hydroxyphenylacetic acid", "microbiota", "PRODUCED BY"], ["levodopa", "GM", "IMPACT"], ["Probiotics", "anxiety", "INFLUENCE"], ["probiotics", "participants", "ADMINISTERED"], ["ultra-processed diet", "gut microbiota", "IMPACT"], ["Lactobacillales", "AET mice", "LOCATED IN"], ["cognitive decline", "humans", "TARGET"], ["cucurbitacin E", "DSS-induced alterations", "INFLUENCE"], ["phenolic compounds", "mental health outcomes", "INFLUENCE"], ["probiotic microorganisms", "gut microbiota", "PART OF"], ["Short-Chain Fatty Acid-Producing Gut Microbiota", "Rapid-Eye-Movement Sleep Behavior Disorder", "INFLUENCE"], ["physical therapists", "exercise regimens", "USED BY"], ["gut microbiota", "AD", "IS LINKED TO"], ["blood-brain barrier", "mice", "LOCATED IN"], ["gut microbiota", "PD-affected patients", "LOCATED IN"], ["Prevotella copri", "human gastrointestinal microbiome", "PART OF"], ["Actinobacteria", "MDD", "INFLUENCE"], ["gut dysbiosis", "Parkinson's patients", "TARGET"], ["gastrointestinal symptoms", "individuals", "TARGET"], ["dysbiosis of mouse gut microbiota", "Muribaculum", "CHANGE ABUNDANCE"], ["PD", "GM", "CHANGE ABUNDANCE"], ["gut flora", "CNS pathology", "IS LINKED TO"], ["highly processed", "overweight", "INFLUENCE"], ["gut microbiome", "neurologic disorders", "IS LINKED TO"], ["MDD", "beneficial symbionts", "CHANGE ABUNDANCE"], ["control group (healthy controls)", "16S rRNA sequencing", "USED BY"], ["rats", "adeno-associated virus (AAV)-alpha-synuclein", "USED BY"], ["controls", "GC-MS", "USED BY"], ["gut microbiota", "neuroimmune diseases", "IS LINKED TO"], ["Gut microbiota composition", "adults", "LOCATED IN"], ["honey", "Bifidobacteria", "IMPACT"], ["Eggerthella", "negative affectivity", "INFLUENCE"], ["probiotics", "GI symptoms", "INFLUENCE"], ["human gut microbiota", "imbalance", "IS LINKED TO"], ["AD", "impaired cognition", "AFFECT"], ["Sleep Disturbance", "Chinese and Korean Immigrants", "TARGET"], ["PIPO patients", "qPCR", "USED BY"], ["genera", "anxiety", "INFLUENCE"], ["gut microbiota", "Drosophila melanogaster", "LOCATED IN"], ["lipid", "Parkinson's disease", "INFLUENCE"], ["Non-communicable diseases", "age-groups", "TARGET"], ["commensal microorganisms", "gut microbiota", "PART OF"], ["<i>L. plantarum</i> DP189", "MDA", "INTERACT"], ["probiotics", "gut microbiota alterations", "INFLUENCE"], ["GI issues", "non-GI group", "TARGET"], ["c_Clostridia", "depression", "INFLUENCE"], ["<i>L. plantarum</i> DP189", "interleukin-1\u03b2", "INTERACT"], ["human gut microbiota", "Graves' disease", "IS LINKED TO"], ["plasma SCFAs", "PD", "INFLUENCE"], ["Gut Microbiota", "Mild Cognitive Impairment", "IS LINKED TO"], ["ASD", "Listeria monocytogenes", "CHANGE ABUNDANCE"], ["poorly soluble antipsychotic", "poor oral bioavailability", "CHANGE EFFECT"], ["intestinal inflammatory factors", "intestinal flora", "IMPACT"], ["bile acids", "depression", "INFLUENCE"], ["Obesity", "host", "TARGET"], ["dysfunctional microbiome", "inflammation", "AFFECT"], ["MA", "addiction", "CHANGE EFFECT"], ["chronic LPS plus MPTP-induced toxicity to the brain and gut", "C57BL/6 mice", "TARGET"], ["Piperine", "JNK/P38 MAPK", "INTERACT"], ["metabolites", "schizophrenia", "INFLUENCE"], ["Graves' disease", "human host", "TARGET"], ["KD", "gut microbiome", "IMPACT"], ["altered gut microbiota", "CNS disorders", "AFFECT"], ["Clostridium genus", "Parkinson's disease", "INFLUENCE"], ["gut microbiota", "OSA", "IS LINKED TO"], ["realgar", "disturbance of gut microbiota", "INFLUENCE"], ["Diarrhea", "Prevotella", "CHANGE ABUNDANCE"], ["Lachnospiraceae", "MPTP group gut microbiota", "PART OF"], ["psychiatric disorders", "children", "TARGET"], ["Lachnospira", "gut microbiota", "PART OF"], ["dysregulated microbiota-gut-brain axis", "multiple sclerosis", "AFFECT"], ["Depression", "Actinobacteria spp.", "CHANGE ABUNDANCE"], ["organic solvents", "gut microbiome", "IMPACT"], ["Mercury sulfides", "gut microbiomes", "IMPACT"], ["Parkinson's disease", "rhesus monkeys", "TARGET"], ["LCIG group", "gas chromatography mass spectrometry", "USED BY"], ["microbiota", "obesity", "IS LINKED TO"], ["microbiota-targeted therapeutics", "SZ", "CHANGE EFFECT"], ["succinate", "gut", "LOCATED IN"], ["NAS", "metabolic abnormalities", "INFLUENCE"], ["anti-inflammatory bacteria", "negative emotionality", "INFLUENCE"], ["APAP", "ALI", "CHANGE EFFECT"], ["serotonin", "PIPO", "INFLUENCE"], ["calorie-dense foods", "overweight", "INFLUENCE"], ["experimental perinatal MMD", "offspring", "TARGET"], ["lipopolysaccharide", "Iba1", "CHANGE EXPRESSION"], ["repeated infection", "Pink1</i><sup>-/-</sup> mice", "TARGET"], ["amyloidogenic protein", "amyloid-related diseases", "INFLUENCE"], ["dysbiosis", "peripheral inflammatory states", "AFFECT"], ["bioactive factors", "microbes", "IMPACT"], ["Parkinson's disease", "SOD1 mice", "TARGET"], ["Anxiety disorders", "dogs", "TARGET"], ["gut microbiota", "brain cognition", "IS LINKED TO"], ["highest Th1 inflammatory response", "SD rats", "TARGET"], ["antidiarrheals", "Irritable bowel syndrome", "CHANGE EFFECT"], ["vancomycin pretreatment", "TLR4/MyD88/NF-\u03baB/TNF-\u03b1", "CHANGE EXPRESSION"], ["cooked soybean", "Bacillus", "IMPACT"], ["short-chain fatty acids", "Gut Microbiota", "PRODUCED BY"], ["gut bacterial dysbiosis", "metabolites", "INTERACT"], ["intestinal microbiota", "host", "LOCATED IN"], ["inulin", "mental health", "INFLUENCE"], ["neurodegenerative diseases", "cognition abilities", "AFFECT"], ["Parkinson's disease", "ND patients", "TARGET"], ["(R)-ketamine", "MS", "CHANGE EFFECT"], ["colorectal cancer", "SD rats", "TARGET"], ["LPS", "gut microbiota", "IMPACT"], ["cognitive impairment", "altered gut microbiota", "CHANGE ABUNDANCE"], ["tight junction associated proteins", "SNpc", "LOCATED IN"], ["steroid esters", "gut microbiome", "PRODUCED BY"], ["human gut microbiomes", "depression", "IS LINKED TO"], ["lactulose", "short-term memory", "INFLUENCE"], ["gut microbiota", "FCR", "IS LINKED TO"], ["TNF inhibitor XPro1595", "PD", "CHANGE EFFECT"], ["Enterobacter", "infant gut microbiota", "PART OF"], ["cinnabar", "disturbance of gut microbiota", "INFLUENCE"], ["ABX", "ALI", "CHANGE EFFECT"], ["Inflammatory bowel disease", "gastrointestinal tract", "STRIKE"], ["gut microbiota", "obesity-induced changes", "IS LINKED TO"], ["increased oxidative stress", "AD", "AFFECT"], ["novel antidepressant (R)-ketamine", "reduced BMD", "CHANGE EFFECT"], ["gut microbiota", "adolescents", "LOCATED IN"], ["loss of chromosome X inactivation", "females", "TARGET"], ["Lachnospiraceae", "gut microbiota", "PART OF"], ["symptoms and radiological signs suggestive of intestinal obstruction", "Pediatric chronic intestinal pseudo-obstruction", "AFFECT"], ["gut microbiota", "human subjects", "LOCATED IN"], ["acupuncture-treated mice", "16S rRNA sequence analysis", "USED BY"], ["\u03b1-syn", "bacterial lipid components", "INTERACT"], ["HFD-reduced", "Lactobacteriaceae", "IMPACT"], ["A. muciniphila", "gut microbiota", "PART OF"], ["insomnia disorder", "individuals", "TARGET"], ["irritable bowel syndrome", "patients", "TARGET"], ["disease-related malnutrition", "geriatric populations", "TARGET"], ["microbial dysbiosis", "BP", "AFFECT"], ["PM", "Parkinson's disease", "INFLUENCE"], ["intestinal tract", "PD mice", "LOCATED IN"], ["Lactobacillus_gasseri", "AET mice", "LOCATED IN"], ["gut microbiome", "Male C57BL/6 mice", "LOCATED IN"], ["gut microbiome", "amyotrophic lateral sclerosis", "IS LINKED TO"], ["Gut Microbiota", "AR", "IS LINKED TO"], ["gut", "PD groups", "LOCATED IN"], ["fermented foods", "multiple sclerosis disease", "INFLUENCE"], ["SDV", "abnormal blood levels", "AFFECT"], ["mucosal immunity", "microbiota", "CHANGE ABUNDANCE"], ["high vagal tone", "propionate", "INTERACT"], ["Bifidobacterium", "depression", "INFLUENCE"], ["BCAAs", "Gut microbiota", "PRODUCED BY"], ["HgS", "LPS plus rotenone-induced neurotoxicity", "INFLUENCE"], ["TMAO", "PD", "INFLUENCE"], ["gut microbiota", "akinetic-rigid features", "IS LINKED TO"], ["alpha-synuclein", "Parkinson's disease", "INFLUENCE"], ["Lacticaseibacillus rhamnosus GG", "short chain fatty acids", "INTERACT"], ["gut microbial community", "Dysbiosis", "IS LINKED TO"], ["Polycystic ovarian syndrome", "anxiety", "AFFECT"], ["conditions", "inpatients", "TARGET"], ["unaffected first-degree relatives", "16S rRNA gene amplicon sequencing", "USED BY"], ["gut microbiota", "responder and non-responder groups", "LOCATED IN"], ["JPJDF", "intestinal microbiota", "IMPACT"], ["Probiotics", "CMS-induced anxiety- and depressive-like behaviors", "INFLUENCE"], ["L-3,4-dihydroxyphenylalanine (L-DOPA)", "dyskinetic side effects", "CHANGE EFFECT"], ["microbiota-derived short-chain fatty acids", "autism", "INFLUENCE"], ["neurotoxins", "late onset neuropathologies", "INFLUENCE"], ["TAS2R38 bitter taste receptor", "Parkinson's disease", "INFLUENCE"], ["<i>Helicobacter pylori</i> infection", "neurodegeneration", "AFFECT"], ["BD", "Ruminococcus", "CHANGE ABUNDANCE"], ["gut flora", "mice", "LOCATED IN"], ["gut microbiota", "neurological", "IS LINKED TO"], ["Deltaproteobacteria", "susceptible mice", "LOCATED IN"], ["microbial dysbiosis", "schizophrenia", "AFFECT"], ["gut microbiota", "Alzheimer disease", "IS LINKED TO"], ["endocannabinoid N-arachidonoylethanolamide", "anxiety-like behavior", "INFLUENCE"], ["gut microbiota", "women during pregnancy (prenatal) and after childbirth (postnatal)", "LOCATED IN"], ["stomach", "pigs", "LOCATED IN"], ["probiotic", "PD", "INFLUENCE"], ["Actinomycetaceae", "AD oral microbiota", "PART OF"], ["age-associated brain diseases", "neurodegeneration", "AFFECT"], ["Self-Reported Gastrointestinal Symptoms", "Trained Recreative and Competitive Athletes", "TARGET"], ["micronutrients", "mammalian gut microbiota", "IMPACT"], ["Bacillus licheniformis", "anxiety-like and depression-like behaviours", "INFLUENCE"], ["post-biotic sodium butyrate", "PD", "INFLUENCE"], ["Myristic acid", "microbiota", "PRODUCED BY"], ["astilbin", "HT", "INTERACT"], ["gut microbiome", "persons", "LOCATED IN"], ["Participants", "microbiota sequencing", "USED BY"], ["acetate-producing bacteria", "Long-term acetate deficiency", "INFLUENCE"], ["canine intestinal microbiota", "gastrointestinal disorders", "IS LINKED TO"], ["gut microbiota", "controls", "LOCATED IN"], ["mental illness", "populations", "TARGET"], ["neurodegenerative disease", "A53T transgenic monkeys", "TARGET"], ["microbial population", "16S rRNA sequencing", "USED BY"], ["Triphala", "stress-induced mental health problems", "INFLUENCE"], ["depression", "non-depressed groups", "TARGET"], ["Akkermansia", "Gut microbiota", "PART OF"], ["Lactobacillaceae Lactobacillus", "gut microbiota", "PART OF"], ["inflammatory conditions", "intestine", "STRIKE"], ["gut microbiota", "erectile dysfunction", "IS LINKED TO"], ["rats", "bilateral nigral injection of adeno-associated virus (AAV)-\u03b1-synuclein", "USED BY"], ["perinatal distress", "gastrointestinal complaints", "AFFECT"], ["(expectant) mothers", "Composite International Diagnostic Interview for Women", "USED BY"], ["individuals", "LC-MS/MS", "USED BY"], ["motor neuron disease", "patients", "TARGET"], ["MPTP", "pathological state", "CHANGE EFFECT"], ["malnutrition", "patients", "TARGET"], ["antagomiR-149", "LPS-induced depression-like behavior", "INFLUENCE"], ["SD", "young adults", "TARGET"], ["antibiotic cocktail", "Proteobacteria", "IMPACT"], ["bacteria", "gut microbiota", "PART OF"], ["gut microbes", "SZ", "IS LINKED TO"], ["L", "stress", "INFLUENCE"], ["healthy diet", "neurological diseases", "INFLUENCE"], ["gut microbiota", "disorders of the central nervous system", "IS LINKED TO"], ["gastrointestinal conditions and symptoms", "patients", "TARGET"], ["high-fiber diet", "Bifidobacterium", "IMPACT"], ["gut microbiota", "cognitive test", "USED BY"], ["Zn", "novel coronavirus infection", "INFLUENCE"], ["MDD", "Ruthenibacterium lactatiformans", "CHANGE ABUNDANCE"], ["depressive disorders", "(expectant) mothers", "TARGET"], ["probiotics-based products", "central nervous system diseases", "INFLUENCE"], ["schizophrenia", "neuropsychiatric disorders", "AFFECT"], ["Gut Microbiota Dysbiosis", "late onset neuropathology", "AFFECT"], ["Desulfovibrio", "CUMS group", "LOCATED IN"], ["CD", "IBDs", "IS A"], ["Probiotics", "Major Depressive Disorder", "INFLUENCE"], ["microbiome-directed supplemental foods", "EDs", "INFLUENCE"], ["substantia nigra", "Parkinson's disease (PD) mice", "LOCATED IN"], ["Motor dysfunction", "PD", "AFFECT"], ["cognitive impairment", "school-aged children", "TARGET"], ["increased enteric glial expression", "Gastrointestinal (GI) symptoms and pathology", "AFFECT"], ["neuroinflammation", "CUMS-induced depression", "AFFECT"], ["PD", "gastrointestinal tract", "STRIKE"], ["QUR", "ovulation disorder", "INFLUENCE"], ["p-cresol", "Parkinson's microbiota", "PRODUCED BY"], ["psychobiotic bacteria", "stressed-related disorders", "INFLUENCE"], ["lipopolysaccharide", "Clostridaceae species", "IMPACT"], ["gut microbiome", "adult rats", "LOCATED IN"], ["Gut microbiota", "autism", "IS LINKED TO"], ["Artificial sweeteners", "glucose intolerance", "INFLUENCE"], ["physiological alterations", "offspring", "TARGET"], ["GM", "depression", "IS LINKED TO"], ["SLAB51", "PD", "INFLUENCE"], ["Oral Lactobacillus", "PD patients", "LOCATED IN"], ["PD patients", "microbiota shotgun metagenomic sequencing", "USED BY"], ["TNF-a", "gut dysbiosis", "INFLUENCE"], ["dopaminergic neuronal loss", "Parkinson's disease", "AFFECT"], ["4EPS", "brain", "LOCATED IN"], ["gut microbiota", "SGS-10W group", "LOCATED IN"], ["GM", "physical and mental problems", "IS LINKED TO"], ["TLR4", "neuroinflammation", "INFLUENCE"], ["4EP", "brain", "LOCATED IN"], ["perinatal psychopathological symptoms", "early infant diseases", "AFFECT"], ["gut microbiota", "Real-time quantitative polymerase chain reaction", "USED BY"], ["PD", "impaired movement", "AFFECT"], ["migraine", "women", "TARGET"], ["GI dysfunction", "Transgenic mice", "TARGET"], ["ND", "patients", "TARGET"], ["microbiota", "control monkeys", "LOCATED IN"], ["fermented soy foods", "Parkinson's diseases", "INFLUENCE"], ["HFD-reduced", "gut microbiome", "IMPACT"], ["\u03b2-HgS-containing 70 Wei-Zhen-Zhu-Wan", "chronic LPS plus MPTP-induced toxicity to the brain and gut", "CHANGE EFFECT"], ["synaptic proteins", "mPFC", "LOCATED IN"], ["anti-inflammatory drugs", "psychiatric disorders", "CHANGE EFFECT"], ["metabolites", "nervous system disorders", "INFLUENCE"], ["B. licheniformis", "depressive-like behaviours", "INFLUENCE"], ["commensal gut microbiota", "Autism Spectrum Disorder", "IS LINKED TO"], ["<i>Lactobacillus plantarum</i> DP189", "Oxidative Damage", "INFLUENCE"], ["autism spectrum disorders", "adolescents", "TARGET"], ["\u03b1-HgS-containing Hua-Feng-Dan", "Methanobacteriaceae", "IMPACT"], ["Depression", "Fusobacterium spp.", "CHANGE ABUNDANCE"], ["Ping-wei-san plus", "Parkinson's disease", "INFLUENCE"], ["macrolides", "PD", "CHANGE EFFECT"], ["Christensenellaceae", "smokers", "LOCATED IN"], ["constipation", "PD", "AFFECT"], ["non-tremor dominant", "Enterobacteriaceae", "CHANGE ABUNDANCE"], ["migraine headache", "patients", "TARGET"], ["gut microbiota", "Brain", "LOCATED IN"], ["psychiatric disturbances", "Intestinal inflammation", "AFFECT"], ["Gut Microbiota", "non-TD", "IS LINKED TO"], ["Quercetin", "PCOS", "INFLUENCE"], ["IBS-D", "depression gut microbiota", "CHANGE ABUNDANCE"], ["colon", "PIPO patients", "LOCATED IN"], ["CBD", "social and behavioral processing", "INFLUENCE"], ["AD", "amyloid-\u03b2 plaques", "INTERACT"], ["Maternal Fiber Intake", "Perinatal Depression", "INFLUENCE"], ["neurodegenerative disease", "elderly patients", "TARGET"], ["herpesvirus", "vitiligo", "INFLUENCE"], ["GMB", "SCZ symptomatology", "IS LINKED TO"], ["progressive neurodegenerative disease", "GM", "CHANGE ABUNDANCE"], ["Gut Microbiome", "bipolar disorder", "IS LINKED TO"], ["well-known pharmacological effects", "OIC", "AFFECT"], ["dopamine", "periphery", "LOCATED IN"], ["chronic unpredictable stress", "anhedonia", "AFFECT"], ["Parkinson's disease", "tremor at rest", "AFFECT"], ["parasitic diseases", "chronic brain inflammation processes", "AFFECT"], ["dysbiosis of the microbiota", "schizophrenia", "AFFECT"], ["dietary fiber", "depression", "INFLUENCE"], ["ketogenic diet", "anxiety", "INFLUENCE"], ["TPG", "glia-mediated neuroinflammation", "CHANGE EFFECT"], ["commensal gut microbiota", "neurological disorders", "IS LINKED TO"], ["gut microbiota", "human host", "LOCATED IN"], ["microbiome-derived metabolites", "depression", "INFLUENCE"], ["dopaminergic treatments", "PD", "INFLUENCE"], ["gut microbiota dysbiosis", "anxiety-like behaviour", "AFFECT"], ["parasite infections", "gut microbiota", "CHANGE ABUNDANCE"], ["GM", "PD device-assisted therapies", "USED BY"], ["ultra-processed foods", "chronic metabolic diseases", "INFLUENCE"], ["insomnia", "healthy adults", "TARGET"], ["arginine", "GM", "PRODUCED BY"], ["Parkinson's disease", "PD and healthy controls", "TARGET"], ["Gut Microbiome", "Depression", "IS LINKED TO"], ["bioactive polyphenols", "oxidative stress", "INFLUENCE"], ["butyrate", "controls", "LOCATED IN"], ["Porphyra haitanensis Polysaccharides", "Blood Lipid", "INTERACT"], ["gastrointestinal symptoms", "patients", "TARGET"], ["olanzapine", "Secondary metabolic disturbances", "CHANGE EFFECT"], ["motor and non-motor symptoms", "people", "TARGET"], ["neurological symptoms", "patients", "TARGET"], ["gut microbiota", "inflammation-related depression", "IS LINKED TO"], ["cucurbitacin E", "microbiota composition", "INFLUENCE"], ["beta-hydroxy butyrate", "FA3R", "INTERACT"], ["HgS", "neurological disorders", "INFLUENCE"], ["MDD", "individuals", "TARGET"], ["therapeutic approaches", "obesity", "CHANGE EFFECT"], ["depressive/anxiety disorder", "participants", "TARGET"], ["neurodegenerative diseases", "second brain", "STRIKE"], ["PD patients", "seed amplification assays", "USED BY"], ["lasting effects", "offspring's health", "AFFECT"], ["microglia activation", "MPTP-induced mice", "TARGET"], ["depressive-like and anxiety-like behaviours", "chronic unpredictable mild stress", "AFFECT"], ["selenium", "Parkinson's disease", "INFLUENCE"], ["Glyceric acid", "gut microbiota", "PRODUCED BY"], ["probiotics", "dopaminergic neuronal degeneration", "INFLUENCE"], ["(R)-ketamine", "osteoporosis", "CHANGE EFFECT"], ["As<sub>4</sub>S<sub>4</sub>", "LPS plus rotenone-induced neurotoxicity", "INFLUENCE"], ["T2DM", "TH", "TARGET"], ["omega-3 fatty acids", "mental disorders", "INFLUENCE"], ["nucleus accumbens", "adult mice", "LOCATED IN"], ["NDOs", "microbiota", "IMPACT"], ["postpartum mental health issues", "women", "TARGET"], ["SD", "rats", "TARGET"], ["chemical pollutant", "inflammation", "INFLUENCE"], ["L. reuteri DSM 17938", "ADHD", "INFLUENCE"], ["SMI", "I-FABP", "INTERACT"], ["Lipids", "aged and Alzheimer's disease (AD) brains", "LOCATED IN"], ["prebiotic", "Parkinson's disease", "INFLUENCE"], ["gut microbiome", "epilepsy", "IS LINKED TO"], ["Parkinson's disease", "gut microbiota", "CHANGE ABUNDANCE"], ["Lachnospiraceae", "patients", "LOCATED IN"], ["gut microbiota", "non-PD populations", "LOCATED IN"], ["Vasovagal syncope", "VVS patients", "TARGET"], ["calorie-dense foods", "metabolic dysfunction", "INFLUENCE"], ["Gut microbiota", "vascular endothelial dysfunction", "IS LINKED TO"], ["gut microbiota", "AD patients", "LOCATED IN"], ["Insomnia disorder", "clinical sleep and psychiatric disorders", "IS A"], ["antibiotics", "amyotrophic lateral sclerosis", "CHANGE EFFECT"], ["\u03b1-LA", "insulin resistance", "INFLUENCE"], ["gut microbiota", "C57BL/6 mice", "LOCATED IN"], ["inflammatory compounds", "depression", "INFLUENCE"], ["GI symptoms", "Autistic individuals", "TARGET"], ["<i>L. plantarum</i> DP189", "IL-10", "INTERACT"], ["acetic and propionic acids", "gut microbiota", "PRODUCED BY"], ["gut microbiota", "normal rats", "LOCATED IN"], ["PM", "inflammation", "INFLUENCE"], ["Nef", "Lactobacillus", "IMPACT"], ["glucose intolerance", "healthy human subjects", "TARGET"], ["criteria-acute group (patients with acute schizophrenia)", "16S rRNA sequencing", "USED BY"], ["substantia nigra pars compacta", "PD mice", "LOCATED IN"], ["Obesity", "low-grade chronic systemic inflammation", "AFFECT"], ["short-chain fatty acids", "stroke", "INFLUENCE"], ["Gut Microbiota Dysbiosis", "Bile Acids", "INTERACT"], ["<i>L. plantarum</i> DP189", "GSH-Px", "INTERACT"], ["neurodegeneration", "individuals diagnosed with PD", "TARGET"], ["pro-inflammatory bacteria", "reward-seeking", "INFLUENCE"], ["probiotics", "chronic-stress-induced depression", "INFLUENCE"], ["microbiota-derived metabolites", "stroke", "INFLUENCE"], ["gut microbiota", "neurologic disease", "IS LINKED TO"], ["Prevotellaceae NK3B31", "gut microbiota", "PART OF"], ["Group 2", "double-blind, randomized, placebo-controlled trial", "USED BY"], ["KD", "AD", "INFLUENCE"], ["microbiome-derived metabolites", "gut microbiota", "PRODUCED BY"], ["altered microbiota", "offspring", "LOCATED IN"], ["LCIG", "inflammatory intestinal microenvironment", "CHANGE EFFECT"], ["gut microbiota composition", "gas chromatography-mass spectrometry", "USED BY"], ["microbiota-derived metabolites", "neuromyelitis optica spectrum disorders", "INFLUENCE"], ["Bifidobacteriaceae", "Parkinson's subjects", "LOCATED IN"], ["gut microbiota", "intestinal regions", "LOCATED IN"], ["Bilophila", "PD", "INFLUENCE"], ["early PD", "rhesus monkeys", "TARGET"], ["gut-associated microbes", "myalgic encephalomyelitis", "INFLUENCE"], ["polyphenols", "NND", "INFLUENCE"], ["GM", "striatum", "LOCATED IN"], ["Mediterranean diet", "chronic low-grade inflammation-related diseases", "INFLUENCE"], ["progressive neurological disorder", "impaired movement", "AFFECT"], ["psychopathological symptoms", "inflammatory diseases", "AFFECT"], ["Gut Microbiota", "HCs", "LOCATED IN"], ["oral and nasal microbiota", "PD", "IS LINKED TO"], ["Streptococcaceae", "AD oral microbiota", "PART OF"], ["sleep and circadian rhythm disruption", "\u03b2-amyloid", "INTERACT"], ["metformin", "Akkermansia muciniphila", "IMPACT"], ["probiotics", "ASD", "INFLUENCE"], ["<i>Lacticaseibacillus rhamnosus</i> HN001 probiotic", "prediabetes", "INFLUENCE"], ["microbial metabolites", "psychiatric clinical symptoms", "INFLUENCE"], ["Difficulty in Explicit Emotion Regulation", "Young Children", "TARGET"], ["intestinal microbial ecosystem", "obesity", "IS LINKED TO"], ["controls", "V3-V5 sequencing region", "USED BY"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson's disease", "mice", "TARGET"], ["agents", "Gut microbiota", "IMPACT"], ["Mice", "LF-TMS", "USED BY"], ["5-HT", "gut microbiota", "IMPACT"], ["oxaliplatin", "Alloprevotella", "IMPACT"], ["cognitive impairments", "TALLYHO/JngJ mice", "TARGET"], ["gut microbiota", "Alzheimer's disease", "IS LINKED TO"], ["chronic LPS plus MPTP-induced toxicity to the brain and gut", "mice", "TARGET"], ["3,4-diHBA", "intracellular \u03b1-syn seeding aggregation", "INFLUENCE"], ["Zn", "obesity", "INFLUENCE"], ["Mediterranean diet", "cancers", "INFLUENCE"], ["microbiome", "brain health", "IS LINKED TO"], ["prebiotics", "metabolic health", "INFLUENCE"], ["individuals", "targeted liquid chromatography mass spectrometry method", "USED BY"], ["gut microbiota", "microbiota alterations", "IS LINKED TO"], ["probiotics", "obesity", "INFLUENCE"], ["Zn2+", "neurodegeneration", "INFLUENCE"], ["entacapone", "nightmare", "CHANGE EFFECT"], ["phyla Actinobacteria", "gut microbiome", "PART OF"], ["gut microbiota", "susceptible mice", "LOCATED IN"], ["AAAs", "microbial taxa", "PRODUCED BY"], ["mice", "pole text", "USED BY"], ["hydrophobic and secondary bile acids", "PD appendix", "LOCATED IN"], ["behavioral dysfunction", "Lactobacillus johnsonii", "CHANGE ABUNDANCE"], ["early PD", "L-Aspartic acid", "INTERACT"], ["gastrointestinal microbiota", "peripheral inflammation", "IS LINKED TO"], ["microbiota", "Graves' disease", "IS LINKED TO"], ["Proline supplementation", "depression", "INFLUENCE"], ["neurocysticercosis", "chronic brain inflammation processes", "AFFECT"], ["honey", "Clostridiodes difficile", "IMPACT"], ["microbial diversity", "gut", "LOCATED IN"], ["probiotics", "neurodegeneration", "INFLUENCE"], ["Parkinson's disease", "neurodegenerative disease", "IS A"], ["gut microbiota", "bipolar disorder", "IS LINKED TO"], ["Weissella", "ARGs", "CHANGE EXPRESSION"], ["gut microbiota", "two-sample MR methods", "USED BY"], ["fecal microbiome", "risk for earlier death", "IS LINKED TO"], ["QUR", "IR", "INFLUENCE"], ["probiotic supplements", "intestinal microbiota", "IMPACT"], ["intestine microbiota", "A53T transgenic monkeys", "LOCATED IN"], ["gut microbiota", "pups", "LOCATED IN"], ["interleukin (IL)-1\u03b2", "Social avoidance behaviors", "INFLUENCE"], ["intestinal microbiome", "schizophrenia", "IS LINKED TO"], ["CUMS", "Mice", "TARGET"], ["Tianqi Pingchan Granule", "6-OHDA-Induced Parkinson's Disease", "CHANGE EFFECT"], ["adequate protein", "gut microbiota", "IMPACT"], ["Gram-negative bacteria", "ND", "INFLUENCE"], ["patients", "multi-omics approach", "USED BY"], ["observed differences", "bacteria", "CHANGE ABUNDANCE"], ["breast milk microbiota", "infant\u2019s gut microbiota", "COMPARED TO"], ["Aerococcaceae", "dopa", "INTERACT"], ["HFD", "DA neuron loss", "CHANGE EFFECT"], ["Lactobacillus genus", "Bacilli class", "INTERACT"], ["neuroinflammation", "dysbiosis", "AFFECT"], ["gut", "human", "LOCATED IN"], ["Parkinson disease", "gut microbiome", "CHANGE ABUNDANCE"], ["gut microbiome", "Gut Microbiota Dysbiosis", "IS LINKED TO"], ["Turicibacter", "glycodeoxycholic acid", "INTERACT"], ["intestine microbiota", "PD", "IS LINKED TO"], ["doxycycline", "AD and PD patients", "ADMINISTERED"], ["GABA", "microbiota", "IMPACT"], ["astilbin", "gut microbiota", "IMPACT"], ["low-FODMAP diet", "anxiety", "INFLUENCE"], ["Di-(2-ethylhexyl) phthalate", "diabetes", "INFLUENCE"], ["time-dependent dopaminergic neurodegeneration", "PD mice", "TARGET"], ["Faecalibacterium spp.", "exclusion group", "LOCATED IN"], ["anxiety", "adult female mice", "TARGET"], ["LPS", "Methanobacteriaceae", "IMPACT"], ["Gut Microbiota", "Patients", "LOCATED IN"], ["gut microbial dysbiosis", "older individuals", "TARGET"], ["Mitochondrial dysfunction", "cancer", "AFFECT"], ["antidepressant treatment", "MDD", "CHANGE EFFECT"], ["contrasting effects", "gut microbiota", "CHANGE ABUNDANCE"], ["gut flora", "neurologic and neuropsychological disorders", "IS LINKED TO"], ["gut microbiome", "major depressive disorder", "IS LINKED TO"], ["calorie-dense foods", "obesity", "INFLUENCE"], ["leucine rich repeat", "duodenum", "LOCATED IN"], ["inhibition", "CST injury", "CHANGE EFFECT"], ["SCFAs", "healthy controls", "LOCATED IN"], ["BPD", "microbes", "CHANGE ABUNDANCE"], ["probiotic strains", "CNS disorders", "INFLUENCE"], ["Cb", "motor deficits", "INFLUENCE"], ["DA neuron loss", "Rats", "TARGET"], ["MDD", "patients with major depressive disorder", "TARGET"], ["controls", "16S rRNA gene amplified sequencing", "USED BY"], ["polyphenols", "neurodegenerative diseases", "INFLUENCE"], ["Kyn", "Venous blood", "LOCATED IN"], ["Desulfovibrionaceae", "Parkinson's disease", "INFLUENCE"], ["nuts", "neurological diseases", "INFLUENCE"], ["microbiota", "gastrointestinal tract", "LOCATED IN"], ["Lactobacillus", "PD mice", "LOCATED IN"], ["SMI", "sMAdCAM-1", "INTERACT"], ["microbiota", "A53T transgenic monkeys", "LOCATED IN"], ["Ruminococcus sp AM07-15", "PD patient group", "LOCATED IN"], ["gut microbiota", "stress-related psychiatric disorders", "IS LINKED TO"], ["Subdoligranulum", "hub-genes", "CHANGE EXPRESSION"], ["neurodegenerative diseases", "gut microbiota", "CHANGE ABUNDANCE"], ["microbes-derived metabolites", "subdiaphragmatic vagus nerve", "LOCATED IN"], ["rotenone", "Lactobacteriaceae", "IMPACT"], ["gut microbiota", "psychological changes", "IS LINKED TO"], ["MAM", "PIPO", "IS LINKED TO"], ["highly processed", "disease susceptibility", "INFLUENCE"], ["probiotic supplementation", "Fecalibacterium prausnitzii", "IMPACT"], ["Gut dysbiosis", "AI", "AFFECT"], ["microbiota", "PD", "IS LINKED TO"], ["gut microbiome", "neurodevelopmental and neurodegenerative disorders", "IS LINKED TO"], ["Parkinson's disease", "behavioral changes", "AFFECT"], ["CSDS", "water-treated mice", "TARGET"], ["Prenatal Stress", "Ethanol Exposure", "AFFECT"], ["zinc", "obesity", "INFLUENCE"], ["ketogenic diet", "ALS", "INFLUENCE"], ["Symprove\u2122", "early-stage PD", "INFLUENCE"], ["IL-1\u03b2", "serum", "LOCATED IN"], ["MPTP neurotoxicity", "decreased motor activity", "AFFECT"], ["Parkinson's disease", "intestinal flora", "CHANGE ABUNDANCE"], ["fecal SCFAs", "PD", "INFLUENCE"], ["gut microbiota", "FMT via colonoscopy", "USED BY"], ["PD", "Colonic FMT group", "TARGET"], ["glutamate", "GM", "PRODUCED BY"], ["MPTP", "DA", "INTERACT"], ["intestinal metabolites of microbial origin", "intestinal microbiota", "PRODUCED BY"], ["unhealthy nutrition", "diseases of the central nervous system", "AFFECT"], ["gut microbiome", "Sucrose preference test", "USED BY"], ["Sutterella", "GM", "PART OF"], ["gut microbial metabolites", "PD", "INFLUENCE"], ["Microbiome", "Growth-Period Mice", "LOCATED IN"], ["adequate protein", "multiple sclerosis", "INFLUENCE"], ["Shrimp Head Hydrolysate", "Depression-like Behaviour", "INFLUENCE"], ["Bifidobacterium longum", "gut microbiota", "PART OF"], ["disturbances", "metabolites", "INTERACT"], ["probiotics", "motor disability", "INFLUENCE"], ["maternal obesity", "maternal microbiota", "CHANGE ABUNDANCE"], ["Clostridium", "gut microbiome", "PART OF"], ["DEHP", "increasing body weight gain", "INFLUENCE"], ["\u03b1-syn", "MSA", "INFLUENCE"], ["PD patients", "Disease-associated metagenomics studies", "USED BY"], ["gut microbiota", "traumatic or stress events", "IS LINKED TO"], ["neuropsychiatric disorders", "men", "TARGET"], ["prebiotic PM", "Parkinson's disease", "INFLUENCE"], ["gut microbiome", "PD", "IS LINKED TO"], ["Piperine", "oral cancer", "INFLUENCE"], ["intestinal pathology", "PD mice", "TARGET"], ["gut microbiota", "SCZ", "IS LINKED TO"], ["sex- and age-matched healthy controls", "Shotgun metagenomic sequencing", "USED BY"], ["Mercury sulfides", "gut microbiota", "IMPACT"], ["early PD", "p-Hydroxyphenylacetic acid", "INTERACT"], ["\u03b3-aminobutyric acid", "substantia nigra pars compacta", "LOCATED IN"], ["microbes", "ALS", "INFLUENCE"], ["trichloroethylene", "gut microbiome", "IMPACT"], ["gut flora dysbiosis", "developmental disorders", "AFFECT"], ["gut microbiome", "autism", "IS LINKED TO"], ["probiotics", "major depressive disorder", "INFLUENCE"], ["CKD", "participants aged 55-75\u00a0years", "TARGET"], ["CsgA", "amyloid-related diseases", "INFLUENCE"], ["stress", "maternal gut microbiota", "CHANGE ABUNDANCE"], ["human gut microbiota", "metabolic syndrome", "IS LINKED TO"], ["neuroinflammation", "brain", "STRIKE"], ["nigral \u03b1-synuclein pathology", "rats", "TARGET"], ["PD-specific gut microbiome", "PD", "IS LINKED TO"], ["common patterns", "Streptococcus", "CHANGE ABUNDANCE"], ["bacterial amyloid proteins", "\u03b1-synuclein", "INTERACT"], ["gut microbiota", "collagen-induced arthritis (CIA) mice", "LOCATED IN"], ["gut microbiota", "schizophrenia patients", "LOCATED IN"], ["deleterious amino acid metabolites", "Parkinson's microbiota", "PRODUCED BY"], ["Mn", "Parkinson's disease", "INFLUENCE"], ["Baseline gut microbiota profiles", "patients", "LOCATED IN"], ["oral and gut microbiota", "Mental health disorders", "IS LINKED TO"], ["AEP", "\u03b1-Synuclein N103", "CHANGE EXPRESSION"], ["prebiotic", "SCZ", "INFLUENCE"], ["novel therapeutic strategies", "SCIs", "CHANGE EFFECT"], ["atypical parkinsonism cohorts", "multi-omics assessments", "USED BY"], ["IL-1\u03b2", "DEX-treated mice", "LOCATED IN"], ["neurological and psychiatric disorders", "patients", "TARGET"], ["mice", "voluntary wheel running", "USED BY"], ["gut microbiota", "unaffected individuals", "LOCATED IN"], ["Parkinson's disease", "Myristic acid", "INTERACT"], ["Actinobacteria phylum", "anhedonia", "INFLUENCE"], ["controls", "Illumina HiSeq 2000", "USED BY"], ["SCFAs-producing gut bacteria", "healthy controls", "LOCATED IN"], ["realgar", "gut microbiota", "IMPACT"], ["microbiota", "rats", "LOCATED IN"], ["\u03b1-HgS-containing Hua-Feng-Dan", "chronic LPS plus MPTP-induced toxicity to the brain and gut", "CHANGE EFFECT"], ["fecal microbial diversities", "patients", "TARGET"], ["epiandrosterone sulfate", "OSA", "INFLUENCE"], ["P. gingivalis", "PD", "INFLUENCE"], ["heavy metals", "neurological and overall mental health", "INFLUENCE"], ["CMUS group", "forced swim test", "USED BY"], ["PD", "Dialister", "CHANGE ABUNDANCE"], ["psychosis", "adults", "TARGET"], ["traumatic brain injuries", "male", "TARGET"], ["adequate protein", "stress", "INFLUENCE"], ["Paracasei 37", "ADHD", "INFLUENCE"], ["hyperhomocysteinemia-related brain cortical thinning", "neurodegenerative central nervous system disorders", "AFFECT"], ["gut microbiota", "Parkinson's disease patients", "LOCATED IN"], ["striatum of antibiotic-treated animals", "antibiotic treated animals", "LOCATED IN"], ["ADP", "cell danger response", "INFLUENCE"], ["fear of cancer recurrence", "cancer survivors", "TARGET"], ["major depressive disorder", "patients", "TARGET"], ["Listeria monocytogenes", "TD children", "LOCATED IN"], ["Kefir", "genus <i>Lactococcus</i>", "IMPACT"], ["food bioactive compounds", "Down's syndrome", "INFLUENCE"], ["probiotics", "treatment for depression", "INFLUENCE"], ["Turicibacter spp.", "Social avoidance behaviors", "INFLUENCE"], ["depressive symptoms", "Chinese and Korean immigrants", "TARGET"], ["Bifidobacterium catenulatum", "bacterial taxa", "INTERACT"], ["fCS-<i>Ib</i>", "PD", "INFLUENCE"], ["gut microbiota", "FMT recipients", "LOCATED IN"], ["PHP", "gut microbiota", "IMPACT"], ["baseline gut microbial profiles", "patients", "LOCATED IN"], ["antibiotics", "homeostatic genes", "CHANGE EXPRESSION"], ["alterations of the enteric nervous system", "Parkinson's disease (PD) symptomatology and pathophysiology", "AFFECT"], ["human case-control studies", "oral LPS", "USED BY"], ["Rikenellaceae", "PD-MCI group", "LOCATED IN"], ["vitamins", "memory and cognition impairment", "INFLUENCE"], ["nutraceuticals", "CKD", "INFLUENCE"], ["Parabacteroides", "microbiota", "PART OF"], ["neurological conditions", "Dysbiosis", "AFFECT"], ["inflammation", "stress-related depression", "AFFECT"], ["grains", "patients", "ADMINISTERED"], ["high stress", "males", "TARGET"], ["psychobiotics", "gut microbiota", "IMPACT"], ["PS150", "hypnotic effects", "INFLUENCE"], ["bacterial taxa", "lipid", "INTERACT"], ["Gut Microbiome", "Parkinson's disease", "IS LINKED TO"], ["Tibetan Buddhist monks", "16S rRNA gene sequencing", "USED BY"], ["Gut microbiota", "Huntington's disease", "IS LINKED TO"], ["Mediterranean diet", "memory and cognition impairment", "INFLUENCE"], ["dysbiosis", "gut microbiota", "CHANGE ABUNDANCE"], ["SS-related symptoms", "Eleven-week-old NOD mice", "TARGET"], ["exopolysaccharide", "hypnotic effects", "INFLUENCE"], ["intestinal microbiota", "small and large intestine", "LOCATED IN"], ["gut microbiota", "neuronal disorders", "IS LINKED TO"], ["K01626", "gut microbiota", "PRODUCED BY"], ["neurological disorders", "Rats", "TARGET"], ["Mediterranean Diet", "Irritable Bowel Syndrome", "INFLUENCE"], ["Gut Microbiota", "motor deficits", "IS LINKED TO"], ["cinnabar", "gut microbiota", "IMPACT"], ["AD", "poststroke cognitive impairment patients", "TARGET"], ["Bifidobacterium spp.", "gut microbiota", "PART OF"], ["K01817", "MDD group", "LOCATED IN"], ["neurodegenerative disorders", "patients", "TARGET"], ["gut microbiota", "human case-control studies", "LOCATED IN"], ["Depression", "dementias", "AFFECT"], ["gut microbiota", "CNS disorders", "IS LINKED TO"], ["dysbiosis of the gastrointestinal tract", "obesity", "AFFECT"], ["serum metabolome", "gut microbiota", "PRODUCED BY"], ["lipid metabolites", "\u03b1-syn", "INTERACT"], ["mild to moderate Parkinson's disease", "patients", "TARGET"], ["gut microbiota", "neurological and psychological changes", "IS LINKED TO"], ["Depression Symptoms", "Adults", "TARGET"], ["extremely severe impairment of propulsive motility", "PIPO", "AFFECT"], ["Clostridium", "controls", "LOCATED IN"], ["probiotic formulations", "SCZ", "INFLUENCE"], ["probiotic strain", "stress", "INFLUENCE"], ["gut microbiota", "MDD group", "LOCATED IN"], ["beta-casomorphin-7", "cardiovascular diseases", "INFLUENCE"], ["Iba-1", "ileum", "LOCATED IN"], ["gastroenteritis", "severe depression", "AFFECT"], ["Cryptotanshinone", "CUMS induced depressive symptoms", "INFLUENCE"], ["PD", "Prevotella", "CHANGE ABUNDANCE"], ["Obesity", "cognitive dysfunctions", "AFFECT"], ["gut microbiota", "human intestine", "LOCATED IN"], ["gastrointestinal tract", "people", "LOCATED IN"], ["prebiotics", "microbiota", "IMPACT"], ["mucosa associated microbiota", "next generation sequencing (NGS) of the V3-V4 region of the bacterial RNA 16\u00a0S", "USED BY"], ["Bacteroides", "bacteria", "INTERACT"], ["gut microbiota", "neurological disorders", "IS LINKED TO"], ["ASD", "somatic complaints", "AFFECT"], ["mental disorders", "adolescents", "TARGET"], ["Wistar-Kyoto rats", "sucrose preference test", "USED BY"], ["Obesity", "mood disorders", "AFFECT"], ["obesity", "neuroinflammation", "AFFECT"], ["motor deficits", "human PD cases", "TARGET"], ["IL-22", "ileum", "LOCATED IN"], ["probiotics", "intestinal microbiota", "IMPACT"], ["epigenetic processes", "traumatic or stress events", "AFFECT"], ["gut microbiota", "unaffected first-degree relatives", "LOCATED IN"], ["Parkinson's disease", "Lacticaseibacillus rhamnosus GG", "CHANGE ABUNDANCE"], ["gastrointestinal (GI) disorders", "schizophrenia", "AFFECT"], ["Inulin", "stress", "INFLUENCE"], ["vagus nerve", "disease subpopulations", "LOCATED IN"], ["gut microbiota", "RISP SCZ", "LOCATED IN"], ["several microbiome", "three groups [wild-type (WT)\u00a0+\u00a0sham group, KO\u00a0+\u00a0sham group, KO\u00a0+\u00a0SDV group]", "LOCATED IN"], ["PD", "bradykinesia", "AFFECT"], ["gut microbiota", "non-communicable diseases", "IS LINKED TO"], ["volunteer Chinese patients", "shotgun metagenomic sequencing", "USED BY"], ["(R)-ketamine", "PD", "CHANGE EFFECT"], ["plasticizer", "glucose metabolism disorder", "INFLUENCE"], ["hippocampal degeneration", "brain", "STRIKE"], ["gut microbiota", "psychotic illness", "IS LINKED TO"], ["gut microbiota", "Multiple Sclerosis", "IS LINKED TO"], ["intestinal microbiota", "anxiety/depression", "IS LINKED TO"], ["HFD", "Verrucomicrobiaceae", "IMPACT"], ["patients", "next-generation sequencing", "USED BY"], ["Intestinal flora disorders", "metabolic diseases", "AFFECT"], ["Hippophae rhamnoides", "CUMS-induced depressive disorder", "INFLUENCE"], ["CT-26", "Parabacteroides", "IMPACT"], ["piperine", "breast cancer resistance protein", "INTERACT"], ["gut microbiota", "immune dysfunction", "IS LINKED TO"], ["disrupted microbiome", "Alzheimer disease", "IS LINKED TO"], ["butyrate producing gut microbiota", "controls", "LOCATED IN"], ["intestinal damage", "mice", "TARGET"], ["\u03b1-synuclein", "gut microbiome", "IMPACT"], ["<i>genus</i>_<i>Subdoligranulum</i>", "gut microbiota", "PART OF"], ["alkaloids", "RA", "INFLUENCE"], ["Piperine", "NF-\u03baB/AP-1/MMP-9", "INTERACT"], ["altered gut microbiome", "Parkinson's disease (PD) patients", "TARGET"], ["Psychobiotics", "autism", "INFLUENCE"], ["splenomegaly", "sham-operated mice", "TARGET"], ["PD-MCI", "Blautia", "CHANGE ABUNDANCE"], ["probiotics", "mental disorders", "INFLUENCE"], ["autistic symptoms", "ASD", "AFFECT"], ["B. licheniformis", "depressive-like and anxiety-like behaviours", "INFLUENCE"], ["gut microbes", "dysregulation of iron metabolism", "INFLUENCE"], ["reduced bone mineral density", "ovariectomized mice", "TARGET"], ["endogenous or exogenous chemicals", "dysbiosis", "INFLUENCE"], ["Dorea", "insomnia", "INFLUENCE"], ["LD-carbidopa intestinal gel", "GM", "IMPACT"], ["fecal metagenomes", "probiotic group", "LOCATED IN"], ["gut microbiota", "microbiota abundance and diversity", "IS LINKED TO"], ["gut dysbiosis", "\u03b1-synuclein fibrils", "INTERACT"], ["increased intestinal permeability", "autistic individuals", "TARGET"], ["gut microbiota", "child and adolescent population (0-18\u00a0years old)", "LOCATED IN"], ["GOS", "Lactobacillus spp.", "IMPACT"], ["depressive symptoms", "healthy women", "TARGET"], ["glutamate", "dementia", "INFLUENCE"], ["schizophrenia", "Autoimmunity", "AFFECT"], ["GM", "BP", "IS LINKED TO"], ["intestinal microbiota", "brain", "LOCATED IN"], ["PD", "persons", "TARGET"], ["Kefir", "microbiota", "IMPACT"], ["incident subthreshold depression", "Chinese young adults", "TARGET"], ["human microbiota", "gut", "LOCATED IN"], ["PIPO", "PIPO patients", "TARGET"], ["A53T monkeys", "metagenomic sequencing", "USED BY"], ["chronic social defeat stress", "mice", "TARGET"], ["Maternal Obesity", "Maternal Microbiota", "CHANGE ABUNDANCE"], ["unhealthy nutrition", "Parkinson's disease", "AFFECT"], ["autism spectrum disorder", "children", "TARGET"], ["MCC950", "Paenibacillus", "IMPACT"], ["gut microbiota", "anxiety disorder", "IS LINKED TO"], ["gut microbiota", "ADHD", "IS LINKED TO"], ["Ruminococcus", "gut microbiota", "PART OF"], ["control (CON) group", "western blot", "USED BY"], ["intestinal mucosal barrier condition", "intestinal flora", "CHANGE ABUNDANCE"], ["gut microbiota", "Parkinson's disease", "IS LINKED TO"], ["human gut microbiota", "multiple sclerosis", "IS LINKED TO"], ["depression", "depressed and non-depressed groups", "TARGET"], ["<i>Actinobacteria</i> class", "gut microbiome", "PART OF"], ["antibiotics", "PD", "CHANGE EFFECT"], ["gut microbiota", "CST injury", "IS LINKED TO"], ["Akkermansia", "neuropsychiatric disorders", "INFLUENCE"], ["phytochemicals", "TREM2", "CHANGE EXPRESSION"], ["L-Aspartic acid", "Gut microbiota", "PRODUCED BY"], ["microbiota", "human diseases", "IS LINKED TO"], ["gut bacterium C. sporogenes", "gut microbiota", "PART OF"], ["five compositional different metabolites", "Gut microbiota", "PRODUCED BY"], ["Hua-Feng-Dan", "gut microbiome", "IMPACT"], ["PD", "Sybergistetes", "CHANGE ABUNDANCE"], ["intestine microbiota", "neurodegenerative disease", "IS LINKED TO"], ["dietary animal protein", "Prevotella", "IMPACT"], ["severe mental disorders", "patients", "TARGET"], ["Helicobacter_ganmani", "KO and WT mice", "LOCATED IN"], ["gut microbiome", "SGM", "IS LINKED TO"], ["Gut Microbiota", "Obstructive Sleep Apnea", "IS LINKED TO"], ["low plasma TMAO level", "PD group", "TARGET"], ["several bacterial metabolites", "gut microbes", "PRODUCED BY"], ["microbes", "depression", "INFLUENCE"], ["chronic and selective process of neuron cell death", "neurodegenerative diseases", "AFFECT"], ["fecal microbiota", "schizophrenia patients", "LOCATED IN"], ["HFD-original", "neurological disorders", "CHANGE EFFECT"], ["phosphonates", "schizophrenia", "INFLUENCE"], ["serotonin", "Gut microbiota", "IMPACT"], ["PD", "classic motor symptoms", "AFFECT"], ["Adiponectin", "Neurodegenerative diseases", "INFLUENCE"], ["increased body weight", "fathers", "TARGET"], ["PD", "Lactobacillaceae", "CHANGE ABUNDANCE"], ["ketogenic diet", "ASDs", "INFLUENCE"], ["Bacillus licheniformis", "gut diseases", "INFLUENCE"], ["limonene", "IBS", "INFLUENCE"], ["Firmicutes phylum", "groups", "LOCATED IN"], ["subjects", "16s rRNA gene V3-V4 region sequencing", "USED BY"], ["cucurbitacin E", "host gene expression", "INFLUENCE"], ["neurodegenerative disorders", "human subjects", "TARGET"], ["CUMS", "depressed mother", "TARGET"], ["lactoferrin", "stress", "INFLUENCE"], ["glucose metabolism disorder", "male rodents", "TARGET"], ["MPTP", "\u03b1-synuclein", "INTERACT"], ["common patterns", "Lachnospiraceae ND3007 group", "CHANGE ABUNDANCE"], ["microbiota", "neurodegenerative disease", "IS LINKED TO"], ["QUR", "PCOS", "INFLUENCE"], ["L. Planetarium 128", "children's neurodevelopmental disorders", "INFLUENCE"], ["Adiponectin", "Neurodegenerative Diseases", "INFLUENCE"], ["dysbiosis of mouse gut microbiota", "NK4A136", "CHANGE ABUNDANCE"], ["analogues", "major depressive disorder", "CHANGE EFFECT"], ["histone deacetylases", "genetic and epigenetic mechanisms", "INFLUENCE"], ["cytokines", "CFC patients", "LOCATED IN"], ["chronic SD", "p_Bacteroidetes", "CHANGE ABUNDANCE"], ["(R)-ketamine", "reduced cortical BMD and total BMD", "CHANGE EFFECT"], ["gut microbiota", "Neurodegenerative Disease", "IS LINKED TO"], ["TPG", "gut microbiota", "IMPACT"], ["dietary fiber intake", "immune function", "INFLUENCE"], ["saponins", "GM", "IMPACT"], ["gut microbiota", "VVS", "IS LINKED TO"], ["NF-\u03baB", "neuroinflammation", "INFLUENCE"], ["Prebiotics", "Neurodegenerative Disease", "INFLUENCE"], ["maternal rectal microbiota", "infant microbiota", "COMPARED TO"], ["dysbiosis", "PD patients", "TARGET"], ["glucuronic acid", "Gut Microbiota", "PRODUCED BY"], ["SBF", "gut microbiota", "IMPACT"], ["LGG", "Parkinson's disease", "INFLUENCE"], ["Spanish cohort", "16S ribosomal RNA gene V3-4 amplicon sequencing", "USED BY"], ["SG031", "gut microbiota", "PART OF"], ["GM", "population", "LOCATED IN"], ["young adults", "cerebrospinal fluid and blood biomarkers", "USED BY"], ["gut microbiota", "spleen nerve denervation", "USED BY"], ["Mercury sulfide-containing Hua-Feng-Dan", "LPS plus MPTP-induced neurotoxicity", "CHANGE EFFECT"], ["Lactobacillus_plantaru", "gut microbiota", "PART OF"], ["psychiatric comorbidity", "patients", "TARGET"], ["microbes", "ASDs", "INFLUENCE"], ["Clostriumtertium", "gut microbiota", "PART OF"], ["mycobiota", "SCH", "IS LINKED TO"], ["Parkinson's disease", "tremor", "AFFECT"], ["chronic SD", "g_Enterococcus", "CHANGE ABUNDANCE"], ["SZ\u00a0patients", "sequencing", "USED BY"], ["Alzheimer's disease", "human host", "TARGET"], ["nutrition", "SZ", "INFLUENCE"], ["probiotics", "PD", "INFLUENCE"], ["Caffeine", "Parkinson's Disease", "INFLUENCE"], ["KD", "microbiota", "IMPACT"], ["F. rodentium", "interleukin-6", "INTERACT"], ["AGPs", "gut microbiome", "IMPACT"], ["Gut Microbiome", "MS", "IS LINKED TO"], ["Patescibacteria", "MPTP group", "INTERACT"], ["gut", "human PD cases", "LOCATED IN"], ["Rannasangpei", "disturbance of gut microbiota", "CHANGE EFFECT"], ["chemically modified alginate hydrogel", "bacterial cells", "IMPACT"], ["microbiota", "neurological diseases", "IS LINKED TO"], ["PD", "non-motor symptoms", "AFFECT"], ["ketogenic diet", "gut microbes", "IMPACT"], ["pesticides", "gut microbiome", "IMPACT"], ["SHH", "depression-like behaviour", "INFLUENCE"], ["\u03b2-HgS-containing 70W", "Methanobacteriaceae", "IMPACT"], ["dysbiosis", "chronic diseases", "AFFECT"], ["Chronic stress", "behavioral, cognitive, biochemical, and gut microbiota aberrations", "AFFECT"], ["(R)-ketamine", "humans", "ADMINISTERED"], ["butyrate", "anxiety", "INFLUENCE"], ["fiber", "perinatal depression and anxiety", "INFLUENCE"], ["Butylated Starch", "Gut Microbiota", "IMPACT"], ["gingerol", "Irritable bowel syndrome", "INFLUENCE"], ["depression", "general population", "TARGET"], ["patients", "bioinformatics analysis", "USED BY"], ["gut microbiota", "mental health outcomes", "IS LINKED TO"], ["microbial community", "humans", "LOCATED IN"], ["healthy controls", "bioinformatics analysis", "USED BY"], ["Parkinson's disease", "periphery of the body", "STRIKE"], ["HFD-reduced", "Verrucomicrobiaceae", "IMPACT"], ["gut microbiota", "Autism Spectrum Disorder", "IS LINKED TO"], ["piperine", "cytochrome P450 3A4", "INTERACT"], ["early PD", "3-Methylindole", "INTERACT"], ["coffee", "TH neuron loss", "INFLUENCE"], ["plant foods", "type 2 diabetes", "INFLUENCE"], ["Faecalibacterium", "reward-seeking", "INFLUENCE"], ["Human gut microbiota", "Parkinson's disease", "IS LINKED TO"], ["chronic social defeat", "male mice", "TARGET"], ["rifaximin", "patients", "ADMINISTERED"], ["interleukin (IL)-1\u03b2", "Flavobacterium spp.", "IMPACT"], ["BAs", "liver", "LOCATED IN"], ["PD", "Negativicutes", "CHANGE ABUNDANCE"], ["enterotype-P", "health controls", "LOCATED IN"], ["gut microbiota", "motor", "IS LINKED TO"], ["gut microbiota", "mood disorders", "IS LINKED TO"], ["splenomegaly", "rodents", "TARGET"], ["stress", "microbiota", "CHANGE ABUNDANCE"], ["ASD", "PAX3", "INTERACT"], ["SCFAs", "gut", "LOCATED IN"], ["\u03b2-HgS-containing 70 Wei-Zhen-Zhu-Wan", "Clostridaceae species", "IMPACT"], ["Parkinson's disease", "individuals", "TARGET"], ["nutraceutical supplementations", "Multiple sclerosis", "INFLUENCE"], ["Gut Microbiota", "PD patients", "LOCATED IN"], ["vegetables", "chronic human diseases", "INFLUENCE"], ["rhEPO", "Lachnospiraceae", "IMPACT"], ["depression", "Proteobacteria", "CHANGE ABUNDANCE"], ["novel microbial ligands", "well-being", "INFLUENCE"], ["Di-(2-ethylhexyl) phthalate", "highest Th1 inflammatory response", "INFLUENCE"], ["Psychological Stress", "Psychiatrically Healthy Medical Students", "TARGET"], ["human disorders", "gut microbiota", "CHANGE ABUNDANCE"], ["Probiotics", "Human Migraine Headache", "INFLUENCE"], ["gut", "healthy donor", "LOCATED IN"], ["Mitochondrial dysfunction", "Parkinson's Disease", "AFFECT"], ["neurodegenerative", "SOD1 mice", "TARGET"], ["plasticizer", "Proteobacteria abundance in the fecal samples", "INFLUENCE"], ["herbs", "depressive symptoms", "INFLUENCE"], ["stress", "mice", "TARGET"], ["PD and healthy controls", "gas chromatography", "USED BY"], ["VSL#3", "LPS paraquat-induced weight loss", "INFLUENCE"], ["CD4", "midbrain", "LOCATED IN"], ["depression-like behaviors", "mice", "TARGET"], ["fecal microbiota", "psychotic illness", "IS LINKED TO"], ["Ruminococcus Torques", "gut microbiome", "PART OF"], ["SG031", "mental health", "INFLUENCE"], ["<i>L. plantarum</i> DP189", "\u03b1-SYN", "INTERACT"], ["GMB", "bipolar disorder", "IS LINKED TO"], ["gut microbiota", "VVS children", "LOCATED IN"], ["chicoric acid", "gut microbiota", "IMPACT"], ["parasite infections", "neuropathophysiological processes", "AFFECT"], ["GM", "mild cognitive impairment", "IS LINKED TO"], ["gut microbiome", "metabolic disorders", "IS LINKED TO"], ["MCC950", "neurological deficits", "CHANGE EFFECT"], ["academic stress", "undergraduate students", "TARGET"], ["PD", "Serratia", "CHANGE ABUNDANCE"], ["microbiota", "Parkinson's diseases", "IS LINKED TO"], ["depression", "cohabited rat pups", "TARGET"], ["gut dysbiosis", "CS patients", "TARGET"], ["multi-ingredient fermented whey supplement", "self-reported GI symptoms", "INFLUENCE"], ["<i>genus</i>_<i>Subdoligranulum</i>", "OSA onset", "INFLUENCE"], ["BCAAs", "Hoehn and Yahr stage", "INFLUENCE"], ["gut inflammation", "LD group", "TARGET"], ["antibiotics", "gut microbiota", "IMPACT"], ["MIA", "ASD", "AFFECT"], ["gut microbiota alterations", "NDDs", "AFFECT"], ["upward and downward 150 mT SMF groups", "open field and elevated plus test", "USED BY"], ["Fisetin", "Parkinson's Disease", "CHANGE EFFECT"], ["PD", "dopaminergic neuron loss", "AFFECT"], ["MPTP-treated mice", "16S rRNA sequencing", "USED BY"], ["gut microbiota", "brain dysfunctions", "IS LINKED TO"], ["anxiety disorder", "gut dysbiosis", "AFFECT"], ["CA", "SCFA", "INTERACT"], ["CUMS", "Offspring rats", "TARGET"], ["Parkinson's disease", "dopaminergic neuron degeneration", "AFFECT"], ["Parkinson's disease", "Occidental Patients", "TARGET"], ["depression", "healthy adults", "TARGET"], ["intestinal microbiota", "wild-type littermates", "LOCATED IN"], ["chronic diseases", "GM-SCI", "AFFECT"], ["gut microbiota", "CNS", "LOCATED IN"], ["dexamethasone (DEX) group", "western blot", "USED BY"], ["Mediterranean Diet", "Gut Microbiota", "IMPACT"], ["Christensenellaceae", "PD", "INFLUENCE"], ["NCs", "16S rRNA sequencing", "USED BY"], ["neurotoxic compounds", "neuronal injury", "INFLUENCE"], ["central nervous system (CNS) antigens", "psychological stress", "INFLUENCE"], ["dietary therapy", "NDs", "INFLUENCE"], ["Lactobacillus_salivarius", "GM", "PART OF"], ["neurodegenerative disease", "rhesus monkeys", "TARGET"], ["LP299v", "N-acyl taurines", "INTERACT"], ["Levilactobacillus brevis", "stress-related sleep disturbances", "INFLUENCE"], ["<i>Ping-wei-san plus</i> herbal therapy", "Parkinson's disease", "INFLUENCE"], ["Parkinson's disease", "GAPDH", "INTERACT"], ["psychoactive metabolites", "stress-related disorders", "INFLUENCE"], ["SN", "PD mice", "LOCATED IN"], ["Vagal Tone", "Adults", "TARGET"], ["microbiota-derived short-chain fatty acids", "vascular dementia", "INFLUENCE"], ["Mediterranean diet", "cognitive decline", "INFLUENCE"], ["Western diet", "neurodegenerative diseases", "INFLUENCE"], ["Gut microbiota", "alteration", "IS LINKED TO"], ["calorie-controlled diets", "Parkinson disease", "INFLUENCE"], ["GM", "behavioural and psychological symptoms of dementia", "IS LINKED TO"], ["fermented foods", "diabetes", "INFLUENCE"], ["NAS-induced dysbiosis", "healthy human subjects", "TARGET"], ["PM", "BDNF", "INTERACT"], ["pollutants", "gut microbiome", "IMPACT"], ["Stenotrophomonas", "AD-induced <i>Drosophila</i>", "LOCATED IN"], ["BMAA", "diatoms", "IMPACT"], ["butyrate-producing taxa", "Akkermansia", "INTERACT"], ["5-HIAA", "SNpc", "LOCATED IN"], ["probiotics", "human gut microbiota", "IMPACT"], ["LPS plus rotenone-induced neurotoxicity", "Rats", "TARGET"], ["intestinal metabolites of microbial origin", "small and large intestine", "LOCATED IN"], ["progressive impairment of motor and non-motor functions", "aging people", "TARGET"], ["ASO mice", "Single-cell RNA-seq analysis", "USED BY"], ["Mediterranean Diet", "Depression", "INFLUENCE"], ["CSDS", "Ephx2 knock-out (KO) mice", "TARGET"], ["prefrontal cortex", "antibiotic-treated mice", "LOCATED IN"], ["gut microbiota", "type 2 diabetes mellitus", "IS LINKED TO"], ["gut microbiota", "Alzheimer's and Parkinson's diseases", "IS LINKED TO"], ["anxiety-like behaviour", "anxious mice", "TARGET"], ["malnutrition", "cognitive decline", "AFFECT"], ["intestinal flora", "MDD patients", "LOCATED IN"], ["Adult specific pathogen free (SPF) Sprague-Dawley rats", "ORT", "USED BY"], ["CUR", "Staphylococcaceae", "IMPACT"], ["migraine", "gastrointestinal disorders", "AFFECT"], ["patients", "HOMA-IR", "USED BY"], ["Depression", "stroke", "AFFECT"], ["anorexia nervosa", "patients", "TARGET"], ["host gut microbiome", "PD patients", "LOCATED IN"], ["gut microbiota", "multimodal MRI", "USED BY"], ["Olanzapine", "Gut Microbiota", "IMPACT"], ["stress response", "intestinal", "STRIKE"], ["Gut microbiota", "rhesus monkeys", "LOCATED IN"], ["fiber intake", "maternal mental health disorders", "INFLUENCE"], ["EGCG", "PD symptoms", "INFLUENCE"], ["GI infections", "postinfection disorders of gut-brain interaction", "AFFECT"], ["gut microbiome", "metabotype-0 patients", "LOCATED IN"], ["alterations", "PD and healthy controls", "TARGET"], ["excess body weight during and after pregnancy", "obesity", "AFFECT"], ["SCFA", "colon", "LOCATED IN"], ["psychobiotics", "psychiatric conditions", "INFLUENCE"], ["cinnabar", "neurodegenerative diseases", "INFLUENCE"], ["Flavonoids from Seabuckthorn", "CUMS-induced depressive disorder", "INFLUENCE"], ["Bacillus subtilis probiotic strain PXN21", "synucleinopathy", "INFLUENCE"], ["SCFAs", "adult mice", "LOCATED IN"], ["gastrointestinal disorders", "schizophrenia", "AFFECT"], ["SHH", "Prevotellaceae_UCG-001", "IMPACT"], ["neurodegenerative disease", "A53T monkeys", "TARGET"], ["As<sub>4</sub>S<sub>4</sub>", "LPS plus ROT induced neurotoxicity", "INFLUENCE"], ["CBD", "specific ASD symptoms and comorbidities", "INFLUENCE"], ["Flavonifractor", "positive emotionality", "INFLUENCE"], ["oral microbiota", "neuroinflammation", "IS LINKED TO"], ["Dry eye discomfort", "anxiety disorders", "AFFECT"], ["fermented soy foods", "neurodegenerative diseases", "INFLUENCE"], ["prebiotics", "intestinal inflammatory diseases", "INFLUENCE"], ["CRS", "mice", "TARGET"], ["anxiety/depression", "depressed mother rats", "TARGET"], ["Gram-negative bacteria", "Neurodegenerative diseases", "INFLUENCE"], ["terpenoids", "MDD", "INFLUENCE"], ["GMB", "SCZ", "IS LINKED TO"], ["bioactive polyphenols", "neuronal death", "INFLUENCE"], ["AFF", "I-FABP", "INTERACT"], ["Acetaminophen (APAP) overdose-induced acute liver injury", "extensive oxidative stress", "AFFECT"], ["amino acid transmitters", "gut microbiota", "IMPACT"], ["healthy diet", "brain health", "INFLUENCE"], ["Verrucomicrobiaceae", "gut microbiota", "PART OF"], ["Roseburia", "PD", "INFLUENCE"], ["trehalose", "synaptic protein expression level", "CHANGE EXPRESSION"], ["<i>Lactobacillus plantarum</i> DP189", "\u03b1-synuclein (\u03b1-SYN) aggregates", "INTERACT"], ["microbiota-derived short-chain fatty acids", "multiple sclerosis", "INFLUENCE"], ["PD", "Eggerthella lenta", "CHANGE ABUNDANCE"], ["TPG", "Selenomonadales", "IMPACT"], ["antibiotic therapy", "Gut microbes", "IMPACT"], ["Piperine", "arthritis", "INFLUENCE"], ["Depression", "osteoporosis", "AFFECT"], ["gut microbes", "controls", "LOCATED IN"], ["psychological stress", "psychiatrically healthy medical students", "TARGET"], ["cadmium", "bacteria", "IMPACT"], ["amyotrophic lateral sclerosis", "SOD1 mice", "TARGET"], ["patients", "Quantitative SYBR Green Real-Time PCR", "USED BY"], ["PM", "neuronal loss", "INFLUENCE"], ["FWGs", "stress-induced depression", "INFLUENCE"], ["Bisphenol A", "neurological and overall mental health", "INFLUENCE"], ["KD", "Gut microbes", "IMPACT"], ["Jianpi Jiedu decoction", "M2", "CHANGE EXPRESSION"], ["people", "therapeutic exercises", "USED BY"], ["misfolded protein \u03b1-syn", "gut", "LOCATED IN"], ["memory deficits", "KO mice", "TARGET"], ["SCFAs", "amyotrophic lateral sclerosis", "INFLUENCE"], ["associated synaptic proteins", "FD mice", "LOCATED IN"], ["amyotrophic lateral sclerosis", "ND patients", "TARGET"], ["control animals", "immunohistochemistry", "USED BY"], ["sleep quality", "athletes", "TARGET"], ["liver", "humans", "LOCATED IN"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "dopamine", "INTERACT"], ["stress", "interleukin-18", "INTERACT"], ["70W", "Methanobacteriaceae", "IMPACT"], ["dysbiosis of the gastrointestinal tract", "autism", "AFFECT"], ["Gut Microbiota", "Neurodegenerative Diseases", "IS LINKED TO"], ["gut microbiota", "gut-brain", "LOCATED IN"], ["gut microbiota", "lesion studies", "USED BY"], ["gastric cancer", "substantiated local gastric pathologies", "AFFECT"], ["<i>Lactobacillus</i> strains", "AD-induced <i>Drosophila</i>", "LOCATED IN"], ["gut microbiota", "eating disorders", "IS LINKED TO"], ["disturbances", "gut bacterial community", "CHANGE ABUNDANCE"], ["IBD", "patients", "TARGET"], ["CORT", "DEX-treated mice", "LOCATED IN"], ["Enterococcus faecalis", "PD", "INFLUENCE"], ["PD", "rigidity", "AFFECT"], ["ketogenic diet", "epilepsy", "INFLUENCE"], ["Low FODMAP diet", "Psychopathology", "INFLUENCE"], ["healthy controls", "multiomics study", "USED BY"], ["gut microbiota", "metatranscriptomics", "USED BY"], ["PD", "reduced microbial diversity", "CHANGE ABUNDANCE"], ["dyslipidemia", "Chinese population", "TARGET"], ["GM", "neural plasticity", "IS LINKED TO"], ["oxaliplatin", "butyrate-producing bacteria", "IMPACT"], ["Bipolar disorder", "reduced life expectancy", "AFFECT"], ["Anti-Infective Agents", "Parkinson's Disease", "CHANGE EFFECT"], ["gut microbiota", "disease-related malnutrition", "IS LINKED TO"], ["Fibrobacteres", "phosphocholine", "INTERACT"], ["gastrointestinal microbiota", "multiple sclerosis", "IS LINKED TO"], ["progressive, multifaceted neurodegenerative disease", "gut problems", "AFFECT"], ["IS", "elastin degradation", "INFLUENCE"], ["Probiotic treatment", "gut microbioma", "IMPACT"], ["appendix microbiome", "vermiform appendix", "LOCATED IN"], ["adipokine", "adipose tissue", "LOCATED IN"], ["psychiatric and neurological conditions", "gut microbiota", "CHANGE ABUNDANCE"], ["microbiome", "neurodegenerative diseases", "IS LINKED TO"], ["AAA", "PD patients", "LOCATED IN"], ["occludin", "increased gut permeability", "INFLUENCE"], ["herpesvirus", "AD", "INFLUENCE"], ["Serratia", "Gut Microbiota", "PART OF"], ["progressive, multifaceted neurodegenerative disease", "weight loss", "AFFECT"], ["Nutritional interventions", "mental health decline", "INFLUENCE"], ["breast milk microbiota", "newborns", "LOCATED IN"], ["SND", "Parvibacter_caecicola", "CHANGE ABUNDANCE"], ["PD", "progressive neurodegenerative disorder", "IS A"], ["transient gut dysbiosis", "late onset neuropathologies", "AFFECT"], ["propionate", "patients", "LOCATED IN"], ["chronic insomnia disorder", "Individuals", "TARGET"], ["Clostridium genus", "PD", "INFLUENCE"], ["BHB", "FA3R", "INTERACT"], ["Di-(2-ethylhexyl) phthalate", "severe organ damage", "INFLUENCE"], ["entacapone", "16S rRNA", "CHANGE EXPRESSION"], ["non-suicidal self-injury", "adolescents", "TARGET"], ["human gut microbiota", "dysbiosis", "IS LINKED TO"], ["IBS", "chronic debilitating issues", "IS A"], ["Parkinson's disease", "human host", "TARGET"], ["levodopa", "Parkinson's disease", "CHANGE EFFECT"], ["butyrate-producing bacteria", "gut microbiota", "PART OF"], ["PD patients", "deep brain stimulation", "USED BY"], ["3-Methylindole", "Gut microbiota", "PRODUCED BY"], ["gut bacteria", "PD therapy", "INFLUENCE"], ["Enterococcus faecalis", "Gut microbiota", "PART OF"], ["6-OHDA", "Bcl-2/Bax", "CHANGE EXPRESSION"], ["gut microbiota", "qPCR", "USED BY"], ["Parkinson's disease", "Bifidobacterium", "CHANGE ABUNDANCE"], ["microbial metabolites", "nervous system", "LOCATED IN"], ["microbiota", "metabolic diseases", "IS LINKED TO"], ["bacteria", "human microbiome", "PART OF"], ["PD", "midbrain", "STRIKE"], ["microbiota modifications", "fecal metabolites", "INTERACT"], ["arketamine", "NMDAR", "INTERACT"], ["Porphyromonas gingivalis", "cognitive impairment", "INFLUENCE"], ["Synergistetes", "gut microbiota", "PART OF"], ["early PD", "Myristic acid", "INTERACT"], ["gut microbiome", "neurological diseases", "IS LINKED TO"], ["Meals", "microbiota", "IMPACT"], ["stress", "interleukin-1\u03b2", "INTERACT"], ["cytokines", "inflammation", "INFLUENCE"], ["JPJDF", "gut microbiota", "IMPACT"], ["gut microbiota", "C. rodentium</i> infection", "IS LINKED TO"], ["claudin-5", "systemic inflammation", "INFLUENCE"], ["Fermented foods", "Lactobacilli", "IMPACT"], ["Lachnospiraceae", "fisetin intervented MPTP group gut microbiota", "PART OF"], ["polyunsaturated fatty acids", "depression", "INFLUENCE"], ["caffeine consumption", "PD", "INFLUENCE"], ["IBD-associated comorbidities", "IBD patients", "TARGET"], ["mental disorders", "bacteria associated with glutamate and GABA metabolism", "CHANGE ABUNDANCE"], ["Adolescent female mice", "sequencing 16S rDNAs", "USED BY"], ["nutraceutical supplementations", "bronchopulmonary dysplasia", "INFLUENCE"], ["Gut microbiota-derived metabolite trimethylamine N-oxide", "early Parkinson's disease", "INFLUENCE"], ["glutamate metabolites", "ASD group", "LOCATED IN"], ["\u03b2-HgS-containing 70W", "chronic LPS plus MPTP-induced toxicity to the brain and gut", "CHANGE EFFECT"], ["antidepressant", "depressive symptoms", "CHANGE EFFECT"], ["gut microbiota", "PD-related gut microbiota dysbiosis", "IS LINKED TO"], ["Firmicutes", "depression", "INFLUENCE"], ["antidepressants", "gut microbiome", "IMPACT"], ["menthol", "IBS", "INFLUENCE"], ["Bacteroidetes", "GM", "PART OF"], ["BAs", "terminal ileum", "LOCATED IN"], ["patients", "16S ribosomal RNA gene sequencing", "USED BY"], ["serum metabolites", "PD", "INFLUENCE"], ["extremely severe impairment of propulsive motility", "Pediatric chronic intestinal pseudo-obstruction", "AFFECT"], ["motor symptoms", "human PD cases", "TARGET"], ["Enterobacteriaceae", "intestinal microbiota", "PART OF"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "intestinal pathology", "INFLUENCE"], ["intestinal bacteria", "MDD", "INFLUENCE"], ["LPHP", "Pnpla3", "CHANGE EXPRESSION"], ["gut dysbiosis", "human PD cases", "TARGET"], ["valerate", "gut microbiota", "PRODUCED BY"], ["GI infections", "DGBI", "AFFECT"], ["gut-microbiome", "adult Attention-deficit/hyperactivity disorder", "IS LINKED TO"], ["phylum Actinobacteria", "gut microbiota", "PART OF"], ["severe parkinsonism", "male cases", "TARGET"], ["PM", "PD", "INFLUENCE"], ["Cyanidin-3-<i>O</i>-Glucoside", "Parkinson's Disease", "INFLUENCE"], ["lipopolysaccharide", "ND", "INFLUENCE"], ["microbiota-derived metabolites", "neurological disorders", "INFLUENCE"], ["motor deficits", "PD patients", "TARGET"], ["epigenetic modification", "NaB", "INTERACT"], ["ICH", "Dubosiella", "CHANGE ABUNDANCE"], ["realgar", "neurodegenerative diseases", "INFLUENCE"], ["polymannuronic acid", "BDNF", "INTERACT"], ["gut microbiota", "neurological and psychiatric diseases", "IS LINKED TO"], ["MS", "patients", "TARGET"], ["Clostridium", "anxiety", "INFLUENCE"], ["eicosapentaenoic acid", "depressive symptoms", "INFLUENCE"], ["dietary components", "bacterial communities", "IMPACT"], ["glucose", "gut microbiota", "PRODUCED BY"], ["heavy metals", "bacteria", "IMPACT"], ["pathogenic bacteria", "gut microbiota", "PART OF"], ["Parkinson's disease", "patients", "TARGET"], ["L. reuteri DSM 17938", "ASD", "INFLUENCE"], ["significantly altered bacterial taxa", "gut microbiota", "PART OF"], ["microbiota", "PD incidence and progression", "IS LINKED TO"], ["gut microbiota", "two-sample Mendelian randomization (MR) analysis", "USED BY"], ["neurodegenerative disorder", "microbiota composition", "CHANGE ABUNDANCE"], ["nutritional and dietary interventions", "maternal depression and anxiety", "INFLUENCE"], ["PD", "peripheral dysregulations", "AFFECT"], ["gut microbiota", "autism spectrum disorders", "IS LINKED TO"], ["Gut Microbiota", "OSA", "IS LINKED TO"], ["uncontrolled intake of refined carbohydrates", "metabolic syndrome", "INFLUENCE"], ["obesity", "peripheral low-grade inflammation", "AFFECT"], ["TAS2R38 bitter taste receptor", "PD", "INFLUENCE"], ["mice", "16S rRNA (V3 and V4 regions) sequencing", "USED BY"], ["probiotics", "neurological diseases", "INFLUENCE"], ["(R,S)-ketamine", "rodents", "ADMINISTERED"], ["gut microbiome", "metabolic syndrome", "IS LINKED TO"], ["intestine microbiota", "rhesus monkeys", "LOCATED IN"], ["LPS", "Iba1", "CHANGE EXPRESSION"], ["sulforaphane", "TREM2", "CHANGE EXPRESSION"], ["Sodium oligomannate", "gut bacterial amino acids-shaped neuroinflammation", "INFLUENCE"], ["K01817", "gut microbiota", "PRODUCED BY"], ["canine anxiety disorders", "dogs", "TARGET"], ["gut microbiomes", "PD", "IS LINKED TO"], ["DEHP", "reproductive toxicity", "INFLUENCE"], ["major depressive disorder", "Asian, Chinese group", "TARGET"], ["MDD", "Bifidobacterium", "CHANGE ABUNDANCE"], ["HA", "gut microbiota", "IMPACT"], ["Gram-negative bacteria", "Parkinson's disease", "INFLUENCE"], ["environmental heavy metals", "host-associated microbiome", "IMPACT"], ["Lactobacillus", "neurological disorders", "INFLUENCE"], ["BHB", "SALS", "INTERACT"], ["metabolites", "GM", "PRODUCED BY"], ["gut microbes", "ALS", "IS LINKED TO"], ["Zn<sup>2+</sup>", "COVID-19", "INFLUENCE"], ["healthy volunteers", "ELISA technology", "USED BY"], ["IA", "mice", "TARGET"], ["Verrucomicrobiaceae", "gut microbiomes", "PART OF"], ["immune response", "blood-brain barrier", "STRIKE"], ["intestinal microenvironment", "mice", "LOCATED IN"], ["families Christensenellaceae and Eggerthellaceae", "gut microbiota", "PART OF"], ["probiotics", "Gut Microbiota", "IMPACT"], ["gut microbiota", "behavioral dysfunction", "IS LINKED TO"], ["KD", "anxiety", "INFLUENCE"], ["nutritional deficiencies", "NDDs", "AFFECT"], ["rotenone", "Verrucomicrobiaceae", "IMPACT"], ["Yersinia spp.", "gut microbiota", "PART OF"], ["gut microbiota", "neurodevelopmental disorders", "IS LINKED TO"], ["caffeine", "dopaminergic neurodegeneration", "INFLUENCE"], ["non-TD", "Lachnospira", "CHANGE ABUNDANCE"], ["polyphenols", "microbiota", "IMPACT"], ["Psychoses", "People", "TARGET"], ["PD", "SCFAs", "INTERACT"], ["inflammatory lesions", "KO mice", "TARGET"], ["non-TD", "Coprococcus", "CHANGE ABUNDANCE"], ["IBS-D", "Patients", "TARGET"], ["gut microbiota metabolites", "vascular dementia", "INFLUENCE"], ["Lachnospiraceae", "microbiota", "PART OF"], ["SC-I-84", "NS patients", "LOCATED IN"], ["BMAA", "intestinal inflammation", "INFLUENCE"], ["glucuronic acid", "gut microbiota", "PRODUCED BY"], ["gut microbiota", "depressed rats", "LOCATED IN"], ["schizophrenia", "mental health disorders", "IS A"], ["PD patients", "functional analysis", "USED BY"], ["microbiota", "SOD1 mice", "LOCATED IN"], ["gut microbiome", "Prader-Willi syndrome", "IS LINKED TO"], ["intestinal dysbacteriosis", "MPTP mice", "TARGET"], ["BAs", "liver depression and spleen deficiency", "INFLUENCE"], ["Haemophilus", "depression", "INFLUENCE"], ["gut microbes", "Alzheimer's disease", "IS LINKED TO"], ["intestine microbiota", "A53T monkeys", "LOCATED IN"], ["Parkinson's disease", "Glyceraldehyde-3-phosphate dehydrogenase", "INTERACT"], ["altered gut microbiota", "SCFA receptor knockout mice", "LOCATED IN"], ["Gut Microbiome", "amyotrophic lateral sclerosis", "IS LINKED TO"], ["zinc", "diabetes", "INFLUENCE"], ["Major depression", "disability", "AFFECT"], ["antidepressant treatment", "gut microbiome", "IMPACT"], ["Parkinson's Disease", "Mice", "TARGET"], ["gut disorders", "irritable bowel syndrome", "AFFECT"], ["gastrointestinal symptoms", "Parkinson's disease", "AFFECT"], ["Microbiome", "Depression-like Behaviour", "IS LINKED TO"], ["altered gut microbiota", "patients", "LOCATED IN"], ["plasticizer", "toxicity", "INFLUENCE"], ["PD", "alterations to the protein \u03b1-synuclein", "AFFECT"], ["PD", "Erysipelotrichaceae", "CHANGE ABUNDANCE"], ["Glyceric acid", "intestine microbiota", "PRODUCED BY"], ["patients", "liquid chromatography-tandem mass spectrometry analysis", "USED BY"], ["SD", "gut microbiota", "CHANGE ABUNDANCE"], ["human microbiota", "reproductive organs", "LOCATED IN"], ["depression", "human host", "TARGET"], ["GV-971", "gut dysbiosis", "CHANGE EFFECT"], ["Turicibacteraceae", "TLCA", "INTERACT"], ["BB05", "gut microbial", "IMPACT"], ["Gut Microbiota", "akinetic-rigid features", "IS LINKED TO"], ["probiotic NVP-1704", "sleep disturbances", "INFLUENCE"], ["gut microbiome", "rats", "LOCATED IN"], ["\u03b1-synuclein fibrils", "gut dysbiosis", "INFLUENCE"], ["Dialister", "bacteria", "INTERACT"], ["gut microbiota", "psychiatry and other central nervous system (CNS) disorders", "IS LINKED TO"], ["arketamine", "CRS-induced body weight loss", "CHANGE EFFECT"], ["LPS plus ROT induced neurotoxicity", "Rats", "TARGET"], ["mild metabolic disturbances", "patients", "TARGET"], ["Campylobacter jejuni", "2-keto-glutaramic acid", "INTERACT"], ["PD", "PD mice", "TARGET"], ["lead", "Alzheimer's disease", "INFLUENCE"], ["gut epithelium", "autistic individuals", "LOCATED IN"], ["Gut microbial-derived metabolites", "neurological diseases", "INFLUENCE"], ["ROT", "Enterobacteeriaceae", "IMPACT"], ["<i>L. plantarum</i> DP189", "oxidative stress", "INFLUENCE"], ["Lactobacillus", "Parkinson's disease", "INFLUENCE"], ["plasticizer", "abundance of potential pathogens and microbial genes", "INFLUENCE"], ["depression-like behaviors", "Rats", "TARGET"], ["CT-26", "Alloprevotella", "IMPACT"], ["5-HIAA", "substantia nigra pars compacta", "LOCATED IN"], ["rhEPO", "Odoribacter", "IMPACT"], ["EPS", "hypnotic effects", "INFLUENCE"], ["distinct clustering", "groups", "TARGET"], ["Lactobacillus plantarum PS128", "abnormal behaviors", "INFLUENCE"], ["Parkinson's disease", "neurodegenerative diseases", "IS A"], ["Actinobacteria phylum", "suicidality", "INFLUENCE"], ["pathogenic microbial metabolites", "neuroinflammation", "INFLUENCE"], ["Cinnabar", "DA neuron loss", "INFLUENCE"], ["curcumin", "Parkinson's disease", "INFLUENCE"], ["chronic stress", "patients", "TARGET"], ["AEA", "anxiety-like behavior", "INFLUENCE"], ["gut microbiota", "Amyotrophic Lateral Sclerosis", "IS LINKED TO"], ["ND", "gut microbiota-induced systemic chronic inflammation", "AFFECT"], ["Probiotics", "major depressive disorder", "INFLUENCE"], ["Psychoactive Metabolites", "Gut Bacteria", "IMPACT"], ["LPS", "Enterobacteeriaceae", "IMPACT"], ["intestinal microbiota disorders", "patients", "TARGET"], ["Rikenellaceae", "microbiota", "PART OF"], ["gut microbiota", "chronic metabolic diseases", "IS LINKED TO"], ["Parkinson's disease", "SD rats", "TARGET"], ["Gut Microbiota", "Glaucoma Progression", "IS LINKED TO"], ["gut microbiota", "motor complications", "IS LINKED TO"], ["PD", "Verrucomicrobiaceae", "CHANGE ABUNDANCE"], ["propionate", "controls", "LOCATED IN"], ["Gut microbes", "central nervous system (CNS) disorders", "IS LINKED TO"], ["\u03b1-LA", "polycystic ovary syndrome", "INFLUENCE"], ["HFD-original", "behavioral dysfunction", "CHANGE EFFECT"], ["increased intestinal permeability", "R6/2 mice", "TARGET"], ["gut microbiota", "ocular conditions", "IS LINKED TO"], ["Human Gut-Microbiota", "Neurodegenerative Disorders", "IS LINKED TO"], ["NOX2", "Neurodegenerative diseases", "INFLUENCE"], ["SS", "patients", "TARGET"], ["taxa", "PD", "INFLUENCE"], ["PINK1", "hippocampus", "LOCATED IN"], ["\"depression-related\" microbiome", "depression", "IS LINKED TO"], ["bacteria", "microbiota", "PART OF"], ["amyloidogenic proteins", "amyloid-related diseases", "INFLUENCE"], ["Gastrointestinal (GI) symptoms and pathology", "PD", "AFFECT"], ["trimethylamine N-oxide", "early Parkinson's disease", "INFLUENCE"], ["Tianqi Pingchan Granule", "Parkinson's disease", "CHANGE EFFECT"], ["PwP", "Illumina sequencing", "USED BY"], ["<i>L. plantarum</i> DP189", "reactive oxygen species", "INTERACT"], ["gut microbiota", "aging related neurodegeneration", "IS LINKED TO"], ["intestine microbiota", "metagenomic sequencing", "USED BY"], ["XPro1595", "PD", "CHANGE EFFECT"], ["swollen tyrosine hydroxylase-positive varicosities", "submucosal plexus", "STRIKE"], ["microbiota", "radioactive labeling", "USED BY"], ["MPTP", "Pronicromonosporaceae", "IMPACT"], ["hippocampus", "C57BL/6J mice", "LOCATED IN"], ["Firmicutes", "PD mice", "LOCATED IN"], ["viral infection", "PD patients", "TARGET"], ["gut microbiota dysbiosis", "multiple sclerosis", "AFFECT"], ["adequate protein", "AD", "INFLUENCE"], ["paraprobiotics", "behavioural and neurobiological abnormalities", "INFLUENCE"], ["AD progression", "isoleucine", "INTERACT"], ["Enterococusfaecalis", "gut microbiota", "PART OF"], ["Blautia", "PD", "INFLUENCE"], ["Di-(2-ethylhexyl) phthalate", "liver toxicity", "INFLUENCE"], ["P. gingivalis", "\u03b1-Syn", "INTERACT"], ["depression", "male mice", "TARGET"], ["Methamphetamine", "addiction", "CHANGE EFFECT"], ["microbiota-derived metabolites", "anxiety", "INFLUENCE"], ["gut microbiota", "peripheral inflammation", "IS LINKED TO"], ["trimethoprim", "PD", "CHANGE EFFECT"], ["Crohn\u2019s disease", "patients", "TARGET"], ["live L. plantarum CCFM8661", "serum hormone", "INTERACT"], ["betulinic acid", "TREM2", "CHANGE EXPRESSION"], ["gastrointestinal dysfunctions", "PD patients", "TARGET"], ["constipation", "systemic microbial metabolites", "INTERACT"], ["LPS", "LPS-induced splenomegaly", "INFLUENCE"], ["phytochemicals", "mammalian gut microbiota", "IMPACT"], ["\u03b1-synuclein protein", "neuronal loss", "INFLUENCE"], ["flu", "ASD", "AFFECT"], ["Parabacteroides", "Children", "LOCATED IN"], ["microbiota-based probiotic dietary supplementation", "neurodegeneration", "INFLUENCE"], ["gut microbiota", "alterations", "IS LINKED TO"], ["endogenous host proteins", "BDPAs", "INTERACT"], ["Eisenbergiella", "ADHD", "INFLUENCE"], ["GM", "Alzheimer's disease", "IS LINKED TO"], ["gut microbial", "diarrhea", "IS LINKED TO"], ["Gut microbiota dysbiosis", "murine rodents", "TARGET"], ["LPS", "Clostridaceae species", "IMPACT"], ["PD", "Robinsoniella", "CHANGE ABUNDANCE"], ["Verucomicrobia", "gut microorganisms", "PART OF"], ["microbiota", "metagenomic sequencing", "USED BY"], ["probiotics", "intestinal inflammation", "INFLUENCE"], ["dysbiosis", "human host", "TARGET"], ["PD", "butyrate producing bacteria", "CHANGE ABUNDANCE"], ["gut microbiota", "NOD mice", "LOCATED IN"], ["Bipolar disorder", "morbidity", "AFFECT"], ["Psychotropics", "antidepressant effects", "CHANGE EFFECT"], ["inflammatory processes", "neurological diseases", "AFFECT"], ["Dysbiosis", "mental health disorders", "AFFECT"], ["gut microbes", "MS", "IS LINKED TO"], ["neuroinflammation", "mouse offspring", "TARGET"], ["Cinnabar", "gut microbiome", "IMPACT"], ["hippocampus", "DEX and CUMS groups", "LOCATED IN"], ["oral pathogens", "microbial diversity", "PART OF"], ["SD", "individuals", "TARGET"], ["AAA", "early PD patients", "LOCATED IN"], ["Piperine", "hypertension", "INFLUENCE"], ["lipopolysaccharide", "depression-like phenotype", "INFLUENCE"], ["Helicobacter pylori", "non-commensal gut microbiome", "PART OF"], ["Depression", "AsA", "TARGET"], ["gut microbiota", "amyotrophic lateral sclerosis", "IS LINKED TO"], ["mice", "pole and traction tests", "USED BY"], ["Bifidobacterium", "control", "LOCATED IN"], ["Adiponectin", "diseases of the central nervous system", "INFLUENCE"], ["neuroinflammation", "ND patients", "TARGET"], ["GDNF", "neurodegenerative diseases", "INFLUENCE"], ["GM", "bipolar disorder", "IS LINKED TO"], ["TLE", "people", "TARGET"], ["limonene", "IBS/FD", "INFLUENCE"], ["impaired gut microbiota", "neurological disorders", "IS LINKED TO"], ["Parkinson's disease", "dopaminergic (DA) neurons", "INTERACT"], ["pSS-mediated dry eye", "patients", "TARGET"], ["oral and gut microbiome", "healthy controls", "LOCATED IN"], ["CPZ", "demyelination", "CHANGE EFFECT"], ["SIBO", "primary biliary cholangitis", "AFFECT"], ["gut microbiome", "multiple sclerosis", "IS LINKED TO"], ["intestinal microbiota", "PD patients", "LOCATED IN"], ["fiber", "type 2 diabetes", "INFLUENCE"], ["astilbin", "GM", "IMPACT"], ["Blautia", "altered metabolism rates", "INFLUENCE"], ["stress", "gut microbiome", "CHANGE ABUNDANCE"], ["GM", "neuroinflammation", "IS LINKED TO"], ["MyD88", "gut inflammation", "INFLUENCE"], ["cytokines", "gut microbiota", "IMPACT"], ["probiotics", "anxiety disorders", "INFLUENCE"], ["phosphocholine", "anxiety", "INFLUENCE"], ["entacapone", "auditory hallucinations", "CHANGE EFFECT"], ["plant polysaccharides", "neurodegenerative diseases", "INFLUENCE"], ["Zinc", "Zn deficiency", "INFLUENCE"], ["Bifidobacteriaceae", "suicidality", "INFLUENCE"], ["gut microbiome", "idiopathic PD", "IS LINKED TO"], ["Parabacteroides distasonis", "gut microbiome", "PART OF"], ["Lactobacillaceae", "AET mice", "LOCATED IN"], ["Neferine", "chronic stress-induced depression", "CHANGE EFFECT"], ["microbiota", "cancer", "IS LINKED TO"], ["SCZ", "SCZ patients", "TARGET"], ["behavioral dysfunction", "Firmicutes", "CHANGE ABUNDANCE"], ["PD", "Glyceric acid", "INTERACT"], ["Gut Microbiota", "Mild Metabolic Disorders", "IS LINKED TO"], ["generalized anxiety", "men", "TARGET"], ["leucine", "PD patients", "LOCATED IN"], ["anhedonia", "mice", "TARGET"], ["Mediterranean diet", "diabetes", "INFLUENCE"], ["antidepressant medications", "MDD", "CHANGE EFFECT"], ["Chrna7 KO mice", "subdiaphragmatic vagotomy", "USED BY"], ["probiotic bacteria", "neurodegeneration", "INFLUENCE"], ["\"abnormal\" microbiota", "Alzheimer's", "IS LINKED TO"], ["PD symptoms", "mice", "TARGET"], ["microbiota", "stress", "IS LINKED TO"], ["lactulose", "neuroprotective effect", "INFLUENCE"], ["ASD", "ASD group", "TARGET"], ["L-3,4-dihydroxyphenylalanine (L-DOPA)", "PD", "CHANGE EFFECT"], ["phosphinates", "schizophrenia", "INFLUENCE"], ["Mediterranean diet", "neurological diseases", "INFLUENCE"], ["triphala polyphenols", "stress-induced depression", "INFLUENCE"], ["control (CON) group", "ELISA", "USED BY"], ["Short-chain fatty acid (SCFA)-producing bacteria", "PD", "INFLUENCE"], ["Diarrhea", "Bacteroides", "CHANGE ABUNDANCE"], ["SCFAs", "PD", "INFLUENCE"], ["SCI", "gut dysbiosis", "AFFECT"], ["\u03b1-synuclein protein", "\u03b1-synuclein pathology", "INFLUENCE"], ["(R)-ketamine", "Butyricimonas", "IMPACT"], ["Gram-negative bacteria", "disability", "INFLUENCE"], ["MP extract", "inflammation", "INFLUENCE"], ["lipopolysaccharide", "Verrucomicrobiaceae", "IMPACT"], ["Cryptotanshinone", "gut microbiota", "IMPACT"], ["Altered gut microbiota", "individuals", "LOCATED IN"], ["SCFAs", "autism", "INFLUENCE"], ["SHH", "CS", "INFLUENCE"], ["Flavonifractor", "smokers", "LOCATED IN"], ["commensal gut microbiota", "obesity", "IS LINKED TO"], ["Glyceric acid", "microbiota", "PRODUCED BY"], ["BPD", "Bacteroidetes", "CHANGE ABUNDANCE"], ["Clostridium", "schizophrenia", "INFLUENCE"], ["NADPH oxidase 2", "ND", "INFLUENCE"], ["prebiotics", "depression", "INFLUENCE"], ["Hydrogen Sulfide", "Parkinson's Disease", "INFLUENCE"], ["gut microbiota", "type 1 diabetes mellitus", "IS LINKED TO"], ["gut microbiota", "PMAD", "IS LINKED TO"], ["intestinal flora disorders", "PD patients", "TARGET"], ["TNF-a", "arthropathy", "INFLUENCE"], ["DEHP", "issue and functional damages", "INFLUENCE"], ["arsenic", "late onset neuropathologies", "INFLUENCE"], ["Symprove\u2122", "neurodegeneration", "INFLUENCE"], ["depression", "sleep disturbance", "AFFECT"], ["UC", "idiopathic disorders", "IS A"], ["Bacteroides", "Children", "LOCATED IN"], ["gut dysbiosis", "gut microbiota", "CHANGE ABUNDANCE"], ["food supplement", "IBS", "INFLUENCE"], ["\u03b1-syn", "Parkinson's disease", "INFLUENCE"], ["Lipids", "healthy mature brains", "LOCATED IN"], ["schizophrenia", "people with the major psychiatric disorders", "TARGET"], ["control diet microbiota", "mice", "LOCATED IN"], ["Alzheimer's and Parkinson's disease", "Zn", "INTERACT"], ["aluminum", "late onset neuropathologies", "INFLUENCE"], ["neurological disorder", "people", "TARGET"], ["gut microbes", "CNS disorders", "IS LINKED TO"], ["gut microbiota", "CRS-exposed mice", "LOCATED IN"], ["gut microbiota", "Core antibiotic resistance genes", "CHANGE EXPRESSION"], ["anxiety", "pSS", "AFFECT"], ["dysfunction", "mice", "TARGET"], ["toxicants", "dysbiosis", "INFLUENCE"], ["psychiatric", "patients", "TARGET"], ["Parkinson's disease", "Rikenellaceae_RC9_gut_group", "CHANGE ABUNDANCE"], ["synbiotic", "GM", "IMPACT"], ["anxiety disorder", "individuals", "TARGET"], ["human gut microbiota", "cancer", "IS LINKED TO"], ["tyrosine", "PD patients", "LOCATED IN"], ["Akkermansia", "gut microbiota", "PART OF"], ["patients", "Shotgun metagenomic sequencing", "USED BY"], ["probiotics", "multiple sclerosis", "INFLUENCE"], ["gastrointestinal microbiota", "gut", "LOCATED IN"], ["antibiotic treatments", "Alzheimer's disease", "CHANGE EFFECT"], ["Microbially derived toxic bile acids", "Parkinson's disease", "INFLUENCE"], ["Inflammatory bowel disease", "intestine", "STRIKE"], ["Participants", "untargeted metabolomics", "USED BY"], ["esophageal carcinoma", "patients", "TARGET"], ["Chronic stress", "adolescents", "TARGET"], ["Short-chain fatty acids", "Parkinson disease", "INFLUENCE"], ["invasive breast cancer", "women", "TARGET"], ["maternal fiber intake", "PDA", "INFLUENCE"], ["JPJDF", "intestinal inflammation", "CHANGE EFFECT"], ["Major Depressive Disorder", "Patients", "TARGET"], ["<i>Lactobacillus plantarum</i> DR7", "AD-induced <i>Drosophila</i>", "LOCATED IN"], ["subthreshold depression", "young adults", "TARGET"], ["PD", "TMAO", "INTERACT"], ["microbes", "AD", "INFLUENCE"], ["gut microbes", "ASDs", "IS LINKED TO"], ["non-TD", "Blautia", "CHANGE ABUNDANCE"], ["Lactobacillaceae", "tyrosine", "INTERACT"], ["Gut microbiota", "MDD", "IS LINKED TO"], ["altered gut microbiota", "human case-control studies", "LOCATED IN"], ["gut flora", "colorectal cancer", "IS LINKED TO"], ["inflammation", "non-human primates", "TARGET"], ["mild metabolic disorders", "patients", "TARGET"], ["plant foods", "colon cancer", "INFLUENCE"], ["Pseudobutyrivibrio", "altered metabolism rates", "INFLUENCE"], ["p-Hydroxyphenylacetic acid", "Gut microbiota", "PRODUCED BY"], ["Serratia", "gut microbiota", "PART OF"], ["group 1", "double-blind, randomized, placebo-controlled trial", "USED BY"], ["vegetables", "gut microbiota", "IMPACT"], ["PD", "Escherichia", "CHANGE ABUNDANCE"], ["PD", "multiple system atrophy", "AFFECT"], ["NOX2", "Parkinson's disease", "INFLUENCE"], ["Prenatal Stress", "Microbiota-Induced Immune Dysregulation", "AFFECT"], ["GMB", "SCZ patients", "LOCATED IN"], ["Injury to neurons", "chronic traumatic encephalopathy", "AFFECT"], ["social avoidance effects", "chronic social defeat", "AFFECT"], ["Parkinson's disease", "GM", "CHANGE ABUNDANCE"], ["minocycline", "AD and PD patients", "ADMINISTERED"], ["neurological diseases", "aetiopathogenesis", "AFFECT"], ["impact", "IBS patients", "TARGET"], ["chronic psychological stress", "participants", "TARGET"], ["disrupted microbiome", "glioma", "IS LINKED TO"], ["spermidine", "GM", "PRODUCED BY"], ["Parkinson's disease", "impaired movement", "AFFECT"], ["ultra-processed foods", "low-grade systemic inflammatory and oxidative changes", "INFLUENCE"], ["patients with schizophrenia", "16S rRNA sequencing", "USED BY"], ["Adult specific pathogen free (SPF) Sprague-Dawley rats", "sucrose preference test", "USED BY"], ["Proteobacteria abundance in the fecal samples", "SD rats", "TARGET"], ["neurodegenerative diseases", "patients", "TARGET"], ["DEHP", "Parkinson's disease", "INFLUENCE"], ["oral antibiotics", "PD", "CHANGE EFFECT"], ["harmful substances", "GM", "PRODUCED BY"], ["IL-17", "AI", "INFLUENCE"], ["chronic unpredictable mild stress", "depressed mother", "TARGET"], ["gut microbiota", "LPS-treated mice", "LOCATED IN"], ["PS128", "motor deficits", "INFLUENCE"], ["Depression", "Asian Americans", "TARGET"], ["intestines", "dogs", "LOCATED IN"], ["dihydro-3-coumaric acid", "gut microbiota", "IMPACT"], ["nucleotide-binding oligomerization domain", "substantia nigra", "LOCATED IN"], ["gastric <i>H. suis</i>", "oxidative stress", "INFLUENCE"], ["KD", "autism spectrum disorders", "INFLUENCE"], ["maternal depression", "offspring", "TARGET"], ["prebiotics", "psychiatric disorders", "INFLUENCE"], ["dysbiotic gut microbiome", "chronic restraint stress", "IS LINKED TO"], ["probiotic formulation", "Lactiplantibacillus plantarum P30025", "IMPACT"], ["host gut microbiome", "Parkinson's disease", "IS LINKED TO"], ["Coprococcus", "Parkinson's disease", "INFLUENCE"], ["BMAA", "loss of barrier integrity", "INFLUENCE"], ["NTS-binding IgG", "Parkinson's disease", "INFLUENCE"], ["MDD", "participants", "TARGET"], ["Maternal Gut Microbiome", "PMAD", "IS LINKED TO"], ["KD", "MS", "INFLUENCE"], ["helminth infections", "cognitive impairment", "AFFECT"], ["social avoidance behaviors", "Male C57BL/6 mice", "TARGET"], ["Betaine supplementation", "chronic social defeat stress", "INFLUENCE"], ["low carbohydrate", "gut microbiome", "IMPACT"], ["short-chain fatty acids", "Alzheimer's disease", "INFLUENCE"], ["prebiotic PM", "PD", "INFLUENCE"], ["rifaximin", "inflammation status", "CHANGE EFFECT"], ["pathogens", "neuroinflammation", "INFLUENCE"], ["gut microbiota", "cholesterol accumulation", "IS LINKED TO"], ["lipopolysaccharide", "chronic neuroinflammation", "INFLUENCE"], ["CT-26", "Lachnospiraceae", "IMPACT"], ["polyphenols", "glycosylation", "INTERACT"], ["immune cell infiltration", "mice", "TARGET"], ["anxiety", "rhesus monkeys", "TARGET"], ["Sporobacter", "microbial genera", "PART OF"], ["coffee intake", "PD", "INFLUENCE"], ["short-chain fatty acids", "anxiety", "INFLUENCE"], ["low plasma TMAO level", "PD-dementia conversion", "AFFECT"], ["Nitrates", "gut", "LOCATED IN"], ["Bifidobacterium", "Gut microbiota", "PART OF"], ["GM", "brain aging", "IS LINKED TO"], ["GBM", "Parasutterella", "CHANGE ABUNDANCE"], ["Probiotics", "Depression", "INFLUENCE"], ["host receptor-targeted drugs", "chronic pain management", "CHANGE EFFECT"], ["Clostridium", "children", "LOCATED IN"], ["depression", "patients", "TARGET"], ["Ruminococcaceae", "PD", "INFLUENCE"], ["gut microbiota", "ASD", "IS LINKED TO"], ["allergy", "preterm babies", "TARGET"], ["bipolar depression", "gut microbiome", "CHANGE ABUNDANCE"], ["group III mGlu", "MPTP", "INTERACT"], ["behavioral dysfunction", "Erysipelotrichaceae", "CHANGE ABUNDANCE"], ["lipid", "liver", "LOCATED IN"], ["dysbiosis", "fly microbiota", "CHANGE ABUNDANCE"], ["affective disorders", "depression", "AFFECT"], ["maternal rectal microbiota", "infant stool microbiota", "COMPARED TO"], ["low carbohydrate", "depression", "INFLUENCE"], ["intestinal microbiota", "mothers", "LOCATED IN"], ["commensal gut microbiota", "metabolic disorders", "IS LINKED TO"], ["gut microbiota", "epilepsy", "IS LINKED TO"], ["\u03b3-aminobutyric acid", "gut microbiota composition", "IMPACT"], ["Psychiatric comorbidities", "IBD patients", "TARGET"], ["dopaminergic (DAergic) neuron injury and inflammation", "PD mice", "TARGET"], ["Aestuariispira", "anxiety", "INFLUENCE"], ["particulate matter", "SCZ", "INFLUENCE"], ["Dietary polyphenols", "oxidative stress", "INFLUENCE"], ["SCI", "patients", "TARGET"], ["non-tremor dominant", "Lachnospiraceae", "CHANGE ABUNDANCE"], ["TCE", "endolysosomal deficits", "INFLUENCE"], ["Gut Microbiota", "16S rRNA sequencing", "USED BY"], ["Adiponectin", "Parkinson's disease", "INFLUENCE"], ["Parkinson's disease", "Akkermansia", "CHANGE ABUNDANCE"], ["parkinsonism", "gut microbiota", "CHANGE ABUNDANCE"], ["anxiety", "Fusicatenibacter saccharivorans", "CHANGE ABUNDANCE"], ["Hua-Feng-Dan", "Enterobacteeriaceae", "IMPACT"], ["nervous system disturbances", "human host", "TARGET"], ["Specific amino acids", "PD", "INFLUENCE"], ["excess body weight", "cardiovascular problems", "AFFECT"], ["Gut Microbiome", "neurodegenerative disorders", "IS LINKED TO"], ["microbiota-derived metabolites", "schizophrenia", "INFLUENCE"], ["SD", "mammalian gut microbiota", "CHANGE ABUNDANCE"], ["severe organ damage", "Sprague-Dawley (SD) rats", "TARGET"], ["gut dysbiosis", "plasma short-chain fatty acids", "INTERACT"], ["dexamethasone (DEX) group", "ELISA", "USED BY"], ["chemotherapy-induced myelosuppression", "Colon cancer-related anemia", "AFFECT"], ["lower baseline plasma TMAO levels", "early stage PD", "AFFECT"], ["intestinal inflammation", "PD patients", "TARGET"], ["probiotics", "gut microbiota", "IMPACT"], ["patients", "oral LPS", "USED BY"], ["SIBO", "systemic sclerosis", "AFFECT"], ["Alzheimer's and Parkinson's disease", "zinc", "INTERACT"], ["rifaximin", "Flavonifractor", "IMPACT"], ["children", "gut metagenomic and metabolome study", "USED BY"], ["Bacilli", "AET mice", "LOCATED IN"], ["Parkinson's disease", "autoimmune diseases", "AFFECT"], ["anxiety-like behaviour", "male mice", "TARGET"], ["GM", "disturbances", "IS LINKED TO"], ["mice", "open-field test", "USED BY"], ["oxytocin", "controls", "LOCATED IN"], ["fermented foods", "gut microbiota", "IMPACT"], ["intestine", "PD mice", "LOCATED IN"], ["motor symptoms", "PD patients", "TARGET"], ["gut microbiota", "GI symptoms", "IS LINKED TO"], ["KD", "neurologic disorders", "INFLUENCE"], ["HFD microbiota", "ionized calcium-binding adapter molecule 1", "CHANGE EXPRESSION"], ["gut microbiome", "neuropsychiatric or neurodegenerative disorders", "IS LINKED TO"], ["dysbiotic microbiota", "PD patients", "TARGET"], ["gut dysbiosis", "PD patients", "TARGET"], ["LPHP", "Abhd5", "CHANGE EXPRESSION"], ["gut microbiota disorders", "PD mice", "TARGET"], ["antibiotics", "mental health problems", "CHANGE EFFECT"], ["SCI", "microbiota composition", "CHANGE ABUNDANCE"], ["non-tremor dominant", "Blautia", "CHANGE ABUNDANCE"], ["neurodegenerative diseases", "GM", "CHANGE ABUNDANCE"], ["alteration", "PD patients", "TARGET"], ["Lactobacillus", "addiction", "INFLUENCE"], ["SCFAs", "Gut microbiota", "PRODUCED BY"], ["F4 consumption", "CUS-induced anhedonic behaviors", "INFLUENCE"], ["GM", "DATs", "USED BY"], ["GBM", "Bacteroidaceae", "CHANGE ABUNDANCE"], ["Prebiotics", "GI symptoms", "INFLUENCE"], ["CMUS group", "TST", "USED BY"], ["Bifidobacterium", "children", "LOCATED IN"], ["\u03b1-Lactalbumin", "PCOS", "INFLUENCE"], ["depression", "SS patients", "TARGET"], ["entacapone", "gastrointestinal symptoms", "CHANGE EFFECT"], ["NOX2", "neuroinflammation", "INFLUENCE"], ["ASD", "boys", "TARGET"], ["medial prefrontal cortex", "Chrna7 KO mice", "LOCATED IN"], ["depression-mediated gut microbiota composition", "Irritable Bowel Syndrome", "IS LINKED TO"], ["gut microbiota", "clinically heterogenic disorder", "IS LINKED TO"], ["Parkinson's disease", "older adults", "TARGET"], ["psychiatric manifestations of IBD", "IBD patients", "TARGET"], ["Berberine", "Gut Microbiota", "IMPACT"], ["Turicibacteraceae", "GLCA", "INTERACT"], ["initial pathophysiological changes", "gastrointestinal tract", "STRIKE"], ["gut bacteria", "gut microbiota", "PART OF"], ["patients", "gas chromatography-mass spectrometry", "USED BY"], ["Lactobacillus group bacteria", "fecal microbiota", "PART OF"], ["Hippuric acid", "gut microbiota", "IMPACT"], ["Intestinibacter", "gut microbiota", "PART OF"], ["microbiota-produced substances", "permeability of the intestinal (\"leaky gut\") and the blood brain barrier", "INFLUENCE"], ["FWG", "gut microbiota", "IMPACT"], ["commensal gut microbiota", "allergy", "IS LINKED TO"], ["gut dysbiosis", "older individuals", "TARGET"], ["academic stress", "male participants", "TARGET"], ["Akkermansia muciniphila", "neuropsychiatric disorders", "INFLUENCE"], ["Myristic acid", "Gut microbiota", "PRODUCED BY"], ["Acne vulgaris", "inflammatory disease", "IS A"], ["first-episode schizophrenia", "drug-na\u00efve", "TARGET"], ["ASD", "neurodevelopmental disorders", "IS A"], ["Sybergistetes", "gut microbiota", "PART OF"], ["Enterococcus", "gut microbiota", "PART OF"], ["gut microbiota", "agile, fit hunter gatherers", "LOCATED IN"], ["colonic microbiome", "NDs", "IS LINKED TO"], ["dyspnea", "elderly population", "TARGET"], ["tetracycline compounds", "AD/PD pathology", "INFLUENCE"], ["gut microbiota", "CI", "IS LINKED TO"], ["GM", "Parkinson's disease", "IS LINKED TO"], ["prenatal faecal microbiota", "children", "LOCATED IN"], ["Western diet", "microbiota", "IMPACT"], ["human gut microbiota", "neurodegenerative diseases", "IS LINKED TO"], ["Nervous system disorders", "people", "TARGET"], ["microbiota", "microbial dysbiosis", "IS LINKED TO"], ["Flavonifractor", "stress response", "INFLUENCE"], ["MeDi", "neurodegeneration", "INFLUENCE"], ["intestinal inflammation", "microbiome", "CHANGE ABUNDANCE"], ["gastrointestinal (GI) symptoms", "patients", "TARGET"], ["Gut Microbiome", "Mice", "LOCATED IN"], ["HFD", "neurological disorders", "CHANGE EFFECT"], ["3-HPPA", "MSA-induced aggregation of monomer", "INFLUENCE"], ["gut microbiota", "major depressive disorder", "IS LINKED TO"], ["Cb", "Parkinson's disease", "INFLUENCE"], ["limonene", "irritable bowel syndrome", "INFLUENCE"], ["stomach", "non-human primates", "LOCATED IN"], ["lipopolysaccharide", "Neurodegenerative diseases", "INFLUENCE"], ["healthy subjects", "Quantitative SYBR Green Real-Time PCR", "USED BY"], ["Anthocyanins", "Chronic Diseases", "INFLUENCE"], ["psychobiotics", "neuropsychiatric diseases", "CHANGE EFFECT"], ["brain", "people", "LOCATED IN"], ["Gut Microbiome", "Parkinson's Disease", "IS LINKED TO"], ["human microbiome", "nose", "LOCATED IN"], ["Autism Spectrum Disorder", "children", "TARGET"], ["dysbiosis", "nervous system disturbances", "AFFECT"], ["depression", "adolescents", "TARGET"], ["HCs", "shotgun metagenomic sequencing", "USED BY"], ["trichloroethylene", "neuroinflammation", "INFLUENCE"], ["\u03b2-<i>N</i>-methylamino-L-alanine", "cyanobacteria", "IMPACT"], ["<i>Coprococcus</i> spp.", "neurological disorders", "INFLUENCE"], ["gut microbiota", "neurodevelopmental and neurodegenerative disorders", "IS LINKED TO"], ["phosphorylated \u03b1-synuclein", "Parkinson's Disease", "INFLUENCE"], ["dysbiosis", "microbiota", "CHANGE ABUNDANCE"], ["live L. plantarum CCFM8661", "insulin", "INTERACT"], ["KO mice", "Y-maze", "USED BY"], ["gut microbiota", "RA patients", "LOCATED IN"], ["GBM", "Prevotella_9", "CHANGE ABUNDANCE"], ["MP extract", "gut microbiota", "IMPACT"], ["KD", "amyotrophic lateral sclerosis", "INFLUENCE"], ["predominant bacteria", "clinical symptoms", "INFLUENCE"], ["TNF inhibitor XPro1595", "monkeys", "ADMINISTERED"], ["pro-inflammatory status", "recurrent gastrointestinal symptoms", "AFFECT"], ["KD", "gut microbes", "IMPACT"], ["gut microbiota dysbiosis", "metabolic diseases", "AFFECT"], ["disturbances", "PD mice", "TARGET"], ["physical disorders", "patients", "TARGET"], ["mucin-degrading genus Akkermansia", "PD", "INFLUENCE"], ["commensal bacteria", "Alzheimer's disease", "INFLUENCE"], ["Oscillibacter", "bacteria", "INTERACT"], ["\u03b2-HgS-containing 70W", "Clostridaceae species", "IMPACT"], ["disease susceptibility", "offspring", "TARGET"], ["mother-infant pairs", "16S rRNA sequencing", "USED BY"], ["dysbiosis of mouse gut microbiota", "Lachnospiraceae", "CHANGE ABUNDANCE"], ["\u03b1-synuclein", "Parkinson's disease", "INFLUENCE"], ["Polyphenols", "neurodegenerative diseases", "INFLUENCE"], ["AGE inhibitor", "diabetes", "CHANGE EFFECT"], ["CBD", "central symptoms and comorbidities of ASD", "CHANGE EFFECT"], ["microbiota", "gut", "LOCATED IN"], ["lactic acid", "metabolites", "PART OF"], ["constipation", "rats", "TARGET"], ["sleep disturbance", "Asian Americans", "TARGET"], ["functional bowel disorder", "patients", "TARGET"], ["gastrointestinal dysbiosis", "women", "TARGET"], ["neuroinflammation", "human PD cases", "TARGET"], ["Fe", "CCRA", "INFLUENCE"], ["butyrate", "gut microbiota", "PRODUCED BY"], ["Wolbachia", "gut microbiota", "PART OF"], ["Neurodegenerative protein conformational diseases", "metastable proteins", "INTERACT"], ["Pronicromonosporaceae", "gut microbiota", "PART OF"], ["ketamine enantiomers", "CSDS-susceptible mice", "ADMINISTERED"], ["gastrointestinal microbiota", "stroke", "IS LINKED TO"], ["Probiotic supplementation", "intestinal inflammation", "INFLUENCE"], ["Firmicutes", "gut microbiota disorder", "INFLUENCE"], ["Opioids", "management of severe chronic cancer pain", "CHANGE EFFECT"], ["Verrucomicrobia", "MPTP group", "INTERACT"], ["<i>plantarum</i> P-8", "stress", "INFLUENCE"], ["CA", "gut inflammation", "INFLUENCE"], ["gut microbiota", "brain regions", "LOCATED IN"], ["probiotic intake", "constipation", "INFLUENCE"], ["CMUS group", "tail suspension test", "USED BY"], ["aging", "Defective mitochondrial homeostasis", "AFFECT"], ["probiotics", "stress", "INFLUENCE"], ["anxiety", "stressed adults", "TARGET"], ["gut microbiota", "PD", "IS LINKED TO"], ["Th1 inflammatory response", "Sprague-Dawley (SD) rats", "TARGET"], ["probiotics", "intestinal flora", "IMPACT"], ["control monkeys", "metagenomic sequencing", "USED BY"], ["gut microbiota", "attention-deficit hyperactivity disorder", "IS LINKED TO"], ["antidiarrheals", "IBS", "CHANGE EFFECT"], ["adequate protein", "microbiota", "IMPACT"], ["depression", "gut bacteria", "CHANGE ABUNDANCE"], ["apigenin", "TREM2", "CHANGE EXPRESSION"], ["gut microbiota", "autism", "IS LINKED TO"], ["high stress", "females", "TARGET"], ["non-constipated PD (NC-PD) patients", "16S rRNA sequencing", "USED BY"], ["Turicibacterales", "taurodeoxycholic acid", "INTERACT"], ["CCL19", "gut microbiota", "IMPACT"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "intestinal pathology", "CHANGE EFFECT"], ["Mn", "neurodegenerative disorders", "INFLUENCE"], ["gut microbes", "ischemic stroke", "IS LINKED TO"], ["late onset neuropathologies", "Inflammation", "AFFECT"], ["substantia nigra", "mice", "LOCATED IN"], ["RA", "gut microbiota", "CHANGE ABUNDANCE"], ["gut microbiota", "gastrointestinal symptoms", "IS LINKED TO"], ["Parkinson disease", "Roseburia", "CHANGE ABUNDANCE"], ["gut microbiome", "gut", "LOCATED IN"], ["Ethanol Exposure", "Microbiota-Induced Immune Dysregulation", "AFFECT"], ["dysregulated adaptive and innate immunity", "drug-resistant epilepsy", "AFFECT"], ["MeDiet", "Alzheimer's disease", "INFLUENCE"], ["gastrointestinal microbiota", "stress", "IS LINKED TO"], ["functional dysbiosis", "human PD cases", "TARGET"], ["Acetobacter", "gut microbiota", "PART OF"], ["Western diet", "cognitive decline", "INFLUENCE"], ["Gut Microbiome", "BPSD", "IS LINKED TO"], ["control (CON) group", "Enzyme-linked immunosorbent assay", "USED BY"], ["BP", "mental health and neurocognitive disorders", "IS A"], ["Bifidobacteriaceae", "PD", "INFLUENCE"], ["Alzheimer's disease", "impaired cognition", "AFFECT"], ["Mitochondrial Dysfunction", "Parkinson's Disease", "AFFECT"], ["increased body weight", "F0 males", "TARGET"], ["rifaximin", "transgenic PD mice", "ADMINISTERED"], ["LPS", "Lactobacteriaceae", "IMPACT"], ["desaminotyrosine", "gut microbiota", "IMPACT"], ["low mood", "people", "TARGET"], ["terpenoids", "RA", "INFLUENCE"], ["neurobehavioral deficits", "mice", "TARGET"], ["Dysbiosis", "psychiatric illnesses", "AFFECT"], ["L. lactis", "anxiety behavior", "INFLUENCE"], ["striatal tissue cells", "mice", "LOCATED IN"], ["intestinal bleeding", "CCRA", "AFFECT"], ["TPG", "Mollicutes", "IMPACT"], ["IL-6", "severe social avoidance behaviors", "INFLUENCE"], ["natural non-proteinogenic diamino acid", "diatoms", "IMPACT"], ["sulforaphane glucosinolate", "depression-like behaviors", "INFLUENCE"], ["neurodegenerative disorder", "impaired cognition", "AFFECT"], ["gut microbiota", "BBB", "LOCATED IN"], ["patients", "shotgun metagenomic sequencing", "USED BY"], ["synbiotic", "\u03b1-synucleinopathies", "INFLUENCE"], ["Stool microbiota", "16S ribosomal RNA gene sequencing", "USED BY"], ["probiotics", "central nervous system diseases", "INFLUENCE"], ["dopaminergic neuron loss", "MPTP-induced mice", "TARGET"], ["EPA", "Long-chain <i>n</i>-3 fatty acids", "PART OF"], ["Akkermansia municiphila", "gut microbiome", "PART OF"], ["eGFR-CysC", "CKD", "INFLUENCE"], ["short-chain fatty acids", "schizophrenia", "INFLUENCE"], ["<i>L. plantarum</i> DP189", "superoxide dismutase", "INTERACT"], ["PD", "alpha-synuclein", "INTERACT"], ["PTSD", "mental health and neurocognitive disorders", "IS A"], ["cholestane steroids", "gut microbiome", "PRODUCED BY"], ["Major depressive disorder", "patient", "TARGET"], ["depression", "low bone mineral density", "AFFECT"], ["gut dysbiosis", "patients", "TARGET"], ["gut microbiota", "ET", "IS LINKED TO"], ["acetate", "vascular dementia", "INFLUENCE"], ["Gut microbiota", "psychiatric conditions", "IS LINKED TO"], ["all participants", "16S V3-V4 rRNA sequencing", "USED BY"], ["pro-inflammatory variations", "socially stressed mice", "TARGET"], ["<i>Verrucomicrobiaceae</i> families", "PD patients", "LOCATED IN"], ["human microbiota", "Parkinson's diseases", "IS LINKED TO"], ["PD", "A53T monkeys", "TARGET"], ["Gut bacteria", "Parkinson's disease", "INFLUENCE"], ["acacetin", "TREM2", "CHANGE EXPRESSION"], ["alleviated neurodegeneration", "eye", "STRIKE"], ["gut microbiome", "southern hemisphere PD population", "LOCATED IN"], ["microbiota abundance and diversity", "PD groups", "TARGET"], ["maternal microbiota", "microbiota of infant gut and nose", "COMPARED TO"], ["Migraine", "mood changes", "AFFECT"], ["HFD-reduced", "neurological disorders", "CHANGE EFFECT"], ["GI motility agents", "PD", "CHANGE EFFECT"], ["BMAA", "neurodegenerative diseases", "INFLUENCE"], ["ketogenic diet", "Gut microbes", "IMPACT"], ["PD", "PD", "AFFECT"], ["prebiotics", "mental health", "INFLUENCE"], ["depressive symptoms", "patient", "TARGET"], ["Gut bacterial tyrosine decarboxylase", "Parkinsons disease", "INFLUENCE"], ["Alterations", "PD patients", "TARGET"], ["Clostridiales bacterium NK3B98", "PD patient group", "LOCATED IN"], ["PD", "human case-control studies", "TARGET"], ["gut-associated microbes", "Alzheimer's disease", "INFLUENCE"], ["Mediterranean diet", "gut microbiota", "IMPACT"], ["Alzheimer's and Parkinson's disease", "Zinc", "INTERACT"], ["commensal gut microbiota", "extra-uterine growth restriction", "IS LINKED TO"], ["human gut", "host", "LOCATED IN"], ["neurological and gastrointestinal symptoms", "Parkinson's disease (PD) patients", "TARGET"], ["gut microbiota", "mental disorders", "IS LINKED TO"], ["TCE", "PD-related neurodegeneration", "INFLUENCE"], ["gut microbiota", "neurological and gastrointestinal diseases", "IS LINKED TO"], ["DA neuron loss", "rat", "TARGET"], ["microbiota", "mental health", "IS LINKED TO"], ["Hua-Feng-Dan", "pathological lesions in the brain", "CHANGE EFFECT"], ["LAC", "stress", "INFLUENCE"], ["gut microbiota", "chronic social defeat", "IS LINKED TO"], ["(R)-ketamine", "Mollicutes", "IMPACT"], ["gut microbiomes", "placebo group", "LOCATED IN"], ["cytokines", "Pseudobutyrivibrio", "IMPACT"], ["multi-ingredient fermented whey supplement", "wellbeing", "INFLUENCE"], ["GI complaints", "well-trained athletes", "TARGET"], ["MEs", "children", "LOCATED IN"], ["depressive symptoms", "Actinobacteria", "CHANGE ABUNDANCE"], ["dead cells", "Inflammation", "INFLUENCE"], ["non-TD", "Lachnospiraceae", "CHANGE ABUNDANCE"], ["pesticides", "Parkinson's disease", "INFLUENCE"], ["gut microbiota", "intestinal dysbiosis", "IS LINKED TO"], ["gut microbiota", "sleep disorders", "IS LINKED TO"], ["SHH", "Parabacteroides", "IMPACT"], ["gut microbiota", "adult offspring", "LOCATED IN"], ["gut microbiota", "older populations", "LOCATED IN"], ["Human gut microbes", "human diseases", "IS LINKED TO"], ["inactivated L. plantarum CCFM8661", "PPAR-\u03b3", "CHANGE EXPRESSION"], ["flavonoids", "MDD", "INFLUENCE"], ["gut microbiota", "neuromyelitis optica", "IS LINKED TO"], ["Medicinal Plants", "Gut Microbiome", "IMPACT"], ["neurological disease", "disease subpopulations", "TARGET"], ["schizophrenia", "gastrointestinal (GI) disorders", "AFFECT"], ["Rannasangpei", "LPS plus MPTP-induced neurotoxicity", "CHANGE EFFECT"], ["Adolescence Inflammatory Stress", "Neurodegeneration", "AFFECT"], ["COVID-19", "PD", "AFFECT"], ["schizophrenia", "individuals", "TARGET"], ["fiber", "gut bacteria", "IMPACT"], ["Autism spectrum disorder", "adolescents", "TARGET"], ["gut bacterial dysbiosis", "SCFAs", "INTERACT"], ["Ruminococcus", "ALS", "INFLUENCE"], ["manganese", "late onset neuropathologies", "INFLUENCE"], ["lung cancer", "gut microbiota", "CHANGE ABUNDANCE"], ["BAs", "stroke", "INFLUENCE"], ["alkaloids", "GM", "IMPACT"], ["Mediterranean Diet", "Anxiety", "INFLUENCE"], ["acetate", "multiple sclerosis", "INFLUENCE"], ["anxiety/depression", "pups", "TARGET"], ["gut bacteria", "type 2 diabetes", "INFLUENCE"], ["Academic stress", "females", "TARGET"], ["Fecal calprotectin", "gut inflammation", "INFLUENCE"], ["RISP SCZ", "16s rRNA sequencing", "USED BY"], ["gut microbial compositions", "PINK1<sup>B9</sup> flies", "LOCATED IN"], ["<i>Lactobacillus fermentum</i> PS150", "sleep disturbances", "INFLUENCE"], ["Wolbachia", "AD", "INFLUENCE"], ["piperine", "Cyclooxygenase-2", "INTERACT"], ["gut leakage", "PD patients", "TARGET"], ["Bifidobacteria", "vaginally delivered, fully breastfed infants", "LOCATED IN"], ["Behavioral dysfunction", "rat", "TARGET"], ["altered gut microbiota", "children", "TARGET"], ["metabolites", "vascular dementia", "INFLUENCE"], ["4EP", "increased intestinal permeability", "INFLUENCE"], ["SIBO", "functional diarrhea", "AFFECT"], ["PD", "pain", "AFFECT"], ["Flavonifractor", "negative emotionality", "INFLUENCE"], ["antibiotics cocktail", "inflammation", "CHANGE EFFECT"], ["DSS", "gut inflammation", "INFLUENCE"], ["serum metabolites", "healthy control subjects", "LOCATED IN"], ["oral and gut microbiome", "shotgun metagenomic sequencing", "USED BY"], ["lipopolysaccharide", "systemic inflammation", "INFLUENCE"], ["gut microbiota", "Danes", "LOCATED IN"], ["Probiotic supplementation", "inflammation", "INFLUENCE"], ["MedDiet", "Huntington's diseases", "INFLUENCE"], ["mood disorders", "BMI", "AFFECT"], ["70W", "Clostridaceae species", "IMPACT"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "gut microbiome", "IMPACT"], ["dysbiosis", "Parkinson's disease", "AFFECT"], ["Probiotics", "neurological diseases", "INFLUENCE"], ["Megamonas", "gut microbiota", "PART OF"], ["MEs", "ASD children", "LOCATED IN"], ["MPTP", "SN", "LOCATED IN"], ["stress", "FHWs", "TARGET"], ["KD", "epilepsy", "INFLUENCE"], ["Human Gut Microbiota", "multiple sclerosis", "IS LINKED TO"], ["unhealthy nutrition", "metabolic and inflammatory diseases", "AFFECT"], ["anti-infective agents", "neuroinflammation", "CHANGE EFFECT"], ["healthy controls", "FMT", "USED BY"], ["WD", "phenotypic changes", "CHANGE EXPRESSION"], ["gut microbiota", "TD", "IS LINKED TO"], ["the nucleotide-binding oligomerization domain leucine rich repeat and pyrin domain-containing protein 3 (NLRP3) inflammasome", "CNS diseases", "INFLUENCE"], ["SHH", "chronic stress damage", "INFLUENCE"], ["intestinal microbiota", "Parkinson's disease", "IS LINKED TO"], ["organochlorines", "Parkinson's disease", "INFLUENCE"], ["probiotic supplementation", "Roseburia faecis", "IMPACT"], ["CT-26", "Odoribacter", "IMPACT"], ["IL-6", "prefrontal cortex", "LOCATED IN"], ["volatile organic compounds", "gut microbiota", "PRODUCED BY"], ["Human Gut Microbiota", "gut microbiota dysbiosis", "IS LINKED TO"], ["Ralstonia", "gut microbiota", "PART OF"], ["gut microbiota", "hospitalized acutely ill older adults", "LOCATED IN"], ["pro-inflammatory mediators", "low-grade chronic inflammation", "INFLUENCE"], ["intestinal SCFA", "iRBD", "INFLUENCE"], ["Polyphenols", "intestinal microbiota", "PRODUCED BY"], ["gut microbiota", "molecular dynamics simulation", "USED BY"], ["Lactobacillus helveticus", "depression", "INFLUENCE"], ["sodium oligomannate", "isoleucine", "INTERACT"], ["colonic microbiome", "AD", "IS LINKED TO"], ["AD", "gut microbiota", "CHANGE ABUNDANCE"], ["glutamate", "PD patients", "LOCATED IN"], ["Parkinson's disease", "Colonic FMT group", "TARGET"], ["Parkinson's disease patients", "microbiota sequencing", "USED BY"], ["gut disorders", "ulcerative colitis", "AFFECT"], ["gut microbiota", "neurodegenerative disorders", "IS LINKED TO"], ["non-tremor dominant", "Escherichia", "CHANGE ABUNDANCE"], ["gut microbiota", "Alzheimer\u2019s disease", "IS LINKED TO"], ["indoles", "depressive behavior", "INFLUENCE"], ["gut microbiota", "T1D", "IS LINKED TO"], ["Gut microbiota", "control monkeys", "LOCATED IN"], ["Actinobacteria", "immobility", "INFLUENCE"], ["gut microbiota", "A53T transgenic monkeys", "LOCATED IN"], ["resveratrol", "cognitive decline", "INFLUENCE"], ["fly's gut microbiota", "humans", "LOCATED IN"], ["gut", "controls", "LOCATED IN"], ["AAA metabolites", "Bacteroides sp. CF01-10NS", "IMPACT"], ["PD-associated GM", "DAT", "USED BY"], ["gut microbiota", "obstructive sleep apnea", "IS LINKED TO"], ["beneficial bacteria", "neurotransmitters", "INTERACT"], ["Chronic Unpredictable Mild Stress", "Mice", "TARGET"], ["probiotics", "neurodegenerative diseases", "INFLUENCE"], ["metabolites", "multiple sclerosis", "INFLUENCE"], ["oxaliplatin", "Escherichia-Shigella", "IMPACT"], ["gut", "individual", "LOCATED IN"], ["fecal microbiota", "PD", "IS LINKED TO"], ["Inflammation", "Alzheimer's disease", "AFFECT"], ["altered gut microbiomes", "individuals", "TARGET"], ["gut microbiota", "rodent gut", "LOCATED IN"], ["chemical pollutants", "gut dysbiosis", "INFLUENCE"], ["Parkinson's Disease", "Gut Microbiota", "CHANGE ABUNDANCE"], ["Microbiota", "Adolescents", "LOCATED IN"], ["LPS", "depression", "INFLUENCE"], ["gut microbiota", "16S rRNA sequence analysis", "USED BY"], ["gut microbiota", "inflammatory response", "IS LINKED TO"], ["pro-inflammatory bacteria", "Gut microbiota", "PART OF"], ["DR7", "AD-induced <i>Drosophila</i>", "LOCATED IN"], ["inflammation", "male cases", "TARGET"], ["disturbance of gut microbiota", "Rats", "TARGET"], ["trace elements", "control subjects", "LOCATED IN"], ["prefrontal cortex", "male mice", "LOCATED IN"], ["EGCG", "gut microbial compositions", "IMPACT"], ["behavioral despair", "offspring", "TARGET"], ["SCI", "metabolic disorders", "AFFECT"], ["pre-SD", "rats", "TARGET"], ["Gut microbes", "central nervous system", "LOCATED IN"], ["ultra-processed foods", "gut microbiota", "IMPACT"], ["mice", "EAE", "USED BY"], ["canine intestinal microbiota", "food allergies", "IS LINKED TO"], ["PD", "Actinobacteria", "CHANGE ABUNDANCE"], ["Parkinson's disease", "intestinal permeability", "AFFECT"], ["acetate", "gut", "LOCATED IN"], ["prebiotics", "weight management", "INFLUENCE"], ["\u03c9-3 fatty acids", "maternal depression and anxiety", "INFLUENCE"], ["gut dysbiosis", "C-section infants", "TARGET"], ["L-Aspartic acid", "gut microbiota", "PRODUCED BY"], ["curcumin", "motor impairment", "INFLUENCE"], ["prebiotic", "PD", "INFLUENCE"], ["SIBO", "gallstone disease", "AFFECT"], ["neurophysiological, inflammatory or hypothalamic-pituitary-adrenal axis dysregulations", "psychological stress", "AFFECT"], ["Probiotics", "Parkinson's diseases", "INFLUENCE"], ["MPTP", "cleaved caspase-3", "INTERACT"], ["piperine", "coronaviruses", "INFLUENCE"], ["spasmolytics", "irritable bowel syndrome", "CHANGE EFFECT"], ["PD", "rhesus monkeys", "TARGET"], ["gut microbiota", "antibiotic-treated group", "LOCATED IN"], ["Parkinson's disease", "Roseburia", "CHANGE ABUNDANCE"], ["DEHP", "highest Th1 inflammatory response", "INFLUENCE"], ["PD", "family Lactobacillaceae", "CHANGE ABUNDANCE"], ["coffee", "PD", "INFLUENCE"], ["vancomycin pretreatment", "Akkermansia", "IMPACT"], ["pathogenic proteins", "neurodegenerative diseases", "INFLUENCE"], ["Gut Microbiome", "obsessive-compulsive disorder", "IS LINKED TO"], ["Actinobacteria", "gut microbiota", "PART OF"], ["prebiotics", "Neurodegenerative diseases", "INFLUENCE"], ["harmful substances", "intestinal barrier", "LOCATED IN"], ["lipid", "central nervous system", "LOCATED IN"], ["female mice", "OVX", "USED BY"], ["prebiotic treatment", "microglial activation", "INFLUENCE"], ["gut microbiota dysbiosis", "cancer", "AFFECT"], ["impaired sleep and circadian patterns", "AD", "AFFECT"], ["fiber", "gut microorganisms", "IMPACT"], ["intestinal microbiota", "Huntington's disease", "IS LINKED TO"], ["Coffee", "Neurodegeneration", "INFLUENCE"], ["intestinal microbiota", "anxiety", "IS LINKED TO"], ["food supplement", "IBS/FD", "INFLUENCE"], ["<i>Helicobacter pylori</i> infection", "neurodegenerative disorders", "AFFECT"], ["antibiotic treatments", "late onset neuropathologies", "CHANGE EFFECT"], ["prebiotics", "Neurodegenerative Diseases", "INFLUENCE"], ["Gut microbiota", "neurodegenerative diseases", "IS LINKED TO"], ["Chronic kidney disease", "elderly", "TARGET"], ["GM", "Chinese and Korean American immigrants", "LOCATED IN"], ["PD", "gastrointestinal (GI) tract", "STRIKE"], ["Antipsychotics", "SCZ", "CHANGE EFFECT"], ["Temperament", "Early Childhood", "TARGET"], ["Odoribacter", "PD-MCI group", "LOCATED IN"], ["oral microbiota", "gut microbiota", "COMPARED TO"], ["berberine", "firmicutes", "IMPACT"], ["probiotics", "MDD", "INFLUENCE"], ["gut microbiota", "intractable diseases", "IS LINKED TO"], ["OPA", "dysbiosis of gut microbiota", "INFLUENCE"], ["Ruminococcus_torques_group", "ADHD", "INFLUENCE"], ["CFC", "CFC patients", "TARGET"], ["prebiotic", "Lactobacillus", "IMPACT"], ["gut microbiota", "attention deficit/hyperactivity disorder", "IS LINKED TO"], ["Ruminococcus", "microbiota", "PART OF"], ["L. Planetarium 128", "ADHD", "INFLUENCE"], ["gut microbiome", "stroke", "IS LINKED TO"], ["Mercury sulfide-containing Hua-Feng-Dan", "Verrucomicrobiaceae", "IMPACT"], ["Parkinson's disease", "dopaminergic", "INTERACT"], ["Trimethylamine", "dauer formation", "INFLUENCE"], ["lipopolysaccharides", "dysbiosis", "INFLUENCE"], ["gut microbiota", "rats", "LOCATED IN"], ["MDD", "gut microbiome", "CHANGE ABUNDANCE"], ["piperine", "P-glycoprotein", "INTERACT"], ["iatrogenic psychiatric disorder", "patients", "TARGET"], ["dietary fiber pectins", "digestive health", "INFLUENCE"], ["Levilactobacillus brevis SG031", "Wistar-Kyoto rats", "LOCATED IN"], ["live L. plantarum CCFM8661", "skin lipid metabolism-related genes", "CHANGE EXPRESSION"], ["gut microbiome", "PD pathogenesis", "IS LINKED TO"], ["ncultured_Erysipelotrichales_bacterium", "AET mice", "LOCATED IN"], ["propionate", "gut microbiota", "PRODUCED BY"], ["Gut microbes", "ulcer stomach and intestine", "INFLUENCE"], ["LD group", "gas chromatography mass spectrometry", "USED BY"], ["major depressive disorder", "Pseudomonades", "CHANGE ABUNDANCE"], ["fecal microbiota", "mental disorders", "IS LINKED TO"], ["polyphenols", "immune diseases", "INFLUENCE"], ["age-/sex-matched healthy controls", "next generation sequencing (NGS) of the V3-V4 region of the bacterial RNA 16\u00a0S", "USED BY"], ["metabolic diseases", "human host", "TARGET"], ["gut microbiota", "EphB6-deficient mice", "LOCATED IN"], ["healthy controls", "serum metabolomics profiling", "USED BY"], ["GP", "NS patients", "TARGET"], ["neurodegenerative diseases", "progressive functional loss of neurons", "AFFECT"], ["gut microbes", "neurologic disorders", "IS LINKED TO"], ["gut microbiota", "offspring rats", "LOCATED IN"], ["NLRP3", "Mn exposure rats", "LOCATED IN"], ["mental health issues", "Non-communicable diseases", "AFFECT"], ["patients", "16S ribosomal RNA gene sequencing analysis", "USED BY"], ["Parkinson disease", "central nervous system", "STRIKE"], ["coliform", "patients", "LOCATED IN"], ["Disordered gut microbiota", "TAO", "IS LINKED TO"], ["PD patients", "DBS", "USED BY"], ["gut", "worms", "LOCATED IN"], ["ileum", "PD mice", "LOCATED IN"], ["Parkinson's disease", "Prevotella", "CHANGE ABUNDANCE"], ["probiotics", "gut microbiota", "PART OF"], ["oxaliplatin", "Helicobacter", "IMPACT"], ["APs", "metabolic perturbations", "CHANGE EFFECT"], ["intestinal flora", "patients", "LOCATED IN"], ["faecal gut microbiota", "faecal metagenomics", "USED BY"], ["depression", "Synergistetes phyla", "CHANGE ABUNDANCE"], ["NOX2", "amyotrophic lateral sclerosis", "INFLUENCE"], ["Omega-3 and -6", "neuron degeneration", "INFLUENCE"], ["microbes", "tissue", "LOCATED IN"], ["gut microbiota", "Huntington's disease", "IS LINKED TO"], ["unique patterns", "SCZ", "TARGET"], ["L. helveticus NS8", "anxiety", "INFLUENCE"], ["Ruminococcaceae UCG-009", "depressive symptoms", "INFLUENCE"], ["nutrition", "schizophrenia", "INFLUENCE"], ["Gut Microbiome", "dementia", "IS LINKED TO"], ["schizophrenia", "Clostridium_sensu_stricto_1", "CHANGE ABUNDANCE"], ["Fecal calprotectin", "inflammatory bowel disease", "INFLUENCE"], ["anxiety disorders", "people", "TARGET"], ["dysregulated adaptive and innate immunity", "refractory status epilepticus", "AFFECT"], ["polyunsaturated fatty acids", "inflammation", "INFLUENCE"], ["Mediterranean diet", "Parkinson's", "INFLUENCE"], ["Verrucomicrobiaceae", "Parkinson's subjects", "LOCATED IN"], ["DSS", "Bacteroidaceae and Porphyromonadaceae families", "IMPACT"], ["MDD", "reduced activity", "AFFECT"], ["HgS", "disturbance of gut microbiota", "INFLUENCE"], ["adequate protein", "anxiety", "INFLUENCE"], ["MPTP", "inflammation", "INFLUENCE"], ["gut dysbiosis", "systemic inflammation", "AFFECT"], ["diet", "oral microbiota", "IMPACT"], ["gut microbiota", "16S ribosomal RNA gene sequencing analysis", "USED BY"], ["specific ASD symptoms and comorbidities", "humans", "TARGET"], ["intestinal microbiota", "Gut", "LOCATED IN"], ["Parkinson's disease", "bradykinesia", "AFFECT"], ["ketogenic diet", "Parkinson's disease", "INFLUENCE"], ["early PD", "Akkermansia", "CHANGE ABUNDANCE"], ["fermented foods", "stroke", "INFLUENCE"], ["traumatic brain injury", "brain", "STRIKE"], ["Parkinson's disease", "Oscillospiraceae", "CHANGE ABUNDANCE"], ["phytochemicals", "age-associated molecular dysfunctions", "INFLUENCE"], ["ASD", "males", "TARGET"], ["Gut dysbiosis", "late onset neuropathologies", "AFFECT"], ["Cognitive impairment", "neurodegenerative diseases", "AFFECT"], ["esketamine", "treatment-resistant depression", "CHANGE EFFECT"], ["Clostridia_UCG-014", "NS patients", "LOCATED IN"], ["Parkinson's disease", "pathogens", "CHANGE ABUNDANCE"], ["Gut microbiota", "neuropsychiatric diseases", "IS LINKED TO"], ["proinflammatory cytokines", "depression", "INFLUENCE"], ["fermented foods", "cardiovascular", "INFLUENCE"], ["(R)-ketamine", "Deltaproteobacteria", "IMPACT"], ["baicalin", "gut-brain axis disorders", "INFLUENCE"], ["microbiota", "AD", "IS LINKED TO"], ["psychobiotics", "psychiatric disorders", "INFLUENCE"], ["PD", "short-chain fatty acid-producing Roseburia and Faecalibacterium", "CHANGE ABUNDANCE"], ["PD", "nasointestinal FMT group", "TARGET"], ["PM", "gut microbiota derived SCFAs", "INTERACT"], ["medicinal plants", "gut microbiome", "IMPACT"], ["Gut microbiota", "oxidative stress", "IS LINKED TO"], ["MAM", "dysbiosis", "IS LINKED TO"], ["H. pylori", "gastrointestinal impairments", "INFLUENCE"], ["succinate", "stroke", "INFLUENCE"], ["Parkinson's microbiota", "reduced carbohydrate fermentation and butyrate synthesis capacity", "IS LINKED TO"], ["\u03b1-synuclein pathology", "human PD cases", "TARGET"], ["C-EPS", "hypnotic effects", "INFLUENCE"], ["gut flora", "autoimmune disease", "IS LINKED TO"], ["CA", "gut microbiota", "IMPACT"], ["succinate", "neuromyelitis optica spectrum disorders", "INFLUENCE"], ["PS150", "sleep disturbances", "INFLUENCE"], ["PD", "Coprococcus", "CHANGE ABUNDANCE"], ["Alzheimer's Disease", "disease subpopulations", "TARGET"], ["nutraceuticals", "personality disorders", "INFLUENCE"], ["gut microbes", "amyotrophic lateral sclerosis", "IS LINKED TO"], ["active AN", "specific SCFA-producing bacteria", "CHANGE ABUNDANCE"], ["microbes", "Parkinson's disease", "INFLUENCE"], ["infants\u2019 SCFAs", "breastfeeding group", "LOCATED IN"], ["cucurbitacin E", "DSS-induced body weight loss", "INFLUENCE"], ["Christensenellaceae", "systemic low-grade inflammation", "INFLUENCE"], ["probiotic strain", "anxiety", "INFLUENCE"], ["symptoms of stress and depression", "cohort of healthy women", "TARGET"], ["Prevotella-Enterotype", "Schizophrenia Patients", "LOCATED IN"], ["K11358", "MDD group", "LOCATED IN"], ["catecholamines", "human gut", "LOCATED IN"], ["microbiota", "neurodegenerative", "IS LINKED TO"], ["LPHP", "Elovl6", "CHANGE EXPRESSION"], ["ICH", "sham group", "TARGET"], ["5-HT", "brain", "LOCATED IN"], ["(R,S)-ketamine", "N-methyl-D-aspartate receptor", "INTERACT"], ["gut microbiota", "HC", "LOCATED IN"], ["comorbid anxiety", "PD mice", "TARGET"], ["bacterial metabolites", "central nervous system inflammation", "INFLUENCE"], ["glial markers", "Parkinson's disease pathophysiology", "INFLUENCE"], ["GMB", "metabolic alterations", "IS LINKED TO"], ["healthy people", "16S rRNA sequencing", "USED BY"], ["gut microbiota", "liver depression and spleen deficiency", "IS LINKED TO"], ["gut microbiota", "pathology", "IS LINKED TO"], ["bile acids", "major depressive disorder", "INFLUENCE"], ["healthy controls", "quantitative PCR", "USED BY"], ["specific gut bacteria", "analgesia", "INFLUENCE"], ["mental deterioration", "patients", "TARGET"], ["acetylcholine", "human gut", "LOCATED IN"], ["As<sub>4</sub>S<sub>4</sub>", "loss of DA neurons", "INFLUENCE"], ["brain-derived neurotrophic factor", "intestinal flora", "IMPACT"], ["plant protein", "Firmicutes", "IMPACT"], ["MDD patients", "16S rRNA sequencing", "USED BY"], ["gut microbiota", "microglia activation", "IS LINKED TO"], ["bioactive polyphenols", "neuroinflammation", "INFLUENCE"], ["Pro-inflammatory bacteria", "PD gut microbiota", "PART OF"], ["(R)-ketamine", "stroke", "CHANGE EFFECT"], ["probiotic", "neuroprotection", "INFLUENCE"], ["mildly impaired cognitive functions", "community-dwelling individuals", "TARGET"], ["gastrointestinal dysfunction", "human PD cases", "TARGET"], ["microbiota", "human host", "LOCATED IN"], ["Mediterranean diet", "neurodegenerative diseases", "INFLUENCE"], ["Christensenellaceae", "gut microbiota", "PART OF"], ["therapeutic potential", "chronic human diseases", "CHANGE EFFECT"], ["Gut microbial dysbiosis", "mitochondrial dysfunction", "AFFECT"], ["cerebral NLRP3 inflammasome", "neuroinflammation", "INFLUENCE"], ["Human Gut Microbiota", "Hashimoto's thyroidis", "IS LINKED TO"], ["oral drugs", "gut microbiota", "IMPACT"], ["MPTP", "nigrostriatal dopaminergic loss", "INFLUENCE"], ["neurodegeneration", "CNS pathologies", "IS A"], ["motor deficits", "human case-control studies", "TARGET"], ["gut microbiota", "small intestine", "LOCATED IN"], ["Gram-negative bacteria", "amyotrophic lateral sclerosis", "INFLUENCE"], ["kefir", "microbiota", "IMPACT"], ["helminth infections", "school-aged children", "TARGET"], ["dietary proteins and fats", "fecal short chain fatty acids", "INTERACT"], ["LGG", "Bacilli class", "INTERACT"], ["metabolites", "stroke", "INFLUENCE"], ["Intestinimonas", "gut microbiome", "PART OF"], ["LPS", "depression-like phenotype", "INFLUENCE"], ["dietary fiber", "increased production of neurotransmitters", "INFLUENCE"], ["syncope", "VVS patients", "TARGET"], ["L. helveticus NS8", "cognitive dysfunction", "INFLUENCE"], ["gut microbiota", "pathologies", "IS LINKED TO"], ["Gut Microbiota", "PD-related gut microbiota dysbiosis", "IS LINKED TO"], ["PD patients", "16S rRNA sequencing", "USED BY"], ["Gut microbiome", "AN", "IS LINKED TO"], ["choline", "microbiota", "IMPACT"], ["Campylobacter jejuni", "Gut microbiota", "PART OF"], ["Male and female Sprague-Dawley rats", "SPS", "USED BY"], ["caffeine", "PD", "INFLUENCE"], ["PS128", "neuroinflammation", "INFLUENCE"], ["protein fermentation", "intestinal microbiome", "IMPACT"], ["PD", "individuals diagnosed with PD", "TARGET"], ["Huntington's disease", "gut problems", "AFFECT"], ["SZ\u00a0patients", "measurement", "USED BY"], ["Children", "16S rRNA sequencing", "USED BY"], ["IBS", "anxiety disorders", "AFFECT"], ["Parkinson Disease", "Gut Microbiota", "CHANGE ABUNDANCE"], ["conjugated linoleic acids", "GM", "PRODUCED BY"], ["Microbiota", "Physical Exercise", "USED BY"], ["dietary therapy", "pathogenic proteins", "IMPACT"], ["pesticides", "schizophrenia", "INFLUENCE"], ["breast milk microbiota", "mixed feeding group", "LOCATED IN"], ["intestinal microbiota", "Alzheimer's disease", "IS LINKED TO"], ["gut microbiota", "IBS symptoms", "IS LINKED TO"], ["PMAD", "mother", "TARGET"], ["inflammatory diseases", "offspring", "TARGET"], ["lipid-based nutraceuticals", "cognitive impairment", "INFLUENCE"], ["microbiota abundance and diversity", "PD", "TARGET"], ["geriatric patients", "16S rRNA gene-sequenced gut microbiota data", "USED BY"], ["gastrointestinal symptoms", "PD", "AFFECT"], ["wheat gluten", "non-celiac food sensitivities", "INFLUENCE"], ["MAM", "next generation sequencing (NGS) of the V3-V4 region of the bacterial RNA 16\u00a0S", "USED BY"], ["diabetic neuropathy", "patients", "TARGET"], ["4EP", "gut microbiome", "PRODUCED BY"], ["bile acids", "neurological and neuropsychiatric diseases", "INFLUENCE"], ["gut microbiota alterations", "Parkinson's disease", "AFFECT"], ["bacterial endotoxin", "LPS", "INTERACT"], ["NADPH oxidase 2", "Alzheimer's disease", "INFLUENCE"], ["DSM-IV lifetime anxiety and depressive disorders", "(expectant) mothers", "TARGET"], ["Neurotoxins", "Parkinson's disease", "INFLUENCE"], ["GBM", "Enterobacteriaceae", "CHANGE ABUNDANCE"], ["microbes", "Alzheimer's disease", "INFLUENCE"], ["gut microbiome", "individuals", "LOCATED IN"], ["herbal preparations", "health-beneficial microorganisms", "IMPACT"], ["IL-17C", "gut microbiota", "IMPACT"], ["IL-6", "genus Blautia", "IMPACT"], ["PCOS", "reproductive-aged women", "TARGET"], ["gut microbiota", "neurodegenerative disease", "IS LINKED TO"], ["short-chain fatty acids (SCFAs)", "essential metabolites", "PART OF"], ["microbes", "anxiety", "INFLUENCE"], ["gut microbiota", "C57BL/6J mice", "LOCATED IN"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "Parkinsonism", "INFLUENCE"], ["gut microbiome", "Parkinson disease", "IS LINKED TO"], ["OPA", "Periplaneta Americana", "LOCATED IN"], ["Piperine", "5'-AMP-activated protein", "INTERACT"], ["mood disorders", "patients", "TARGET"], ["4EPS", "gut epithelium", "LOCATED IN"], ["liver depression and spleen deficiency", "diarrhea-predominant irritable bowel syndrome", "AFFECT"], ["systemic inflammation", "CS patients", "TARGET"], ["selenium", "late onset neuropathology", "INFLUENCE"], ["4EP", "gut epithelium", "LOCATED IN"], ["colonic microbiome", "ALS", "IS LINKED TO"], ["Parkinson's disease", "non-motor symptoms", "AFFECT"], ["gut microbiota", "mouse offspring", "LOCATED IN"], ["Parabacteroides", "Gut microbiota", "PART OF"], ["Gut Microbiota", "Participants", "LOCATED IN"], ["gut microbiota", "host", "LOCATED IN"], ["bacterial endotoxin", "progressive neurodegeneration", "INFLUENCE"], ["fecal microbiota", "EphB6-deficient mice", "LOCATED IN"], ["cancer", "human host", "TARGET"], ["Antibiotics", "Gut Microbiota Dysbiosis", "CHANGE EFFECT"], ["AD", "Christensenellaceae", "CHANGE ABUNDANCE"], ["atypical parkinsonism cohorts", "measurements of fecal microbial concentrations", "USED BY"], ["ED", "men", "TARGET"], ["antibiotics", "gut microorganisms", "IMPACT"], ["gut microbiota", "CSDS-susceptible mice", "LOCATED IN"], ["Inflammation", "Parkinson's disease", "AFFECT"], ["Yaniella", "gut microbiota", "PART OF"], ["lipopolysaccharide", "Parkinson's disease", "INFLUENCE"], ["CHKCI001", "microbial genera", "PART OF"], ["Drosophila", "mono-association", "USED BY"], ["amyotrophic lateral sclerosis", "patients", "TARGET"], ["Italian patients", "next-generation sequencing approach", "USED BY"], ["Gut Microbiome", "Prader-Willi Syndrome", "IS LINKED TO"], ["Actinobacteria", "PD mice", "LOCATED IN"], ["Inflammatory bowel diseases", "IBD patients", "TARGET"], ["neurodegeneration", "PD and healthy controls", "TARGET"], ["SIBO", "MAFLD", "AFFECT"], ["Gut Microbiome", "pathogenesis", "IS LINKED TO"], ["depression", "Enterobacter cloacae", "CHANGE ABUNDANCE"], ["Psychotropics", "mental health benefits", "CHANGE EFFECT"], ["spleen-gut-brain", "knock-out mice", "LOCATED IN"], ["gut microbiome", "neurodegenerative diseases", "IS LINKED TO"], ["dyskinesia", "mice", "TARGET"], ["GMC", "young infants", "LOCATED IN"], ["misfolded \u03b1-synuclein", "PD", "INFLUENCE"], ["Suturella", "SZC", "INFLUENCE"], ["fat", "microbiota", "IMPACT"], ["As<sub>4</sub>S<sub>4</sub>", "disturbance of gut microbiota", "INFLUENCE"], ["gut microbiota", "infants", "LOCATED IN"], ["schizophrenia-spectrum disorders", "patients", "TARGET"], ["Gut, oral and nasal microbiota", "Parkinson's disease", "IS LINKED TO"], ["gut microbiome", "Occidental Patients", "LOCATED IN"], ["gut dysbiosis", "CS", "AFFECT"], ["pro-inflammatory and anti-inflammatory cytokines", "mRNA", "CHANGE EXPRESSION"], ["gut microbiota", "neurological diseases", "IS LINKED TO"], ["Lacticaseibacillus rhamnosus GG", "Bacilli class", "INTERACT"], ["Bacteroides vulgatus", "2-keto-glutaramic acid", "INTERACT"], ["KD", "dysregulated adaptive and innate immunity", "INFLUENCE"], ["gut microbiota", "stress-related disorders", "IS LINKED TO"], ["beta-casomorphin-7", "A1 beta-casein", "INTERACT"], ["spices", "neurological diseases", "INFLUENCE"], ["gut microbiome", "psychiatric conditions", "IS LINKED TO"], ["C. albicans", "anxiety-like behavior", "INFLUENCE"], ["gut dysbiosis", "Guillain-Barre syndrome", "AFFECT"], ["probiotic NVP-1704", "stress", "INFLUENCE"], ["highly processed", "obesity", "INFLUENCE"], ["Streptococcus", "intestinal microbiota", "PART OF"], ["Alzheimer's disease", "humans", "TARGET"], ["ASD children", "blast shotgun metagenomic sequencing", "USED BY"], ["gut disorders", "Alzheimer's and Parkinson's diseases", "AFFECT"], ["gut metabolite SCFAs", "PD", "INFLUENCE"], ["Cinnabar", "LPS plus rotenone-induced neurotoxicity", "INFLUENCE"], ["Gut microbiota", "early PD", "IS LINKED TO"], ["Pseudobutyrivibrio", "experiment group", "LOCATED IN"], ["maternal perinatal distress", "infant inflammatory diseases", "AFFECT"], ["ketogenic diet", "autism spectrum disorders", "INFLUENCE"], ["prebiotic treatment", "gut microbiome", "IMPACT"], ["lipopolysaccharide", "disability", "INFLUENCE"], ["healthy spouses", "gas chromatography-mass spectrometry", "USED BY"], ["prebiotics", "neuroinflammation", "INFLUENCE"], ["Lactobacillus", "AET mice", "LOCATED IN"], ["(R,S)-ketamine", "depression", "CHANGE EFFECT"], ["NLRP3 inflammasome", "neurological disorders", "INFLUENCE"], ["\u03b2-HgS-containing 70 Wei-Zhen-Zhu-Wan", "Pronicromonosporaceae", "IMPACT"], ["PD", "neurodegenerative disorder", "IS A"], ["(R)-ketamine", "AD", "CHANGE EFFECT"], ["cucurbitacin E", "Intestinal tight junction", "INFLUENCE"], ["phytochemicals", "colon cancer", "INFLUENCE"], ["SCFAs", "stress", "INFLUENCE"], ["autism spectrum disorder", "neuropsychiatric diseases", "IS A"], ["Betaine supplementation", "CSDS", "INFLUENCE"], ["progressive loss of neuron function", "Neurodegenerative diseases", "AFFECT"], ["astilbin", "hydroxytyrosol", "INTERACT"], ["Rifaximin", "tumor necrosis factor-\u03b1", "INTERACT"], ["Neurotoxins", "Alzheimer's disease", "INFLUENCE"], ["gut microbial", "PD-like phenotype", "CHANGE EXPRESSION"], ["gut microbiota", "young adults", "LOCATED IN"], ["mental disorders", "Lachnospiraceae", "CHANGE ABUNDANCE"], ["schizoaffective psychosis", "patients", "TARGET"], ["depression", "persons", "TARGET"], ["Mercury sulfide-containing Hua-Feng-Dan", "Pronicromonosporaceae", "IMPACT"], ["oral microbiota", "humans", "LOCATED IN"], ["Probiotics", "gut microbiota", "IMPACT"], ["sleep disorders", "gut microbiota", "CHANGE ABUNDANCE"], ["gingerol", "irritable bowel syndrome", "INFLUENCE"], ["Hua-Feng-Dan", "LPS plus rotenone-induced neurotoxicity", "CHANGE EFFECT"], ["KD", "carbohydrate and lipid metabolism", "INFLUENCE"], ["KD", "disease-related symptoms", "INFLUENCE"], ["MPTP", "GM disorders", "CHANGE EFFECT"], ["intestinal microbiota", "MS", "IS LINKED TO"], ["glutamine", "gut microbiota", "PRODUCED BY"], ["Disruption of the intestinal microbiota", "diseases in the gut", "AFFECT"], ["oral diseases", "gastrointestinal problems", "AFFECT"], ["independent group of 78 patients", "quantitative PCR", "USED BY"], ["gastrointestinal problems", "periodontitis", "AFFECT"], ["endotoxins", "dysbiosis", "INFLUENCE"], ["Male C57BL/6 mice", "16S rRNA sequencing analysis", "USED BY"], ["coffee", "cytochrome c", "CHANGE EXPRESSION"], ["bacterial amyloid", "neurological disorders", "INFLUENCE"], ["anxiety", "infants' inflammatory diseases", "AFFECT"], ["Alzheimer's diseases", "AD-induced <i>Drosophila</i>", "TARGET"], ["Antibiotics", "depression and anxiety", "CHANGE EFFECT"], ["Lachnospiraceae.g", "gut microbiota", "PART OF"], ["proteins", "mammalian gut microbiota", "IMPACT"], ["fecal microbiota", "FEP-patients", "LOCATED IN"], ["gut dysbiosis", "dopamine-related pathological conditions", "AFFECT"], ["stress-related", "patients", "TARGET"], ["(R)-ketamine", "rodents", "ADMINISTERED"], ["well-known pharmacological effects", "analgesia", "AFFECT"], ["psychoactive metabolites", "gut bacteria", "IMPACT"], ["ICH", "Proteobacteria", "CHANGE ABUNDANCE"], ["gut", "human case-control studies", "LOCATED IN"], ["gut microbiota-induced systemic chronic inflammation", "chronic diseases", "AFFECT"], ["acetylcholine", "microbiota", "IMPACT"], ["Inflammatory Bowel Disease", "Patients", "TARGET"], ["MPTP", "apoptotic protein Bim", "INTERACT"], ["glucose metabolism disorder", "rodents", "TARGET"], ["dexamethasone (DEX) group", "Enzyme-linked immunosorbent assay", "USED BY"], ["gut flora", "dysbiosis", "IS LINKED TO"], ["gut microbiota", "parasite infections", "IS LINKED TO"], ["Parkinson's disease patients", "real-time PCR", "USED BY"], ["Panax ginseng", "gut microbiota", "IMPACT"], ["specific brain areas", "SCI patients", "LOCATED IN"], ["gut microbiota", "metabolic syndrome", "IS LINKED TO"], ["gut microbiota", "Parkinson's diseases", "IS LINKED TO"], ["Inulin", "depression", "INFLUENCE"], ["SN", "Parkinson's disease (PD) mice", "LOCATED IN"], ["gut flora", "bacterial translocation", "IS LINKED TO"], ["gut microbiome", "patients with major depressive disorder", "LOCATED IN"], ["realgar", "gut microbiome", "IMPACT"], ["glutathione", "primary open-angle glaucoma", "INFLUENCE"], ["maternal immune activation", "autism spectrum disorder", "AFFECT"], ["Fecal Microbiota", "Depressive Episode", "IS LINKED TO"], ["short-chain fatty acids", "depressive behavior", "INFLUENCE"], ["Hua-Feng-Dan", "Parkinson's disease", "CHANGE EFFECT"], ["behavioral dysfunction", "Saccharibacteria", "CHANGE ABUNDANCE"], ["Cb", "dopaminergic neuron loss", "INFLUENCE"], ["probiotics", "migraine headache", "INFLUENCE"], ["iron", "children", "LOCATED IN"], ["trimethylamine N-oxide", "PD", "INFLUENCE"], ["<i>H. pylori</i> infection", "extragastric diseases", "AFFECT"], ["novel therapeutic strategies", "gut dysbiosis", "CHANGE EFFECT"], ["Mucispirillum", "ET", "INFLUENCE"], ["maternal overnutrition", "dysregulated brain hormones", "AFFECT"], ["Gut Microbiota", "Patients With Parkinson's Disease", "LOCATED IN"], ["MPTP", "gut microbiota", "IMPACT"], ["DN SCZ", "16s rRNA sequencing", "USED BY"], ["Intestinal histomorphological and molecular alterations", "patients", "TARGET"], ["gut microbiome", "neuropsychiatric diseases", "IS LINKED TO"], ["colon microbiota", "diabetes", "IS LINKED TO"], ["impairment of cough reflex", "elderly population", "TARGET"], ["intestinal barrier", "individuals", "LOCATED IN"], ["intestinal inflammation", "Parkinson's disease patients", "TARGET"], ["Main gut microbiota alterations", "anxiety", "AFFECT"], ["endotoxins", "altered gut microbiota", "INFLUENCE"], ["probiotics", "perinatal depression", "INFLUENCE"], ["prebiotics", "Attention Deficit Hyperactivity Disorder", "INFLUENCE"], ["Ruthenibacterium lactatiformans", "GM", "PART OF"], ["fungi", "neurological diseases", "INFLUENCE"], ["NLRP3 inflammasome", "Parkinson's disease", "INFLUENCE"], ["stress-related disorders", "men", "TARGET"], ["Medicinal Herbs", "Neurodegenerative Disease", "INFLUENCE"], ["Autoimmune diseases", "schizophrenia", "AFFECT"], ["Short-chain fatty acids", "gut microbiota", "PRODUCED BY"], ["lurasidone", "significant food effect", "CHANGE EFFECT"], ["Adult specific pathogen free (SPF) Sprague-Dawley rats", "OPT", "USED BY"], ["LCA", "PD appendix", "LOCATED IN"], ["occludin", "DEX-treated mice", "LOCATED IN"], ["Psychobiotics", "Antidepressants", "INTERACT"], ["prenatal ethanol exposure", "maternal and offspring microbiota", "CHANGE ABUNDANCE"], ["Monoamine-based antidepressants", "major depressive disorder", "CHANGE EFFECT"], ["gut microbiota", "IA", "IS LINKED TO"], ["ICH", "Campilobacterota", "CHANGE ABUNDANCE"], ["mercury", "Parkinson's disease", "INFLUENCE"], ["acetone", "gut microbiota", "PRODUCED BY"], ["Bacteroidetes", "MDD patients", "LOCATED IN"], ["DEHP", "liver toxicity", "INFLUENCE"], ["PTSD", "Spanish cohort", "TARGET"], ["gut microbial diversity", "females", "LOCATED IN"], ["MIA", "autism spectrum disorder", "AFFECT"], ["Phenolic Compounds", "Genetic and Epigenetic Aspects", "INFLUENCE"], ["MA", "GM", "IMPACT"], ["Streptococcaceae", "PD mice", "LOCATED IN"], ["VVS children", "16S rRNA gene sequencing", "USED BY"], ["PUFAs", "depression", "INFLUENCE"], ["CUR", "Lactobacillaceae", "IMPACT"], ["significant differences", "MDD and SCZ patients", "TARGET"], ["anxiety", "gut microbiota", "CHANGE ABUNDANCE"], ["vitiligo", "melanin", "INTERACT"], ["PD", "L-Aspartic acid", "INTERACT"], ["Plant polysaccharides", "central and peripheral inflammation", "INFLUENCE"], ["intestinal microbiota", "CNS disorders", "IS LINKED TO"], ["PCOS", "women of reproductive age", "TARGET"], ["PD", "3-Methylindole", "INTERACT"], ["gut microbiota", "afferent sensory neurons function and pain", "IS LINKED TO"], ["GM disorders", "PD mice", "TARGET"], ["Huntington's disease", "weight loss", "AFFECT"], ["stress", "Intestinal inflammation", "AFFECT"], ["patients with schizophrenia", "quantitative fluorescence in situ hybridization", "USED BY"], ["Gut microbiota", "dopaminergic neuronal loss", "IS LINKED TO"], ["probiotics", "viral respiratory infections", "INFLUENCE"], ["PD", "elderly individuals", "TARGET"], ["Clostridium XVIII", "DEX-treated mice", "LOCATED IN"], ["bile acid metabolites", "gut microbiome", "PRODUCED BY"], ["Melainabacteria", "human gut microbiota", "PART OF"], ["intestinal regions", "host", "LOCATED IN"], ["gut microbiota", "rhesus monkeys", "LOCATED IN"], ["Butyrate", "Salsolinol-Induced Toxicity", "INFLUENCE"], ["PD", "short-chain fatty acid-producing bacteria", "CHANGE ABUNDANCE"], ["Bacteroides", "children", "LOCATED IN"], ["neuronal damage", "NDDs", "AFFECT"], ["GV-971", "neuroinflammation", "CHANGE EFFECT"], ["mPFC", "stressed mice", "LOCATED IN"], ["gut microbiota", "Asian Americans", "LOCATED IN"], ["Probiotics", "Anxiety", "INFLUENCE"], ["gut microbiota dysbiosis", "FD mice", "TARGET"], ["probiotics", "mental illnesses", "INFLUENCE"], ["gut flora", "multiple sclerosis", "IS LINKED TO"], ["intestinal milieu", "PD", "IS LINKED TO"], ["microbes", "CNS disorders", "INFLUENCE"], ["\u03b2-glucan", "gut microbiota", "IMPACT"], ["gut microbiota", "GC-MS", "USED BY"], ["Prevotellaceae", "CUMS group", "LOCATED IN"], ["(S)-ketamine", "Butyricimonas", "IMPACT"], ["systemic microbial metabolites", "Parkinson's disease", "INFLUENCE"], ["chronic constipation", "men and women over 40 years old", "TARGET"], ["Sodium oligomannate", "gut microbiota", "IMPACT"], ["Gut microbiota", "host", "LOCATED IN"], ["Probiotic consumption", "anxiety symptoms", "INFLUENCE"], ["five compositional different metabolites", "intestine microbiota", "PRODUCED BY"], ["UIA", "patients", "TARGET"], ["stroke (both ischemic and hemorrhagic)", "neurological disorders", "IS A"], ["dysfunction of the serotonin pathway, possibly related to or triggered by an altered microbiota", "dysmotility", "AFFECT"], ["central and peripheral inflammation", "mental disorders", "AFFECT"], ["dysbiosis of gut microbiome", "Parkinson's disease", "AFFECT"], ["A. muciniphila", "Parkinson's disease", "INFLUENCE"], ["intestinal microbiota", "dogs", "LOCATED IN"], ["walnut consumption", "academic stress", "INFLUENCE"], ["gut microbiome", "autism spectrum disorder", "IS LINKED TO"], ["probiotics", "Lactobacillus helveticus R0052", "IMPACT"], ["Parkinson's disease", "PD mice", "TARGET"], ["Parkinson's disease", "rigidity", "AFFECT"], ["microbiota", "intestinal regions", "LOCATED IN"], ["Hippophae rhamnoides", "gut microbiota", "IMPACT"], ["stroke", "patients", "TARGET"], ["IL-6", "arthropathy", "INFLUENCE"], ["gut microbiota", "extraintestinal disorders", "IS LINKED TO"], ["CBD", "gut microbiota", "IMPACT"], ["gut microbiota", "GM disorders", "IS LINKED TO"], ["microbiota", "patients", "LOCATED IN"], ["gastrointestinal microbiota", "mental illnesses", "IS LINKED TO"], ["subdiaphragmatic vagotomy", "demyelination", "AFFECT"], ["MED-LFD", "IBS symptoms", "INFLUENCE"], ["PPD", "mothers", "TARGET"], ["gut microbiota composition", "Research Domain Criteria (RDoC) domains", "USED BY"], ["LPS", "Verrucomicrobiaceae", "IMPACT"], ["Dietary supplements", "brain aging", "INFLUENCE"], ["prebiotics", "Alzheimer's disease", "INFLUENCE"], ["gut and oral microbiota", "females", "LOCATED IN"], ["NLRP3 inflammasome", "Alzheimer's disease", "INFLUENCE"], ["psychotic illness", "patients", "TARGET"], ["microbiome-associated short-chain fatty acids", "PD", "INFLUENCE"], ["depression", "depressed father rats", "TARGET"], ["depression", "Bifidobacteriaceae", "CHANGE ABUNDANCE"], ["gut bacteria", "colon cancer", "INFLUENCE"], ["Trimethylamine", "neurodegeneration", "INFLUENCE"], ["Parkinson's disease", "enteric nervous system dysfunction", "IS A"], ["fecal microbiota", "depressed women", "LOCATED IN"], ["lasting effects", "inflammation response", "AFFECT"], ["spleen deficiency pattern", "IBS-D patients", "TARGET"], ["vasovagal syncope", "children", "TARGET"], ["KD", "weight gain reduction", "INFLUENCE"], ["gut microbiota", "A53T monkeys", "LOCATED IN"], ["Parkinson's disease", "progressive neurodegenerative disorder", "IS A"], ["glutamate", "microbiota", "IMPACT"], ["inflammation", "mice", "TARGET"], ["Gut microbes", "Schizophrenia", "IS LINKED TO"], ["gut microbiota", "motor symptom generation", "IS LINKED TO"], ["mercury", "Alzheimer's disease", "INFLUENCE"], ["gut dysfunction", "Parkinson's disease patients", "TARGET"], ["Parkinson disease", "Faecalibacterium", "CHANGE ABUNDANCE"], ["plasticizer", "reproductive toxicity", "INFLUENCE"], ["honey", "healthy gut microbiome", "IMPACT"], ["5-hydroxytryptamine", "gut microbiota", "IMPACT"], ["behavioural and neurobiological abnormalities", "elderly patients", "TARGET"], ["gastrointestinal complaints", "offspring", "TARGET"], ["Dietary polyphenols", "chronic disorders", "INFLUENCE"], ["Hua-Feng-Dan", "neurological disorders", "CHANGE EFFECT"], ["CMUS group", "MS and CUMS paradigms", "USED BY"], ["prebiotics", "intestinal barrier integrity", "INFLUENCE"], ["maternal obesity-related gut dysbiosis", "maternal microbiota", "CHANGE ABUNDANCE"], ["Enterobacter spp.", "gut microbiota", "PART OF"], ["Parkinson's disease", "midbrain", "STRIKE"], ["Proteobacteria", "Dcf1<sup>-/-</sup> (KO) mice", "LOCATED IN"], ["rifaximin", "PD", "CHANGE EFFECT"], ["arsenic", "Alzheimer's disease", "INFLUENCE"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration", "mice", "TARGET"], ["levodopa", "intestinal bacteria", "IMPACT"], ["Piperine", "obesity", "INFLUENCE"], ["plant protein", "Bacteroidetes", "IMPACT"], ["gut microbiome", "EDs", "IS LINKED TO"], ["oral and gut microbiota", "healthy controls", "LOCATED IN"], ["Gut microbiota dysbiosis", "Parkinson disease", "AFFECT"], ["therapeutic agents", "infectious diseases", "CHANGE EFFECT"], ["PD", "p-Hydroxyphenylacetic acid", "INTERACT"], ["anxiety disorders", "male mice", "TARGET"], ["low carbohydrate", "Parkinson's disease", "INFLUENCE"], ["mPFC", "sham-operated mice", "LOCATED IN"], ["Phosphodiesterase Type-5 Inhibitor Tadalafil", "CNS Autoimmunity", "CHANGE EFFECT"], ["Polymannuronic acid", "dopaminergic neuronal loss", "INFLUENCE"], ["IL-6", "Turicibacter spp.", "IMPACT"], ["Clostridium botulinum", "ASD group", "LOCATED IN"], ["ultra-processed foods", "neurodegenerative diseases", "INFLUENCE"], ["c_Actinobacteria", "gut microbiota", "PART OF"], ["gut microbiota", "bioinformatics", "USED BY"], ["polyphenols", "Neurodegenerative diseases", "INFLUENCE"], ["controls", "high-sensitivity C-reactive protein", "USED BY"], ["gut microbes", "PD", "IS LINKED TO"], ["probiotics", "Bifidobacterium", "IMPACT"], ["pathogenic metabolites", "enteric nervous system", "LOCATED IN"], ["psychoactive compounds", "gut microbiota", "PRODUCED BY"], ["gut microbiota", "Network pharmacology", "USED BY"], ["prebiotic/probiotic formulations", "SCZ symptoms", "INFLUENCE"], ["brain aging", "GM-SCI", "AFFECT"], ["chronic insomnia disorder", "patients", "TARGET"], ["brain", "host", "LOCATED IN"], ["motor symptoms", "wild-type control mouse strain", "TARGET"], ["acetate", "controls", "LOCATED IN"], ["Gut microbiota alterations", "prodromal and established Parkinson's disease", "AFFECT"], ["maternal overnutrition", "disrupted neuronal circuities and connectivity", "AFFECT"], ["dysregulated microbiota-gut-brain axis", "neuroimmune-mediated disorders", "AFFECT"], ["gut microbiota composition", "16S rRNA sequencing", "USED BY"], ["depression", "mental health and neurocognitive disorders", "IS A"], ["Rifaximin", "claudin-5", "INTERACT"], ["nutraceutical supplementations", "Type-II diabetes", "INFLUENCE"], ["dietary fiber pectins", "gut microbiota", "IMPACT"], ["DEX", "DEX group", "ADMINISTERED"], ["polyphenols", "Neurodegenerative Diseases", "INFLUENCE"], ["gut microbiota", "healthy Korean adults", "LOCATED IN"], ["gut microbiota", "PD-related alterations", "IS LINKED TO"], ["A. muciniphila", "Alzheimer's disease", "INFLUENCE"], ["systemic inflammation", "gut microbiota", "CHANGE ABUNDANCE"], ["probiotics", "Lactobacillus plantarum R1012", "IMPACT"], ["depression", "neurological disorders", "IS A"], ["butyric", "GM", "PRODUCED BY"], ["Coprococcus", "altered metabolism rates", "INFLUENCE"], ["fecal metabolites", "gut microbiota", "PRODUCED BY"], ["misfolded protein alpha-synuclein", "vagus nerve", "LOCATED IN"], ["MEs", "ASD", "INFLUENCE"], ["Christensenellaceae", "AD", "INFLUENCE"], ["PHP", "Faecalibaculum", "IMPACT"], ["neuroinflammation", "IBD patients", "TARGET"], ["Opioid Use", "Cancer Pain Patients", "ADMINISTERED"], ["Novel Pharmacological Approaches", "Depression", "CHANGE EFFECT"], ["AAA metabolites", "Bacteroides vulgatus", "IMPACT"], ["bulimia nervosa", "eating disorders", "AFFECT"], ["PD", "progressive impairment of motor and non-motor functions", "AFFECT"], ["gut microbiota", "multiple sclerosis", "IS LINKED TO"], ["major depressive disorder patients", "Shotgun metagenomics", "USED BY"], ["Zinc", "COVID-19", "INFLUENCE"], ["duodenum", "PIPO patients", "LOCATED IN"], ["GM", "AsA", "LOCATED IN"], ["Injurious Behavior", "Chicken", "TARGET"], ["prebiotics", "diseases of the central nervous system", "INFLUENCE"], ["human gut microbiome", "neurological disorders", "IS LINKED TO"], ["ABX", "gut microbiota", "IMPACT"], ["aerotolerant bacteria", "PLWH", "LOCATED IN"], ["microbes", "MS", "INFLUENCE"], ["neurodegenerative diseases", "Rats", "TARGET"], ["Bifidobacteria", "gut microbiota", "PART OF"], ["Gut Microbiota", "Monozygotic Twins Discordant", "LOCATED IN"], ["systemic inflammation", "sham-operated mice", "TARGET"], ["Ruminococcus torques group", "SCZ", "INFLUENCE"], ["gut microbiota", "liver injury", "IS LINKED TO"], ["gut microbiota", "age-related CNS disorders", "IS LINKED TO"], ["cardinal PD motor symptoms", "PD patients", "TARGET"], ["MedDiet", "cognitive decline", "INFLUENCE"], ["gut microbiota", "responder group", "LOCATED IN"], ["Major depressive disorder", "Roseburia intestinalis", "CHANGE ABUNDANCE"], ["first-episode psychosis", "people", "TARGET"], ["BAs", "colon", "LOCATED IN"], ["MMD", "obsessive-compulsive-like behavior", "AFFECT"], ["microbiota", "T cell depletion", "USED BY"], ["rosacea", "patients", "TARGET"], ["medication option", "gut microbiota", "IMPACT"], ["gut microbiota-metabolites- cytokines", "lung cancer", "INFLUENCE"], ["\u03b1-synuclein", "nigral \u03b1-synuclein pathology", "INFLUENCE"], ["Polyphenols", "antioxidants", "INTERACT"], ["microbiota of infant gut and nose", "qPCR", "USED BY"], ["microbiota-derived short-chain fatty acids", "anxiety", "INFLUENCE"], ["probiotics", "EDs", "INFLUENCE"], ["HgS", "gut microbiota", "IMPACT"], ["Neurological disorders", "patients", "TARGET"], ["<i>Desulfovibrio</i> species", "PD", "INFLUENCE"], ["limonene", "FD", "INFLUENCE"], ["human intestinal microbiota", "anxiety", "IS LINKED TO"], ["Schizophrenia", "death", "AFFECT"], ["neuroinflammation", "patients", "TARGET"], ["prefrontal cortex", "HI/R-injured mice", "LOCATED IN"], ["gut microbiota", "10-week-old offspring", "LOCATED IN"], ["levodopa-induced dyskinesia", "patients", "TARGET"], ["constipation", "gut microbiota", "CHANGE ABUNDANCE"], ["HFD", "behavioral dysfunction", "CHANGE EFFECT"], ["CDR", "gut microbiome", "CHANGE ABUNDANCE"], ["prodromal/pre-motor features", "non-human primates", "TARGET"], ["bacterial endotoxin", "Lipopolysaccharide", "INTERACT"], ["oral microbiome", "Parkinson's disease", "IS LINKED TO"], ["Low FODMAP diet", "Irritable Bowel Syndrome", "INFLUENCE"], ["Agathobaculum", "gut microbiota", "PART OF"], ["Clostridium bacteria", "Parkinson's disease", "INFLUENCE"], ["SCZ", "Individuals", "TARGET"], ["fecal microbial diversities", "PD-MCI", "AFFECT"], ["unbalanced nutrition", "inflammation", "INFLUENCE"], ["distinct microbial patterns", "HC", "LOCATED IN"], ["Dcf1 deletion", "gut microbiota", "CHANGE ABUNDANCE"], ["anti-inflammatory drugs", "Psychiatric disorders", "CHANGE EFFECT"], ["chronic hyperglycemia", "metabolic disorder", "AFFECT"], ["L. brevis SG031", "depression", "INFLUENCE"], ["HgS", "loss of DA neurons", "INFLUENCE"], ["gut microbiota", "fatty liver", "IS LINKED TO"], ["Poorer mental health", "undergraduate students", "TARGET"], ["headaches", "patients", "TARGET"], ["psychotherapeutic treatments", "depressive mood", "CHANGE EFFECT"], ["ketogenic diet", "gut microbiota", "IMPACT"], ["gut microbiome", "social avoidance behaviors", "IS LINKED TO"], ["Lachnoclostridium", "insomnia", "INFLUENCE"], ["Ruminococcus-dominant enterotype", "PD", "IS LINKED TO"], ["DEPs", "substantia nigra", "LOCATED IN"], ["gut microbiota", "pathogenesis", "IS LINKED TO"], ["postbiotics", "MDD patients", "ADMINISTERED"], ["Artificial sweeteners", "gut microbiota", "IMPACT"], ["fiber", "microbial ecosystem", "IMPACT"], ["HFD-original", "loss of DA neurons", "CHANGE EFFECT"], ["bipolar disorders", "severe depression", "AFFECT"], ["dietary components", "neurodegenerative diseases", "INFLUENCE"], ["APs", "GMB", "IMPACT"], ["unique patterns", "Clostridium sensu stricto 1", "CHANGE ABUNDANCE"], ["Bifidobacterium longum", "children's neurodevelopmental disorders", "INFLUENCE"], ["Dietary Fiber", "Genetic and Epigenetic Aspects", "INFLUENCE"], ["nutraceutical supplementations", "commensal gut microbiota", "IMPACT"], ["KD", "neurological diseases", "INFLUENCE"], ["anxiety", "depressed and non-depressed groups", "TARGET"], ["Clostridia_vadinBB60_group", "GM", "PART OF"], ["Gut microbiota", "posttraumatic stress disorder", "IS LINKED TO"], ["dopamine", "striatum", "LOCATED IN"], ["Eggerthella", "Gut microbiota", "PART OF"], ["gut microbiota", "EPHB6", "CHANGE EXPRESSION"], ["PD", "decreased genera Roseburia and Faecalibacterium", "CHANGE ABUNDANCE"], ["GM", "PD", "IS LINKED TO"], ["gut microbiota", "stress", "IS LINKED TO"], ["Rifaximin", "Inflammation", "CHANGE EFFECT"], ["HD", "increased intestinal permeability", "AFFECT"], ["gut microbiota", "splenic nerve denervation", "USED BY"], ["5-HT", "SNpc", "LOCATED IN"], ["XPro1595", "monkeys", "ADMINISTERED"], ["non-celiac food sensitivities", "individuals", "TARGET"], ["microbiota", "MPTP-treated mice", "LOCATED IN"], ["Christensenellaceae", "enhanced oxidative stress", "INFLUENCE"], ["MCI", "patients", "TARGET"], ["Bacteroides", "gut microorganisms", "PART OF"], ["Gut Microbiota", "Depressive Symptoms", "IS LINKED TO"], ["Probiotic supplementation", "depressive symptoms", "INFLUENCE"], ["BMAA", "dopaminergic neuronal loss", "INFLUENCE"], ["inflammation", "female cases", "TARGET"], ["amyloidogenic protein", "gut", "LOCATED IN"], ["maternal gut microbiota dysbiosis", "combined effects", "AFFECT"], ["dopaminergic neurons", "intestinal flora", "IMPACT"], ["gut microbiota", "patient's gastrointestinal tract", "LOCATED IN"], ["Gut Microbiota", "Rhesus Monkeys", "LOCATED IN"], ["DEHP", "Proteobacteria abundance in the fecal samples", "INFLUENCE"], ["MS", "young patients", "TARGET"], ["major depression", "disability", "AFFECT"], ["idiopathic PD", "individuals", "TARGET"], ["fermented foods", "microbiota", "IMPACT"], ["o_Clostridiales", "IBS", "INFLUENCE"], ["AGPs", "inflammation", "CHANGE EFFECT"], ["brain", "CPZ-treated mice", "LOCATED IN"], ["gut microbiota alterations", "neurodevelopmental disorders", "AFFECT"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "Verrucomicrobiaceae", "IMPACT"], ["control subjects", "real-time PCR", "USED BY"], ["daucosterol", "TREM2", "CHANGE EXPRESSION"], ["gut microbiota", "AI", "IS LINKED TO"], ["T2DM", "chronic hyperglycaemia-related damage", "AFFECT"], ["4EP", "kidneys", "LOCATED IN"], ["antibiotic treatments", "Gut Microbiota Dysbiosis", "CHANGE EFFECT"], ["enterotype-P", "patients", "LOCATED IN"], ["fiber", "maternal depression and anxiety", "INFLUENCE"], ["depression", "Firmicutes", "CHANGE ABUNDANCE"], ["DSS", "Rikencellaceae", "IMPACT"], ["DA neuron loss", "rats", "TARGET"], ["Probiotics", "cognitive impairment", "INFLUENCE"], ["kefir", "genus <i>Lactococcus</i>", "IMPACT"], ["Environmental Pollutants", "Gut Microbiome", "IMPACT"], ["polyphenols", "obesity", "INFLUENCE"], ["microbial metabolites", "luminal microorganisms", "PRODUCED BY"], ["fecal calprotectin", "gut microbial dysbiosis", "INFLUENCE"], ["Low-dose PHP", "Pnpla3", "CHANGE EXPRESSION"], ["microbial dysbiosis", "psychiatric diseases", "AFFECT"], ["p-Hydroxyphenylacetic acid", "gut microbiota", "PRODUCED BY"], ["intestinal inflammation", "Parkinson's disease", "AFFECT"], ["Human gut microbiota", "disease conditions", "IS LINKED TO"], ["schizophrenia", "Bifidobacterium", "CHANGE ABUNDANCE"], ["Diarrhea", "Streptococcus", "CHANGE ABUNDANCE"], ["microorganisms", "Human gut microbiota", "COMPARED TO"], ["microbiota", "NAc", "LOCATED IN"], ["anxiety", "diarrhea", "AFFECT"], ["gut dysbiosis", "anxiety disorder", "AFFECT"], ["IBS", "gut microbiota", "CHANGE ABUNDANCE"], ["Acute and Chronic Insomnia", "Patients", "TARGET"], ["phenylacetylglutamine", "Parkinson's microbiota", "PRODUCED BY"], ["gut microbiome", "comorbidities", "IS LINKED TO"], ["depression", "population", "TARGET"], ["gut microbiota", "autism-like behavior", "IS LINKED TO"], ["gut microbiota", "dopaminergic neuron loss", "IS LINKED TO"], ["MAM", "PIPO patients", "LOCATED IN"], ["Parkinson's disease", "gut", "STRIKE"], ["Proteobacteria", "gut microbiota", "PART OF"], ["gut microbiota", "liver injuries", "IS LINKED TO"], ["Gut Microbiota", "clinically heterogenic disorder", "IS LINKED TO"], ["\u03b1-synuclein aggregation", "substantia nigra", "STRIKE"], ["gut microbiota", "16S rRNA sequencing analysis", "USED BY"], ["TNF-\u03b1", "serum", "LOCATED IN"], ["APs", "metabolic adverse effects", "CHANGE EFFECT"], ["SIBO", "functional constipation", "AFFECT"], ["\u03b1-synuclein", "vagus nerve", "LOCATED IN"], ["<i>Desulfovibrio</i> bacteria", "hydrogen sulfide", "INTERACT"], ["individuals", "exercise", "USED BY"], ["AGE inhibitor", "neurodegenerative diseases", "CHANGE EFFECT"], ["GI symptoms", "athletes", "TARGET"], ["Parkinson's disease", "Verrucomicrobiaceae", "CHANGE ABUNDANCE"], ["Antibiotics", "Gut dysbiosis", "CHANGE EFFECT"], ["TPG", "Negativicutes", "IMPACT"], ["lipid-based nutraceuticals", "AD", "INFLUENCE"], ["prebiotics", "neurological disorders", "INFLUENCE"], ["OPA", "apoptosis-related genes", "CHANGE EXPRESSION"], ["depression", "humans", "TARGET"], ["Motor Neuron Disease", "patients", "TARGET"], ["Male C57BL/6 mice", "beam walking teat", "USED BY"], ["Behavioral dysfunction", "rats", "TARGET"], ["acetate", "patients", "LOCATED IN"], ["PFC", "antibiotic cocktail (ABX)-treated mice", "LOCATED IN"], ["Gut Microbiota Dysbiosis", "late onset neuropathologies", "AFFECT"], ["Depression", "Lactobacillus spp.", "CHANGE ABUNDANCE"], ["autism spectrum disorders", "children", "TARGET"], ["ADHD", "individuals", "TARGET"], ["Major Depressive Disorder", "participants", "TARGET"], ["maternal microbiota", "16S rRNA sequencing", "USED BY"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "gut microbial dysbiosis", "INFLUENCE"], ["6-OHDA", "motor dysfunction", "INFLUENCE"], ["GM", "Comparative taxonomic analysis", "USED BY"], ["gut microbiota", "Neuroinflammation", "IS LINKED TO"], ["cuprizone", "demyelination", "CHANGE EFFECT"], ["LPS", "systemic inflammation", "INFLUENCE"], ["microbiota", "radiation", "USED BY"], ["prebiotics", "patients", "ADMINISTERED"], ["Di-(2-ethylhexyl) phthalate", "increasing body weight gain", "INFLUENCE"], ["idiopathic PD patients", "gastric biopsies", "USED BY"], ["type 2 diabetes", "Sprague-Dawley (SD) rats", "TARGET"], ["GABA", "gut microbiota composition", "IMPACT"], ["Gut Microbiome", "PTSD", "IS LINKED TO"], ["iRBD", "Short-chain fatty acid (SCFA)-producing bacteria", "CHANGE ABUNDANCE"], ["LPS-binding protein", "systemic inflammation", "INFLUENCE"], ["prebiotic", "gut microbiota", "IMPACT"], ["Hungatella", "microbial genera", "PART OF"], ["SCIs", "SCI patients", "TARGET"], ["Parkinson's disease", "Serratia", "CHANGE ABUNDANCE"], ["Gut Microbiota", "major depressive disorder", "IS LINKED TO"], ["HFD", "LPS plus ROT induced neurotoxicity", "CHANGE EFFECT"], ["Probiotic supplementation", "cognitive impairments", "INFLUENCE"], ["neurological diseases", "animals", "TARGET"], ["dysbiosis", "Hashimoto's thyroidis", "AFFECT"], ["microbes", "amyotrophic lateral sclerosis", "INFLUENCE"], ["Epithelial mucins", "mucosal remodelling", "INFLUENCE"], ["Flavonoids from Seabuckthorn", "gut microbiota", "IMPACT"], ["HFD-reduced", "behavioral dysfunction", "CHANGE EFFECT"], ["CNS", "mice", "LOCATED IN"], ["lipopolysaccharide", "dysbiosis", "INFLUENCE"], ["PD", "individuals", "TARGET"], ["KD", "pain", "INFLUENCE"], ["viral infections", "gut microbiota", "CHANGE ABUNDANCE"], ["GBM", "Escherichia coli", "CHANGE ABUNDANCE"], ["gut microbiota", "BD patients", "LOCATED IN"], ["metabolites", "intestines", "LOCATED IN"], ["fermented foods", "gastrointestinal diseases", "INFLUENCE"], ["Oxidative Stress", "Neurodegenerative Disease", "AFFECT"], ["<i>Lactobacillus reuteri</i> ATG-F4", "Chronic Stress-induced Anhedonia", "INFLUENCE"], ["LPS", "Pronicromonosporaceae", "IMPACT"], ["fat and sugar content", "systemic inflammation", "INFLUENCE"], ["BD", "patients", "TARGET"], ["gut microbiome", "inflammatory gastrointestinal disorders", "IS LINKED TO"], ["upper and lower gastrointestinal issues", "patients", "TARGET"], ["depression-like behaviors", "NOD mice", "TARGET"], ["HgS", "gut microbiomes", "IMPACT"], ["3-Methylindole", "intestine microbiota", "PRODUCED BY"], ["genus Blautia", "gut microbiota", "PART OF"], ["As<sub>4</sub>S<sub>4</sub>", "gut microbiota", "IMPACT"], ["perturbed metabolic function", "AD", "AFFECT"], ["microbiota", "mice", "LOCATED IN"], ["GBM", "Rikenellaceae", "CHANGE ABUNDANCE"], ["Gut Microbiota", "Neuropsychiatric Disorders", "IS LINKED TO"], ["iron", "maternal depression and anxiety", "INFLUENCE"], ["gut microbes", "human diseases", "IS LINKED TO"], ["Gut microbiota dysbiosis", "toxicity", "AFFECT"], ["Ruminiclostridium", "experiment group", "LOCATED IN"], ["Turicibacter", "GI symptoms", "INFLUENCE"], ["inulin", "migraine", "INFLUENCE"], ["pesticides", "neoplasms", "INFLUENCE"], ["Firmicutes", "major depressive disorder", "INFLUENCE"], ["fiber intake", "depression", "INFLUENCE"], ["prebiotics", "ADHD", "INFLUENCE"], ["hippocampus", "CUMS model rats", "LOCATED IN"], ["SIBO", "heart failure", "AFFECT"], ["zinc", "controls", "LOCATED IN"], ["ASD", "Patients", "TARGET"], ["gut microbiota", "nasointestinal FMT group", "LOCATED IN"], ["synbiotics", "mental health", "INFLUENCE"], ["prebiotics", "Parkinson's disease", "INFLUENCE"], ["gut microbiota", "malnutrition", "IS LINKED TO"], ["MPTP", "PD-related injury", "CHANGE EFFECT"], ["MS group", "MS and CUMS paradigms", "USED BY"], ["Dietary polyphenols", "brain disorders", "INFLUENCE"], ["Probiotics", "gut microbiota", "PART OF"], ["Constipation", "patients", "TARGET"], ["gut bacterial community composition", "Parkinson's disease", "IS LINKED TO"], ["PD", "Butyricimonas", "CHANGE ABUNDANCE"], ["Fecalibacterium prausnitzii", "fecal metagenomes", "PART OF"], ["Gut Microbiota", "PD", "IS LINKED TO"], ["L. brevis", "mood disorders", "INFLUENCE"], ["bronchopulmonary dysplasia", "preterm babies", "TARGET"], ["Infant inflammatory diseases", "offspring", "TARGET"], ["mild stress (CUMS) group", "ELISA", "USED BY"], ["\u03b1-HgS-containing Hua-Feng-Dan", "Pronicromonosporaceae", "IMPACT"], ["adequate protein", "epilepsy", "INFLUENCE"], ["migraine", "gastrointestinal diseases", "AFFECT"], ["Levodopa", "dysbiotic microbiota", "CHANGE EFFECT"], ["low carbohydrate", "CNS disorders", "INFLUENCE"], ["PD", "PD individuals", "TARGET"], ["microbial disorders", "PD", "AFFECT"], ["Antibiotics", "transient gut dysbiosis", "CHANGE EFFECT"], ["unique patterns", "MDD", "TARGET"], ["GM", "inflammatory or \"leaky\" IB", "IS LINKED TO"], ["Flavobacterium spp.", "severe social avoidance behaviors", "INFLUENCE"], ["microbes-derived compounds", "psychiatric disorders", "INFLUENCE"], ["lead", "Parkinson's disease", "INFLUENCE"], ["Lysinibacillus", "PD mice", "LOCATED IN"], ["major depressive disorder", "Actinobacteria", "CHANGE ABUNDANCE"], ["probiotics", "IBS", "INFLUENCE"], ["short-chain fatty acids", "autism", "INFLUENCE"], ["psychiatric disorders", "adolescents", "TARGET"], ["anxiety disorders", "mice", "TARGET"], ["chronic and selective process of neuron cell death", "Neurodegenerative Diseases", "AFFECT"], ["Lactobacteriaceae", "gut microbiota", "PART OF"], ["Sellimonas", "microbial genera", "PART OF"], ["gut microbiota", "PD clinical features", "IS LINKED TO"], ["arsenic", "Parkinson's disease", "INFLUENCE"], ["firmicutes", "patients", "LOCATED IN"], ["\u03b1-synuclein protein", "gut microbiota", "IMPACT"], ["PD", "PD and healthy controls", "TARGET"], ["MDD", "patient", "TARGET"], ["nutraceutical supplementations", "neurological disorders", "INFLUENCE"], ["MeDiet", "memory and cognition impairment", "INFLUENCE"], ["interleukin-1\u03b2", "systemic inflammation", "INFLUENCE"], ["HC", "fecal sampling", "USED BY"], ["polyphenols", "neuroinflammation", "INFLUENCE"], ["\u03b2-HgS-containing 70W", "Verrucomicrobiaceae", "IMPACT"], ["gut microbiota", "preschool children", "LOCATED IN"], ["gut microbiota", "Hashimoto's thyroidis", "IS LINKED TO"], ["Glyceric acid", "Gut microbiota", "PRODUCED BY"], ["probiotics", "commensal gut microbiota", "IMPACT"], ["4-ethylphenol sulfate", "anxiety phenotype", "INFLUENCE"], ["neuroinflammation", "neurodegeneration", "AFFECT"], ["mood disorders", "overweight adults", "TARGET"], ["schizophrenia", "criteria-acute group (patients with acute schizophrenia)", "TARGET"], ["gut flora dysbiosis", "autoimmune disease", "AFFECT"], ["Adult specific pathogen free (SPF) Sprague-Dawley rats", "object placement test", "USED BY"], ["Nutraceuticals", "commensal gut microbiota", "IMPACT"], ["gut microbiota", "metabolomics", "USED BY"], ["Prosaic Foods", "Alzheimer Disease", "INFLUENCE"], ["microbiota-derived short-chain fatty acids", "schizophrenia", "INFLUENCE"], ["L-Aspartic acid", "intestine microbiota", "PRODUCED BY"], ["microbiota", "ALS", "IS LINKED TO"], ["Lactobacillaceae", "PD mice", "LOCATED IN"], ["Turicibacter", "GLCA", "INTERACT"], ["microbiota", "SS-related symptoms", "IS LINKED TO"], ["gastrointestinal dysfunction", "PD patients", "TARGET"], ["GM", "animals", "LOCATED IN"], ["HFD-original", "DA neuron loss", "CHANGE EFFECT"], ["inescapable stress", "rats", "TARGET"], ["gut microbiota disorder", "patients", "TARGET"], ["short-chain fatty acids or the amino acid tryptophan", "Microbes in the gut", "PRODUCED BY"], ["five compositional different metabolites", "mitochondrial dysfunction", "INFLUENCE"], ["chronic social defeat", "Mice", "TARGET"], ["gut microbes", "neurological diseases", "IS LINKED TO"], ["anxiety- and depression-like behaviors", "father", "TARGET"], ["nutrition", "mental illness", "INFLUENCE"], ["Probiotics", "Parkinson's Disease", "INFLUENCE"], ["oral agents", "Parkinson's disease", "CHANGE EFFECT"], ["skin", "patients", "LOCATED IN"], ["aluminum", "late onset neuropathology", "INFLUENCE"], ["EPA", "memory and cognition impairment", "INFLUENCE"], ["intestinal barrier", "patients", "LOCATED IN"], ["olanzapine", "mild metabolic disorders", "CHANGE EFFECT"], ["bovine milk casein", "non-celiac food sensitivities", "INFLUENCE"], ["Gut microbiota", "gut permeability", "IS LINKED TO"], ["chronic unpredictable mild stress", "Offspring rats", "TARGET"], ["short-chain fatty acid producers", "fatigue", "INFLUENCE"], ["gut microbiota", "older population", "LOCATED IN"], ["oral and gut microbiota", "functional gastrointestinal disorders", "IS LINKED TO"], ["BB05", "Diarrhea", "INFLUENCE"], ["malnutrition", "hospitalized older adults", "TARGET"], ["gut microbiota", "PD and healthy controls", "LOCATED IN"], ["gut microbiota", "dysbiosis", "IS LINKED TO"], ["nutraceuticals", "brain disorders", "INFLUENCE"], ["CNO", "gut microbiota", "IMPACT"], ["ceftriaxone", "PD", "CHANGE EFFECT"], ["Parkinson's Disease", "Lachnospiraceae", "CHANGE ABUNDANCE"], ["NRTN", "hyperglycemia", "INFLUENCE"], ["antibiotic growth promotants", "inflammation", "CHANGE EFFECT"], ["neurodegeneration", "PD patients", "TARGET"], ["faecal metabolites", "microbiome", "PRODUCED BY"], ["Parkinson's disease", "Escherichia", "CHANGE ABUNDANCE"], ["gut microbiota", "clinical symptoms", "IS LINKED TO"], ["appendix", "adults", "LOCATED IN"], ["controls", "gas chromatography", "USED BY"], ["HFD microbiota", "toll-like receptor 2", "CHANGE EXPRESSION"], ["Curcumin", "gut flora", "IMPACT"], ["Low FODMAP diet", "Gut Microbiota", "IMPACT"], ["KD", "multiple sclerosis", "INFLUENCE"], ["piperine", "MicroRNA", "CHANGE EXPRESSION"], ["SCFAs", "neuromyelitis optica spectrum disorders", "INFLUENCE"], ["human gut microbiota", "Neurodegenerative Disease", "IS LINKED TO"], ["UDCA", "neuroinflammation", "INFLUENCE"], ["microbiota", "anxiety", "IS LINKED TO"], ["butyrate", "vascular dementia", "INFLUENCE"], ["proinflammatory microbes", "PD patient group", "LOCATED IN"], ["patients", "quantitative real-time PCR", "USED BY"], ["antibiotic treatments", "Gut dysbiosis", "CHANGE EFFECT"], ["levodopa", "idiopathic PD", "CHANGE EFFECT"], ["diet", "brain health", "INFLUENCE"], ["depressive disorders", "infants' inflammatory diseases", "AFFECT"], ["gut microbiota", "cognitive disorders", "IS LINKED TO"], ["constipation", "control group", "TARGET"], ["polymannuronic acid", "short chain fatty acids", "INTERACT"], ["gut microbiome alpha-diversity", "neurological disorders", "AFFECT"], ["PD", "postural instability", "AFFECT"], ["Inflammation", "gut", "STRIKE"], ["parkinsonism", "pathogens", "CHANGE ABUNDANCE"], ["Helicobacter", "Neurological Disorders", "INFLUENCE"], ["trait anxiety", "Individuals", "TARGET"], ["natural polysaccharides", "intestinal flora", "IMPACT"], ["lurasidone", "rate-limiting dissolution", "CHANGE EFFECT"], ["nutraceutical supplementations", "Parkinson's disease", "INFLUENCE"], ["MDD", "Escherichia coli", "CHANGE ABUNDANCE"], ["Corynebacterium", "malnutrition", "INFLUENCE"], ["gut microbiota", "adults", "LOCATED IN"], ["anxiety", "individuals", "TARGET"], ["Sybergistetes", "microbiota", "PART OF"], ["Parkinson's disease", "Enterobacteriaceae", "CHANGE ABUNDANCE"], ["gut microbiota", "immune-driven pathogenesis", "IS LINKED TO"], ["gastrointestinal (GI) symptoms", "general physical and mental wellbeing", "AFFECT"], ["individuals", "serum metabolomics profiling", "USED BY"], ["SCFAs-producing gut bacteria", "SCFAs", "INTERACT"], ["piperine", "Nitric oxide synthases-2", "INTERACT"], ["\u03b1-HgS-containing Hua-Feng-Dan", "Verrucomicrobiaceae", "IMPACT"], ["NPs", "GM", "IMPACT"], ["Guillain-Barr\u00e9", "patients", "TARGET"], ["depression", "Spanish cohort", "TARGET"], ["Klebsiella", "depression", "INFLUENCE"], ["leucine rich repeat", "substantia nigra", "LOCATED IN"], ["Polycystic ovarian syndrome", "reproductive-aged women", "TARGET"], ["istradefylline", "PD", "CHANGE EFFECT"], ["menthol", "FD", "INFLUENCE"], ["Prebiotics", "inflammatory bowel disease", "INFLUENCE"], ["behavioral abnormalities", "offspring", "TARGET"], ["Parkinson's Disease", "People", "TARGET"], ["microbiota", "MDD and SCZ patients", "LOCATED IN"], ["neurological problems", "patients", "TARGET"], ["oral and gut microbiota", "PD", "IS LINKED TO"], ["Increasing antibiotic resistance", "Gram-negative bacteria", "CHANGE ABUNDANCE"], ["low carbohydrate", "MS", "INFLUENCE"], ["gut flora", "neurodegenerative diseases", "IS LINKED TO"], ["gut microbiota", "gut", "LOCATED IN"], ["gut microbiota", "SNCA", "CHANGE EXPRESSION"], ["gut microbiome", "anxiety", "IS LINKED TO"], ["Human Gut Microbiota", "metabolic syndrome", "IS LINKED TO"], ["high-fiber diet", "inflammation", "INFLUENCE"], ["female mice", "sham", "USED BY"], ["PD patients", "16S ribosomal RNA (16S rRNA) gene sequencing", "USED BY"], ["Gram-negative bacteria", "LPS", "INTERACT"], ["Holdemania", "SZC", "INFLUENCE"], ["5-HT", "substantia nigra pars compacta", "LOCATED IN"], ["plasticizer", "issue and functional damages", "INFLUENCE"], ["Bacillus licheniformis", "gut microbiome", "IMPACT"], ["Hua-Feng-Dan", "LPS plus ROT induced neurotoxicity", "CHANGE EFFECT"], ["obesity", "Patients", "TARGET"], ["nutraceutical formulation", "mood disorders", "INFLUENCE"], ["gut microbiota", "streptozotocin (STZ)-induced T1D mice", "LOCATED IN"], ["<i>L. plantarum</i> DP189", "tumor necrosis factor-\u03b1", "INTERACT"], ["zinc", "COVID-19", "INFLUENCE"], ["gut microbiota", "infant gastrointestinal complaints", "IS LINKED TO"], ["type 2 diabetes", "host", "TARGET"], ["Mediterranean diet", "atherosclerosis progression", "INFLUENCE"], ["gut microbiota", "depressed/normal mother rats", "LOCATED IN"], ["\u03b1-synuclein", "multiple system atrophy", "INFLUENCE"], ["ketamine enantiomers", "susceptible mice", "ADMINISTERED"], ["butyrate", "multiple sclerosis", "INFLUENCE"], ["Fermented Wheat Germ", "Depression-like Behavior", "INFLUENCE"], ["obesity", "gut microbiota", "CHANGE ABUNDANCE"], ["DREADD ligands", "gut microbiota", "IMPACT"], ["inflammatory conditions", "lungs", "STRIKE"], ["BAs", "gut bacteria", "IMPACT"], ["AGEs", "AD", "INFLUENCE"], ["toxicity", "murine rodents", "TARGET"], ["SD", "Firmicutes", "CHANGE ABUNDANCE"], ["Fecal microbiota", "16S sequencing", "USED BY"], ["dietary fiber pectins", "immune function", "INFLUENCE"], ["diet", "gut microbiota", "IMPACT"], ["\u03b1-synuclein", "neuronal loss", "INFLUENCE"], ["gut microbiota", "sequencing", "USED BY"], ["Gut Microbiota", "TD", "IS LINKED TO"], ["Cardiometabolic Disorder", "Humanized Gnotobiotic Mice", "TARGET"], ["GFAP", "DEX and CUMS groups", "LOCATED IN"], ["pathological state", "PD mice", "TARGET"], ["Gut microbiota", "striatum", "LOCATED IN"], ["antibiotic-treated animals", "amphetamine-induced rotation test", "USED BY"], ["NLRP3 inflammasome", "amyotrophic lateral sclerosis", "INFLUENCE"], ["gut microbiota", "Chronic insomnia", "IS LINKED TO"], ["self-reported symptoms", "athletes", "TARGET"], ["gut flora", "gut flora dysbiosis", "IS LINKED TO"], ["pro-inflammatory bacteria", "stress response", "INFLUENCE"], ["Flavonol Fisetin", "Neurological Disorders", "INFLUENCE"], ["fecal microbiota", "metagenomic sequencing", "USED BY"], ["gut microbiota", "PD motor", "IS LINKED TO"], ["gut microbiota", "Shotgun metagenomics", "USED BY"], ["maternal vaginal microbiota", "infant faecal microbiota", "COMPARED TO"], ["GM", "PD symptoms", "IS LINKED TO"], ["prenatal maternal stress", "susceptibility to depression", "AFFECT"], ["pro-inflammatory bacteria", "negative emotionality", "INFLUENCE"], ["Helicobacter_ganmani", "inflammatory lesions", "INFLUENCE"], ["human-associated microbiota", "Neurodegeneration", "IS LINKED TO"], ["taxa", "Parkinson disease", "INFLUENCE"], ["infant gastrointestinal complaints", "offspring", "TARGET"], ["(R)-ketamine", "reduced BMD", "CHANGE EFFECT"], ["mitochondrial function", "6-OHDA-induced motor deficit", "AFFECT"], ["prebiotic supplementation", "Lachnospiraceae family", "IMPACT"], ["Verrucomicrobia", "gut microbiome", "PART OF"], ["microbiota", "mPFC", "LOCATED IN"], ["Parabacteroides", "SCFAs", "INTERACT"], ["Gut Microbiota", "obstructive sleep apnea", "IS LINKED TO"], ["Multiple B.\u00a0subtilis strains", "bacterial metabolites", "INTERACT"], ["lipid contents", "\u03b1-syn amyloidogenesis", "INFLUENCE"], ["oral astilbin", "GM", "IMPACT"], ["plasma BCAAs", "PD patients", "LOCATED IN"], ["VVS patients", "head-up tilt test", "USED BY"], ["anxiety", "gastrointestinal complaints", "AFFECT"], ["pathogenic proteins", "GM", "PART OF"], ["Firmicutes", "MDD", "INFLUENCE"], ["microbiota", "type 2 diabetes mellitus", "IS LINKED TO"], ["ketogenic diet", "central nervous system (CNS) disorders", "INFLUENCE"], ["s_Desulfovibrio_piger", "IBS", "INFLUENCE"], ["neurotoxic compounds", "neuroinflammation", "INFLUENCE"], ["cognitive defects", "older individuals", "TARGET"], ["disturbances of plasma BCAAs and AAAs", "PD severity", "AFFECT"], ["Endogenous \u03b1-syn", "brain", "LOCATED IN"], ["reduced colonic transit time", "Parkinson's disease", "AFFECT"], ["psychosis", "patients", "TARGET"], ["PDX", "Lactobacillus spp.", "IMPACT"], ["plasticizer", "Parkinson's disease", "INFLUENCE"], ["healthy controls", "gas chromatography-mass spectrometer", "USED BY"], ["PD", "MSA", "AFFECT"], ["\u03b1-syn", "PD", "INFLUENCE"], ["cadmium", "Alzheimer's disease", "INFLUENCE"], ["Coriobacteriia", "immobility", "INFLUENCE"], ["sucrose", "CUMS-induced depression-like behaviors", "INFLUENCE"], ["Lactobacillus rhamnosus", "chronic unpredictable mild stress-induced depression", "INFLUENCE"], ["microbiota modulators", "ASD", "INFLUENCE"], ["intestinal microbial metabolites", "multiple sclerosis", "INFLUENCE"], ["probiotic supplementation", "gut microbiota", "IMPACT"], ["Higher dietary animal protein intake", "psychological distress", "INFLUENCE"], ["Probiotics", "Bifidobacterium", "IMPACT"], ["\u03b3-aminobutyric acid", "brain", "LOCATED IN"], ["PD", "People", "TARGET"], ["comorbid patients", "fecal metagenome-wide sequencing", "USED BY"], ["ADHD", "Eubacterium_xylanophilum_group", "CHANGE ABUNDANCE"], ["Borrelia Burgdorferi", "OCD", "INFLUENCE"], ["Dietary polyphenols", "neurodegeneration", "INFLUENCE"], ["Faecal metabolome", "inflammatory bowel disease", "INFLUENCE"], ["probiotic", "Bacilli class", "IMPACT"], ["PD patients", "gas chromatography", "USED BY"], ["L. reuteri DSM 17938", "children's neurodevelopmental disorders", "INFLUENCE"], ["bacterial genera", "faecal gut microbiota", "PART OF"], ["non-T-cell-depleted group", "radiation", "USED BY"], ["amyloidogenic proteins", "gut bacteria", "IMPACT"], ["Gut microbiota", "gut disorders", "IS LINKED TO"], ["Bifidobacterium longum", "fecal metagenomes", "PART OF"], ["abdominal pain", "liver depression and spleen deficiency", "AFFECT"], ["coffee", "PD incidence and progression", "INFLUENCE"], ["therapeutic drug", "low BMD", "CHANGE EFFECT"], ["Mental Health", "Children", "TARGET"], ["malignant tumors", "host", "TARGET"], ["gastrointestinal dysfunction", "patients", "TARGET"], ["Akkermansia", "GP Patients", "LOCATED IN"], ["MeDiet", "PD", "INFLUENCE"], ["Gut microbiota", "brain", "LOCATED IN"], ["Short-Chain Fatty Acids", "Gut Microbiota", "IMPACT"], ["gut microbiota", "neurodegenerative diseases", "IS LINKED TO"], ["Paracasei 37", "children's neurodevelopmental disorders", "INFLUENCE"], ["microbiota-derived short-chain fatty acids", "nervous system disorders", "INFLUENCE"], ["Microbial BMAA", "Parkinson's Disease Neurodegeneration", "INFLUENCE"], ["PD", "heterogeneous pathology", "IS A"], ["Inflammatory bowel disease", "chronic, relapse-remitting condition", "AFFECT"], ["hippocampus", "SND-operated mice", "LOCATED IN"], ["Hua-Feng-Dan", "Pronicromonosporaceae", "IMPACT"], ["gut microbiota", "cognitive impairment", "IS LINKED TO"], ["human gut microbiota", "type 2 diabetes mellitus", "IS LINKED TO"], ["gut microbiota", "oxidative stress-mediated neurodegenerative diseases", "IS LINKED TO"], ["Perinatal Mental Health", "Mothers", "TARGET"], ["T2DM", "patients", "TARGET"], ["Polymannuronic acid prebiotic", "GM", "IMPACT"], ["intestinal microbiota", "CNS diseases", "IS LINKED TO"], ["food bioactive compounds", "anxiety", "INFLUENCE"], ["diets/dietary components", "oral pathogens", "IMPACT"], ["Ralstonia", "anxiety", "INFLUENCE"], ["systemic inflammation", "CNS", "STRIKE"], ["Probiotics", "Autism spectrum disorders", "INFLUENCE"], ["gut microbiota", "Alterations", "IS LINKED TO"], ["gut microbiota", "mood disorder", "IS LINKED TO"], ["neuropsychiatric disorders", "humans", "TARGET"], ["ASD", "eyes absent homolog 1 isoform 4", "INTERACT"], ["Neurodegenerative Disease", "ND patients", "TARGET"], ["cucurbitacin E", "inflammatory response", "INFLUENCE"], ["Gut Microbiome", "individuals", "LOCATED IN"], ["succinate", "neurological disorders", "INFLUENCE"], ["intestinal microbiota", "neurodegenerative disorders", "IS LINKED TO"], ["gut microbiome", "gastrointestinal diseases", "IS LINKED TO"], ["gut microbiota", "microbiome profiling", "USED BY"], ["motor function", "PD rats", "TARGET"], ["collagen fibres", "enteric glial activation", "INFLUENCE"], ["prebiotics", "neuropsychiatric disorders", "INFLUENCE"], ["PD", "Glyceraldehyde-3-phosphate dehydrogenase", "INTERACT"], ["CS patients", "16S rRNA sequencing", "USED BY"], ["<i>Helicobacter pylori</i> infection", "BCT", "AFFECT"], ["Psychobiotics", "Alzheimer's disease", "INFLUENCE"], ["K11358", "gut microbiota", "PRODUCED BY"], ["p_Actinobacteria", "gut microbiota", "PART OF"], ["Parkinson's Disease", "Christensenellaceae", "CHANGE ABUNDANCE"], ["synbiotic", "Parkinson's disease", "INFLUENCE"], ["Gastrointestinal Dysfunction", "Parkinson's Disease", "AFFECT"], ["vagal and spinal afferent neurons", "brain", "LOCATED IN"], ["non-commensal gut microbiome", "neurodegenerative diseases", "IS LINKED TO"], ["Gut microbiota", "Alzheimer's", "IS LINKED TO"], ["phytochemicals", "HMGB1", "CHANGE EXPRESSION"], ["Psychobiotics", "anxiety", "INFLUENCE"], ["IBDs", "IBD patients", "TARGET"], ["medial prefrontal cortex", "sham-operated mice", "LOCATED IN"], ["Soluble epoxide hydrolase", "inflammation", "INFLUENCE"], ["probiotics", "depressive behaviour", "INFLUENCE"], ["SCFAs", "Parkinson disease", "INFLUENCE"], ["gut microbiome", "healthy individuals", "LOCATED IN"], ["Ethanol Exposure", "Psychiatric Risks", "AFFECT"], ["gut microbiome", "ALS", "IS LINKED TO"], ["astilbin", "acetaminophen-induced acute liver injury", "INFLUENCE"], ["depression-like phenotypes", "antibiotic cocktail (ABX)-treated mice", "TARGET"], ["Gastrointestinal disorders", "Parkinson disease", "AFFECT"], ["Gut microbiota", "tyrosine decarboxylase gene", "CHANGE EXPRESSION"], ["low carbohydrate", "amyotrophic lateral sclerosis", "INFLUENCE"], ["animals", "AAV-alpha-synuclein", "USED BY"], ["faecal microbiota", "16S rRNA amplicon sequencing", "USED BY"], ["As<sub>4</sub>S<sub>4</sub>", "neurodegenerative diseases", "INFLUENCE"], ["gut microbiome", "human", "LOCATED IN"], ["neuropsychiatric outcomes", "patient", "TARGET"], ["human microbiota", "gastrointestinal (GI) tract", "LOCATED IN"], ["Prebiotics", "effects", "INFLUENCE"], ["KD", "Febrile Infection-Related Epilepsy Syndrome", "INFLUENCE"], ["acetic-, butyric-, formic-, isobutyric-, isovaleric-, propionic-, and succinic acid", "gut microbiota", "PRODUCED BY"], ["probiotic supplementation", "Bifidobacterium longum", "IMPACT"], ["Seabuckthorn flavonoids", "major depressive disorders", "INFLUENCE"], ["CsgA protein", "mice", "LOCATED IN"], ["live L. plantarum CCFM8661", "skin inflammation", "INFLUENCE"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "pathological state", "CHANGE EFFECT"], ["CPT", "depression", "INFLUENCE"], ["synbiotics", "neurodegeneration", "INFLUENCE"], ["Firmicutes", "short-chain fatty acids", "INTERACT"], ["carbohydrates", "mammalian gut microbiota", "IMPACT"], ["Flavonifractor", "enhanced oxidative stress", "INFLUENCE"], ["\u03b2-HgS-containing 70W", "Pronicromonosporaceae", "IMPACT"], ["microbiota", "ASDs", "IS LINKED TO"], ["ASD", "gap junction alpha-1", "INTERACT"], ["depressive disorders", "early infant diseases", "AFFECT"], ["childhood anxiety", "mothers", "TARGET"], ["Pharmacomicrobiomics", "Depression", "IS LINKED TO"], ["Mitochondrial dysfunction", "Parkinson's disease", "AFFECT"], ["small intestinal microbiome", "duodenal aspirates", "USED BY"], ["beneficial bacteria", "short-chain fatty acids", "INTERACT"], ["Bifidobacterium_dentium", "PD", "INFLUENCE"], ["gut microbiota", "HD group", "LOCATED IN"], ["SND", "Maribacter_arcticus", "CHANGE ABUNDANCE"], ["(COVID)-19", "patients", "TARGET"], ["bipolar disorder", "people with the major psychiatric disorders", "TARGET"], ["HFD-original", "Enterobacteeriaceae", "IMPACT"], ["LPS", "disability", "INFLUENCE"], ["Perinatal mood and anxiety disorders", "child", "TARGET"], ["HgS", "neurodegenerative diseases", "INFLUENCE"], ["bipolar disorder", "Firmicutes", "CHANGE ABUNDANCE"], ["antibiotics", "Alzheimer's disease", "CHANGE EFFECT"], ["PVD", "severe depression", "AFFECT"], ["gut bacteria", "gut microbes", "PART OF"], ["Alzheimer's disease", "SOD1 mice", "TARGET"], ["gut dysbiosis", "neuropsychiatric manifestations", "AFFECT"], ["gut microbiota", "chemotherapy-associated psychological distress", "IS LINKED TO"], ["AGPs", "poultry gut microbiome", "IMPACT"], ["misfolded protein alpha-synuclein", "PD", "INFLUENCE"], ["young adults", "neurological examinations", "USED BY"], ["iron deficiency", "CCRA", "AFFECT"], ["PD", "intestinal mucin layer-degrading Akkermansia", "CHANGE ABUNDANCE"], ["Yersinia aleksiciae", "gut microbiota", "PART OF"], ["Gut dysbiosis", "cancer patients", "TARGET"], ["psychobiotic", "COVID-19", "INFLUENCE"], ["Helicobacter hepaticus", "motor disorders", "INFLUENCE"], ["intestinal microbiota", "neurological and psychiatric disorders", "IS LINKED TO"], ["physiological alterations", "F1", "TARGET"], ["gut microbiota", "LD group", "LOCATED IN"], ["gut microbiota", "ABX\u00a0+\u00a0LPS group", "LOCATED IN"], ["intestinal microbiota", "depressed mice", "LOCATED IN"], ["stress", "cognitive impairment", "AFFECT"], ["chronic SD", "g_Akkermansia", "CHANGE ABUNDANCE"], ["Gut Microbiome", "microbial dysbiosis", "IS LINKED TO"], ["antibiotic cocktail", "gut microbiota", "IMPACT"], ["PD", "Mycoplasmatales", "CHANGE ABUNDANCE"], ["gut microbiota", "gut-derived inflammation", "IS LINKED TO"], ["butyrate", "GIT microbiome", "IMPACT"], ["probiotics", "ALS", "INFLUENCE"], ["cadmium", "late onset neuropathologies", "INFLUENCE"], ["mouse model", "repeated social defeat stress", "USED BY"], ["AD", "patients with mild to severe cognitive impairment", "TARGET"], ["coffee", "cleaved caspase-3", "CHANGE EXPRESSION"], ["Gut microbiota disturbance", "helminth infection", "AFFECT"], ["pain", "patients", "TARGET"], ["PD", "cholecystectomy group", "TARGET"], ["depression", "AsA", "TARGET"], ["Phascolarctobacterium spp.", "gut microbiota", "PART OF"], ["mental health", "asymptomatic individuals", "TARGET"], ["gut microbiota", "metagenomic sequencing", "USED BY"], ["butyrate-producing bacteria", "microbiome", "PART OF"], ["gut microbiota", "autism-like social behavior", "IS LINKED TO"], ["control (CON) group", "sequencing 16S rDNAs", "USED BY"], ["mPFC", "CUS mice", "LOCATED IN"], ["Parkinson's Disease", "Egyptian patients", "TARGET"], ["anxiety", "patients", "TARGET"], ["i>Bacteroides thetaiotaomicron</i> DSM 2079", "acid-induced cellular damage", "INFLUENCE"], ["demyelination", "brain", "STRIKE"], ["TNF-\u03b1", "striatum", "LOCATED IN"], ["maternal-infant microbiota", "gut dysbiosis", "IS LINKED TO"], ["TH", "ileum", "LOCATED IN"], ["PD", "Christensenellaceae", "CHANGE ABUNDANCE"], ["Bacteroides xylanisolvens", "MCI", "INFLUENCE"], ["depression-like symptoms", "SCI patients", "TARGET"], ["PD-MCI", "patients", "TARGET"], ["gut microbiota metabolites", "stress", "INFLUENCE"], ["colonic microbiome", "amyotrophic lateral sclerosis", "IS LINKED TO"], ["systemic inflammation", "CCRA", "AFFECT"], ["Trp", "MDD", "INFLUENCE"], ["dysbiosis", "intestinal microbiota", "CHANGE ABUNDANCE"], ["Parkinson's disease", "alpha-synuclein", "INTERACT"], ["dopaminergic neuron degeneration", "Oxidative stress", "AFFECT"], ["Phytochemicals", "Neurodegenerative Diseases", "INFLUENCE"], ["L. plantarum CCFM8661", "acne", "INFLUENCE"], ["gut microbiota", "stroke", "IS LINKED TO"], ["Flavonifractor", "negative affectivity", "INFLUENCE"], ["depression-like phenotype", "SND-operated mice", "TARGET"], ["SIBO", "metabolic-associated fatty liver disease", "AFFECT"], ["Gut Microbiome", "AD", "IS LINKED TO"], ["antibiotic treatments", "transient gut dysbiosis", "CHANGE EFFECT"], ["migraine headache", "gut microbiota", "CHANGE ABUNDANCE"], ["<i>plantarum</i> P-8", "anxiety", "INFLUENCE"], ["1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine", "Male C57BL/6 mice", "LOCATED IN"], ["Na\u00efve group", "gas chromatography mass spectrometry", "USED BY"], ["high-fiber diet", "gut microbiota", "IMPACT"], ["catalysidins", "antimicrobial proteins", "PART OF"], ["caecal microbiota", "radiation", "USED BY"], ["ASD", "females", "TARGET"], ["GM", "obsessive-compulsive disorder", "IS LINKED TO"], ["post-COVID-19 IBS", "Patients", "TARGET"], ["pesticides", "PD", "INFLUENCE"], ["fecal microbiota", "RNA-seq", "USED BY"], ["gut microbiome", "pathogenesis of PD", "IS LINKED TO"], ["PD", "loss of neurons", "AFFECT"], ["PD", "dopaminergic (DA) neurons", "INTERACT"], ["food supplement", "FD", "INFLUENCE"], ["interleukin (IL)-1\u03b2", "severe social avoidance behaviors", "INFLUENCE"], ["diarrhea-predominant IBS", "depression", "AFFECT"], ["Dietary Polyphenols", "Parkinson's Disease", "INFLUENCE"], ["infant microbiota", "maternal microbiota", "COMPARED TO"], ["medial prefrontal cortex", "stressed mice", "LOCATED IN"], ["CSDS", "adult mice", "TARGET"], ["traumatic stress", "women", "TARGET"], ["festive foods", "microbiota", "IMPACT"], ["Psychobiotics", "aging brain", "INFLUENCE"], ["Bacteroidetes", "MDD", "INFLUENCE"], ["gut microbiota", "matched controls", "LOCATED IN"], ["CKD", "Group 1", "TARGET"], ["immune response", "intestinal", "STRIKE"], ["gut microbiota", "stress related disorders", "IS LINKED TO"], ["MedDiet", "gut microbiota", "IMPACT"], ["o_Clostridiales", "depression", "INFLUENCE"], ["beneficial bacteria", "SCFAs", "INTERACT"], ["depressive disorders", "diarrhea", "AFFECT"], ["SIBO", "pancreatitis", "AFFECT"], ["Antibiotics", "late onset neuropathology", "CHANGE EFFECT"], ["succinate", "Alzheimer's disease", "INFLUENCE"], ["calorie-controlled diets", "cognitive decline", "INFLUENCE"], ["CKD", "elderly", "TARGET"], ["dysbiosis of the gastrointestinal tract", "cardiovascular disease", "AFFECT"], ["PS128", "MPTP-induced motor deficits", "INFLUENCE"], ["berberine", "patients", "ADMINISTERED"], ["Child temperament", "Gut microbiota", "CHANGE ABUNDANCE"], ["bloating", "alleviation of symptoms", "AFFECT"], ["herpesvirus", "apoptosis", "INFLUENCE"], ["Polyphenols", "brain disorders", "INFLUENCE"], ["triphala polyphenols", "stress-induced mental health problems", "INFLUENCE"], ["depression", "ET", "AFFECT"], ["acetate", "human gut microbiota", "PRODUCED BY"], ["gut microbiota", "psychiatric conditions", "IS LINKED TO"], ["Microbiota Alterations", "Neurodegeneration", "AFFECT"], ["manganese", "Parkinson's disease", "INFLUENCE"], ["neuroinflammation", "Parkinson's disease", "AFFECT"], ["Male C57BL/6 mice", "open field test", "USED BY"], ["Alphaproteobacteria", "depression score", "INFLUENCE"], ["Christensenellaceae", "Parkinson's subjects", "LOCATED IN"], ["acetic", "GM", "PRODUCED BY"], ["SMI", "LBP", "INTERACT"], ["prominent inflammatory component", "illness", "AFFECT"], ["antibiotics", "neurodegenerative disease genes", "CHANGE EXPRESSION"], ["Mediterranean diet", "Alzheimer's", "INFLUENCE"], ["fecal microbiota", "cognitive impairment", "IS LINKED TO"], ["Faecalibacterium prausnitzii", "GM", "PART OF"], ["isoleucine", "PD patients", "LOCATED IN"], ["sodium oligomannate", "gut dysbiosis", "CHANGE EFFECT"], ["depression", "PCOS patients", "TARGET"], ["microbiota", "nasal passages", "LOCATED IN"], ["amyotrophic lateral sclerosis", "neurological disorders", "IS A"], ["healthy controls", "Illumina sequencing", "USED BY"], ["vagus nerve", "participants", "LOCATED IN"], ["Mn", "neurodegenerative diseases", "INFLUENCE"], ["duodenal microbiome", "Parkinson's disease", "IS LINKED TO"], ["AFF", "LBP", "INTERACT"], ["gastrointestinal dysfunction", "human case-control studies", "TARGET"], ["coffee", "astrocyte activation marker GFAP", "CHANGE EXPRESSION"], ["Casein", "Nigrostriatal Disease", "INFLUENCE"], ["Flavonifractor", "gut microbiota", "PART OF"], ["\u03b1-synuclein fibrils", "PD", "INFLUENCE"], ["Mediterranean diet", "cardiovascular disease", "INFLUENCE"], ["Fecal microbiota", "patients", "LOCATED IN"], ["hippocampus", "mice", "LOCATED IN"], ["CUR", "neurological disorders", "INFLUENCE"], ["Lactococcus", "AET mice", "LOCATED IN"], ["active AN", "females", "TARGET"], ["Gut Microbiota", "Motor Deficit", "IS LINKED TO"], ["vegetables", "depression", "INFLUENCE"], ["gut microbiota", "Untargeted metabolomics analysis", "USED BY"], ["microbial symbionts", "host", "LOCATED IN"], ["chronic and selective process of neuron cell death", "Alzheimer's disease", "AFFECT"], ["type 2 diabetes", "SD rats", "TARGET"], ["AR 420626", "FA3R", "INTERACT"], ["type-2 diabetes mellitus", "patients", "TARGET"], ["SHH", "Bacteroides", "IMPACT"], ["MPTP", "dopamine", "INTERACT"], ["nutrients", "gut microbiota", "IMPACT"], ["Adult specific pathogen free (SPF) Sprague-Dawley rats", "open-field test", "USED BY"], ["patients", "cholecystectomy", "USED BY"], ["AN", "individuals", "TARGET"], ["Probiotics", "perinatal mood disorders", "INFLUENCE"], ["substantia nigra pars compacta", "mice", "LOCATED IN"], ["intestinal microflora", "schizophrenia", "IS LINKED TO"], ["Gut Microbiome", "post-traumatic stress disorder", "IS LINKED TO"], ["disturbance of gut microbiota", "rat", "TARGET"], ["neuroinflammation", "mice", "TARGET"], ["Short-chain fatty acid (SCFA)-producing bacteria", "controls", "LOCATED IN"], ["butyric acid", "liver", "LOCATED IN"], ["faecal gut microbiota", "depression and fatigue symptoms", "IS LINKED TO"], ["Psychobiotics", "CNS disorders", "INFLUENCE"], ["glutamate", "gut microbiota", "PRODUCED BY"], ["\u03b1-synuclein", "PD", "INFLUENCE"], ["PD", "iRBD patients", "TARGET"], ["CKD", "Group 2", "TARGET"], ["infective pathogens", "Parkinson's disease", "INFLUENCE"], ["Prevotellaceae_UCG-001", "KO and WT mice", "LOCATED IN"], ["lactulose", "learning retrieval", "INFLUENCE"], ["microbiota", "sepsis", "IS LINKED TO"], ["LPS", "splenomegaly", "INFLUENCE"], ["GM", "males", "LOCATED IN"], ["high-dose B. breve 207-1", "healthy adults", "ADMINISTERED"], ["autoimmune disease", "patients", "TARGET"], ["Gut microbiome", "schizophrenia", "IS LINKED TO"], ["Wolbachia", "AD-induced <i>Drosophila</i>", "LOCATED IN"], ["gut microbiome", "gut disorders", "IS LINKED TO"], ["Fermented foods", "Lactic acid bacteria", "IMPACT"], ["fecal short-chain fatty acids", "PD", "INFLUENCE"], ["sleep disorders", "patients", "TARGET"], ["control group", "double-blind, randomized, placebo-controlled trial", "USED BY"], ["Intestinal Microbiota", "Migraine", "IS LINKED TO"], ["CA", "viruses", "INFLUENCE"], ["70W", "Pronicromonosporaceae", "IMPACT"], ["HPHP", "Acacb", "INTERACT"], ["Parkinson's Disease", "Mouse", "TARGET"], ["QUR", "androgen", "INTERACT"], ["prebiotics", "behavioural and neurobiological abnormalities", "INFLUENCE"], ["gut microbiome", "brain", "LOCATED IN"], ["urolithin metabotypes", "gut microbial ecologies", "PRODUCED BY"], ["GM", "dementia", "IS LINKED TO"], ["autism spectrum disorder", "patients", "TARGET"], ["Depression-like Behavior", "Rats", "TARGET"], ["Disruption of the intestinal microbiota", "Parkinson disease", "AFFECT"], ["cinnabar", "neurological disorders", "INFLUENCE"], ["probiotics", "cardiovascular benefits", "INFLUENCE"], ["unique patterns", "Sutterella", "CHANGE ABUNDANCE"], ["GM", "rhesus monkeys", "LOCATED IN"], ["autism-like behavior", "EphB6-deficient mice", "TARGET"], ["oxytocin", "Children", "LOCATED IN"], ["GM", "Asian Americans", "LOCATED IN"], ["metabolites", "human gut microbiota", "PRODUCED BY"], ["gut microbiota", "16s rRNA analysis", "USED BY"], ["Psychobiotics", "commensal gut microbiota", "IMPACT"], ["probiotic", "intestinal microbiota", "IMPACT"], ["gut dysbiosis", "addictive behavior", "AFFECT"], ["striatum", "PD mice", "LOCATED IN"], ["bipolar disorder", "major depressive episode patients", "TARGET"], ["organophosphate pesticides", "Alzheimer's disease", "INFLUENCE"], ["GM", "bacterial genes", "CHANGE EXPRESSION"], ["gut microbes", "multiple sclerosis", "IS LINKED TO"], ["Ruminococcaceae Incertae Sedis", "malnutrition", "INFLUENCE"], ["Iba-1", "midbrain", "LOCATED IN"], ["dysregulated microbiota-gut-brain axis", "Alzheimer's and Parkinson's disease", "AFFECT"], ["Adult Female Mice", "Long-Term Moderate Static Magnetic Field Exposure", "USED BY"], ["branched and short-chain fatty acids", "gut microbiota", "PRODUCED BY"], ["dietary sources", "PD", "INFLUENCE"], ["lactulose", "AD", "INFLUENCE"], ["Rannasangpei", "pathological lesions in the brain", "CHANGE EFFECT"], ["zinc", "neurodegenerative and neurodevelopmental disorders", "INFLUENCE"], ["gut", "agile, fit hunter gatherers", "LOCATED IN"], ["<i>L. plantarum</i> DP189", "ARE", "CHANGE EXPRESSION"], ["Roseburia", "GM", "PART OF"], ["Parkinson's disease", "Parabacteroides", "CHANGE ABUNDANCE"], ["serum inflammation", "older individuals", "TARGET"], ["dietary fiber pectins", "metabolic health", "INFLUENCE"], ["piperine", "cAMP response element-binding protein", "INTERACT"], ["limonene", "IBS/functional dyspepsia", "INFLUENCE"], ["psychiatric-related abnormalities", "maternal gut microbiota", "CHANGE ABUNDANCE"], ["human microbiome", "human body", "LOCATED IN"], ["chemotherapy-induced myelosuppression", "CCRA", "AFFECT"], ["HCs", "Full-length bacterial 16S rRNA gene sequencing", "USED BY"], ["IL-22", "midbrain", "LOCATED IN"], ["food", "gut microbiota", "IMPACT"], ["anxiety", "IBD patients", "TARGET"], ["Di-(2-ethylhexyl) phthalate", "reproductive toxicity", "INFLUENCE"], ["microbiota-derived metabolites", "vascular dementia", "INFLUENCE"], ["B vitamins", "neurological diseases", "INFLUENCE"], ["CUR", "Eggerthellaceae", "IMPACT"], ["constipation", "patients", "TARGET"], ["Anxiety", "Adults", "TARGET"], ["human gut microbiota", "Cancers", "IS LINKED TO"], ["aberrant macronutrient", "gut microbes", "IMPACT"], ["milder anxiety", "depressed father rats", "TARGET"], ["mouse model", "RSDS", "USED BY"], ["dexamethasone (DEX) group", "sequencing 16S rDNAs", "USED BY"], ["Turicibacter spp.", "severe social avoidance behaviors", "INFLUENCE"], ["Crohn's disease", "intestine", "STRIKE"], ["individual's specific gut microbiota", "reduced systemic inflammation", "IS LINKED TO"], ["MPTP-induced central and peripheral inflammatory dysfunction", "non-human primates", "TARGET"], ["psychological stress", "women", "TARGET"], ["SCZ", "CCL25", "INTERACT"], ["\u03b1-synuclein", "Parkinson's Disease", "INFLUENCE"], ["Parkinsonian pathology", "aged rats", "TARGET"], ["SIBO", "diseases", "AFFECT"], ["dysbiosis", "mental disorders", "AFFECT"], ["healthy control subjects", "quantitative PCR", "USED BY"], ["NLRP3 inflammasome", "obesity", "INFLUENCE"], ["Baicalin", "intestinal microorganisms", "IMPACT"], ["gut microbiome", "ASDs", "IS LINKED TO"], ["Citrobacter freundii", "gut microbiota", "PART OF"], ["tryptophan", "gut microbiome", "IMPACT"], ["DCA", "PD appendix", "LOCATED IN"], ["PROP", "PD patients", "LOCATED IN"], ["BMAA", "gut dysbiosis", "INFLUENCE"], ["intestinal microbial metabolites", "neuropsychiatric disorders", "INFLUENCE"], ["neurotransmitter 5-hydroxytryptamine", "Gut microbiota", "IMPACT"], ["LGG", "Lactobacillus genus", "INTERACT"], ["ASD", "patients", "TARGET"], ["Trp", "major depressive disorder", "INFLUENCE"], ["microbes", "liver", "LOCATED IN"], ["gut microbiome", "participants", "LOCATED IN"], ["SIBO", "cirrhosis", "AFFECT"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "DA", "INTERACT"], ["Prevotellaceae_UCG-001", "glycolipid metabolism disorders", "INFLUENCE"], ["SCFA", "cognitive impairment", "INFLUENCE"], ["host receptor-targeted drugs", "well-being", "CHANGE EFFECT"], ["Cinnabar", "behavioral dysfunction", "INFLUENCE"], ["AR 420626", "SALS", "INTERACT"], ["microbiota", "amyotrophic lateral sclerosis", "IS LINKED TO"], ["mice", "SND", "USED BY"], ["PD-related alterations", "patients", "TARGET"], ["coffee", "antiapoptotic protein Bcl-2", "CHANGE EXPRESSION"], ["behavioral dysfunction", "Desulfovibrionaceae", "CHANGE ABUNDANCE"], ["probiotics", "depression", "INFLUENCE"], ["gut microbiota-serum metabolites-cytokines", "lung cancer", "INFLUENCE"], ["SZ\u00a0patients", "metagenome analysis", "USED BY"], ["phosphorylated \u03b1-synuclein", "\u03b1-synuclein pathology", "INFLUENCE"], ["gut microbiota", "SNCA p.A53T mice", "LOCATED IN"], ["Zinc", "novel coronavirus infection", "INFLUENCE"], ["curcumin", "TH", "CHANGE EXPRESSION"], ["Bacteroides", "ET", "INFLUENCE"], ["trichloroethylene", "endolysosomal deficits", "INFLUENCE"], ["melibiose", "neuroprotective effect", "INFLUENCE"], ["anxiety", "neuropsychiatric diseases", "IS A"], ["depression-like behaviors", "CIA mice", "TARGET"], ["curcumin", "TREM2", "CHANGE EXPRESSION"], ["postural instability", "Bifidobacteria", "CHANGE ABUNDANCE"], ["gastrointestinal symptoms", "PD individuals", "TARGET"], ["microbial communities", "gut", "LOCATED IN"], ["irritable bowel syndrome", "people", "TARGET"], ["magnetite", "<i>Desulfovibrio</i> bacteria", "IMPACT"], ["gut microbiota", "individuals", "LOCATED IN"], ["Low FODMAP diet", "Anxiety", "INFLUENCE"], ["enterotype-P", "subjects", "LOCATED IN"], ["Parkinson's disease", "gastrointestinal (GI) tract", "STRIKE"], ["gut microbes", "stress", "IS LINKED TO"], ["nutraceutical supplementations", "Autism Spectrum Disorder", "INFLUENCE"], ["Mollicutes", "susceptible mice", "LOCATED IN"], ["maternal gut microbiota dysbiosis", "immune system dysfunction", "AFFECT"], ["microbiota-based probiotic dietary supplementation", "dementia", "INFLUENCE"], ["A. muciniphila", "strokes", "INFLUENCE"], ["Korean red ginseng", "gut microbiota", "IMPACT"], ["gut microbiota", "Parkinson disease", "IS LINKED TO"], ["dysbiosis of gut microbiome", "PD", "AFFECT"], ["Curcumin", "neurological disorders", "INFLUENCE"], ["microbiota-derived metabolites", "multiple sclerosis", "INFLUENCE"], ["gut microbiome", "mice", "LOCATED IN"], ["diet", "microbiome", "IMPACT"], ["serum metabolites", "Parkinson's disease", "INFLUENCE"], ["Flavonifractor", "AD", "INFLUENCE"], ["CA", "TNF-\u03b1", "INTERACT"], ["Gut microbiota dysbiosis", "taxa", "CHANGE ABUNDANCE"], ["morphofunctional alterations", "PD patients", "TARGET"], ["trimethylamine", "age-related diseases", "INFLUENCE"], ["glutamine", "GM", "PRODUCED BY"], ["antibiotic treatments", "late onset neuropathology", "CHANGE EFFECT"], ["microglial activation", "human PD cases", "TARGET"], ["Faecalibacterium", "stress response", "INFLUENCE"], ["infants\u2019 SCFAs", "mixed feeding group", "LOCATED IN"], ["Gut microbes", "Parkinson's disease", "IS LINKED TO"], ["Parkinson's disease", "Cristensenellaceae", "CHANGE ABUNDANCE"], ["gut microbiota", "incident SD", "IS LINKED TO"], ["amantadine", "PD", "CHANGE EFFECT"], ["butyrate-producer bacteria", "gut microbiota", "PART OF"], ["FWG", "depression", "INFLUENCE"], ["Neurological diseases", "disability", "AFFECT"], ["Faecalibacterium", "negative emotionality", "INFLUENCE"], ["Parkinson's disease", "multi-system disorder", "IS A"], ["human gut microbiota", "neurodegeneration", "IS LINKED TO"], ["tetracyclines", "PD", "CHANGE EFFECT"], ["unhealthy nutrition", "neurodegenerative diseases", "AFFECT"], ["probiotic", "Gut microbiota", "IMPACT"], ["probiotics", "ASDs", "INFLUENCE"], ["KD", "gut microbiota", "IMPACT"], ["maternal gut microbiota dysbiosis", "chronic inflammation", "AFFECT"], ["LD", "GM", "IMPACT"], ["LDSD", "deoxycholic acid", "INTERACT"], ["polyunsaturated fatty acids", "PD", "INFLUENCE"], ["nutraceuticals", "bipolar disorder", "INFLUENCE"], ["Gut microbiota", "neurocognitive", "IS LINKED TO"], ["polyphenols", "intestinal enzymes", "INTERACT"], ["chocolate biscuit", "microbiota", "IMPACT"], ["human vermiform appendix", "adults", "LOCATED IN"], ["BMAA", "motor deficits", "INFLUENCE"], ["Parkinson's disease", "Coriobacteriaceae", "CHANGE ABUNDANCE"], ["glucocorticoids", "depression", "INFLUENCE"], ["PD", "SCFA-producing genera", "CHANGE ABUNDANCE"], ["neurotransmitters", "gut microbiota", "IMPACT"], ["gut microbiome", "Multi-omics analyses", "USED BY"], ["spinal cord injury", "intestinal dysfunction", "AFFECT"], ["Gut microbiota", "physical and mental problems", "IS LINKED TO"], ["Fatty Acids", "Genetic and Epigenetic Aspects", "INFLUENCE"], ["Psychobiotics", "COVID-19 Pandemic", "INFLUENCE"], ["plasticizer", "severe organ damage", "INFLUENCE"], ["colorectal cancer", "Sprague-Dawley (SD) rats", "TARGET"], ["Turicibacterales", "glycodeoxycholic acid", "INTERACT"], ["inflammation", "PD mice", "TARGET"], ["Gut Microbiome", "Functional Constipation Patients", "LOCATED IN"], ["5-hydroxyindole acetic acid", "SNpc", "LOCATED IN"], ["Urolithins", "gut microbial ecologies", "PRODUCED BY"], ["Mercury sulfide-containing Hua-Feng-Dan", "Parkinson's disease", "CHANGE EFFECT"], ["GM", "MDD patients", "LOCATED IN"], ["acetoacetate", "gut microbiota", "PRODUCED BY"], ["breast milk microbiota", "gut microbiota", "COMPARED TO"], ["Di-(2-ethylhexyl) phthalate", "type 2 diabetes", "INFLUENCE"], ["increasing body weight gain", "SD rats", "TARGET"], ["Lacticaseibacillus rhamnosus GG", "Lactobacillus genus", "INTERACT"], ["AD", "gut microbiome", "CHANGE ABUNDANCE"], ["constipated PD patients", "16S rRNA sequencing", "USED BY"], ["Lachnospiraceae", "short-chain fatty acids", "INTERACT"], ["MPTP", "GM", "IMPACT"], ["<i>xylanophilum</i>_<i>group</i>", "gut microbiota", "PART OF"], ["gut microbiota", "oral LPS", "USED BY"], ["Psychobiotics containing nutrients", "central nervous system (CNS) disorders", "INFLUENCE"], ["multiple B-vitamins", "gut microbiota", "PRODUCED BY"], ["dysbiosis", "PD", "AFFECT"], ["Gut Microbiome", "HD", "IS LINKED TO"], ["probiotics", "psychiatric disorders", "INFLUENCE"], ["beneficial bacteria", "NND", "INFLUENCE"], ["serotonin", "brain", "LOCATED IN"], ["gut microbiota", "PD patients", "LOCATED IN"], ["3-(3,4-dihydroxyphenyl)propionic acid", "gut microbiota", "PRODUCED BY"], ["Bifidobacterium", "infant gut microbiota", "PART OF"], ["Baicalin", "intestinal disorders", "INFLUENCE"], ["A. muciniphila", "neurological and psychiatric disorders", "INFLUENCE"], ["sleep disorders comorbid with neuropsychiatric disorders", "gut bacteria", "CHANGE ABUNDANCE"], ["HgS-containing traditional medicines", "gut microbiota", "IMPACT"], ["anxiety", "mice", "TARGET"], ["organophosphate pesticides", "late onset neuropathologies", "INFLUENCE"], ["Gut microbiota", "metagenomic shotgun sequencing", "USED BY"], ["intestinal bleeding", "Colon cancer-related anemia", "AFFECT"], ["alanine betaine", "gut microbiota", "PRODUCED BY"], ["metabolites", "HI/R", "INFLUENCE"], ["high vagal tone", "glutamate", "INTERACT"], ["intestinal microbiota", "PD", "IS LINKED TO"], ["novel pharmacological targets", "major depressive disorder", "CHANGE EFFECT"], ["PD patients", "metatranscriptomic analysis", "USED BY"], ["E. amylovora 1189", "multidrug resistant bacteria", "INTERACT"], ["Lipopolysaccharide", "Enterobacteeriaceae", "IMPACT"], ["gut microbiota", "microbial dysbiosis", "IS LINKED TO"], ["ocular Alzheimer's disease", "glaucoma", "IS A"], ["Bacilli", "GP patients", "LOCATED IN"], ["microbiota composition", "depression", "IS LINKED TO"], ["gut microbiota-derived metabolite", "early Parkinson's disease", "INFLUENCE"], ["minerals", "mammalian gut microbiota", "IMPACT"], ["sleep disorders", "gut bacteria", "CHANGE ABUNDANCE"], ["colon", "PD mice", "LOCATED IN"], ["Group 1", "double-blind, randomized, placebo-controlled trial", "USED BY"], ["succinate", "nervous system disorders", "INFLUENCE"], ["glucose metabolism disorder", "rodent", "TARGET"], ["gastrointestinal microbiota", "schizophrenia", "IS LINKED TO"], ["functional microbiota", "metatranscriptomic analysis", "USED BY"], ["Gut Microbiota", "Chinese and Korean Immigrants", "LOCATED IN"], ["Human Gut Microbiota", "metabolic diseases", "IS LINKED TO"], ["autoimmune disorders", "gut microbiota", "CHANGE ABUNDANCE"], ["mental health", "children", "TARGET"], ["DEHP", "damage to different tissues", "INFLUENCE"], ["gut flora", "developmental disorders", "IS LINKED TO"], ["interleukin-6", "gut microbiota", "IMPACT"], ["SIBO", "fibromyalgia", "AFFECT"], ["prebiotics", "gut Bifidobacterium", "IMPACT"], ["fiber intake", "depressed and non-depressed groups", "ADMINISTERED"], ["microbes", "PD", "INFLUENCE"], ["Major depressive disorder", "Escherichia coli", "CHANGE ABUNDANCE"], ["GM", "local immune disorders of the intestine", "IS LINKED TO"], ["anxiety phenotype", "autistic individuals", "TARGET"], ["Parkinson's disease", "nasointestinal FMT group", "TARGET"], ["gut microbiota", "barrier dysfunction", "IS LINKED TO"], ["central nervous system (CNS) antigens", "nerve injury", "INFLUENCE"], ["PD", "Clostridia UCG 014", "CHANGE ABUNDANCE"], ["ASD", "adolescents", "TARGET"], ["insulin", "central nervous system", "LOCATED IN"], ["AD", "gut Christensenellaceae family", "CHANGE ABUNDANCE"], ["Sleep deprivation", "gut microbiota", "CHANGE ABUNDANCE"], ["non-TD", "PD patients", "TARGET"], ["Parkinson's disease", "Lachnospira", "CHANGE ABUNDANCE"], ["Gut microbes", "anxiety", "IS LINKED TO"], ["diet", "mental health", "INFLUENCE"], ["neurodegenerative disorders", "gut microbiota", "CHANGE ABUNDANCE"], ["gut microbiome", "young children", "LOCATED IN"], ["Gut dysbiosis", "late onset neuropathology", "AFFECT"], ["increasing body weight gain", "Sprague-Dawley (SD) rats", "TARGET"], ["Akkermansia", "microbiome", "PART OF"], ["Parkinson's disease", "Coprococcus", "CHANGE ABUNDANCE"], ["Cinnabar", "LPS plus ROT induced neurotoxicity", "INFLUENCE"], ["gut microbiota", "control mice", "LOCATED IN"], ["Lactobacillus", "stress", "INFLUENCE"], ["berberine", "intestinal flora", "IMPACT"], ["neuronal damage", "Neurodegenerative diseases", "AFFECT"], ["Major depressive disorder", "Faecalibacterium prausnitzii", "CHANGE ABUNDANCE"], ["Gut microbiota", "major depression disorder", "IS LINKED TO"], ["valine", "PD patients", "LOCATED IN"], ["micronutrients", "gut microbiota", "IMPACT"], ["neurodegenerative disease", "disease subpopulations", "TARGET"], ["Fe", "Lachnospiraceae", "IMPACT"], ["several bacterial metabolites", "altered homeostasis", "INFLUENCE"], ["Gut microbes", "gastrointestinal diseases", "INFLUENCE"], ["metabolic syndrome", "human host", "TARGET"], ["PD-related gut microbiota dysbiosis", "impairment", "AFFECT"], ["gut microbiota", "neuropsychiatric diseases", "IS LINKED TO"], ["LPHP", "Me1", "CHANGE EXPRESSION"], ["progressive neurological disorder", "loss of neurons", "AFFECT"], ["uncultured_bacterium_g_Escherichia-Shigella", "MPTP group gut microbiota", "PART OF"], ["gut microbiota", "metabolomics analysis", "USED BY"], ["genera Turicibacter", "gut microbiota", "PART OF"], ["succinate", "Parkinson's disease", "INFLUENCE"], ["short-chain fatty acid producers", "Depression", "INFLUENCE"], ["serotonin", "SNpc", "LOCATED IN"], ["depression-like behaviors", "ABX-treated mice", "TARGET"], ["psychoactive metabolites", "gut microbiome", "PRODUCED BY"], ["gut microbiota", "Pink1</i><sup>-/-</sup> and wild-type control littermates", "LOCATED IN"], ["Chicoric acid", "obesity", "INFLUENCE"], ["Alzheimer's and Parkinson's disease", "elderly people", "TARGET"], ["depressive disorders", "gastrointestinal complaints", "AFFECT"], ["Clostridium bacteria", "PD", "INFLUENCE"], ["cognitive impairments", "patients", "TARGET"], ["sphingolipid", "schizophrenia", "INFLUENCE"], ["SCFAs", "infant gut microbiota", "PRODUCED BY"], ["genus Roseburia", "rs11751561", "CHANGE EXPRESSION"], ["oxaliplatin", "Ruminococcaceae_UCG-014", "IMPACT"], ["adequate protein", "Gut microbes", "IMPACT"], ["short-chain fatty acids", "vascular dementia", "INFLUENCE"], ["Lactobacillus", "depression", "INFLUENCE"], ["NLRP3", "normal rats", "LOCATED IN"], ["lipid", "human body", "LOCATED IN"], ["energy metabolism", "Parkinson's disease", "INFLUENCE"], ["colonic microbiome", "PD", "IS LINKED TO"], ["Klebsilla", "intestinal microbiota", "PART OF"], ["adults", "CogState Battery test", "USED BY"], ["gut microbiota", "irritable bowel syndrome", "IS LINKED TO"], ["GV-971", "phenylalanine", "INTERACT"], ["coronary artery disease", "patients", "TARGET"], ["IFN-\u03b1", "depression", "INFLUENCE"], ["major depressive disorder", "people with the major psychiatric disorders", "TARGET"], ["tight junction proteins", "increased gut permeability", "INFLUENCE"], ["infective pathogens", "hepatitis C virus", "INFLUENCE"], ["KD", "stress", "INFLUENCE"], ["disturbances of plasma BCAAs and AAAs", "PD patients", "TARGET"], ["nutraceuticals", "cognitive decline", "INFLUENCE"], ["LDSD", "IBS-D patients", "TARGET"], ["LPS", "gut microbiomes", "IMPACT"], ["gut microbiota", "Two-sample MR analysis", "USED BY"], ["NADPH oxidase 2", "Neurodegenerative diseases", "INFLUENCE"], ["Turicibacter spp.", "chronic social defeat", "INFLUENCE"], ["plant polysaccharides", "gut flora", "IMPACT"], ["probiotics", "MDD patients", "ADMINISTERED"], ["saline", "reduced BMD", "INFLUENCE"], ["Lachnospiraceae Blautia", "gut microbiota", "PART OF"], ["Iron", "bacteria", "IMPACT"], ["saponins", "MDD", "INFLUENCE"], ["GM", "healthy volunteers", "LOCATED IN"], ["NLRP3 inflammasome", "rheumatoid arthritis", "INFLUENCE"], ["Aeromonas", "ET", "INFLUENCE"], ["Faecalibacterium", "PD", "INFLUENCE"], ["microbial dysbiosis", "depression", "AFFECT"], ["probiotics", "neurocognitive and mental health disorders", "INFLUENCE"], ["Prevotellaceae_UCG-001", "PD mice", "LOCATED IN"], ["microbiota", "epilepsy", "IS LINKED TO"], ["dysbiosis of the gastrointestinal tract", "depression", "AFFECT"], ["Subdoligranulum", "malnutrition", "INFLUENCE"], ["Roseburia_inulinivorans", "GM", "PART OF"], ["Curcumin", "Gut Microbiota", "IMPACT"], ["Gut Microbiota", "PD-related alterations", "IS LINKED TO"], ["aromatic amino acids", "fecal microbiome", "PRODUCED BY"], ["Parkinson's disease", "individuals diagnosed with PD", "TARGET"], ["prebiotic and probiotic food", "intestinal microbiota", "IMPACT"], ["GM dysbiosis", "rats", "TARGET"], ["gut microbiota", "psychotic disorders", "IS LINKED TO"], ["human microbiota", "neurological disorders", "IS LINKED TO"], ["Gut Microbiota", "healthy controls", "LOCATED IN"], ["Di-(2-ethylhexyl) phthalate", "issue and functional damages", "INFLUENCE"], ["gut microbiota", "BD", "IS LINKED TO"], ["cooked soybean", "Aspergillus", "IMPACT"], ["gut dysbiosis", "MDD", "AFFECT"], ["Blautia", "Parkinson's disease", "INFLUENCE"], ["gut microbiota dysbiosis", "type 2 diabetes mellitus", "AFFECT"], ["NAc", "adult mice", "LOCATED IN"], ["microbiome", "Depression", "IS LINKED TO"], ["intestinal inflammation", "Parkinson's disease (PD) patients", "TARGET"], ["prodromal PD subtypes", "gut", "STRIKE"], ["fisetin", "Parkinson's disease", "CHANGE EFFECT"], ["withaferin A", "TREM2", "CHANGE EXPRESSION"], ["Lactobacillaceae", "microbiota", "PART OF"], ["BD", "unmedicated patients with depressed bipolar disorder", "TARGET"], ["SCFAs", "neurological disorders", "INFLUENCE"], ["impaired colonic microbial metabolism", "patients", "TARGET"], ["Parkinson patients", "DBS", "USED BY"], ["intestinal wall leakage", "patients", "TARGET"], ["mucin", "mice", "LOCATED IN"], ["Parkinson's disease", "short-chain fatty acid-producing bacteria", "CHANGE ABUNDANCE"], ["Lachnospiraceae UCG-001", "MDD", "INFLUENCE"], ["boron reagents", "dysbiosis", "INFLUENCE"], ["gut microbiota", "tremor dominant", "IS LINKED TO"], ["Gut Microbiota", "Sleep Disturbance", "IS LINKED TO"], ["sleep disturbance", "participants", "TARGET"], ["curcumin", "gut microbiota", "IMPACT"], ["antidepressants", "major depressive disorder", "CHANGE EFFECT"], ["PM", "SCZ", "INFLUENCE"], ["LDSD", "7-ketodeoxycholic acid", "INTERACT"], ["impact", "gut microbiota", "CHANGE ABUNDANCE"], ["short-chain fatty acids", "multiple sclerosis", "INFLUENCE"], ["Probiotic bacteria", "depressive behavior", "INFLUENCE"], ["low-dose B. breve 207-1", "healthy adults", "ADMINISTERED"], ["HPA axis hormones", "probiotic groups", "IMPACT"], ["gut bacterial dysbiosis", "butyrate", "INTERACT"], ["Eggerthella", "ARGs", "CHANGE EXPRESSION"], ["gut microbiota", "pSS", "IS LINKED TO"], ["Oral Probiotics", "Chronic Mild Stress", "INFLUENCE"], ["fecal microbial diversities", "PD-NC", "AFFECT"], ["female", "enzyme-linked immunosorbent assay", "USED BY"], ["Gut microbiota", "human gut", "LOCATED IN"], ["PD", "PD-model mice", "TARGET"], ["Prevotella", "microbiota", "PART OF"], ["gingerol", "IBS/FD", "INFLUENCE"], ["first episode SCH", "drug-na\u00efve", "TARGET"], ["PM", "mice colon", "LOCATED IN"], ["arketamine", "gut microbiota", "IMPACT"], ["intestinal inflammation", "PD", "AFFECT"], ["antibiotic therapy", "gut microbiota", "IMPACT"], ["Affective disorders", "Flavonifractor", "CHANGE ABUNDANCE"], ["gut microbiota", "Neurological Disorders", "IS LINKED TO"], ["PD", "Akkermansia", "CHANGE ABUNDANCE"], ["key strains", "infant gut microbiota", "PART OF"], ["PD-NC", "patients", "TARGET"], ["neuroinflammation", "Rats", "TARGET"], ["Male C57BL/6 mice", "forced swimming test", "USED BY"], ["gut microbiota", "Electroacupuncture", "USED BY"], ["Piperine", "gut microbiota", "IMPACT"], ["KD", "FIRES", "INFLUENCE"], ["drug-na\u00efve early stage PD", "patients", "TARGET"], ["altered gut microbiota", "cognitive impairment", "IS LINKED TO"], ["Eggerthella lenta", "ASD group", "LOCATED IN"], ["PD", "synucleinopathy", "AFFECT"], ["mGlu8", "MPTP", "INTERACT"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "\u03b1-synuclein", "INTERACT"], ["stage I disease", "participants", "TARGET"], ["festive cinematic diets", "gut microbiota", "IMPACT"], ["synbiotics", "neurological disorders", "INFLUENCE"], ["GBM", "Faecalibacterium", "CHANGE ABUNDANCE"], ["epithelial barrier dysfunction", "motor symptom generation", "AFFECT"], ["probiotics", "Bifidobacterium longum R0175", "IMPACT"], ["coffee", "Parkinson disease", "INFLUENCE"], ["gut microbiota", "acne mice", "LOCATED IN"], ["MeDi", "PD", "INFLUENCE"], ["Di-(2-ethylhexyl) phthalate", "Parkinson's disease", "INFLUENCE"], ["Gut microbiota", "PD patients", "LOCATED IN"], ["microglia activation", "MPTP neurotoxicity", "AFFECT"], ["psychiatric disorders", "psychiatric patients", "TARGET"], ["chicoric acid", "Parkinson's disease", "INFLUENCE"], ["SCI", "anxiety and depression", "AFFECT"], ["EGCG", "Drosophila melanogaster with PINK1 (PTEN induced putative kinase 1) mutations", "LOCATED IN"], ["gut microbiota", "male mice", "LOCATED IN"], ["psychiatric disorders", "pediatric population", "TARGET"], ["GI Complaints", "Trained Recreative and Competitive Athletes", "TARGET"], ["chronic social defeat stress", "adult mice", "TARGET"], ["probiotics", "anxiety symptoms", "INFLUENCE"], ["tertile PD groups", "Cox regression analysis", "USED BY"], ["gut microbiota", "patients", "LOCATED IN"], ["NF", "GM-SCI", "AFFECT"], ["gut microbiota", "NDs", "IS LINKED TO"], ["Butylated Starch", "Chronic Restraint Stress-Induced Neurobehavioral and Gut Barrier Deficits", "INFLUENCE"], ["gut microbiota", "ARGs", "CHANGE EXPRESSION"], ["Neurodegenerative diseases", "elderly people", "TARGET"], ["Zn", "neurodegenerative and neurodevelopmental disorders", "INFLUENCE"], ["genus Roseburia", "shared genetic variant", "CHANGE EXPRESSION"], ["Excess body weight during pregnancy", "offspring obesity", "AFFECT"], ["canine intestinal microbiota", "chronic enteropathy", "IS LINKED TO"], ["loss of dopaminergic neurons", "MPTP neurotoxicity", "AFFECT"], ["probiotics", "constipation", "INFLUENCE"], ["postbiotics", "neurological disorders", "INFLUENCE"], ["5-HT", "PIPO", "INFLUENCE"], ["bacterial taxa", "microbial symbionts", "PART OF"], ["mild cognitive impairment", "Elderly patients", "TARGET"], ["Gut-Derived Lipopolysaccharides", "Neurodegenerative Disease", "INFLUENCE"], ["neurocognitive and mental health disorders", "individuals", "TARGET"], ["Deinococcus-Thermus", "phosphocholine", "INTERACT"], ["Pseudobutyrivibrio", "Parkinson's disease", "INFLUENCE"], ["menthol", "IBS/functional dyspepsia", "INFLUENCE"], ["SCFAs", "Parkinson's disease", "INFLUENCE"], ["gut microbiota dysbiosis", "Alzheimer's Disease", "AFFECT"], ["PD patients", "fecal sampling", "USED BY"], ["olanzapine", "patients", "ADMINISTERED"], ["typically developing (TD) children", "16S rRNA", "USED BY"], ["amyloidogenic protein", "mice", "LOCATED IN"], ["inflammation", "gut", "STRIKE"], ["gut bacterial dysbiosis", "microbiota-derived metabolites", "INTERACT"], ["liver depression", "IBS-D patients", "TARGET"], ["gut microbiota", "alpha-synuclein (\u03b1-syn) pathology", "IS LINKED TO"], ["chronic inflammation", "risk of depression", "AFFECT"], ["Lactobacillus hominis", "KO\u00a0+\u00a0SDV group", "LOCATED IN"], ["short-chain fatty acids", "stress", "INFLUENCE"], ["Coprococcus", "bacteria", "INTERACT"], ["microbiota", "neurologic disorders", "IS LINKED TO"], ["MedDiet", "Parkinson's", "INFLUENCE"], ["Parkinson's disease", "neurodegenerative disorder", "IS A"], ["reduced BMD", "OVX mice", "TARGET"], ["SG031", "autonomic dysfunction", "INFLUENCE"], ["Manganese", "neurodegenerative disorders", "INFLUENCE"], ["Vasovagal syncope", "children", "TARGET"], ["Anthocyanins", "gut microbiota", "IMPACT"], ["gut microbiota", "obese westerners", "LOCATED IN"], ["PD", "local and systemic inflammation", "AFFECT"], ["NVP-1704", "healthy adults", "ADMINISTERED"], ["gut microbiota", "neurodegenerative conditions", "IS LINKED TO"], ["diet", "children", "ADMINISTERED"], ["SIBO", "multiple sclerosis", "AFFECT"], ["acetate-producing bacteria", "gut microbiota", "PART OF"], ["\u03b3-aminobutyric acid", "SNpc", "LOCATED IN"], ["ICH", "Firmicutes", "CHANGE ABUNDANCE"], ["patients", "liquid and gas chromatography mass spectrometry", "USED BY"], ["mucus-associated species", "Parkinson's disease", "INFLUENCE"], ["MMD", "behavioral impairments", "AFFECT"], ["Spinal cord injuries", "SCI patients", "TARGET"], ["offspring rats", "FMT", "USED BY"], ["GIP", "antimicrobial adjuvant re-sensitising multidrug-resistant Gram-negative bacteria", "IMPACT"], ["chronic restraint stress depression", "rats", "TARGET"], ["Gut microbes", "eating disorders", "IS LINKED TO"], ["autism", "individuals", "TARGET"], ["<i>Helicobacter pylori</i> infection", "hyperhomocysteinemia-related brain cortical thinning", "AFFECT"], ["Butyrivibrio", "altered metabolism rates", "INFLUENCE"], ["L. lactis", "Parkinson's disease", "INFLUENCE"], ["dementia", "mental health and neurocognitive disorders", "IS A"], ["pathogens", "gut inflammation", "INFLUENCE"], ["Gut microbes", "Alzheimer's disease", "IS LINKED TO"], ["mild metabolic disorders", "metabolic syndrome", "AFFECT"], ["Mental Disorders", "Gut Microbiota", "CHANGE ABUNDANCE"], ["gut microbiome", "gut-brain", "LOCATED IN"], ["patients", "16S rRNA sequencing", "USED BY"], ["obesity", "generations", "TARGET"], ["Parkinson's disease", "volunteer Chinese patients", "TARGET"], ["inactivated L. plantarum CCFM8661", "ATGL", "CHANGE EXPRESSION"], ["non-commensal gut microbiome", "Alzheimer's disease", "IS LINKED TO"], ["PD patients", "Bile acid analysis", "USED BY"], ["GM", "PTSD", "IS LINKED TO"], ["Impaired Gut-Blood Barrier", "Parkinson's Disease", "AFFECT"], ["altered gut microbiota", "gut", "LOCATED IN"], ["gut microbiota", "youth", "LOCATED IN"], ["PD", "Ruminococcaceae", "CHANGE ABUNDANCE"], ["intestinal microbiota", "pathogenesis", "IS LINKED TO"], ["Fecal Microbiota", "Patients", "LOCATED IN"], ["prebiotics", "PD", "INFLUENCE"], ["PHP", "serum total cholesterol", "INTERACT"], ["brain", "PD patients", "LOCATED IN"], ["lipopolysaccharide", "abnormal composition", "INFLUENCE"], ["astilbin", "intestine", "LOCATED IN"], ["L. rhamnosus", "intestinal damage", "INFLUENCE"], ["Firmicutes", "intestinal barrier", "PART OF"], ["gut microbiota dysbiosis", "schizophrenia", "AFFECT"], ["gut microbiota", "PD", "LOCATED IN"], ["gut microbiota", "middle-aged and older adults", "LOCATED IN"], ["\u03b1-synuclein", "olfactory bulb", "LOCATED IN"], ["neuroinflammation", "gut microbiome", "CHANGE ABUNDANCE"], ["HFD-shaped microbiota", "neuroinflammation", "IS LINKED TO"], ["Psychobiotics", "schizophrenia", "INFLUENCE"], ["gut microbiota", "opioid-mediated analgesia and tolerability", "IS LINKED TO"], ["depression-like phenotype", "gut microbiota", "CHANGE ABUNDANCE"], ["fecal microbiota", "FEP patients", "LOCATED IN"], ["ulcerative colitis", "IBDs", "IS A"], ["brain", "individual", "LOCATED IN"], ["Blautia", "PD-MCI group", "LOCATED IN"], ["probiotic NVP-1704", "anxiety", "INFLUENCE"], ["Inflammation", "tissue damage", "AFFECT"], ["Lactobacillus plantarum", "depression", "INFLUENCE"], ["Wolbachia", "Alzheimer's diseases", "INFLUENCE"], ["Lactobacillus plantarum or Acetobacter pomorum strain", "neuronal and behavioral dysfunction", "INFLUENCE"], ["5-hydroxyindole acetic acid", "substantia nigra pars compacta", "LOCATED IN"], ["Ruminococcaceae", "PD-MCI group", "LOCATED IN"], ["gut microbiota", "oxidative stress", "IS LINKED TO"], ["MAPK", "mice colon", "LOCATED IN"], ["elevated proteolytic metabolites", "constipation", "INFLUENCE"], ["mild stress (CUMS) group", "western blot", "USED BY"], ["Gut Microbiota", "Neuroinflammation", "IS LINKED TO"], ["impairment", "SCFAs", "INTERACT"], ["SCFAs", "Alzheimer's disease", "INFLUENCE"], ["Bifidobacterium", "fecal microbiome", "PART OF"], ["pharmaceutical excipients", "gut microbiota", "IMPACT"], ["Multiple Sclerosis", "Autoimmune Diseases", "IS A"], ["Gut microbiota", "neurodegeneration", "IS LINKED TO"], ["phytochemicals", "SIRT1&6", "CHANGE EXPRESSION"], ["psychological stress", "SCI patients", "TARGET"], ["Gut microbiota", "gas chromatography", "USED BY"], ["ileum", "PIPO patients", "LOCATED IN"], ["<i>genus</i>_<i>Eggerthella</i>", "gut microbiota", "PART OF"], ["gingerol", "IBS/functional dyspepsia", "INFLUENCE"], ["cytokines", "lncRNA", "CHANGE EXPRESSION"], ["host gut", "mice", "LOCATED IN"], ["microbial dysbiosis", "PTSD", "AFFECT"], ["AD", "neurofibrillary tangles", "INTERACT"], ["Proteobacteria", "GM", "PART OF"], ["neurotoxic compounds", "neuropsychiatric disorders", "INFLUENCE"], ["BCAA", "early PD patients", "LOCATED IN"], ["PM", "schizophrenia", "INFLUENCE"], ["preventive and/or therapeutic disaccharide", "AD", "INFLUENCE"], ["SCFAs", "anxiety", "INFLUENCE"], ["gut microbiota", "luminal side", "LOCATED IN"], ["gut microbiota", "Hoehn & Yahr (HY) stages", "USED BY"], ["probiotics", "mental health", "INFLUENCE"], ["F4", "depressive-like behavior", "INFLUENCE"], ["butyrate", "patients", "LOCATED IN"], ["zinc", "novel coronavirus infection", "INFLUENCE"], ["Alistipes", "gut microbiota", "PART OF"], ["systemic inflammation", "Klebsilla", "CHANGE ABUNDANCE"], ["genus <i>Coprococcus</i>", "neurological disorders", "INFLUENCE"], ["GOS", "stress", "INFLUENCE"], ["human gut microbiota", "gastrointestinal tract", "LOCATED IN"], ["neurodegenerative disorder", "elderly individuals", "TARGET"], ["Western diet", "low-grade systemic inflammatory and oxidative changes", "INFLUENCE"], ["human PD", "microbiota", "CHANGE ABUNDANCE"], ["NS8", "improve endogenous depression", "INFLUENCE"], ["intestines", "human host", "LOCATED IN"], ["Pediatric chronic intestinal pseudo-obstruction", "PIPO patients", "TARGET"], ["Parkinson's disease", "L-Aspartic acid", "INTERACT"], ["AD", "non-smoking patients", "TARGET"], ["gut microbiota", "SD rats", "LOCATED IN"], ["gut microbiota", "proinflammatory gut milieu", "IS LINKED TO"], ["Epithelial mucins", "enteric glial activation", "INFLUENCE"], ["fats", "mammalian gut microbiota", "IMPACT"], ["MDD", "people with the major psychiatric disorders", "TARGET"], ["Parkinson disease", "gut microbiota", "CHANGE ABUNDANCE"], ["gut microbiota", "type 2 diabetes", "IS LINKED TO"], ["acetate", "depression", "INFLUENCE"], ["Gut microbiota", "autism spectrum disorder", "IS LINKED TO"], ["gut microbiota", "states of dysmetabolism", "IS LINKED TO"], ["CMUS group", "CUMS", "USED BY"], ["gut inflammation", "LCIG group", "TARGET"], ["Lachnospiraceae", "PD", "INFLUENCE"], ["Dysbiosis", "depression", "AFFECT"], ["striatum", "ASO mice", "LOCATED IN"], ["microglia", "C57BL/6J mice", "LOCATED IN"], ["live and inactivated Lactobacillus plantarum CCFM8661", "oleic acid-induced acne", "INFLUENCE"], ["Parkinson's disease", "elderly individuals", "TARGET"], ["L-urobilin", "IBD", "INFLUENCE"], ["biomarkers", "gut dysbiosis", "INFLUENCE"], ["Romboutsia", "ET", "INFLUENCE"], ["Psychobiotics", "anorexia nervosa", "INFLUENCE"], ["systemic inflammation", "mice", "TARGET"], ["\u03b2-Amyloid", "Alzheimer's and Parkinson's diseases", "INFLUENCE"], ["gut microbes", "neurodegenerative diseases", "IS LINKED TO"], ["stress response", "blood-brain barrier", "STRIKE"], ["prebiotic", "GM", "IMPACT"], ["p_Actinobacteria", "IBS", "INFLUENCE"], ["The high-fat, low-carbohydrate ketogenic diet", "drug-resistant epilepsy", "INFLUENCE"], ["DEPs", "duodenum", "LOCATED IN"], ["insomnia", "gut microbiota", "CHANGE ABUNDANCE"], ["Anxiety symptoms", "mental diseases", "AFFECT"], ["cytokines", "SURF4", "CHANGE EXPRESSION"], ["depression-like behaviors", "chronic unpredictable mild stress", "AFFECT"], ["mental diseases", "world's population", "TARGET"], ["constipation", "Parkinson's disease", "AFFECT"], ["2-keto-glutaramic acid", "ASD group", "LOCATED IN"], ["gut microbiota", "OVX mice", "LOCATED IN"], ["CD", "idiopathic disorders", "IS A"], ["pectin", "depression", "INFLUENCE"], ["non-TD", "Enterobacteriaceae", "CHANGE ABUNDANCE"], ["Mediterranean diet", "chronic noncommunicable diseases", "INFLUENCE"], ["adequate protein", "Parkinson's disease", "INFLUENCE"], ["Gut microbes", "autism spectrum disorders", "IS LINKED TO"], ["misfolded protein \u03b1-syn", "Parkinson's disease", "INFLUENCE"], ["ulcerative colitis", "intestine", "STRIKE"], ["Chrna7 KO mice", "SDV", "USED BY"], ["gut microbiota", "gastrointestinal diseases", "IS LINKED TO"], ["KD", "central nervous system (CNS) disorders", "INFLUENCE"], ["Human Gut Microbiota", "depression", "IS LINKED TO"], ["Gut microbes", "MS", "IS LINKED TO"], ["gut microbes", "EDs", "IS LINKED TO"], ["gut microbiota", "Autism spectrum disorders", "IS LINKED TO"], ["C57BL/6J adult female mice", "behavioral tests", "USED BY"], ["Parkinson's disease", "adults", "TARGET"], ["TNF-a", "AI", "INFLUENCE"], ["cognitive impairment", "A53T transgenic monkeys", "TARGET"], ["adult hippocampal", "people", "LOCATED IN"], ["gut microbiota dysbiosis", "disease subpopulations", "TARGET"], ["4-HBA", "intracellular \u03b1-syn seeding aggregation", "INFLUENCE"], ["Western-style diet", "physiological alterations", "INFLUENCE"], ["Sleep deprivation", "mammalian gut microbiota", "CHANGE ABUNDANCE"], ["antidepressant arketamine", "splenomegaly", "CHANGE EFFECT"], ["Desulfovibrio", "PD therapy", "INFLUENCE"], ["PDX", "gut bacteria", "IMPACT"], ["gut microbiota", "mammals", "LOCATED IN"], ["Gut Microbiome", "Gut", "LOCATED IN"], ["Exopolysaccharide", "<i>Lactobacillus fermentum</i> PS150", "IMPACT"], ["Parkinson's disease", "autonomic dysfunction", "AFFECT"], ["human gut microbiota", "NADDs", "IS LINKED TO"], ["gut microbiota", "non-motor features", "IS LINKED TO"], ["gastrointestinal helminth infections", "childhood cognitive morbidity", "AFFECT"], ["Clostridium", "gut microbiota", "PART OF"], ["cohort of healthy women", "Investigations", "USED BY"], ["Lactobacillaceae", "levodopa", "INTERACT"], ["gut microbiome", "mouth", "LOCATED IN"], ["ulcerative colitis", "patients", "TARGET"], ["Inflammation", "Acute and Chronic Insomnia", "AFFECT"], ["MDD", "Blautia", "CHANGE ABUNDANCE"], ["alpha-synuclein", "amyloidogenic human and non-human proteins", "PART OF"], ["acetate", "gut microbiota", "PRODUCED BY"], ["Dietary polyphenols", "inflammation", "INFLUENCE"], ["Dcf1 deletion", "mice", "TARGET"], ["fecal microbiota", "patients", "LOCATED IN"], ["zinc", "Children", "LOCATED IN"], ["Zn2+", "COVID-19", "INFLUENCE"], ["metabolites", "depression", "INFLUENCE"], ["gut flora dysbiosis", "physiologic response to traumatic injury", "AFFECT"], ["Neurotoxins", "late onset neuropathology", "INFLUENCE"], ["gastric <i>H. suis</i>", "PD pathology", "INFLUENCE"], ["alterations to gut microbiota composition", "Gastrointestinal (GI) symptoms and pathology", "AFFECT"], ["PD", "participants", "TARGET"], ["Dietary supplements", "neurological diseases", "INFLUENCE"], ["Helicobacter hepaticus", "PD gut microbiomes", "PART OF"], ["nutraceutical supplementations", "obesity", "INFLUENCE"], ["plasticizer", "highest Th1 inflammatory response", "INFLUENCE"], ["colon microbiota", "metabolic syndrome", "IS LINKED TO"], ["neurodegenerative diseases", "rat", "TARGET"], ["HFD", "loss of DA neurons", "CHANGE EFFECT"], ["rats", "chronic unpredictable mild stress (CUMS) model", "USED BY"], ["Piperine", "drug-metabolizing enzymes", "PART OF"], ["gut microbiota", "psychiatric symptoms", "IS LINKED TO"], ["bacterial lipid components", "LPS", "INTERACT"], ["excess body weight", "depression", "AFFECT"], ["IBS patients", "structured aerobic exercise programs", "USED BY"], ["LAC", "stress-evoked decreases in mRNA", "INFLUENCE"], ["Porphyromonas gingivalis", "Parkinson's disease", "INFLUENCE"], ["Parkinson's disease", "p-Hydroxyphenylacetic acid", "INTERACT"], ["short-chain fatty acids", "healthy spouses", "LOCATED IN"], ["gut microbiota dysbiosis", "Cancers", "AFFECT"], ["plasticizer", "liver toxicity", "INFLUENCE"], ["intestinal microbes", "PD", "INFLUENCE"], ["brain", "C57BL/6 mice", "LOCATED IN"], ["\u03b1-synuclein", "brain", "LOCATED IN"], ["Lactobacillales", "increased CBF similarities", "INFLUENCE"], ["Parkinson's disease", "Bifidobacteria", "CHANGE ABUNDANCE"], ["4EP", "human brains", "LOCATED IN"], ["walnut consumption", "gut microbial diversity", "IMPACT"], ["arketamine", "GluA1", "INTERACT"], ["Fe", "Odoribacter", "IMPACT"], ["gut microbiota", "insomnia disorder", "IS LINKED TO"], ["Probiotic supplementation", "gut microbiome", "IMPACT"], ["gut microbiome", "CNS neurodegenerative diseases", "IS LINKED TO"], ["pyrin domain containing proteins 6", "substantia nigra", "LOCATED IN"], ["Parkinson's disease", "middle-aged and elderly populations", "TARGET"], ["prebiotics", "metabolic and inflammatory diseases", "INFLUENCE"], ["PD", "mice", "TARGET"], ["A53T transgenic monkeys", "metagenomic sequencing", "USED BY"], ["Gut microbes", "CNS disorders", "IS LINKED TO"], ["Gut Microbiome", "ALS", "IS LINKED TO"], ["obesity", "Dysbiosis", "AFFECT"], ["rhesus monkeys", "targeted gas chromatography", "USED BY"], ["antibiotics", "Microbes in the gut", "IMPACT"], ["loss of dopaminergic neurons", "<i>H. suis/</i>6-OHDA groups", "TARGET"], ["gut microbiota", "mental illnesses", "IS LINKED TO"], ["interleukin (IL)-1\u03b2", "Turicibacter spp.", "IMPACT"], ["Low-dose PHP", "Fasn", "CHANGE EXPRESSION"], ["higher body weights", "pups", "TARGET"], ["(R)-ketamine", "reduced bone mineral density", "CHANGE EFFECT"], ["Exopolysaccharide", "hypnotic psychobiotic strain", "IMPACT"], ["Dietary fiber pectins", "gut microbiota", "IMPACT"], ["gut", "host", "LOCATED IN"], ["multiple sclerosis", "patients", "TARGET"], ["brain", "patients", "LOCATED IN"], ["Insomnia", "systemic disorders", "AFFECT"], ["neurotransmitter 5-hydroxytryptamine", "PIPO", "INFLUENCE"], ["first-episode depression", "patients", "TARGET"], ["insulin", "CNS", "LOCATED IN"], ["parkinsonian symptoms", "PD", "AFFECT"], ["resveratrol", "Alzheimer's disease pathology", "INFLUENCE"], ["SIBO", "cystic fibrosis", "AFFECT"], ["low-FODMAP diet", "IBS", "INFLUENCE"], ["Bacteroidetes", "pSS", "INFLUENCE"], ["neurodegeneration", "Parkinson's disease", "AFFECT"], ["gut microbiota", "Veterans", "LOCATED IN"], ["metabolites", "gut microbiota", "PRODUCED BY"], ["Bifidobacterium", "gut microbiota", "PART OF"], ["<i>Lactobacillus reuteri</i> ATG-F4", "neurometabolic alterations", "INFLUENCE"], ["FD", "human participants", "TARGET"], ["gut microbiota", "iRBD patients", "LOCATED IN"], ["oral microbiome", "PD", "IS LINKED TO"], ["agents", "GM", "IMPACT"], ["celiac disease", "Individuals", "TARGET"], ["NLRP3 inflammasome", "inflammatory issues", "INFLUENCE"], ["rotenone", "PD symptoms", "CHANGE EFFECT"], ["Ruminococcus torques", "gut microbiota", "PART OF"], ["carbohydrate metabolism disorder", "MDD patients", "TARGET"], ["Anxiety symptoms", "physical disorders", "AFFECT"], ["probiotics", "Neurodegenerative Diseases", "INFLUENCE"], ["neighbouring residents", "16S rRNA gene sequencing", "USED BY"], ["Gut Microbiome", "Alzheimer's disease", "IS LINKED TO"], ["spasmolytics", "Irritable bowel syndrome", "CHANGE EFFECT"], ["young adults", "MRI", "USED BY"], ["schizophrenia", "autoimmune disorders", "AFFECT"], ["prefrontal cortex", "C57BL/6J mice", "LOCATED IN"], ["anti-inflammatory bacteria", "Gut microbiota", "PART OF"], ["PFC", "male mice", "LOCATED IN"], ["therapeutic approaches", "intestinal microbial ecosystem", "IMPACT"], ["gut microbiota", "young, healthy adults", "LOCATED IN"], ["gut microbiota", "gut microbiota disorders", "IS LINKED TO"], ["gut microbiota", "mice", "LOCATED IN"], ["meals", "microbiota", "IMPACT"], ["Human glucose-dependent insulinotropic polypeptide", "antimicrobial adjuvant re-sensitising multidrug-resistant Gram-negative bacteria", "IMPACT"], ["Zinc", "obesity", "INFLUENCE"], ["indole derivatives", "gut microbiota", "IMPACT"], ["Gut Microbiome", "anxiety", "IS LINKED TO"], ["GMB", "patients with major depressive disorder", "LOCATED IN"], ["Subdoligranulum", "gut microbiota", "PART OF"], ["generalized anxiety", "Women", "TARGET"], ["GM", "mental health issues", "IS LINKED TO"], ["PUFAs", "inflammation", "INFLUENCE"], ["severe social avoidance behaviors", "Mice", "TARGET"], ["MPTP", "Male C57BL/6 mice", "LOCATED IN"], ["food supplement", "IBS/functional dyspepsia", "INFLUENCE"], ["prebiotic food", "anxiety", "INFLUENCE"], ["primary bile acid biosynthesis", "bacterial taxa", "IMPACT"], ["nutrients", "age-associated molecular dysfunctions", "INFLUENCE"], ["cognitive impairment", "A53T monkeys", "TARGET"], ["gut microbial ecosystem", "acne", "IS LINKED TO"], ["Malnutrition", "cognitive decline", "AFFECT"], ["Gut Microbiota", "Emerging Adults", "LOCATED IN"], ["Mediterranean Diet", "Psychopathology", "INFLUENCE"], ["plasticizer", "obesity", "INFLUENCE"], ["major depressive disorder", "individuals", "TARGET"], ["neuropeptides", "PD", "INFLUENCE"], ["Curcumin", "gut microbiota", "IMPACT"], ["GM", "immune and chronic systemic inflammation", "IS LINKED TO"], ["Gut microbiota", "androgen metabolism disorder", "IS LINKED TO"], ["gut microbiome", "blood-brain barrier", "LOCATED IN"], ["Psychosomatic Diarrhea", "College Students", "TARGET"], ["prebiotics", "digestive health", "INFLUENCE"], ["antidiabetic drugs", "gut microbiota", "IMPACT"], ["chronic SD", "g_Romboutsia", "CHANGE ABUNDANCE"], ["Early life stress", "intestine", "STRIKE"], ["chronic SD", "p_Verrucomicrobia", "CHANGE ABUNDANCE"], ["Proteobacteria", "gut microorganisms", "PART OF"], ["anxiety/depression", "IBS", "AFFECT"], ["prebiotics", "diseases", "INFLUENCE"], ["B. licheniformis", "gut microbiota", "IMPACT"], ["Gut dysbiosis", "inflammatory bowel disease", "AFFECT"], ["DR7", "gut microbiota", "PART OF"], ["gut microbiota", "dyslipidemia", "IS LINKED TO"], ["Actinobacteria", "obesity", "INFLUENCE"], ["Gut Microbiome", "Neurodegenerative Disorders", "IS LINKED TO"], ["gut microbiota", "reduced BMD", "IS LINKED TO"], ["polymannuronic acid", "Parkinson's disease", "INFLUENCE"], ["NOX2", "ND", "INFLUENCE"], ["cognitive impairment", "major accompanying pathological symptom", "AFFECT"], ["probiotics", "neurologic disorders", "INFLUENCE"], ["iRBD", "family <i>Akkermansiaceae</i>", "CHANGE ABUNDANCE"], ["Escherichia-Shigella", "DEGs", "CHANGE EXPRESSION"], ["low carbohydrate", "central nervous system (CNS) disorders", "INFLUENCE"], ["QUR", "gut microbiota", "IMPACT"], ["Western diet", "dysbiosis", "INFLUENCE"], ["SCFAs", "gut microbiota", "PRODUCED BY"], ["controls", "qPCR", "USED BY"], ["gut microbiome", "obesity", "IS LINKED TO"], ["gut microbiota", "dopamine-related pathologies", "IS LINKED TO"], ["microglia activation", "Male C57BL/6 mice", "TARGET"], ["intestinal microbiota", "anxiety disorders", "IS LINKED TO"], ["Hua-Feng-Dan", "Methanobacteriaceae", "IMPACT"], ["microbiota dysbiosis", "RSDS mice", "TARGET"], ["adequate protein", "autism spectrum disorders", "INFLUENCE"], ["microbial micro-environment", "autism spectrum disorder", "IS LINKED TO"], ["gut microbiota", "non-obese diabetic (NOD) mice", "LOCATED IN"], ["5-HT", "hippocampus", "LOCATED IN"], ["CUR", "Aerococcaceae", "IMPACT"], ["LCIG", "LCIG group", "ADMINISTERED"], ["loss of chromosome X inactivation", "neurodegeneration", "AFFECT"], ["women", "cholecystectomy", "USED BY"], ["Gut Microbiota Composition and Diversity", "Early Childhood", "LOCATED IN"], ["gut microbiome", "neurodegeneration", "IS LINKED TO"], ["SCFAs", "nervous system disorders", "INFLUENCE"], ["HFD-reduced", "loss of DA neurons", "CHANGE EFFECT"], ["microbial metabolites", "mitochondrial dysfunction", "INFLUENCE"], ["gut microbiota communities", "motor dysfunction", "IS LINKED TO"], ["Chronic low-grade inflammation", "schizophrenia", "AFFECT"], ["gut bacterial dysbiosis", "microbiota-derived short-chain fatty acids", "INTERACT"], ["gut microbiota diversity", "response initiation", "IS LINKED TO"], ["plant protein", "Bacteriodetes", "IMPACT"], ["motor deficits", "SNCA mice", "TARGET"], ["SCFAs", "schizophrenia", "INFLUENCE"], ["CRP", "systemic inflammation", "INFLUENCE"], ["bacterial cells", "hydrogel", "INTERACT"], ["Dietary fiber pectins", "gut health", "INFLUENCE"], ["dysbiosis", "metabolic diseases", "AFFECT"], ["Myristic acid", "gut microbiota", "PRODUCED BY"], ["gut microbiota", "SS-related symptoms", "IS LINKED TO"], ["VVS", "children", "TARGET"], ["PD and healthy controls", "16S ribosomal RNA (16S rRNA) gene sequencing", "USED BY"], ["human gut microbiota", "Parkinson's disease", "IS LINKED TO"], ["mucosa associated microbiota", "PIPO", "IS LINKED TO"], ["gut microbiota dysbiosis", "human host", "TARGET"], ["posttraumatic stress disorder", "Fusicatenibacter saccharivorans", "CHANGE ABUNDANCE"], ["IBS-D", "Escherichia coli", "CHANGE ABUNDANCE"], ["serotonin", "human gut", "LOCATED IN"], ["depression-like behaviors", "CSDS-susceptible mice", "TARGET"], ["gut microbiota", "dietary-induced alterations", "IS LINKED TO"], ["type 2 diabetes mellitus", "chronic hyperglycaemia-related damage", "AFFECT"], ["limonene", "Irritable bowel syndrome", "INFLUENCE"], ["Lachnostridium", "MDD", "INFLUENCE"], ["altered intestinal serotonin pathway", "PIPO patients", "TARGET"], ["depression", "Depressed mother rats", "TARGET"], ["inactivated L. plantarum CCFM8661", "FASN", "CHANGE EXPRESSION"], ["NLRP3 inflammasome", "cardiovascular diseases", "INFLUENCE"], ["Ketogenic diet", "Neuroinflammation", "INFLUENCE"], ["PD-like pathology", "Pink1</i><sup>-/-</sup> mice", "TARGET"], ["coronavirus disease", "patients", "TARGET"], ["unhealthy nutrition", "Alzheimer's disease", "AFFECT"], ["Prevotella-enriched microbiome", "exclusion group", "LOCATED IN"], ["patients", "donor-FMT pilot study", "USED BY"], ["GBM", "Lachnospiraceae", "CHANGE ABUNDANCE"], ["low carbohydrate", "PD", "INFLUENCE"], ["P. gingivalis", "neurodegeneration", "INFLUENCE"], ["Clostridium", "patients", "LOCATED IN"], ["high-fiber diet", "intestinal microbiota alterations", "INFLUENCE"], ["Parkinson's Disease", "human PD cases", "TARGET"], ["dysmotility", "PIPO patients", "TARGET"], ["dyslipidemia", "subjects", "TARGET"], ["nutrition care", "SZ", "INFLUENCE"], ["probiotics", "immune diseases", "INFLUENCE"], ["healthy controls", "16s rRNA gene V3-V4 region sequencing", "USED BY"], ["sleep disturbance", "population", "TARGET"], ["gut microbiota", "cancer survivors", "LOCATED IN"], ["Coprococcus", "hub-genes", "CHANGE EXPRESSION"], ["carbohydrates", "gut microorganisms", "IMPACT"], ["Ketogenic Diet", "Serious Mental Illness", "INFLUENCE"], ["constipation", "subjects", "TARGET"], ["nutraceuticals", "schizophrenia", "INFLUENCE"], ["uncontrolled intake of refined carbohydrates", "metabolic disease", "INFLUENCE"], ["gastrointestinal microbiome", "brain", "LOCATED IN"], ["gut 2-keto-glutaramic acid", "ASD", "INFLUENCE"], ["amino acid", "fatigue", "INFLUENCE"], ["severe GI complaints", "GI group", "TARGET"], ["Hua-Feng-Dan", "gut microbiota", "IMPACT"], ["Hua-Feng-Dan", "loss of DA neurons", "CHANGE EFFECT"], ["gut microbiota", "anxiety", "IS LINKED TO"], ["PD-MCI", "Ruminococcus", "CHANGE ABUNDANCE"], ["fermented foods", "obesity", "INFLUENCE"], ["B vitamins", "brain health", "INFLUENCE"], ["Probiotics", "depression", "INFLUENCE"], ["gastrointestinal tract", "humans", "LOCATED IN"], ["fecal microbiota", "healthy matched controls", "LOCATED IN"], ["BAs", "intestinal microbiota", "IMPACT"], ["KD", "oxidative stress", "INFLUENCE"], ["liver cirrhosis", "patients", "TARGET"], ["(expectant) mothers", "Brief Symptom Inventory", "USED BY"], ["gut microbiota", "lung cancer", "IS LINKED TO"], ["gut microbes", "AD", "IS LINKED TO"], ["Mediterranean diet", "psychopathology", "INFLUENCE"], ["zoonotic <i>Helicobacter</i> species", "pigs", "LOCATED IN"], ["tremors", "Bifidobacteria", "CHANGE ABUNDANCE"], ["Gut Microbiota", "Schizophrenia", "IS LINKED TO"], ["fucoidan", "TREM2", "CHANGE EXPRESSION"], ["tryptophan", "Venous blood", "LOCATED IN"], ["CsgA", "mice", "LOCATED IN"], ["catechol-O-methyltransferase (COMT) inhibitor", "GI", "CHANGE EFFECT"], ["Attention-deficit/hyperactivity disorder", "individuals", "TARGET"], ["ASD", "GJA1", "INTERACT"], ["Polyphenols", "inflammation", "INFLUENCE"], ["gut", "rats", "LOCATED IN"], ["Bacteroides genus", "FCR", "INFLUENCE"], ["CT-26", "Helicobacter", "IMPACT"], ["anxiety-like disorder", "male mice", "TARGET"], ["Perinatal depression", "women during pregnancy (prenatal) and after childbirth (postnatal)", "TARGET"], ["MPTP", "gut microbiome", "IMPACT"], ["high-fiber diet", "Lactobacillus", "IMPACT"], ["melanomas", "melanin", "INTERACT"], ["kefir", "class Bacilli", "IMPACT"], ["microbiota", "MPTP-induced progressive central and peripheral inflammation", "IS LINKED TO"], ["gut microbiota", "traumatic brain injury", "IS LINKED TO"], ["microbiota", "reduced mental and physical health", "IS LINKED TO"], ["ASD", "Participants", "TARGET"], ["d-glutamate", "gut bacteria", "IMPACT"], ["microbes", "brain", "LOCATED IN"], ["GV-971", "cognition impairment", "CHANGE EFFECT"], ["Mediterranean diet", "Huntington's diseases", "INFLUENCE"], ["levodopa", "Parkinson disease", "CHANGE EFFECT"], ["placebo", "firmicutes", "IMPACT"], ["fecal microbiota", "pups", "LOCATED IN"], ["probiotics", "IRIF", "IMPACT"], ["succinate", "amyotrophic lateral sclerosis", "INFLUENCE"], ["HMP", "inflammation", "INFLUENCE"], ["ketogenic diet", "gut microbiome", "IMPACT"], ["SDV", "demyelination", "AFFECT"], ["medication", "Hoehn and Yahr disease", "CHANGE EFFECT"], ["depressive symptoms", "gut microbiota", "CHANGE ABUNDANCE"], ["Scardovia_inopinata", "PD", "INFLUENCE"], ["Plasma BCAA", "PD patients", "LOCATED IN"], ["nutraceuticals", "autism spectrum disorders", "INFLUENCE"], ["microbiota", "neuroinflammation", "IS LINKED TO"], ["cognitive impairment", "T1D mice", "TARGET"], ["Clostridiales g.i.s", "faecal gut microbiota", "PART OF"], ["7-dehydroxylating bacteria", "LDSD gut microbiota", "PART OF"], ["BMAA", "segmented filamentous bacteria", "IMPACT"], ["microbiome and specific bacterial changes", "Parkinson's disease", "AFFECT"], ["pesticides", "cardiovascular diseases", "INFLUENCE"], ["commensal gut microbiota", "brain", "LOCATED IN"], ["type C lectins", "antimicrobial proteins", "PART OF"], ["lactate", "depressive behavior", "INFLUENCE"], ["faecal gut microbiota", "depression", "IS LINKED TO"], ["bile acids", "intestinal lumen", "LOCATED IN"], ["MDD patients", "bioinformatics analysis", "USED BY"], ["gut microbiota", "central nervous system", "LOCATED IN"], ["Rifaximin", "Bacteroides", "IMPACT"], ["plasticizer", "body weight gain", "INFLUENCE"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "Pronicromonosporaceae", "IMPACT"], ["hormones", "healthy adults", "LOCATED IN"], ["anxiety", "mental health and neurocognitive disorders", "IS A"], ["Actinobacteriota", "dominated breast milk gut microbiota", "PART OF"], ["motor dysfunction", "mice", "TARGET"], ["brain", "human case-control studies", "LOCATED IN"], ["AN", "patients", "TARGET"], ["SIBO", "functional abdominal bloating", "AFFECT"], ["A\u03b2", "Alzheimer's and Parkinson's diseases", "INFLUENCE"], ["inhibitor", "CST injury", "CHANGE EFFECT"], ["Maternal Fiber Intake", "Anxiety", "INFLUENCE"], ["colonic microbiome", "multiple sclerosis", "IS LINKED TO"], ["Major depression", "patients", "TARGET"], ["prebiotic", "\u03b1-synucleinopathies", "INFLUENCE"], ["Gut Microbiome", "CNS disorders", "IS LINKED TO"], ["substance use disorder", "individuals", "TARGET"], ["GABA", "brain", "LOCATED IN"], ["bioactive peptides", "type 1 diabetes", "INFLUENCE"], ["carbohydrate fermentation", "intestinal microbiome", "IMPACT"], ["TNF-\u03b1", "colon", "LOCATED IN"], ["HT", "oxidative stress", "INFLUENCE"], ["Parkinson's disease", "Blautia", "CHANGE ABUNDANCE"], ["fecal microbiota", "16S rRNA sequencing", "USED BY"], ["anxiety and depression-like behavior behavioral abnormalities", "mice", "TARGET"], ["mental disorders", "patients", "TARGET"], ["zoonotic <i>Helicobacter</i> species", "humans", "LOCATED IN"], ["GM", "ND", "IS LINKED TO"], ["human microbiome", "gut", "LOCATED IN"], ["Cinnabar", "disturbance of gut microbiota", "INFLUENCE"], ["gut microbiota dysbiosis", "nervous system disturbances", "AFFECT"], ["PD", "human PD cases", "TARGET"], ["Probiotics", "psychiatric disorders", "INFLUENCE"], ["microbiota", "enteric nervous system", "LOCATED IN"], ["Gut microbiota", "Parkinson's disease", "IS LINKED TO"], ["Parkinson's disease", "PD individuals", "TARGET"], ["gut microbiota", "migraines", "IS LINKED TO"], ["bacteria-derived products", "pain perception", "INFLUENCE"], ["prenatal faecal microbiota", "mothers", "LOCATED IN"], ["gut microbiota", "depressive disorder", "IS LINKED TO"], ["gut microbiota", "Gut", "LOCATED IN"], ["Mediterranean diet", "morbidity", "INFLUENCE"], ["Non-Digestible Oligosaccharides", "Leaky Gut", "INFLUENCE"], ["gut microbiota", "enzyme-linked immune sorbent assay", "USED BY"], ["hippocampal synaptic ultrastructure", "FD mice", "LOCATED IN"], ["alterations in mediators of cholesterol homeostasis and lipid metabolism", "PD gut", "STRIKE"], ["Parkinson's disease", "3-Methylindole", "INTERACT"], ["Psychobiotics", "diabetic neuropathy", "INFLUENCE"], ["anxiety- and depression-like behaviors", "pups", "TARGET"], ["bacteria", "anti-inflammatory properties", "INFLUENCE"], ["CA", "IL-1\u03b2", "INTERACT"], ["gut microbiota", "treatment of depression", "IS LINKED TO"], ["inflammation", "gut bacteria", "CHANGE ABUNDANCE"], ["neurodegenerative diseases", "survived patients", "TARGET"], ["probiotic", "Lactobacillus genus", "IMPACT"], ["Neurodegenerative diseases", "gradual progressive loss of neurons", "AFFECT"], ["commensal bacteria", "gut microbiota", "PART OF"], ["Hua-Feng-Dan", "disturbance of gut microbiota", "CHANGE EFFECT"], ["motor deficits", "gut microbiota", "CHANGE ABUNDANCE"], ["Parkinson Disease", "Patients", "TARGET"], ["patients", "FPG", "USED BY"], ["nutrient-rich diet", "gut microbiota", "IMPACT"], ["GM", "AD", "IS LINKED TO"], ["live and inactivated L. plantarum CCFM8661", "gut microbiota", "PART OF"], ["Gut microbes", "epilepsy", "IS LINKED TO"], ["oral agents", "PD", "CHANGE EFFECT"], ["behavioral dysfunction", "mice", "TARGET"], ["HFD-original", "Lactobacteriaceae", "IMPACT"], ["AP-induced", "metabolic perturbations", "CHANGE EFFECT"], ["cinnabar", "behavioral dysfunction", "INFLUENCE"], ["cytokines", "lung cancer", "INFLUENCE"], ["CA", "obesity", "INFLUENCE"], ["specific MAM associated to underlying pathology", "altered intestinal serotonin pathway", "IS LINKED TO"], ["stroke", "humans", "TARGET"], ["<i>Lactobacillus fermentum</i> PS150", "hypnotic effects", "INFLUENCE"], ["Polycystic ovarian syndrome", "depression", "AFFECT"], ["Parkinson's disease", "brain", "STRIKE"], ["cytokines", "pseudogene-microRNA-SURF4", "CHANGE EXPRESSION"], ["host microbiota", "neuropsychiatric disorders", "IS LINKED TO"], ["PCOS", "patients", "TARGET"], ["Lachnoclostridium", "MDD", "INFLUENCE"], ["SZ patients", "metagenome analysis", "USED BY"], ["gut microbiota", "inflammaging", "IS LINKED TO"], ["<i>Prevotella</i> spp.", "gut microbiome", "PART OF"], ["stress", "stressed adults", "TARGET"], ["Neurodegeneration", "Mice", "TARGET"], ["choline metabolites", "depressive behavior", "INFLUENCE"], ["brain", "mice", "LOCATED IN"], ["Anxiety symptoms", "stress", "AFFECT"], ["pro-inflammatory mediators", "obesity", "INFLUENCE"], ["Gut Dysbiosis", "Cancer Pain Patients", "TARGET"], ["piperine", "cell cycle proteins", "INTERACT"], ["green tea", "PD patients", "ADMINISTERED"], ["Significant microbiota taxonomic differences", "Parkinson's patients", "TARGET"], ["Elderly patients", "randomized-control trial of mindful awareness practice", "USED BY"], ["CUMS", "father rats", "TARGET"], ["gut microbiota", "aged population", "LOCATED IN"], ["Fisetin", "Huntington's disease", "INFLUENCE"], ["Plasma metabolites", "gut microbiota", "PRODUCED BY"], ["metabolic products", "altered gut microbiota", "INFLUENCE"], ["Western diet", "gut microbiota", "IMPACT"], ["serotonin", "substantia nigra pars compacta", "LOCATED IN"], ["fecal BCAA", "advanced PD patients", "LOCATED IN"], ["IRIF", "anxiety symptoms", "IS LINKED TO"], ["\u03b2-HgS-containing 70W", "Parkinson's disease", "CHANGE EFFECT"], ["Inflammatory bowel diseases", "complex chronic inflammatory disorders", "IS A"], ["Piperine", "inflammatory diseases", "INFLUENCE"], ["Ruminococcaceae", "VVS", "INFLUENCE"], ["gut microbiota", "ALS", "IS LINKED TO"], ["<i>H. pylori</i> infection", "Neurological impairments", "AFFECT"], ["effective solubility-enhancing formulations", "gut microbiota", "IMPACT"], ["oxidative brain injury", "PD patients", "TARGET"], ["neuroinflammation", "PD mice", "TARGET"], ["c_Clostridia", "gut microbiota", "PART OF"], ["polyphenols", "PD", "INFLUENCE"], ["multiple sclerosis", "human host", "TARGET"], ["fecal microbiota", "risk for earlier death", "IS LINKED TO"], ["depressive disorder", "patients", "TARGET"], ["ultra-processed diet", "neurodegenerative diseases", "INFLUENCE"], ["gastrointestinal diseases", "inflammation", "AFFECT"], ["HFD-reduced", "DA neuron loss", "CHANGE EFFECT"], ["SHH", "Alistipes", "IMPACT"], ["human gut microbiomes", "PCOS", "IS LINKED TO"], ["MCC950", "Bifidobacterium", "IMPACT"], ["gasdermin D", "duodenum", "LOCATED IN"], ["high sugar", "microbiota", "IMPACT"], ["diet", "gut microorganisms", "IMPACT"], ["mental disorders", "populations", "TARGET"], ["Gut microbiota", "chronic kidney disease", "IS LINKED TO"], ["ulcerative colitis", "idiopathic disorders", "IS A"], ["coffee", "\u03b1-syn", "CHANGE EXPRESSION"], ["SV2C", "FD mice", "LOCATED IN"], ["striatal homovanillic acid", "SNpc", "LOCATED IN"], ["Levilactobacillus brevis SG031", "stress-related sleep disturbance", "INFLUENCE"], ["posttraumatic stress disorder", "Lentisphaerae", "CHANGE ABUNDANCE"], ["antipsychotic-induced", "metabolic alterations", "CHANGE EFFECT"], ["prebiotics", "anxiety disorders", "INFLUENCE"], ["Parkinson's disease", "postural instability", "AFFECT"], ["high mental stress", "healthy adults", "TARGET"], ["bioactive polyphenols", "neurotransmitter dysfunction", "INFLUENCE"], ["TNF inhibitor XPro1595", "inflammation", "CHANGE EFFECT"], ["commensal and pathogenic gut bacteria", "CNS pathologies", "INFLUENCE"], ["phytochemicals", "TNFA", "CHANGE EXPRESSION"], ["gut microbiota", "depressive-like behaviors", "IS LINKED TO"], ["nutraceutical supplementations", "extra-uterine growth restriction", "INFLUENCE"], ["mice", "hanging test", "USED BY"], ["PTSD", "Fusicatenibacter saccharivorans", "CHANGE ABUNDANCE"], ["lithocholic acid", "PD appendix", "LOCATED IN"], ["GM", "post-traumatic stress disorder", "IS LINKED TO"], ["abundance of potential pathogens and microbial genes", "SD rats", "TARGET"], ["SD", "Male specific-pathogen-free Wistar rats", "TARGET"], ["stress response", "BBB", "STRIKE"], ["gut microbiota", "healthy donor", "LOCATED IN"], ["dysregulation of the main neuroendocrine axes coordinated by the hypothalamus", "disruptions at the peripheral level", "AFFECT"], ["gut microbial dysbiosis", "glioblastoma brain tumour", "AFFECT"], ["GM", "Parkinson disease", "IS LINKED TO"], ["As<sub>4</sub>S<sub>4</sub>", "gut microbiome", "IMPACT"], ["gut microbiota dysbiosis", "Graves' disease", "AFFECT"], ["gut microbiota", "drug-na\u00efve (DN SCZ) and risperidone-treated SCZ patients", "LOCATED IN"], ["intestinal SCFA", "PD", "INFLUENCE"], ["CBD", "potential therapeutic effects", "CHANGE EFFECT"], ["inflammatory bowel disease", "Dysbiosis", "AFFECT"], ["GBM", "Bacteroides", "CHANGE ABUNDANCE"], ["gut microbiota", "Major Depressive Disorder", "IS LINKED TO"], ["food supplement", "Irritable bowel syndrome", "INFLUENCE"], ["fecal microbiota", "microbiota alterations", "IS LINKED TO"], ["antibiotic growth promotants", "gut microbiome", "IMPACT"], ["CUR-treated mice", "16S rRNA sequencing", "USED BY"], ["SND", "Fluviimonas_pallidilutea", "CHANGE ABUNDANCE"], ["Flavonifractor", "microbiota", "PART OF"], ["Sybergistetes", "Gut microbiota", "PART OF"], ["early PD", "Sybergistetes", "CHANGE ABUNDANCE"], ["galangin", "TREM2", "CHANGE EXPRESSION"], ["fiber", "gut microbiota", "IMPACT"], ["3-Indolepropionic acid", "hub-genes", "CHANGE EXPRESSION"], ["nutraceutical supplementations", "allergy", "INFLUENCE"], ["FCR", "Ruminococcus", "CHANGE ABUNDANCE"], ["Depression", "PCOS Patients", "TARGET"], ["altered immunological conditions", "gut microbiota", "CHANGE ABUNDANCE"], ["medication", "dysbiotic microbiota", "CHANGE EFFECT"], ["MCC950", "Bacteroides", "IMPACT"], ["peptic ulcers", "substantiated local gastric pathologies", "IS A"], ["L. rhamnosus", "depression", "INFLUENCE"], ["realgar", "LPS plus ROT induced neurotoxicity", "INFLUENCE"], ["butyrate", "human gut microbiota", "PRODUCED BY"], ["ASD", "EYA1", "INTERACT"], ["Microbiota", "Children", "LOCATED IN"], ["Muribaculaceae", "DEGs", "CHANGE EXPRESSION"], ["SG031", "stress-induced sleep disturbance", "INFLUENCE"], ["HgS", "gut microbiome", "IMPACT"], ["HD", "gut problems", "AFFECT"], ["Mitochondrial dysfunction", "chronic pain", "AFFECT"], ["maternal overnutrition", "neuroinflammation", "AFFECT"], ["flora", "nasal mucosa", "LOCATED IN"], ["microbial dysbiosis", "post-traumatic stress disorder", "AFFECT"], ["microbially-derived neurotransmitters", "brain", "LOCATED IN"], ["ALI", "extensive oxidative stress", "AFFECT"], ["chronic unpredictable mild stress", "father rats", "TARGET"], ["dysphagia", "PD patients", "TARGET"], ["Rifaximin", "Parkinson's Disease", "CHANGE EFFECT"], ["probiotics", "neurological illnesses", "INFLUENCE"], ["gut microbiota", "mass spectrometry", "USED BY"], ["Ruminococcaceae", "syncope", "INFLUENCE"], ["gut microbiota", "Neurodegenerative Disorders", "IS LINKED TO"], ["probiotics", "influenza virus infection", "INFLUENCE"], ["intestinal microbiota", "intestine", "LOCATED IN"], ["human gut microbiota", "GEMs", "USED BY"], ["fiber", "PDA", "INFLUENCE"], ["6-OHDA-Induced Parkinson's Disease", "Rats", "TARGET"], ["gut microbiota", "social behavior", "IS LINKED TO"], ["polyphenols", "intestinal microbiota", "PRODUCED BY"], ["SCFA-producing bacteria", "PD", "INFLUENCE"], ["overweight", "healthy adults", "TARGET"], ["dietary fiber intake", "diseases", "INFLUENCE"], ["calorie-controlled diets", "PD", "INFLUENCE"], ["Hashimoto's thyroidis", "human host", "TARGET"], ["Flavobacterium spp.", "gut microbiota", "PART OF"], ["human microbiome", "16S rRNA technology", "USED BY"], ["Alzheimer's disease", "patients", "TARGET"], ["harmful substances", "central center", "LOCATED IN"], ["inflammation-associated microbial genera", "deterioration", "INFLUENCE"], ["gut microbiota", "schizophrenia", "IS LINKED TO"], ["impaired cognition", "FD mice", "TARGET"], ["diets/dietary components", "microbial diversity", "IMPACT"], ["Prebiotics", "host", "ADMINISTERED"], ["Human Gut Microbiota", "nervous system disturbances", "IS LINKED TO"], ["corticospinal tract injury", "mice", "TARGET"], ["gut microbiome", "Alzheimer's and Parkinson's disease", "IS LINKED TO"], ["PD", "gastrointestinal (GI) dysfunction", "AFFECT"], ["gut microbiota", "criteria-acute group (patients with acute schizophrenia)", "LOCATED IN"], ["gut microbiota", "metaproteomics", "USED BY"], ["gut microbiota", "disorders", "IS LINKED TO"], ["tyrosine", "Aerococcaceae", "IMPACT"], ["gut microbiota", "16S rRNA sequencing", "USED BY"], ["PS128", "MPTP-induced oxidative stress", "INFLUENCE"], ["GM", "microbial dysbiosis", "IS LINKED TO"], ["CT-26", "Ruminococcaceae_UCG-014", "IMPACT"], ["ketogenic diet", "depression", "INFLUENCE"], ["realgar", "behavioral dysfunction", "INFLUENCE"], ["Parkinson's disease", "elderly patients", "TARGET"], ["chicoric acid", "TLR4", "CHANGE EXPRESSION"], ["Resistant Starch", "Parkinson'sDisease", "INFLUENCE"], ["Mediterranean diet", "systemic inflammation", "INFLUENCE"], ["type 2 diabetes mellitus", "human host", "TARGET"], ["Alistipes", "PD-MCI group", "LOCATED IN"], ["males", "preclinical studies", "USED BY"], ["human African trypanosomiasis", "chronic brain inflammation processes", "AFFECT"], ["glaucoma", "neurodegenerative central nervous system disorders", "IS A"], ["HCs", "16s rRNA sequencing", "USED BY"], ["PD", "gut microbiome", "CHANGE ABUNDANCE"], ["VVS", "VVS patients", "TARGET"], ["Motor dysfunction", "Parkinson's disease", "AFFECT"], ["bacterial taxa", "gut microbiota", "PART OF"], ["healthy spouses", "16S rRNA sequencing", "USED BY"], ["human microbiome", "CNS diseases", "IS LINKED TO"], ["GM", "females", "LOCATED IN"], ["Probiotics", "constipation", "INFLUENCE"], ["H. hepaticus", "gut microbiota", "PART OF"], ["honey", "microbial communities", "IMPACT"], ["Neurodegenerative Disease", "disease subpopulations", "TARGET"], ["gut microbiota", "systemic lupus erythematosus", "IS LINKED TO"], ["Main gut microbiota alterations", "pSS-mediated dry eye", "AFFECT"], ["pathophysiology of IBD", "IBD patients", "TARGET"], ["Parkinson's disease", "MSA", "AFFECT"], ["liver cirrhosis", "mice", "TARGET"], ["gut microbiota", "IBS patients", "LOCATED IN"], ["menthol", "Irritable bowel syndrome", "INFLUENCE"], ["OS", "apoptosis", "AFFECT"], ["mice", "antibiotic-induced microbiome depletion", "USED BY"], ["gut microbiota", "subjects", "LOCATED IN"], ["gut microbiota", "SMI", "IS LINKED TO"], ["gut microbiome", "16s rRNA sequencing technique", "USED BY"], ["addiction", "animals", "TARGET"], ["Gut microbiota", "inflammation", "IS LINKED TO"], ["Probiotic Clostridium butyricum", "motor deficits", "INFLUENCE"], ["Schizophrenia", "Patients", "TARGET"], ["PD", "microbial metabolites", "INTERACT"], ["gut microbiota", "emotional and neural regulation", "IS LINKED TO"], ["human gut microbiota", "gut microbiota dysbiosis", "IS LINKED TO"], ["solvent", "CON mice", "LOCATED IN"], ["Cb", "synaptic dysfunction", "INFLUENCE"], ["probiotics", "chronic stress", "INFLUENCE"], ["low carbohydrate", "neurological diseases", "INFLUENCE"], ["maternal microbiota", "mental disorders", "IS LINKED TO"], ["Eggerthella lenta", "microbiota", "PART OF"], ["intestinal microbes", "gastrointestinal disturbances", "IS LINKED TO"], ["GM", "Major depressive disorder", "IS LINKED TO"], ["HFD", "neurodegenerative diseases", "CHANGE EFFECT"], ["mitochondrial activities", "brain", "STRIKE"], ["psychiatric disorders", "dysbiosis", "AFFECT"], ["\"abnormal\" microbiota", "neurological diseases", "IS LINKED TO"], ["vitamins", "neurological diseases", "INFLUENCE"], ["<i>Lactobacillus plantarum</i> DP189", "\u03b1-SYN Aggravation", "INFLUENCE"], ["Social avoidance behaviors", "corticosterone", "INTERACT"], ["vancomycin pretreatment", "gut microbiota", "IMPACT"], ["anxiety-like disorder", "mice", "TARGET"], ["Actinobacteria", "CSDS-susceptible mice", "LOCATED IN"], ["short-chain fatty acid butyrate", "Colon microbiota", "PRODUCED BY"], ["Oligosaccharides", "Periplaneta Americana", "LOCATED IN"], ["polymannuronic acid", "blood brain barrier", "LOCATED IN"], ["207-1", "healthy adults", "ADMINISTERED"], ["cardiovascular", "host", "TARGET"], ["cytokines", "pathogenic proteins", "IMPACT"], ["anxiety", "women", "TARGET"], ["sodium oligomannate", "neuroinflammation", "CHANGE EFFECT"], ["Diet", "microbial diversity", "IMPACT"], ["gut microbiota composition", "GC-MS", "USED BY"], ["Walnuts", "Mental Health", "INFLUENCE"], ["probiotic applications", "anxiety", "INFLUENCE"], ["gut microbial metabolites", "Parkinson's disease", "INFLUENCE"], ["other neurodegenerative dementias", "patients", "TARGET"], ["mean pressure drop", "VVS patients", "TARGET"], ["chronic unpredictable mild stress", "C57BL/6 mice", "TARGET"], ["early-stage PD", "patients", "TARGET"], ["Glial cell-derived neurotrophic factor", "neurodegenerative diseases", "INFLUENCE"], ["Helicobacter pylori", "PD therapy", "INFLUENCE"], ["gut dysbiosis", "GBA dysfunction", "AFFECT"], ["neurological diseases", "patients", "TARGET"], ["short- or long-term <i>H. suis</i> infection", "mice", "TARGET"], ["cooked soybean", "Rhizopus", "IMPACT"], ["Low-dose PHP", "fatty acid transport genes", "CHANGE EXPRESSION"], ["microbiota", "rhesus monkeys", "LOCATED IN"], ["probiotic Clostridium butyricum", "Parkinson's disease", "INFLUENCE"], ["gut microbes", "patients", "LOCATED IN"], ["human donors", "FMT", "USED BY"], ["BMAA", "immune cell migration", "INFLUENCE"], ["antidepressants", "gut microbiota", "IMPACT"], ["PD", "Prevotellaceae", "CHANGE ABUNDANCE"], ["MyD88", "neuroinflammation", "INFLUENCE"], ["PD patients", "microbiota sequencing", "USED BY"], ["Lactiplantibacillus", "gut microbiota", "PART OF"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "PD", "INFLUENCE"], ["RIA", "patients", "TARGET"], ["anti-inflammatory drugs", "psychiatric Disorders", "CHANGE EFFECT"], ["Parkinson's Disease", "disease subpopulations", "TARGET"], ["type 2 diabetes mellitus", "patients", "TARGET"], ["<i>Lactobacillus plantarum</i> DP189", "Gut Microbiota Disorder", "INFLUENCE"], ["piperine", "peroxisome proliferator-activated receptor-gamma", "INTERACT"], ["anxiety", "FHWs", "TARGET"], ["selenium", "late onset neuropathologies", "INFLUENCE"], ["bifidobacterial populations", "ASD and healthy controls", "LOCATED IN"], ["mice", "pentobarbital-induced sleep test", "USED BY"], ["nutraceutical supplementations", "non-alcoholic fatty liver disease", "INFLUENCE"], ["70W", "disturbance of gut microbiota", "CHANGE EFFECT"], ["colonic microbiota", "multi-omics approach", "USED BY"], ["SCRD", "A\u03b2", "INTERACT"], ["probiotics", "neuroinflammation", "INFLUENCE"], ["IBD", "IBD patients", "TARGET"], ["<i>L. plantarum</i> DP189", "glutathione peroxide", "INTERACT"], ["\u03b1-synuclein", "MSA", "INFLUENCE"], ["PD rats", "16S rRNA sequence analysis", "USED BY"], ["gut microbiota", "Pink1</i><sup>-/-</sup> mice", "LOCATED IN"], ["iRBD", "Genus <i>Akkermansia</i>", "CHANGE ABUNDANCE"], ["Autoimmunity", "gastrointestinal (GI) disorders", "AFFECT"], ["gut microbiota", "brain", "LOCATED IN"], ["human depression", "proinflammatory cytokines", "INTERACT"], ["metals", "microbiota", "IMPACT"], ["Di-(2-ethylhexyl) phthalate", "Th1 inflammatory response", "INFLUENCE"], ["Zinc", "diabetes", "INFLUENCE"], ["Rannasangpei", "Parkinson's disease", "CHANGE EFFECT"], ["Nestin", "DEX and CUMS groups", "LOCATED IN"], ["infant inflammatory diseases", "offspring", "TARGET"], ["gut microbiota", "non-responder group", "LOCATED IN"], ["probiotic", "gut microbiota dysbiosis", "INFLUENCE"], ["gut microbiota", "remission group (patients with schizophrenia in remission)", "LOCATED IN"], ["cytokines", "schizophrenia", "INFLUENCE"], ["gut microbiota", "depression-like phenotypes", "IS LINKED TO"], ["Gut microbiota", "Alzheimer's disease", "IS LINKED TO"], ["BMAA", "human gut microbiota", "IMPACT"], ["intracerebral hemorrhage", "mice", "TARGET"], ["natural non-proteinogenic diamino acid", "cyanobacteria", "IMPACT"], ["postpartum mental health disturbances", "women", "TARGET"], ["gut microbiota metabolites", "neurological disorders", "INFLUENCE"], ["inulin supplementation", "mental health symptoms", "INFLUENCE"], ["ulcerative colitis", "IBD", "IS A"], ["Butyricimonas", "susceptible mice", "LOCATED IN"], ["Lactobacillus", "GM", "IMPACT"], ["CRP", "children", "LOCATED IN"], ["COVID-19", "Patients", "TARGET"], ["Withania somnifera", "neurodegenerative diseases", "INFLUENCE"], ["honey", "Salmonella", "IMPACT"], ["microbiota", "A53T monkeys", "LOCATED IN"], ["chronic stress", "people", "TARGET"], ["gut microbiota", "PIPO", "IS LINKED TO"], ["prebiotics", "gut microbiota", "IMPACT"], ["rotenone-induced toxicity", "sodium butyrate", "INTERACT"], ["propionate", "PD", "INFLUENCE"], ["Mental Health", "Adolescents", "TARGET"], ["Parkinson's disease", "multiple system atrophy", "AFFECT"], ["Depression", "population", "TARGET"], ["6-OHDA", "short- or long-term <i>H. suis</i> infection", "CHANGE EFFECT"], ["gut microbiota", "sepsis", "IS LINKED TO"], ["BMAA", "dinoflagellates", "IMPACT"], ["Parkinson's", "NAPEs", "INTERACT"], ["disturbance of gut microbiota", "rats", "TARGET"], ["gut microbiome", "UC", "IS LINKED TO"], ["Faecalibaculum rodentium", "anhedonia-like behavior", "INFLUENCE"], ["severe GI symptoms", "well-trained athletes", "TARGET"], ["succinate", "autism", "INFLUENCE"], ["reduced cortical BMD and total BMD", "OVX mice", "TARGET"], ["probiotic formulations", "neuropsychiatric-associated affections", "INFLUENCE"], ["antimicrobial responses", "RSDS mice", "TARGET"], ["CUMS", "gut microbiotas", "CHANGE ABUNDANCE"], ["low-FODMAP diet", "depression", "INFLUENCE"], ["cadaverine", "Gut Microbiota", "PRODUCED BY"], ["microbiota", "oral cavity", "LOCATED IN"], ["gut microbiota", "chronic disease", "IS LINKED TO"], ["g_Streptococcus", "gut microbiota", "PART OF"], ["PD", "gut", "STRIKE"], ["gut microbiota", "Alzheimer's", "IS LINKED TO"], ["MS", "individuals", "TARGET"], ["peripheral organs", "patients", "LOCATED IN"], ["Polycystic ovarian syndrome", "psychiatric disorders", "AFFECT"], ["Curcumin", "Parkinson's Disease", "INFLUENCE"], ["gut microbiota", "typically developing (TD) children", "LOCATED IN"], ["Gut microbiota", "mass spectrometry", "USED BY"], ["ATP", "cell danger response", "INFLUENCE"], ["Acetylated-, butylated-, and isobutylated-starch", "depression-like behaviors", "INFLUENCE"], ["abdominal pain", "alleviation of symptoms", "AFFECT"], ["Citrobacter spp.", "gut microbiota", "PART OF"], ["murine gut microbiota", "T cell depletion", "USED BY"], ["gut microbiota", "ASDs", "IS LINKED TO"], ["immune dysfunction", "Parkinson disease", "AFFECT"], ["DEHP", "type 2 diabetes", "INFLUENCE"], ["Plasma branched-chain and aromatic amino acids", "gut microbiota", "PRODUCED BY"], ["human gut microbiome", "cardiovascular diseases", "IS LINKED TO"], ["gut microbiota", "participants", "LOCATED IN"], ["SCRD", "\u03b2-amyloid", "INTERACT"], ["MS group", "forced swim test", "USED BY"], ["Firmicutes", "dominated breast milk gut microbiota", "PART OF"], ["migraine headache", "anxiety", "AFFECT"], ["beta-hydroxy butyrate", "butyrate", "INTERACT"], ["mitochondrial activities", "muscle", "STRIKE"], ["gut microbiome", "experimental and control groups", "LOCATED IN"], ["Parkinson's Disease", "PD patients", "TARGET"], ["oxaliplatin", "Lachnospiraceae", "IMPACT"], ["WIN55,212-2", "gut microbiota", "IMPACT"], ["cadmium", "Parkinson's disease", "INFLUENCE"], ["HD", "weight loss", "AFFECT"], ["mammalian gut microbiome", "mammals", "LOCATED IN"], ["gut microbiota", "microglial activation", "IS LINKED TO"], ["propionate", "intestinal epithelial barrier", "LOCATED IN"], ["TPG", "Enterobacteriales", "IMPACT"], ["gut microbiota", "addiction", "IS LINKED TO"], ["neurodegeneration", "Alzheimer's and Parkinson's diseases", "AFFECT"], ["antidepressant treatment", "gut microbiota", "IMPACT"], ["PD", "disease subpopulations", "TARGET"], ["tetracycline antibiotic agents", "bacterial resistance", "CHANGE EFFECT"], ["pathogenic proteins", "Gut microbiota", "PART OF"], ["GM", "NDs", "IS LINKED TO"], ["Parkinson's disease", "rotenone", "INTERACT"], ["organs", "humans", "LOCATED IN"], ["psychobiotics", "patients", "LOCATED IN"], ["Injury to neurons", "amyotrophic lateral sclerosis", "AFFECT"], ["fisetin", "PD", "CHANGE EFFECT"], ["splenic nerve", "mice", "LOCATED IN"], ["prebiotic", "Bacilli class", "IMPACT"], ["gut microbiota metabolites", "Parkinson's disease", "INFLUENCE"], ["PD medication", "PD", "CHANGE EFFECT"], ["Human Gut Microbiota", "human host", "LOCATED IN"], ["MAM", "controls", "LOCATED IN"], ["gut microbiota", "psychiatric disorders", "IS LINKED TO"], ["PD flies", "Transcriptomic analysis", "USED BY"], ["Parkinson's disease", "Christensenellaceae", "CHANGE ABUNDANCE"], ["gut microbiota", "breast cancer survivors", "LOCATED IN"], ["canine intestinal microbiota", "inflammatory bowel disease", "IS LINKED TO"], ["caecal microbiota", "non-T-cell-depleted group", "LOCATED IN"], ["Cancers", "human host", "TARGET"], ["CUR", "Lachnospiraceae", "IMPACT"], ["Crohn's disease", "Inflammatory bowel disease", "IS A"], ["cadmium", "late onset neuropathology", "INFLUENCE"], ["Haemophilus", "Gut Microbiota", "PART OF"], ["Wistar-Kyoto rats", "forced swimming test", "USED BY"], ["depression", "rodents", "TARGET"], ["gut microbiota", "sleep behavior recording", "USED BY"], ["gut microbiome", "neurological disorders", "IS LINKED TO"], ["(R)-ketamine", "susceptible mice", "ADMINISTERED"], ["exogenous H<sub>2</sub>", "gut microbiota", "IMPACT"], ["psychological stress-related symptoms", "SCI patients", "TARGET"], ["gut microbiota", "gut dysbiosis", "IS LINKED TO"], ["Disruption of the intestinal microbiota", "Alzheimer disease", "AFFECT"], ["systemic inflammation", "Chrna7 knock-out (KO) mice", "TARGET"], ["PD", "Gram-negative sulfate-reducing bacteria", "CHANGE ABUNDANCE"], ["controls", "quantitative fluorescence in situ hybridization", "USED BY"], ["PD", "Alistipes", "CHANGE ABUNDANCE"], ["Parkinson's disease", "Sprague-Dawley (SD) rats", "TARGET"], ["biomarker", "MS", "INFLUENCE"], ["controls", "single-cell RNA sequencing (RNA-seq) analysis", "USED BY"], ["Parkinson", "neurodegenerative disorder", "IS A"], ["EPS", "hypnotic effect", "INFLUENCE"], ["KD", "ALS", "INFLUENCE"], ["psychotic disorders", "Actinobacteria", "CHANGE ABUNDANCE"], ["Gut Microbiome", "BP", "IS LINKED TO"], ["Parkinson's disease", "loss of neurons", "AFFECT"], ["lactulose", "neuroprotective effects", "INFLUENCE"], ["5-HT receptor", "medial prefrontal cortex", "LOCATED IN"], ["polyphenols", "neurological diseases", "INFLUENCE"], ["microbes", "stress", "INFLUENCE"], ["oral microbiota", "microbial community", "COMPARED TO"], ["gut microbiota", "16S microbiome profiling", "USED BY"], ["Plasma short-chain fatty acids", "PD", "INFLUENCE"], ["gastric <i>H. suis</i>", "neuroprotective effect", "INFLUENCE"], ["Prebiotics", "facilitation of the processing of positive emotions", "INFLUENCE"], ["PD-specific microbiota", "PD patients", "LOCATED IN"], ["depressive symptoms", "sleep disturbance", "AFFECT"], ["HFD", "Enterobacteeriaceae", "IMPACT"], ["SIBO", "hypothyroidism", "AFFECT"], ["inactivated L. plantarum CCFM8661", "skin lipid metabolism-related genes", "CHANGE EXPRESSION"], ["neuroactive compounds", "colon", "LOCATED IN"], ["Gut microbes", "obesity", "IS LINKED TO"], ["Rifaximin", "Prevotellaceae UCG-001", "IMPACT"], ["gut dysregulation", "Parkinson's disease", "AFFECT"], ["gut microbes", "dysbiosis of gut microbiota", "INFLUENCE"], ["<i>Lactobacillus</i> genus", "gut microbiome", "PART OF"], ["MDD", "MDD patients", "TARGET"], ["depressive symptom severity scores", "gut microbiota", "CHANGE ABUNDANCE"], ["\u03b1-syn", "homeostatic protein components", "PART OF"], ["amino acids", "microbiota", "IMPACT"], ["serum metabolite profiles", "PD", "INFLUENCE"], ["NAS", "glucose intolerance", "INFLUENCE"], ["DBD", "CCRA", "INFLUENCE"], ["probiotic", "gut microbiota", "IMPACT"], ["PD-MCI", "Porphyromonadaceae family", "CHANGE ABUNDANCE"], ["butyrate producing gut microbiota", "PD", "LOCATED IN"], ["patients", "ELISA technology", "USED BY"], ["nutrition", "perinatal depression", "INFLUENCE"], ["astilbin", "APAP-induced ALI", "INFLUENCE"], ["Ketamine", "immobility time", "CHANGE EFFECT"], ["MeDiet", "AD", "INFLUENCE"], ["intervention group", "double-blind, randomized, placebo-controlled trial", "USED BY"], ["prebiotics", "stress", "INFLUENCE"], ["chronic SD", "rats", "TARGET"], ["Schisandra chinensis", "gut microbiota", "IMPACT"], ["Faecalibacterium", "fecal microbiome", "PART OF"], ["phytochemicals", "nervous system", "LOCATED IN"], ["trehalose", "learning retrieval", "INFLUENCE"], ["\u03b1-LA", "dysbiosis", "INFLUENCE"], ["microbial dysbiosis", "bipolar disorder", "AFFECT"], ["human microbiome", "mucosal interfaces", "LOCATED IN"], ["microbial dysbiosis", "behavioural and psychological symptoms of dementia", "AFFECT"], ["gut microbiome", "socially stressed mice", "LOCATED IN"], ["PD", "PD patients", "TARGET"], ["Probiotic supplements", "intestinal microbiota", "IMPACT"], ["GABA", "SNpc", "LOCATED IN"], ["UDCA", "DLB", "INFLUENCE"], ["UCG009", "gut microbiota", "PART OF"], ["probiotics", "neurological disorders", "INFLUENCE"], ["gut microbiota metabolites", "Alzheimer's disease", "INFLUENCE"], ["intestinal murine pathogen", "PD-like pathology", "INFLUENCE"], ["parkin", "duodenum", "LOCATED IN"], ["GBM", "Veillonellaceae", "CHANGE ABUNDANCE"], ["spleen nerve", "mice", "LOCATED IN"], ["chronic social defeat stress", "Ephx2 knock-out (KO) mice", "TARGET"], ["men and women over 40 years old", "osteopathic manipulative medicine (OMM) sequence", "USED BY"], ["synbiotic", "PD", "INFLUENCE"], ["gut microbiota interactions", "commonly employed formulations", "INTERACT"], ["Fucosylated Chondroitin Sulfate", "Gut Dysbiosis", "INFLUENCE"], ["abnormal composition", "gut microbiota", "CHANGE ABUNDANCE"], ["4EP", "kidney dysfunction", "INFLUENCE"], ["gut microbiota metabolites", "anxiety", "INFLUENCE"], ["imbalance in the gut microflora", "neurological disorders", "AFFECT"], ["gut microbiome", "Parkinson's disease", "IS LINKED TO"], ["perinatal distress", "infants' inflammatory diseases", "AFFECT"], ["plant protein", "mental disorders", "INFLUENCE"], ["Clostridium", "Parkinson's disease patients", "LOCATED IN"], ["tryptophan metabolites", "essential metabolites", "PART OF"], ["Coprococcus", "neurological disorders", "INFLUENCE"], ["Gut Microbiota", "tremor dominant", "IS LINKED TO"], ["EGCG", "TotM", "CHANGE EXPRESSION"], ["Environmental Pollutants", "Mental Health", "INFLUENCE"], ["metformin", "depressive syndromes", "CHANGE EFFECT"], ["T2DM-like phenotype", "TH mice", "TARGET"], ["acetate", "neurological disorders", "INFLUENCE"], ["focal epilepsy", "people", "TARGET"], ["probiotics", "patients", "ADMINISTERED"], ["antibiotic therapy", "microbiota", "IMPACT"], ["mPFC", "Chrna7 KO mice", "LOCATED IN"], ["Curcumin", "Neuroprotective Effect", "INFLUENCE"], ["<i>Periplaneta Americana</i> oligosaccharides", "Periplaneta Americana", "LOCATED IN"], ["Lactobacillus group bacteria", "FEP", "INFLUENCE"], ["fermented foods", "patients", "ADMINISTERED"], ["Gut microbiome changes", "age-related diseases", "AFFECT"], ["honey", "Escherichia coli", "IMPACT"], ["HPHP", "CD36", "INTERACT"], ["LDSD", "IBS patients", "TARGET"], ["intestinal microbiota", "Pink1</i><sup>-/-</sup> and wild-type control littermates", "LOCATED IN"], ["Cinnabar", "loss of DA neurons", "INFLUENCE"], ["low carbohydrate", "multiple sclerosis", "INFLUENCE"], ["ultra-processed foods", "dysregulation of the microbiota", "INFLUENCE"], ["Mitochondrial dysfunction", "PD", "AFFECT"], ["patients", "randomised, triple-blind, placebo-controlled trial", "USED BY"], ["Probiotic consumption", "human stress", "INFLUENCE"], ["Neurological disorders", "aging population", "TARGET"], ["microglial activation", "patients", "TARGET"], ["gut microbiota", "young children", "LOCATED IN"], ["Gut Microbiota", "Neurological Disorders", "IS LINKED TO"], ["gut microbial ecosystem", "skin inflammation", "IS LINKED TO"], ["Traumatic stress", "dysregulation of gut barrier functions", "AFFECT"], ["Gastrointestinal (GI) symptoms and pathology", "glial pathology", "AFFECT"], ["GM", "brain pathophysiology", "IS LINKED TO"], ["gut microbiota composition", "16\u00a0S rRNA sequencing", "USED BY"], ["gut microbiota", "non-tremor dominant", "IS LINKED TO"], ["Parkinson's disease", "Italian patients", "TARGET"], ["stress", "gut microbiota", "CHANGE ABUNDANCE"], ["coffee", "motor deficits", "INFLUENCE"], ["intestinal microbiome", "SZ patients", "LOCATED IN"], ["FEP", "patients", "TARGET"], ["Psychobiotics", "Huntington's disease", "INFLUENCE"], ["live L. plantarum CCFM8661", "testosterone", "INTERACT"], ["individuals", "16S ribosomal RNA gene V3-4 amplicon sequencing", "USED BY"], ["well-known pharmacological effects", "opioid-induced constipation", "AFFECT"], ["Lactococcus", "PD mice", "LOCATED IN"], ["epigenetic processes", "psychiatric disorders", "AFFECT"], ["dietary fiber pectins", "mental health", "INFLUENCE"], ["CUR", "PD", "INFLUENCE"], ["MeDiet", "Parkinson disease", "INFLUENCE"], ["levodopa-carbidopa intrajejunal gel", "Parkinson disease", "CHANGE EFFECT"], ["Lactobacillus helveticus NS8", "behavioral, cognitive, and biochemical aberrations", "INFLUENCE"], ["gut microbiota", "CUMS rats", "LOCATED IN"], ["(R)-ketamine", "gut microbiota", "IMPACT"], ["Enterobacteriaceae", "Parkinson's disease", "INFLUENCE"], ["severe depression-like behaviours", "CUMS and DEX groups", "TARGET"], ["F4", "CUS-induced depressive-like behaviors", "INFLUENCE"], ["(R)-ketamine", "low BMD", "CHANGE EFFECT"], ["gut microbiota", "\u03b1-Synuclein gene", "CHANGE EXPRESSION"], ["Parkinson disease", "Bifidobacterium", "CHANGE ABUNDANCE"], ["gut microbiome", "WT and KO mice", "LOCATED IN"], ["SGS", "systemic inflammation", "INFLUENCE"], ["depressive symptoms", "patients", "TARGET"], ["gut microbiota", "depression-like phenotype", "IS LINKED TO"], ["fisetin", "gut microbiota", "IMPACT"], ["postbiotics", "PD", "INFLUENCE"], ["gut microbiota", "cognition", "IS LINKED TO"], ["depression-like phenotypes", "non-obese diabetic (NOD) mice", "TARGET"], ["Gut Microbiota", "patients", "LOCATED IN"], ["short-chain fatty acid butyrate", "nonalcoholic fatty liver", "INFLUENCE"], ["gut microbiota", "\u03b1-synuclein pathology", "IS LINKED TO"], ["probiotics", "diseases of the central nervous system", "INFLUENCE"], ["Major depressive disorder", "Ruthenibacterium lactatiformans", "CHANGE ABUNDANCE"], ["bioactive peptides", "cardiovascular diseases", "INFLUENCE"], ["Gut Microbiota Dysbiosis", "Parkinson's Disease", "AFFECT"], ["FCR", "Firmicutes", "CHANGE ABUNDANCE"], ["Human fecal microbiota communities", "metagenomic sequencing", "USED BY"], ["early Parkinson's symptoms", "A53T transgenic monkeys", "TARGET"], ["Depression", "Bacteroidetes phylum", "CHANGE ABUNDANCE"], ["A. muciniphila", "depression", "INFLUENCE"], ["fermentable carbohydrates", "oral pathogens", "IMPACT"], ["adequate protein", "central nervous system (CNS) disorders", "INFLUENCE"], ["gut microbiome", "diabetes", "IS LINKED TO"], ["probiotics", "Parkinson's disease", "INFLUENCE"], ["Wolbachia", "Parkinson's", "INFLUENCE"], ["vitamins", "PD incidence and progression", "INFLUENCE"], ["diastolic pressure drop", "VVS patients", "TARGET"], ["Gut microbiota", "addiction", "IS LINKED TO"], ["Actinobacteria", "MDD patients", "LOCATED IN"], ["lactulose", "synaptic protein expression level", "CHANGE EXPRESSION"], ["newborns", "SCFA detection", "USED BY"], ["Mitochondrial dysfunction", "amyotrophic lateral sclerosis (ALS)", "AFFECT"], ["fermented foods", "Parkinson's disease", "INFLUENCE"], ["GM", "dopaminergic neuronal loss", "IS LINKED TO"], ["short chain fatty acids", "GM", "PRODUCED BY"], ["KD", "SMI", "INFLUENCE"], ["Gut Microbiota", "Neurological Diseases", "IS LINKED TO"], ["BMAA", "neuroinflammation", "INFLUENCE"], ["gut microbiome", "Alzheimer's disease", "IS LINKED TO"], ["microbiota-derived short-chain fatty acids", "gut", "LOCATED IN"], ["bone", "humans", "LOCATED IN"], ["uncultured_bacterium_g_Escherichia-Shigella", "fisetin intervented MPTP group gut microbiota", "PART OF"], ["progressive neurodegenerative disease", "PD mice", "TARGET"], ["macronutrients", "mammalian gut microbiota", "IMPACT"], ["faecal gut microbiota", "fatigue", "IS LINKED TO"], ["Actinobacteria phylum", "appetite changes", "INFLUENCE"], ["acetate", "Parkinson's disease", "INFLUENCE"], ["phenolic compounds", "chronic human diseases", "INFLUENCE"], ["infant eczema", "preterm babies", "TARGET"], ["anxiety", "Spanish cohort", "TARGET"], ["gut microbiota-derived metabolite", "PD", "INFLUENCE"], ["Natural products", "GM", "IMPACT"], ["Probiotics", "Gut microbiota", "IMPACT"], ["individuals", "exercise regimens", "USED BY"], ["LCIG", "GM", "IMPACT"], ["HFD-reduced", "Enterobacteeriaceae", "IMPACT"], ["Polyphenols", "gut microbiome", "PRODUCED BY"], ["betaine supplementation", "anhedonia", "INFLUENCE"], ["beneficial metabolites", "healthy enterotype", "PRODUCED BY"], ["metabolic comorbidities", "Patients", "TARGET"], ["mild stress (CUMS) group", "Enzyme-linked immunosorbent assay", "USED BY"], ["NRTN", "inflammatory airway diseases", "INFLUENCE"], ["mitochondrial dysfunction", "energy metabolism", "AFFECT"], ["impaired memory and learning", "glutamate", "INTERACT"], ["depression", "Psychiatric comorbidities", "IS A"], ["NS", "patients", "TARGET"], ["gut microbiota", "transgenic PD mice", "LOCATED IN"], ["\u03b1-synuclein pathology", "rats", "TARGET"], ["Piperine", "multiple myeloma", "INFLUENCE"], ["psychopathology", "women during pregnancy and postpartum", "TARGET"], ["probiotic microorganisms", "mental health-related disorders", "INFLUENCE"], ["Gut dysbiosis", "idiopathic rapid-eye-movement sleep behavior disorder", "AFFECT"], ["Actinobacteria", "HCs", "LOCATED IN"], ["Neurodegenerative diseases", "patients", "TARGET"], ["neurodegeneration", "synucleinopathies", "AFFECT"], ["findings", "healthy young women", "TARGET"], ["hyposmia", "PD patients", "TARGET"], ["Parkinson's microbiota", "Compositional and metabolic alterations", "IS LINKED TO"], ["LPS", "abnormal composition", "INFLUENCE"], ["PD-associated microbiome", "PD patients", "LOCATED IN"], ["PD", "olfactory impairment", "AFFECT"], ["minerals", "mood disorders", "INFLUENCE"], ["CBD", "low induction of side effects", "CHANGE EFFECT"], ["bile acids", "Alzheimer's disease", "INFLUENCE"], ["microbiota-derived metabolites", "human gut microbiota", "PRODUCED BY"], ["depressive/anxiety disorder", "controls", "TARGET"], ["cancer", "gut microbiota", "CHANGE ABUNDANCE"], ["intestinal inflammation", "intestinal flora", "CHANGE ABUNDANCE"], ["gut microbiota composition", "psychiatric comorbidity", "IS LINKED TO"], ["BCT", "neurodegenerative central nervous system disorders", "AFFECT"], ["gut microbiome", "neuroinflammation", "IS LINKED TO"], ["GM", "mental health and neurocognitive disorders", "IS LINKED TO"], ["CSDS", "succinic acid", "INTERACT"], ["early PD", "A53T transgenic monkeys", "TARGET"], ["behavioral despair", "F1", "TARGET"], ["pathobionts", "DEX-induced depression", "IS LINKED TO"], ["Zn", "diabetes", "INFLUENCE"], ["alpha-synuclein", "PD", "INFLUENCE"], ["gut microbiota alterations", "depressive symptoms", "AFFECT"], ["\u03b2-glucans", "cognitive deficit", "INFLUENCE"], ["laxatives", "Irritable bowel syndrome", "CHANGE EFFECT"], ["gut microbiota", "newborns", "LOCATED IN"], ["Faecalibacterium", "gut microbiota", "PART OF"], ["depressive/anxiety disorder", "females", "TARGET"], ["brain-derived neurotrophic factor", "LGG", "IMPACT"], ["psychiatric symptoms", "PCOS patients", "TARGET"], ["PS128", "neurodegenerative processes", "INFLUENCE"], ["metabolic products", "dysbiosis", "INFLUENCE"], ["metabolites", "intestine microbiota", "PRODUCED BY"], ["WD pellets", "gut microbiota", "IMPACT"], ["microbiota", "autism spectrum disorders", "IS LINKED TO"], ["neuroinflammation", "PD", "AFFECT"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "dopaminergic (DAergic) neuron injury and inflammation", "CHANGE EFFECT"], ["Western diet", "NDs", "INFLUENCE"], ["recurrent gastrointestinal symptoms", "PD patients", "TARGET"], ["Inflammatory Process", "Neurological Diseases", "AFFECT"], ["\u03b1-syn", "synucleinopathy", "INFLUENCE"], ["iron deficiency", "Colon cancer-related anemia", "AFFECT"], ["gut microbiota", "brain-related diseases", "IS LINKED TO"], ["neurotoxins", "Parkinson's disease", "INFLUENCE"], ["(R)-3-(4-Hydroxyphenyl)lactate", "hub-genes", "CHANGE EXPRESSION"], ["Gut Microbiome", "Human Neurological Disorders", "IS LINKED TO"], ["issue and functional damages", "Sprague-Dawley (SD) rats", "TARGET"], ["Piperine", "cardiovascular diseases", "INFLUENCE"], ["prodromal and treatment-na\u00efve de novo PD subjects", "measurements of fecal microbial concentrations", "USED BY"], ["DEHP", "abundance of potential pathogens and microbial genes", "INFLUENCE"], ["GOS", "gut bacteria", "IMPACT"], ["CKD", "participants", "TARGET"], ["acetate", "Alzheimer's disease", "INFLUENCE"], ["PD", "patients", "TARGET"], ["Clostridium sp. BR31", "GI symptoms", "INFLUENCE"], ["gut microbiota metabolites", "depression", "INFLUENCE"], ["P. gingivalis", "neuroinflammation", "INFLUENCE"], ["gastrointestinal symptoms", "Patients", "TARGET"], ["probiotic NVP-1704", "healthy adults", "ADMINISTERED"], ["higher animal protein", "psychological stress", "INFLUENCE"], ["Low-dose PHP", "adipogenesis", "CHANGE EXPRESSION"], ["levodopa", "Eggerthella lenta", "IMPACT"], ["Helicobacter pylori", "neurodegenerative diseases", "INFLUENCE"], ["alteration", "PD and healthy controls", "TARGET"], ["amino acids", "fecal microbiome", "PRODUCED BY"], ["Low-dose PHP", "Me1", "CHANGE EXPRESSION"], ["gut microbiome", "major depressive disorders", "IS LINKED TO"], ["broccoli", "depression", "INFLUENCE"], ["CT-26", "cancer-related bacteria", "IMPACT"], ["MGB", "social stress-induced injurious behaviors", "IS LINKED TO"], ["oral and gut microbiota", "patients", "LOCATED IN"], ["Psychobiotic", "Psychosomatic Diarrhea", "CHANGE EFFECT"], ["MedDiet", "Alzheimer's", "INFLUENCE"], ["altered gut microbiota", "R6/2 mice", "LOCATED IN"], ["Dextran sodium sulfate", "gut", "LOCATED IN"], ["bacteria", "breast cancer", "INFLUENCE"], ["trehalose analogs", "neuroprotective effect", "INFLUENCE"], ["neuroschistosomiasis", "chronic brain inflammation processes", "AFFECT"], ["Clostridium", "bacteria", "INTERACT"], ["CT-26", "imbalance-inducing bacteria", "IMPACT"], ["IL-1\u03b2", "striatum", "LOCATED IN"], ["PD", "gastrointestinal symptoms", "AFFECT"], ["Enterococcus faecalis", "tyrDC", "CHANGE EXPRESSION"], ["microbiota", "nonmotor symptoms", "IS LINKED TO"], ["Altered gut microbiota", "patients", "TARGET"], ["KD", "ASDs", "INFLUENCE"], ["gut microbial metabolites", "gut", "LOCATED IN"], ["LDSD", "IBS-D", "AFFECT"], ["patients", "<sup>13</sup>C-D-xylose breath tests", "USED BY"], ["Human Gut Microbiota", "Alzheimer's disease", "IS LINKED TO"], ["Bifidobacterium", "anxiety", "INFLUENCE"], ["healthy controls", "<sup>13</sup>C-D-xylose breath tests", "USED BY"], ["Alzheimer's disease", "neurodegenerative diseases", "IS A"], ["dysbiosis", "brain disorders", "AFFECT"], ["gut microbes", "anxiety", "IS LINKED TO"], ["Di-(2-ethylhexyl) phthalate", "colorectal cancer", "INFLUENCE"], ["trehalose", "neuroinflammation", "INFLUENCE"], ["Coprobacter", "neuropsychiatric disorders", "INFLUENCE"], ["systemic inflammation", "Colon cancer-related anemia", "AFFECT"], ["gut microbiome", "ASO mice", "LOCATED IN"], ["infection", "dysbiosis", "AFFECT"], ["protein fermentation", "schizophrenia", "INFLUENCE"], ["butyrate", "depression", "INFLUENCE"], ["omega-3 fatty acids", "nervous system", "LOCATED IN"], ["COVID-19", "PD patients", "TARGET"], ["neuromodulator", "gut microbiome", "IMPACT"], ["microbiota", "dysbiosis", "IS LINKED TO"], ["gut microbiome", "inflammation", "IS LINKED TO"], ["probiotic supplementation", "psychiatric disorders", "INFLUENCE"], ["colon", "adults", "LOCATED IN"], ["Ruminococcus torques", "DLB", "INFLUENCE"], ["Bifidobacterium", "anhedonia", "INFLUENCE"], ["human intestinal microbiota", "mental health problems", "IS LINKED TO"], ["human gut microbiota", "Hashimoto's thyroidis", "IS LINKED TO"], ["altered immunological conditions", "neuroimmune diseases", "AFFECT"], ["Holdemania", "anxiety", "INFLUENCE"], ["\u03b1-synuclein", "homeostatic protein components", "PART OF"], ["depression", "ratio of intestinal-derived molecules", "AFFECT"], ["organophosphate pesticides", "late onset neuropathology", "INFLUENCE"], ["valine", "gut microbiota", "PRODUCED BY"], ["ASD", "Children", "TARGET"], ["Inflammation", "Parkinson disease", "AFFECT"], ["Gut Dysbiosis", "Neuroinflammation", "AFFECT"], ["microbiota-derived short-chain fatty acids", "stroke", "INFLUENCE"], ["Parkinson's disease", "Clostridia UCG 014", "CHANGE ABUNDANCE"], ["Adiponectin", "Alzheimer's disease", "INFLUENCE"], ["gut microbial dysbiosis", "patients", "TARGET"], ["pro-inflammatory bacteria", "negative affectivity", "INFLUENCE"], ["MS and CUMS groups", "maternal separation (MS) and chronic unpredictable mild stress (CUMS) modeling approaches", "USED BY"], ["gut microbiota", "neurologic disorders", "IS LINKED TO"], ["Proteus", "ET", "INFLUENCE"], ["gaseous factors", "gut microbiota", "IMPACT"], ["cardiovascular diseases", "patients", "TARGET"], ["Modulator", "Psychological Stress", "CHANGE EFFECT"], ["fatty acids", "mental health outcomes", "INFLUENCE"], ["ayurvedic herbs", "brain health", "INFLUENCE"], ["metabolites", "Alzheimer's disease", "INFLUENCE"], ["microglial activation", "human case-control studies", "TARGET"], ["KD", "drug-resistant epilepsy", "INFLUENCE"], ["multiple sclerosis", "neurodegenerative central nervous system disorders", "IS A"], ["prebiotics", "inflammatory bowel disease", "INFLUENCE"], ["Chronic Sleep Deprivation", "Gut Microbiota", "CHANGE ABUNDANCE"], ["neurotoxins", "Alzheimer's disease", "INFLUENCE"], ["pectin", "microbiota", "IMPACT"], ["cadaverine", "gut microbiota", "PRODUCED BY"], ["microbiota", "neuropsychiatric disorders", "IS LINKED TO"], ["Megasphaera", "schizophrenia", "INFLUENCE"], ["gut microbiota", "Full-length bacterial 16S rRNA gene sequencing", "USED BY"], ["gut microbiota metabolites", "nervous system disorders", "INFLUENCE"], ["<i>Ping-wei-san plus</i> Herbal Decoction", "Parkinson's disease", "INFLUENCE"], ["prebiotics", "immune function", "INFLUENCE"], ["schizophrenia patients", "16S rRNA sequencing", "USED BY"], ["oxaliplatin", "Odoribacter", "IMPACT"], ["alterations to gut microbiota composition", "rats", "TARGET"], ["gut microbiota metabolites", "schizophrenia", "INFLUENCE"], ["microbiota", "inflammatory bowel disease", "IS LINKED TO"], ["ruptured IA", "patients", "TARGET"], ["ND", "GM-SCI", "AFFECT"], ["BPD", "Firmicutes", "CHANGE ABUNDANCE"], ["gamma-Aminobutyric acid", "gut microbiota", "IMPACT"], ["healthy Korean adults", "high-throughput 16S rRNA gene sequencing", "USED BY"], ["ultra-processed foods", "cognitive decline", "INFLUENCE"], ["dysbiosis of the gastrointestinal tract", "Parkinson's disease", "AFFECT"], ["disruptions in multiple cellular systems", "neurological disorders", "AFFECT"], ["neurodegenerative diseases", "host", "TARGET"], ["Eggerthella", "reward-seeking", "INFLUENCE"], ["Injury to neurons", "Parkinson's", "AFFECT"], ["infective pathogens", "influenza virus", "INFLUENCE"], ["human PD cases", "oral LPS", "USED BY"], ["microbiota-derived short-chain fatty acids", "stress", "INFLUENCE"], ["TCE", "neuroinflammation", "INFLUENCE"], ["microbes", "gut microbiota", "PART OF"], ["intestinal microbiota", "HD", "IS LINKED TO"], ["Hua-Feng-Dan", "DA neuron loss", "CHANGE EFFECT"], ["stress", "healthy women", "TARGET"], ["gut flora", "human gut", "LOCATED IN"], ["Chronic stress", "patients", "TARGET"], ["depression", "IBD patients", "TARGET"], ["Synapsin-1", "DEX and CUMS groups", "LOCATED IN"], ["epinephrine", "brain", "LOCATED IN"], ["gut microbiota", "PD mice", "LOCATED IN"], ["phthalates", "neurological and overall mental health", "INFLUENCE"], ["stress-related disorders", "Women", "TARGET"], ["GABA", "substantia nigra pars compacta", "LOCATED IN"], ["gut microbiome", "CNS disorders", "IS LINKED TO"], ["oral microbiome", "NPDs", "IS LINKED TO"], ["simple carbohydrates and refined carbohydrates", "alertness", "INFLUENCE"], ["PD", "Enterobacteriaceae", "CHANGE ABUNDANCE"], ["probiotics", "inflammation", "INFLUENCE"], ["high TMAO level", "group", "TARGET"], ["Lactobacillus", "GM", "PART OF"], ["1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "Parkinson's Disease", "INFLUENCE"], ["inflammation", "central nervous system diseases", "AFFECT"], ["Parkinson's Disease", "human case-control studies", "TARGET"], ["established illness", "people", "TARGET"], ["PD", "fatigue", "AFFECT"], ["Honey", "digestive ailments", "INFLUENCE"], ["key enzymes", "bacterial genes", "CHANGE EXPRESSION"], ["IL-6", "gut dysbiosis", "INFLUENCE"], ["microbiota", "multiple sclerosis", "IS LINKED TO"], ["Lactobacillaceae", "dopa", "INTERACT"], ["placebo", "healthy adults", "ADMINISTERED"], ["CSDS", "short-chain fatty acids", "INTERACT"], ["low carbohydrate", "stress", "INFLUENCE"], ["colonic mucosal barrier remodelling", "Parkinson's disease patients", "TARGET"], ["butyric acid", "colon", "LOCATED IN"], ["Lactobacillus rhamnosus", "depression", "INFLUENCE"], ["GM", "neurogenesis", "IS LINKED TO"], ["unhealthy nutrition", "obesity", "AFFECT"], ["Dysfunction of MAIT cells", "chronic diseases", "AFFECT"], ["polymannuronic acid", "PD", "INFLUENCE"], ["neurturin", "neurodegenerative diseases", "INFLUENCE"], ["microbial community", "Alzheimer's disease", "IS LINKED TO"], ["Parkinson's disease", "C57BL/6 mice", "TARGET"], ["schizophrenia", "enteropathic celiac disease", "AFFECT"], ["gut bacterial dysbiosis", "short-chain fatty acids", "INTERACT"], ["oral microbiota", "brain", "LOCATED IN"], ["microbiota", "gut microbiota dysbiosis", "IS LINKED TO"], ["gut-microbiome", "ADHD", "IS LINKED TO"], ["Parkinson's disease", "Bacteroides", "CHANGE ABUNDANCE"], ["metformin", "depression-like behaviors", "CHANGE EFFECT"], ["gut microbiota", "SCI", "IS LINKED TO"], ["Butyricimonas", "anxiety", "INFLUENCE"], ["mitochondria function", "energy metabolism", "AFFECT"], ["Gut microbiota", "epilepsy", "IS LINKED TO"], ["GM", "anxiety", "IS LINKED TO"], ["Bifidobacterium breve", "Psychosomatic Diarrhea", "INFLUENCE"], ["polyphenolic compounds", "gut microbiota", "IMPACT"], ["(S)-ketamine", "susceptible mice", "ADMINISTERED"], ["intestinal microbes", "breast cancer", "IS LINKED TO"], ["IS", "gut microbiota depletion", "INFLUENCE"], ["metabolites", "microbiota", "PRODUCED BY"], ["dysbiosis of the gastrointestinal tract", "gastrointestinal cancers", "AFFECT"], ["Adult specific pathogen free (SPF) Sprague-Dawley rats", "elevated-plus maze test", "USED BY"], ["active IBD", "patients", "TARGET"], ["psychosis", "adult", "TARGET"], ["short-chain fatty acids", "human gut microbiota", "PRODUCED BY"], ["Dietary constituents", "gene expression", "INFLUENCE"], ["unique patterns", "Anaerostipes", "CHANGE ABUNDANCE"], ["rotenone-induced toxicity", "NaB", "INTERACT"], ["Alloprevotella", "GP patients", "LOCATED IN"], ["gut microbiota", "LC-MS", "USED BY"], ["AAAs", "Hoehn and Yahr stage", "INFLUENCE"], ["CA", "neuroinflammation", "INFLUENCE"], ["Gut microbes", "PD", "IS LINKED TO"], ["sleep disorder", "patients", "TARGET"], ["Lactobacillus", "anxiety", "INFLUENCE"], ["gut microbiota", "taxon-function analysis", "USED BY"], ["low-FODMAP diet", "psychopathology", "INFLUENCE"], ["6-OHDA", "PD", "CHANGE EFFECT"], ["dysbiosis of the gastrointestinal tract", "diabetes", "AFFECT"], ["Eggerthellaceae", "GI symptoms", "INFLUENCE"], ["plasticizer", "damage to different tissues", "INFLUENCE"], ["EGCG", "TREM2", "CHANGE EXPRESSION"], ["non-tremor dominant", "Serratia", "CHANGE ABUNDANCE"], ["<i>Ping-wei-san plus</i> herbal decoction", "Parkinson's disease", "INFLUENCE"], ["Patients", "Subthalamic Deep Brain Stimulation", "USED BY"], ["anhedonic behaviors", "CUMS", "AFFECT"], ["honey", "inflammation", "INFLUENCE"], ["human gut microbiota", "FMT", "USED BY"], ["migraine", "inflammation", "AFFECT"], ["gut microbial dysbiosis", "euthyroid thyroid cancer patients", "TARGET"], ["Dark-coloured fruits", "chronic human diseases", "INFLUENCE"], ["early life stress", "adult psychopathology", "AFFECT"], ["glucocorticoids", "inflammation", "INFLUENCE"], ["gut microbiome", "gut microbiota dysbiosis", "IS LINKED TO"], ["Di-(2-ethylhexyl) phthalate", "body weight gain", "INFLUENCE"], ["psychotropics", "gut microbiota", "IMPACT"], ["Postpartum depression", "mothers", "TARGET"], ["gut microbiota", "healthy females aged 18-50", "LOCATED IN"], ["essential metabolites", "gut microbiome", "PRODUCED BY"], ["gut microbial taxa", "euthyroid thyroid cancer patients", "LOCATED IN"], ["mental health outcomes", "genetic and epigenetic aspects", "AFFECT"], ["HFD", "gut microbiome", "IMPACT"], ["ASD", "paired box protein Pax-3", "INTERACT"], ["CUS", "anhedonia", "AFFECT"], ["alkaloids", "MDD", "INFLUENCE"], ["gastrointestinal symptoms", "PD patients", "TARGET"], ["schizophrenia", "bacterial species", "CHANGE ABUNDANCE"], ["Prevotella", "Gut microbiota", "PART OF"], ["OPA", "P. Americana", "LOCATED IN"], ["gut microbiota", "WMT", "USED BY"], ["probiotics", "pregnancy related stress", "INFLUENCE"], ["SCFAs", "breast milk microbiota", "PRODUCED BY"], ["antenatal diet", "maternal mental health disorders", "INFLUENCE"], ["recombinant tissue inhibitors of metalloproteinase 3", "substantia nigra", "LOCATED IN"], ["Tenericutes", "CSDS-susceptible mice", "LOCATED IN"], ["Parkinson's disease", "synucleinopathy", "AFFECT"], ["dietary fiber", "mental health outcomes", "INFLUENCE"], ["depression-like phenotype", "mice", "TARGET"], ["gut microbiota", "anorexia nervosa", "IS LINKED TO"], ["plant polysaccharides", "mental disorders", "INFLUENCE"], ["liver depression and spleen deficiency", "7-dehydroxylating bacteria", "CHANGE ABUNDANCE"], ["dopaminergic neuron loss", "Male C57BL/6 mice", "TARGET"], ["deoxycholic acid", "PD appendix", "LOCATED IN"], ["Psychiatric comorbidities", "IBD", "AFFECT"], ["dysregulation of gut barrier functions", "RSDS mice", "TARGET"], ["Parkinson's Disease", "Verrucomicrobiaceae", "CHANGE ABUNDANCE"], ["CUR", "Muribaculaceae", "IMPACT"], ["GM", "16S rRNA gene sequencing", "USED BY"], ["antidepressant arketamine", "depression-like behaviors", "CHANGE EFFECT"], ["PD", "neuroinflammatory processes", "AFFECT"], ["succinate", "vascular dementia", "INFLUENCE"], ["General Physical and Mental Wellbeing", "Trained Recreative and Competitive Athletes", "TARGET"], ["progressive loss of neuron function", "NDDs", "AFFECT"], ["mood disorders", "people", "TARGET"], ["<i>L. plantarum</i> DP189", "SOD", "INTERACT"], ["gut microbes", "depression", "IS LINKED TO"], ["Gut mycobiota dysbiosis", "drug-na\u00efve", "TARGET"], ["BMAA", "gut", "LOCATED IN"], ["antibiotics", "butyrate-producing bacteria", "IMPACT"], ["colonic microbiome", "multiple system atrophy", "IS LINKED TO"], ["essential minerals", "neurological diseases", "INFLUENCE"], ["gut microbiota", "hub-genes", "CHANGE EXPRESSION"], ["ulcerative colitis", "Inflammatory bowel disease", "IS A"], ["gut microbiota", "Transgenic mice", "LOCATED IN"], ["Alzheimer's Disease", "Patients", "TARGET"], ["Alterations", "PD and healthy controls", "TARGET"], ["Streptococcaceae", "intestinal microbiota", "PART OF"], ["PHP", "Muribaculaceae", "IMPACT"], ["TD", "PD patients", "TARGET"], ["Piperine", "breast cancer", "INFLUENCE"], ["c-reactive protein", "children", "LOCATED IN"], ["appendix", "PD patients", "LOCATED IN"], ["intestinal microbiota", "AD", "IS LINKED TO"], ["Bifidobacterium", "Alzheimer's disease", "INFLUENCE"], ["cereals", "chronic human diseases", "INFLUENCE"], ["analgesia", "cancer patients", "TARGET"], ["Anaerotruncus", "faecal gut microbiota", "PART OF"], ["SIBO", "asthma", "AFFECT"], ["autism spectrum disorder", "humans", "TARGET"], ["MDD patients", "shotgun metagenomic sequencing", "USED BY"], ["IBDs", "complex chronic inflammatory disorders", "IS A"], ["probiotic bacteria", "systemic inflammation", "INFLUENCE"], ["Piperine", "rhinopharyngitis", "INFLUENCE"], ["gamma-aminobutyric acid", "human gut", "LOCATED IN"], ["HFD-original", "LPS plus ROT induced neurotoxicity", "CHANGE EFFECT"], ["anxiety", "ET", "AFFECT"], ["TD", "age-matched children", "TARGET"], ["High-cholesterol diet", "depression- and anxiety-like behaviors", "INFLUENCE"], ["Nutraceuticals", "CKD", "INFLUENCE"], ["anti-inflammatory bacteria", "negative affectivity", "INFLUENCE"], ["Gut microbiota", "major depressive disorder", "IS LINKED TO"], ["NF", "gut microbiota-induced systemic chronic inflammation", "AFFECT"], ["Streptococcus", "PD mice", "LOCATED IN"], ["gut microbiota", "brain health and function", "IS LINKED TO"], ["obesity", "humans", "TARGET"], ["herbs", "neurological diseases", "INFLUENCE"], ["chronic neuroinflammation", "PD patients", "TARGET"], ["synbiotics", "PD", "INFLUENCE"], ["DD", "patients", "TARGET"], ["gut microbes", "metabolic and chronic diseases", "INFLUENCE"], ["proinflammatory cytokines", "serum", "LOCATED IN"], ["BCAAs", "microbial taxa", "PRODUCED BY"], ["PD", "Deltaproteobacteria", "CHANGE ABUNDANCE"], ["Probiotics", "Pediatric Neurodevelopmental Disorders", "INFLUENCE"], ["gut microbiota", "motor dysfunction", "IS LINKED TO"], ["Lactobacillus reuteri", "KO\u00a0+\u00a0SDV group", "LOCATED IN"], ["gut microbiota", "ELISA", "USED BY"], ["Systemic Chronic Inflammation", "Neuroinflammation", "AFFECT"], ["gut microbiota", "mild cognitive impairment", "IS LINKED TO"], ["\u03b1-synuclein", "synucleinopathy", "INFLUENCE"], ["acetate", "nervous system disorders", "INFLUENCE"], ["gut microbiota", "insomnia", "IS LINKED TO"], ["Frisingicoccus", "anxiety", "INFLUENCE"], ["Prevotellaceae", "PD", "INFLUENCE"], ["colon", "age-/sex-matched healthy controls", "LOCATED IN"], ["inulin supplementation", "migraine headache", "INFLUENCE"], ["SCFAs", "GM", "PRODUCED BY"], ["Dialister", "gut microbiota", "PART OF"], ["CA", "colonic epithelial", "LOCATED IN"], ["AcrB", "inner and outer membrane efflux pump factor proteins", "PART OF"], ["anxiety", "colic complaints", "AFFECT"], ["gut microbiota", "fruit fly", "LOCATED IN"], ["Gram-negative bacteria", "Alzheimer's disease", "INFLUENCE"], ["SCAFs", "GM", "IMPACT"], ["MDD", "Patients", "TARGET"], ["Maternal Gut Microbiome", "mother", "LOCATED IN"], ["nutraceuticals", "major depression", "INFLUENCE"], ["VVS patients", "HUTT", "USED BY"], ["iron", "controls", "LOCATED IN"], ["trihexyphenidyl", "propionic acid", "INTERACT"], ["antibiotic therapy", "gut microbes", "IMPACT"], ["Mitochondrial dysfunction", "CFS", "AFFECT"], ["micronutrients", "child malnutrition", "INFLUENCE"], ["metabolites", "Human Gut Microbiota", "PRODUCED BY"], ["Negativicutes", "insomnia", "INFLUENCE"], ["Fermented Soy Products", "Neurodegenerative Diseases", "INFLUENCE"], ["Parkinson's disease", "Ruminococcaceae", "CHANGE ABUNDANCE"], ["gut microbiota", "Cancers", "IS LINKED TO"], ["splenomegaly", "CSDS-susceptible mice", "TARGET"], ["gut microbiota", "ED", "IS LINKED TO"], ["5-HT receptor", "mPFC", "LOCATED IN"], ["Injury to neurons", "frontotemporal dementia", "AFFECT"], ["T-cell-depleted group", "radiation", "USED BY"], ["pathogenesis of PD", "Parkinson's disease", "AFFECT"], ["gut flora", "systemic inflammation", "IS LINKED TO"], ["transepithelial electrical resistance", "RSDS mice", "TARGET"], ["Elderly patients", "Neuropsychological assessments", "USED BY"], ["pyrin domain containing proteins 6", "duodenum", "LOCATED IN"], ["Barnesiella", "PD-MCI group", "LOCATED IN"], ["gut microbes", "schizophrenia", "IS LINKED TO"], ["gut microbiota", "psychiatric and neurological conditions", "IS LINKED TO"], ["probiotics", "autism spectrum disorders", "INFLUENCE"], ["Intestinimonas", "faecal gut microbiota", "PART OF"], ["vegetables", "chronic metabolic diseases", "INFLUENCE"], ["breast milk microbiota", "infants\u2019 SCFAs", "COMPARED TO"], ["intestinal microbiome", "psychosis", "IS LINKED TO"], ["Levodopa", "Microbial Tyrosine Decarboxylase Gene", "CHANGE EXPRESSION"], ["poorly soluble antipsychotic", "significant food effect", "CHANGE EFFECT"], ["microbial-derived neuroactive metabolites", "gut microbiota", "PRODUCED BY"], ["gut microbiota", "Parkinson\u2019s disease", "IS LINKED TO"], ["probiotics", "MS", "INFLUENCE"], ["trehalose", "short-term memory", "INFLUENCE"], ["plasma C-reactive protein", "systemic inflammation", "INFLUENCE"], ["Dietary constituents", "mental health conditions", "INFLUENCE"], ["microglia activation", "human case-control studies", "TARGET"], ["(R)-ketamine", "multiple sclerosis", "CHANGE EFFECT"], ["gut microbiota metabolites", "amyotrophic lateral sclerosis", "INFLUENCE"], ["microbiota", "vagina", "LOCATED IN"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "GM disorders", "CHANGE EFFECT"], ["chronic pain", "gut microbiota", "CHANGE ABUNDANCE"], ["gut", "PD patients", "LOCATED IN"], ["depression-like phenotypes", "Chrna7 knock-out mice", "TARGET"], ["medicinal plants", "mental disorders", "CHANGE EFFECT"], ["Gut Microbiota", "Psychopathology", "IS LINKED TO"], ["microbiota\u207bgut\u207bbrain dysfunction", "mental disorders", "AFFECT"], ["laxatives", "IBS", "CHANGE EFFECT"], ["commensal bacteria", "neurological disorders", "INFLUENCE"], ["gut microbiota", "male rodents", "LOCATED IN"], ["Psychobiotics", "multiple sclerosis", "INFLUENCE"], ["loss of dopaminergic neurons", "human case-control studies", "TARGET"], ["IBS-D", "individuals", "TARGET"], ["viruses", "neurological diseases", "IS LINKED TO"], ["Antibiotics", "gut dysbiosis", "CHANGE EFFECT"], ["vitamins", "mammalian gut microbiota", "IMPACT"], ["Methanobacteriaceae", "gut microbiota", "PART OF"], ["Physical therapists", "therapeutic exercises", "USED BY"], ["GAP43", "FD mice", "LOCATED IN"], ["effects", "gut microbiota", "CHANGE ABUNDANCE"], ["honey", "infection", "INFLUENCE"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "apoptotic protein Bim", "INTERACT"], ["Bacteroides", "controls", "LOCATED IN"], ["gut microbiota dysbiosis", "Bacteroidetes", "CHANGE ABUNDANCE"], ["Human Gut Microbiota", "Parkinson's disease", "IS LINKED TO"], ["AAA metabolites", "Clostridium sp. AF50-3", "IMPACT"], ["gut microbiota", "BALB/c", "LOCATED IN"], ["motor deficits", "patients", "TARGET"], ["oral and gut microbiota", "Parkinson's disease", "IS LINKED TO"], ["gut microbiota", "obesity", "IS LINKED TO"], ["gut microbiota", "ovariectomized mice", "LOCATED IN"], ["depression", "Asian, Chinese people", "TARGET"], ["gut", "Danes", "LOCATED IN"], ["gut microbiome", "future psychiatric interventions", "IS LINKED TO"], ["nutraceuticals", "mental disorders", "INFLUENCE"], ["Prebiotics", "obesity", "INFLUENCE"], ["symbiotic gut microbiota", "gastrointestinal tract", "LOCATED IN"], ["6-hydroxydopamine", "6-OHDA-induced dopaminergic neuron loss", "INFLUENCE"], ["plant secondary metabolites", "mental health outcomes", "INFLUENCE"], ["oxidative stress", "ND", "AFFECT"], ["stress", "depression", "AFFECT"], ["dysbiosis of gut microbiota", "MPTP-induced mice", "TARGET"], ["dysregulation of CORT production", "acute stress", "AFFECT"], ["gut microbiota", "neurodegeneration", "IS LINKED TO"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "gut microbiota", "IMPACT"], ["gut microbiota", "gas chromatography", "USED BY"], ["highly processed", "metabolic dysfunction", "INFLUENCE"], ["gut microbiome", "healthy controls", "LOCATED IN"], ["Manganese", "neurodegenerative diseases", "INFLUENCE"], ["entacapone", "GI", "CHANGE EFFECT"], ["Arsenic", "bacteria", "IMPACT"], ["ketamine", "gut microbiota", "IMPACT"], ["anxiety", "A53T monkeys", "TARGET"], ["Cinnabar", "neurodegenerative diseases", "INFLUENCE"], ["migraines", "women", "TARGET"], ["plant foods", "chronic disease", "INFLUENCE"], ["antibiotics", "multiple sclerosis", "CHANGE EFFECT"], ["trace elements", "adolescents", "LOCATED IN"], ["CS", "Mice", "TARGET"], ["neurochemicals", "gut microbiota", "IMPACT"], ["gut and vaginal microbiome", "Shotgun metagenomic profiling", "USED BY"], ["probiotics", "neuroinflammatory disorders", "INFLUENCE"], ["dietary polyphenols", "gut microbial ecologies", "PRODUCED BY"], ["mood disorder", "individuals", "TARGET"], ["EGCG", "gut microbiota", "IMPACT"], ["gastrointestinal disorders", "patients", "TARGET"], ["gut microbiota", "nasointestinal FMT", "USED BY"], ["gut microbiota", "endogenous depression", "IS LINKED TO"], ["inflammation", "brain", "STRIKE"], ["microbiota of infant gut and nose", "16S rRNA sequencing", "USED BY"], ["PD", "gastrointestinal issues", "AFFECT"], ["beneficial lipids", "Gut microbiota", "PRODUCED BY"], ["Erysipelotrichaceae UCG-003", "MDD", "INFLUENCE"], ["Faecalibacterium", "controls", "LOCATED IN"], ["depressive-like and anxiety-like behaviours", "rats", "TARGET"], ["<i>H. pylori</i> infection", "neurological, dermatological, hematologic, ocular, cardiovascular, metabolic, hepatobiliary, or even allergic diseases", "AFFECT"], ["Hua-Feng-Dan", "neurodegenerative diseases", "CHANGE EFFECT"], ["Depression", "Firmicutes phylum", "CHANGE ABUNDANCE"], ["neuronal and behavioral dysfunction", "PD flies", "TARGET"], ["probiotics", "neuropsychiatric disorders", "INFLUENCE"], ["Gut Microbiome", "PD", "IS LINKED TO"], ["dysbiosis", "R6/2 mice", "TARGET"], ["nutraceuticals", "gut leakiness", "INFLUENCE"], ["healthy diet", "Chronic noncommunicable diseases", "INFLUENCE"], ["microbiota", "Hashimoto's thyroidis", "IS LINKED TO"], ["Neurodegeneration-associated dementia disorders", "elderly population", "TARGET"], ["GM", "schizophrenia", "IS LINKED TO"], ["Inflammatory microbes and genes", "Parkinson's disease", "IS LINKED TO"], ["LP299v", "improved mitochondrial function", "INFLUENCE"], ["gut microbiota", "systemic inflammation", "IS LINKED TO"], ["MeDi", "AD", "INFLUENCE"], ["phosphorylated \u03b1-synuclein", "PD", "INFLUENCE"], ["gut microbes", "brain", "LOCATED IN"], ["Escherichia", "Gut Microbiota", "PART OF"], ["<i>L. plantarum</i> DP189", "IL-6", "INTERACT"], ["DSS", "gut", "LOCATED IN"], ["Gut Microbiome", "OCD", "IS LINKED TO"], ["sleep disturbance", "Chinese and Korean American immigrants", "TARGET"], ["probiotics", "behavioural and neurobiological abnormalities", "INFLUENCE"], ["g_Streptococcus", "IBS", "INFLUENCE"], ["multi-ingredient fermented whey supplement", "gut microbiota", "IMPACT"], ["PD", "PD rats", "TARGET"], ["ASD", "MEs", "INTERACT"], ["early Parkinson's symptoms", "A53T monkeys", "TARGET"], ["PD", "multi-system disorder", "IS A"], ["functional microbiota", "appendix", "LOCATED IN"], ["Hua-Feng-Dan", "Clostridaceae species", "IMPACT"], ["depression-like phenotypes", "NOD mice", "TARGET"], ["mood disorders", "People", "TARGET"], ["gut microbiome", "Alzheimer's and Parkinson's diseases", "IS LINKED TO"], ["proline consumption", "depression", "INFLUENCE"], ["gut microbiota", "LF-TMS", "USED BY"], ["GI symptoms", "ASD children", "TARGET"], ["4EPS", "anxiety", "INFLUENCE"], ["PD", "Rikenellaceae", "CHANGE ABUNDANCE"], ["AGEs", "TBI", "INFLUENCE"], ["SCFA", "gut microbiota", "PRODUCED BY"], ["Diarrhea", "college students", "TARGET"], ["metabolome", "gut microbiota", "PRODUCED BY"], ["glycosaminoglycan", "depression", "INFLUENCE"], ["SIBO", "functional dyspepsia", "AFFECT"], ["gut microbiomes", "Parkinson's disease", "IS LINKED TO"], ["appendix", "controls", "LOCATED IN"], ["short-chain fatty acid", "gut microbiota", "PRODUCED BY"], ["SGS", "splenomegaly", "INFLUENCE"], ["Metabolites", "Gut Microbiota", "PRODUCED BY"], ["gut microbiome", "stress", "IS LINKED TO"], ["\u03b1-LA", "PCOS", "INFLUENCE"], ["melatonin", "GM", "PRODUCED BY"], ["Klebsiella", "ET", "INFLUENCE"], ["commensal gut microbiota", "Parkinson's disease", "IS LINKED TO"], ["gut microbiome", "mental health symptoms", "IS LINKED TO"], ["gut microbial metabolites", "gut microbiome", "PRODUCED BY"], ["Zn2+", "obesity", "INFLUENCE"], ["gastrointestinal peptides", "gut microbiota", "IMPACT"], ["ESCC", "Bacteroidetes", "CHANGE ABUNDANCE"], ["SS", "non-obese diabetic (NOD) mice", "TARGET"], ["inulin supplementation", "migraine", "INFLUENCE"], ["gut microbiota", "chronic stress", "IS LINKED TO"], ["men", "cholecystectomy", "USED BY"], ["GM", "NF", "IS LINKED TO"], ["GBM", "Proteobacteria", "CHANGE ABUNDANCE"], ["gut microbiota", "AI-related musculoskeletal pathology", "IS LINKED TO"], ["Polyphenols", "intestinal microbiota disorders", "INFLUENCE"], ["Parkinson's disease", "mice", "TARGET"], ["TD", "TD group", "TARGET"], ["increased intestinal permeability-leaky gut syndrome", "Parkinson's disease patients", "TARGET"], ["psychobiotics", "low mood", "INFLUENCE"], ["local and systemic inflammation", "Parkinson's disease", "AFFECT"], ["Ido", "Venous blood", "LOCATED IN"], ["GBM", "Escherichia-Shigella", "CHANGE ABUNDANCE"], ["Parkinson's disease", "gastrointestinal tract", "STRIKE"], ["succinate", "multiple sclerosis", "INFLUENCE"], ["Gut Microbiota Composition", "Anxiety Levels", "IS LINKED TO"], ["gut microbiota", "intestinal decontamination", "USED BY"], ["probiotics", "amyotrophic lateral sclerosis", "INFLUENCE"], ["Akkermansia", "PD-associated microbiota", "PART OF"], ["Verrucomicrobia", "estriol", "INTERACT"], ["CRP", "Children", "LOCATED IN"], ["prebiotic", "human gut microbiota", "IMPACT"], ["people with PD", "Illumina sequencing", "USED BY"], ["Neurodegenerative diseases", "progressive functional loss of neurons", "AFFECT"], ["SIBO", "lactase deficiency", "AFFECT"], ["APs", "metabolic alterations", "CHANGE EFFECT"], ["simple carbohydrates and refined carbohydrates", "tiredness", "INFLUENCE"], ["Depression", "diverse symptoms", "AFFECT"], ["early PD", "A53T monkeys", "TARGET"], ["prefrontal cortex", "CIA mice", "LOCATED IN"], ["GMB composition changes", "SCZ", "IS LINKED TO"], ["HFD", "LPS plus rotenone-induced neurotoxicity", "CHANGE EFFECT"], ["MDD", "gut microbiota", "CHANGE ABUNDANCE"], ["F4", "depressive symptoms", "INFLUENCE"], ["FCR", "Lachnospiraceae.g", "CHANGE ABUNDANCE"], ["microbiota-derived metabolites", "depression", "INFLUENCE"], ["Ruminococcus torques", "microbial genera", "PART OF"], ["entacapone", "fatigue", "CHANGE EFFECT"], ["Faecalibacterium", "negative affectivity", "INFLUENCE"], ["low-grade chronic inflammation", "host", "TARGET"], ["differentially expressed proteins", "duodenum", "LOCATED IN"], ["gut", "patients", "LOCATED IN"], ["Anaerotruncus", "gut microbiome", "PART OF"], ["AD", "brain", "STRIKE"], ["Coprococcus 1", "GI symptoms", "INFLUENCE"], ["gut microbiota", "Dysbiosis", "IS LINKED TO"], ["gut microbiota", "memory, learning, anxiety, stress, neurodevelopmental and neurodegenerative disorders", "IS LINKED TO"], ["dietary components", "gut mucosal immunity dysregulation", "INFLUENCE"], ["\"abnormal\" microbiota", "autism spectrum disorder", "IS LINKED TO"], ["Primary Sj\u00f6gren's syndrome", "psychological disorders", "IS A"], ["GM", "brain", "LOCATED IN"], ["Plant polysaccharides", "mental disorders", "INFLUENCE"], ["ASD", "persistent deficits in social communication and interaction", "AFFECT"], ["patients", "levodopa challenge test", "USED BY"], ["lactulose", "neuroinflammation", "INFLUENCE"], ["PHP", "triglycerides", "INTERACT"], ["Mental health disorders", "functional gastrointestinal disorders", "AFFECT"], ["gut microorganisms", "PD", "INFLUENCE"], ["Gut microbiota", "alterations", "IS LINKED TO"], ["polyphenols", "stress-induced mental health problems", "INFLUENCE"], ["Krebs cycle intermediates", "cell danger response", "INFLUENCE"], ["particulate matter", "schizophrenia", "INFLUENCE"], ["TPG", "Mycoplasmatales", "IMPACT"], ["GBM", "Bacteroides vulgatus", "CHANGE ABUNDANCE"], ["NOX2", "Neurodegenerative Disease", "INFLUENCE"], ["MS", "young <u>a</u>dults", "TARGET"], ["prebiotic", "Gut microbiota", "IMPACT"], ["psychological stress", "FHW", "TARGET"], ["depressive symptoms", "participants", "TARGET"], ["FCR", "Bacteroides", "CHANGE ABUNDANCE"], ["probiotic supplementations", "anxiety symptoms", "INFLUENCE"], ["Dysbiosis", "inflammation", "AFFECT"], ["gut", "obese westerners", "LOCATED IN"], ["issue and functional damages", "SD rats", "TARGET"], ["gut microbiota", "PPD", "IS LINKED TO"], ["transient gut dysbiosis", "Alzheimer's disease", "AFFECT"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "gut microbiomes", "IMPACT"], ["Bacteroidetes", "PD mice", "LOCATED IN"], ["small intestinal malabsorption", "patients", "TARGET"], ["depression", "neuropsychiatric diseases", "IS A"], ["\u03b1-syn pathology", "brain regions", "STRIKE"], ["ROT", "Lactobacteriaceae", "IMPACT"], ["Human Gut Microbiota", "type 2 diabetes mellitus", "IS LINKED TO"], ["succinate", "stress", "INFLUENCE"], ["Anthocyanins", "chronic diseases", "INFLUENCE"], ["human microbiota", "oral cavity", "LOCATED IN"], ["Gut Microbiota", "Neurodegenerative Disorders", "IS LINKED TO"], ["bioactive milk fractions", "stress", "INFLUENCE"], ["L. helveticus", "improve endogenous depression", "INFLUENCE"], ["major depression", "reduced life expectancy", "AFFECT"], ["mental health", "mammalian gut microbiota", "CHANGE ABUNDANCE"], ["reproductive toxicity", "rodents", "TARGET"], ["clinical manifestations", "SCH patients", "TARGET"], ["locomotor function", "brain regions", "STRIKE"], ["DHA", "Long-chain <i>n</i>-3 fatty acids", "PART OF"], ["microbial metabolites", "PD", "INFLUENCE"], ["probiotic Clostridium butyricum", "PD", "INFLUENCE"], ["misfolded protein \u03b1-syn", "PD", "INFLUENCE"], ["chronic multifactorial disease", "host", "TARGET"], ["As<sub>4</sub>S<sub>4</sub>", "neurological disorders", "INFLUENCE"], ["short-chain fatty acids", "gut microbiota", "PRODUCED BY"], ["SIBO", "gastroparesis", "AFFECT"], ["opportunistic pathogens", "dysbiosis of gut microbiome", "INFLUENCE"], ["Di-(2-ethylhexyl) phthalate", "Proteobacteria abundance in the fecal samples", "INFLUENCE"], ["ketogenic diet", "Alzheimer's disease", "INFLUENCE"], ["NLRP3 inflammasome", "type 2 diabetes", "INFLUENCE"], ["Gut Dysbiosis", "Systemic Inflammatory Response", "AFFECT"], ["Betaine supplementation", "gut microbiome", "IMPACT"], ["NOX2", "Alzheimer's disease", "INFLUENCE"], ["gut microbiota", "newborn child", "LOCATED IN"], ["non-TD", "Escherichia", "CHANGE ABUNDANCE"], ["Plasma branched-chain and aromatic amino acids", "Parkinson's disease", "INFLUENCE"], ["chronic restraint stress", "behavioral, cognitive, and biochemical aberrations", "AFFECT"], ["Parkinson's disease", "PD-model mice", "TARGET"], ["3-dehydrocarnitine", "OSA", "INFLUENCE"], ["LPS", "ND", "INFLUENCE"], ["gut microbiota", "PD-like phenotype", "CHANGE EXPRESSION"], ["biomarkers", "schizophrenia", "INFLUENCE"], ["amino acids", "gut microbiota", "PRODUCED BY"], ["dysfunction of the serotonin pathway, possibly related to or triggered by an altered microbiota", "PIPO patients", "TARGET"], ["phytochemicals", "C3aR1", "CHANGE EXPRESSION"], ["Gut microbiota", "neurological and psychiatric disorders", "IS LINKED TO"], ["early Parkinson's symptoms", "rhesus monkeys", "TARGET"], ["Turicibacterales", "TLCA", "INTERACT"], ["medicinal plants", "gut microbiota", "IMPACT"], ["butyrate", "neuromyelitis optica spectrum disorders", "INFLUENCE"], ["amyloidogenic protein", "Parkinson's disease", "INFLUENCE"], ["gut microbiota", "Parkinson's disease (PD) symptomatology and pathophysiology", "IS LINKED TO"], ["long-term neurological symptoms", "patients", "TARGET"], ["autism spectrum disorder", "neurodevelopmental disorders", "IS A"], ["Fusobacterium", "ET", "INFLUENCE"], ["unhealthy nutrition", "Neurodegenerative diseases", "AFFECT"], ["organochlorines", "Alzheimer's disease", "INFLUENCE"], ["neurological disruption", "immune, endocrine, and multisystem dysfunction", "AFFECT"], ["Dcf1<sup>-/-</sup>", "gut microbiota", "CHANGE ABUNDANCE"], ["GM", "addiction", "IS LINKED TO"], ["gut microbiota", "humans", "LOCATED IN"], ["Enterobacteeriaceae", "gut microbiome", "PART OF"], ["anti-PD medication", "gastrointestinal symptoms", "CHANGE EFFECT"], ["gut microbiota dysbiosis", "Hashimoto's thyroidis", "AFFECT"], ["microbiota", "skin", "LOCATED IN"], ["PD patients", "16S and 18S ribosomal RNA amplicon sequencing", "USED BY"], ["gut microbiota", "Neurodegenerative diseases", "IS LINKED TO"], ["metabolic substances", "A. muciniphila", "IMPACT"], ["Obesity", "type 2 diabetes", "AFFECT"], ["Antibiotics", "late onset neuropathologies", "CHANGE EFFECT"], ["gut microbiota", "mental health conditions", "IS LINKED TO"], ["gut microbiota", "NS", "IS LINKED TO"], ["lurasidone", "poor oral bioavailability", "CHANGE EFFECT"], ["bacteria", "short chain fatty acids", "INTERACT"], ["ADHD", "adults", "TARGET"], ["genera Turicibacter", "reduced cortical BMD and total BMD", "INFLUENCE"], ["gastric disturbances", "Parkinson's disease (PD) patients", "TARGET"], ["Prebiotics", "neuroendocrine response to stress", "INFLUENCE"], ["healthy controls", "PICRUSt analysis", "USED BY"], ["liver toxicity", "rodents", "TARGET"], ["MDD", "GMB", "CHANGE ABUNDANCE"], ["phytochemicals", "C3", "CHANGE EXPRESSION"], ["high-fiber diet", "T2DM", "INFLUENCE"], ["70W", "LPS plus MPTP-induced neurotoxicity", "CHANGE EFFECT"], ["epilepsy", "patients", "TARGET"], ["microbiota", "neurodegenerative diseases", "IS LINKED TO"], ["Affective disorders", "patients", "TARGET"], ["SR79", "PD", "INFLUENCE"], ["maternal obesity", "offspring", "TARGET"], ["typically developing (TD) children", "untargeted metabolomics", "USED BY"], ["plasma metabolites", "gut microbiota", "PRODUCED BY"], ["Lactulose", "mice", "LOCATED IN"], ["social cognitive impairment", "schizophrenia", "AFFECT"], ["severe parkinsonism", "female cases", "TARGET"], ["<i>L. plantarum</i> DP189", "nuclear factor erythroid 2-related factor", "CHANGE EXPRESSION"], ["BAs", "neurological and neuropsychiatric disorders", "INFLUENCE"], ["High-fiber diet", "gut microbiota", "IMPACT"], ["gut flora", "disorders", "IS LINKED TO"], ["depression", "mice", "TARGET"], ["Gut dysbiosis", "gut microbiota", "CHANGE ABUNDANCE"], ["(R)-ketamine", "dementias", "CHANGE EFFECT"], ["gut microbiota", "Metabologenomic approach", "USED BY"], ["gut microbiome", "trauma- and stressor-related disorders", "IS LINKED TO"], ["intestinal microbiota", "Neurodegenerative Disorders", "IS LINKED TO"], ["Prevotellaceae_UCG-001", "inflammatory lesions", "INFLUENCE"], ["PCOS", "women", "TARGET"], ["gut microbiota", "presenior population", "LOCATED IN"], ["Low-Caloric Diet", "Type 2 Diabetes Mellitus", "INFLUENCE"], ["psychopathological symptoms", "(expectant) mothers", "TARGET"], ["psychiatric drugs", "gut microbiota", "IMPACT"], ["HFD-reduced", "LPS plus rotenone-induced neurotoxicity", "CHANGE EFFECT"], ["Coprococcus", "neuropsychological and neurodegenerative disorders", "INFLUENCE"], ["dysbiosis", "human neurodegenerative and brain-related diseases", "AFFECT"], ["abnormal expressions", "SND-operated mice", "TARGET"], ["gut microbiota", "cholesterol-related metabolic disorders", "IS LINKED TO"], ["Rikenellaceae_RC9_gut_group", "Gut microbiota", "PART OF"], ["traumatic brain injury", "neurological disorders", "IS A"], ["Lactobacillaceae", "intestinal microbiota", "PART OF"], ["<i>L. plantarum</i> DP189", "interleukin-10", "INTERACT"], ["gastrointestinal microbiota", "CNS diseases", "IS LINKED TO"], ["arketamine", "PSD-95", "INTERACT"], ["synaptic proteins", "PFC", "LOCATED IN"], ["gut microbiota", "16\u00a0S rDNA analysis", "USED BY"], ["AGE breaker compounds", "neurodegenerative diseases", "CHANGE EFFECT"], ["Antidepressants", "gut microbiota", "IMPACT"], ["alpha-synuclein", "familial PD", "INFLUENCE"], ["intestinal microbiota", "childhood anxiety", "IS LINKED TO"], ["women", "placebo supplement", "USED BY"], ["lipopolysaccharides", "intestine", "LOCATED IN"], ["mental disorders", "Firmicutes", "CHANGE ABUNDANCE"], ["ocular conditions", "pSS", "AFFECT"], ["inflamed womb", "dysbiosis", "AFFECT"], ["Dietary fiber pectins", "intestinal inflammatory diseases", "INFLUENCE"], ["antibiotics", "Gut microbiota depletion", "CHANGE EFFECT"], ["gut microbiota composition", "immune system", "LOCATED IN"], ["Psychiatric Comorbidities", "Inflammatory Bowel Disease", "AFFECT"], ["gut microbiota", "imbalance", "IS LINKED TO"], ["neurodegeneration", "PD", "AFFECT"], ["gut-microbiota", "PD", "IS LINKED TO"], ["anxiety- and depression-like behaviors", "mother", "TARGET"], ["gut microbiome", "whole genome shotgun sequencing", "USED BY"], ["microbiota", "central nervous system (CNS) disorders", "IS LINKED TO"], ["Fe", "butyrate-producing bacteria", "IMPACT"], ["idiopathic rapid eye movement sleep behavior disorder patients", "16S and 18S ribosomal RNA amplicon sequencing", "USED BY"], ["depressive episodes", "patients", "TARGET"], ["autoimmune central nervous system disease", "individuals", "TARGET"], ["gut microbiota", "Graves' disease", "IS LINKED TO"], ["PD-specific gut microbiome", "shotgun metagenomic sequencing", "USED BY"], ["selenium", "Alzheimer's disease", "INFLUENCE"], ["cinnabar", "loss of DA neurons", "INFLUENCE"], ["psychiatric disorders", "gut microbiota", "CHANGE ABUNDANCE"], ["AGEs", "diabetes", "INFLUENCE"], ["P2Y12 receptor", "DEX and CUMS groups", "LOCATED IN"], ["ketogenic diet", "MS", "INFLUENCE"], ["commensal gut microbiota", "bronchopulmonary dysplasia", "IS LINKED TO"], ["ketamine enantiomers", "Deltaproteobacteria", "IMPACT"], ["gut microbiota metabolites", "autism", "INFLUENCE"], ["butyrate-producing taxa", "pathogenic metabolites", "INTERACT"], ["prebiotic", "Lactobacillus genus", "IMPACT"], ["piperine", "nuclear factor-\u03baB", "INTERACT"], ["NCDs", "age-groups", "TARGET"], ["dementia", "old population", "TARGET"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "Methanobacteriaceae", "IMPACT"], ["aromatic amino acids", "gut microbiota", "IMPACT"], ["gut microbiota diversity", "impulsivity", "IS LINKED TO"], ["DEHP", "Th1 inflammatory response", "INFLUENCE"], ["schizophrenia", "people", "TARGET"], ["zoonotic <i>Helicobacter</i> species", "non-human primates", "LOCATED IN"], ["Coriobacteriaceae", "microbiota", "PART OF"], ["GM dysbiosis", "GM", "CHANGE ABUNDANCE"], ["microbial-derived neurochemicals", "neurodegeneration", "INFLUENCE"], ["short-chain fatty acids", "depression", "INFLUENCE"], ["children aged 3-4", "16S rRNA gene sequencing", "USED BY"], ["Parkinson's disease", "progressive impairment of motor and non-motor functions", "AFFECT"], ["dysbiosis of mouse gut microbiota", "Bacteroides", "CHANGE ABUNDANCE"], ["GBM", "Prevotellaceae", "CHANGE ABUNDANCE"], ["group III mGlu", "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "INTERACT"], ["curcumin", "N-acetylneuraminate degradation", "INFLUENCE"], ["gut microbiome", "central nervous system (CNS) disorders", "IS LINKED TO"], ["Pathogenic microbes infection", "AD", "AFFECT"], ["gut microbiota", "gastrointestinal tract", "LOCATED IN"], ["sodium oligomannate", "phenylalanine", "INTERACT"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "locomotor deficits", "CHANGE EFFECT"], ["antibiotics", "Akkermansia", "IMPACT"], ["WIN55,212-2", "Iba1", "CHANGE EXPRESSION"], ["excessive immunosuppression with damaged neuronal synapses", "DEX-induced depression", "AFFECT"], ["occludin", "systemic inflammation", "INFLUENCE"], ["herpesvirus", "gut dysbiosis", "INFLUENCE"], ["group 2", "double-blind, randomized, placebo-controlled trial", "USED BY"], ["post-traumatic stress disorder", "mental health and neurocognitive disorders", "IS A"], ["bacterial taxa", "groups", "LOCATED IN"], ["major depression", "patients", "TARGET"], ["Cucurbitacin E", "inflammatory cytokines", "INTERACT"], ["gut microbiome", "MDD", "IS LINKED TO"], ["HP", "16S rRNA sequencing", "USED BY"], ["multidrug resistant bacteria", "human glucose-dependent insulinotropic polypeptide", "INTERACT"], ["skin inflammation", "acne mice", "TARGET"], ["antibiotic treatments", "gut dysbiosis", "CHANGE EFFECT"], ["Probiotic Clostridium butyricum", "Parkinson's disease", "INFLUENCE"], ["diabetes", "Sprague-Dawley (SD) rats", "TARGET"], ["gut microbiota", "3-week-old offspring", "LOCATED IN"], ["probiotics", "psychiatric conditions", "INFLUENCE"], ["beta-casomorphin-7", "type 1 diabetes", "INFLUENCE"], ["dietary fiber pectins", "intestinal barrier integrity", "INFLUENCE"], ["LPS", "chronic neuroinflammation", "INFLUENCE"], ["proinflammatory cytokines", "striatum", "LOCATED IN"], ["adult rats", "whole genome shotgun sequencing", "USED BY"], ["Gut Microbiome", "Huntington's disease", "IS LINKED TO"], ["Dietary fiber", "inflammation", "INFLUENCE"], ["PD-associated microbiota", "intestinal inflammation", "IS LINKED TO"], ["PD", "Participants", "TARGET"], ["Mitochondrial dysfunction", "inflammatory disorders", "AFFECT"], ["Gut microbes", "multiple sclerosis", "IS LINKED TO"], ["dopamine", "central nervous system", "LOCATED IN"], ["oral and gut microbiome", "PD-specific gut microbiome", "COMPARED TO"], ["gut microbes", "neurological illnesses", "IS LINKED TO"], ["abnormalities in the gut function", "Parkinson", "AFFECT"], ["liver injury", "rats", "TARGET"], ["Obese-type gut microbiota", "neurobehavioral changes", "IS LINKED TO"], ["Clostridium", "Children", "LOCATED IN"], ["oral formulations", "contrasting effects", "CHANGE EFFECT"], ["gut microbiota", "mental and brain health", "IS LINKED TO"], ["Behavioral dysfunction", "Rats", "TARGET"], ["akinetic-rigid features", "PD patients", "TARGET"], ["probiotic supplementation", "Bifidobacterium adolescentis", "IMPACT"], ["Faecalibacterium prausnitzii", "malnutrition", "INFLUENCE"], ["disturbances", "maternal microbiota", "CHANGE ABUNDANCE"], ["fiber", "colon cancer", "INFLUENCE"], ["Psychiatric comorbidities", "Inflammatory bowel disease", "AFFECT"], ["taste receptors", "alteration in gut microbiota composition", "INFLUENCE"], ["neurological disorders", "rat", "TARGET"], ["Probiotics", "Neuroinflammatory Disorders", "INFLUENCE"], ["lower baseline plasma TMAO levels", "PD-dementia conversion", "AFFECT"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "PD-related injury", "CHANGE EFFECT"], ["bile acids", "depressive behavior", "INFLUENCE"], ["ketogenic diet", "CNS disorders", "INFLUENCE"], ["depression-like behaviors", "collagen-induced arthritis (CIA) mice", "TARGET"], ["late onset neuropathologies", "autoimmune diseases", "AFFECT"], ["plasma metabolites", "three groups [wild-type (WT)\u00a0+\u00a0sham group, KO\u00a0+\u00a0sham group, KO\u00a0+\u00a0SDV group]", "LOCATED IN"], ["Coprococcus", "MMP9", "CHANGE EXPRESSION"], ["gut microbiota", "alteration", "IS LINKED TO"], ["Theraeutic intervention", "Bifidobacteirum", "IMPACT"], ["alterations of the enteric nervous system", "PD", "AFFECT"], ["osteoporosis", "patients", "TARGET"], ["PD", "intestinal permeability", "AFFECT"], ["collagen fibres", "mucosal remodelling", "INFLUENCE"], ["prion-like \u03b1-synuclein fibrils", "abnormal aggregation", "INFLUENCE"], ["probiotics", "central nervous system (CNS) disorders", "INFLUENCE"], ["<i>L. plantarum</i> DP189", "PGC-1\u03b1", "CHANGE EXPRESSION"], ["GOS", "stress-evoked decreases in mRNA", "INFLUENCE"], ["Dysregulation of gut microbiota-host bile acid (BA) co-metabolism", "IBS-D", "AFFECT"], ["oral and gut microbiome", "PD", "IS LINKED TO"], ["multi-ingredient fermented whey supplement", "GI complaints group", "ADMINISTERED"], ["commensal gut microbiota", "non-alcoholic fatty liver disease", "IS LINKED TO"], ["Parkinson's disease", "Patients", "TARGET"], ["neurodevelopmental disorders", "patients", "TARGET"], ["anxiety", "adults", "TARGET"], ["gut inflammation", "CS patients", "TARGET"], ["bipolar disorder", "patients", "TARGET"], ["dysbiosis of intestinal microbiota", "anxiety", "AFFECT"], ["KD", "refractory status epilepticus", "INFLUENCE"], ["motor symptoms", "patients", "TARGET"], ["newborns", "16S rRNA second-generation sequencing", "USED BY"], ["PD", "increased genus Akkermansia", "CHANGE ABUNDANCE"], ["chronic unpredictable mild stress-induced depression", "mice", "TARGET"], ["Zhe Busong decoction", "stress-induced mental health problems", "INFLUENCE"], ["\u03b2-HgS-containing 70 Wei-Zhen-Zhu-Wan", "Verrucomicrobiaceae", "IMPACT"], ["menthol", "irritable bowel syndrome", "INFLUENCE"], ["butyrate producing bacteria", "gut microbiota", "PART OF"], ["age-/sex-matched healthy controls", "qPCR", "USED BY"], ["PD", "Roseburia", "CHANGE ABUNDANCE"], ["BAs", "neurological and neuropsychiatric diseases", "INFLUENCE"], ["Helicobacter hepaticus", "\u03b1-Synuclein pathologies", "INFLUENCE"], ["Anthocyanins", "Chronic Disorders", "INFLUENCE"], ["Gut microbiota", "neurodegenerative disease", "IS LINKED TO"], ["Enterobacter cloacae", "gut microbiota", "PART OF"], ["Human microbiota", "GABA-, proline-, and extracellular matrix-related prefrontal cortex genes", "CHANGE EXPRESSION"], ["Escherichia", "gut microbiota", "PART OF"], ["natural products", "depressive symptoms", "INFLUENCE"], ["interleukin-6", "systemic inflammation", "INFLUENCE"], ["gut Flavonifractor genus", "gut microbiota", "PART OF"], ["dysbiosis", "neurological disorders", "AFFECT"], ["MS group", "tail suspension test", "USED BY"], ["Nef", "chronic stress-induced depression", "CHANGE EFFECT"], ["gut microbiota", "mental health disorders", "IS LINKED TO"], ["selected brain tissues", "Male and female Sprague-Dawley rats", "LOCATED IN"], ["psychobiotics", "depression", "INFLUENCE"], ["gut microbiota composition", "patients", "LOCATED IN"], ["Bifidobacteriaceae", "Parkinson's disease", "INFLUENCE"], ["dopaminergic neuron degeneration", "classic motor symptoms", "AFFECT"], ["Entacapone", "Gut Microbiota", "IMPACT"], ["probiotics", "psychiatric patients", "ADMINISTERED"], ["narcolepsy type 2", "patients", "TARGET"], ["ketamine enantiomers", "depression", "CHANGE EFFECT"], ["metabolites", "gut", "LOCATED IN"], ["Parkinson's Disease", "Bifidobacteriaceae", "CHANGE ABUNDANCE"], ["levodopa", "GI", "CHANGE EFFECT"], ["gut microbiota-regulated", "TLE", "IS LINKED TO"], ["small molecules", "vagus nerves", "LOCATED IN"], ["Zn<sup>2+</sup>", "novel coronavirus infection", "INFLUENCE"], ["Probiotics", "inflammation", "INFLUENCE"], ["depressive disorders", "colic complaints", "AFFECT"], ["ASD", "gut IgA level", "INTERACT"], ["Parkinson's disease", "healthy spouses", "TARGET"], ["Trp", "Venous blood", "LOCATED IN"], ["casein", "PD", "INFLUENCE"], ["COVID-19", "Depression", "AFFECT"], ["galactooligosaccharide", "stress", "INFLUENCE"], ["major depression", "morbidity", "AFFECT"], ["amino acids", "neurodegeneration", "INFLUENCE"], ["omega-3 fatty acids", "neurological diseases", "INFLUENCE"], ["microbial genera", "RDoC's negative valence", "USED BY"], ["Bifidobacterium", "Children", "LOCATED IN"], ["microbiota", "PSD-95", "CHANGE EXPRESSION"], ["realgar", "loss of DA neurons", "INFLUENCE"], ["probiotics", "COVID-19 disease", "INFLUENCE"], ["gut dysbiosis", "neurologic dysfunction", "AFFECT"], ["BD", "people with the major psychiatric disorders", "TARGET"], ["plant protein", "depression", "INFLUENCE"], ["CA", "MPTP-induced PD mice", "LOCATED IN"], ["fecal microbiota", "presenior population", "LOCATED IN"], ["gut microbiome", "neurological and psychiatric disorders", "IS LINKED TO"], ["plasticizer", "increasing body weight gain", "INFLUENCE"], ["inflammation-associated microbial genera", "PD progression", "INFLUENCE"], ["bacterial antigen", "sub-mucosal inflammation", "INFLUENCE"], ["gut microbiota", "psychological symptoms", "IS LINKED TO"], ["altered microbiome", "ASD", "IS LINKED TO"], ["gut microbiome", "Parkinson's Disease", "IS LINKED TO"], ["transient gut dysbiosis", "Parkinson's disease", "AFFECT"], ["HS", "16S rRNA sequencing", "USED BY"], ["PD", "autonomic dysfunction", "AFFECT"], ["Quercetin", "Polycystic Ovary Syndrome", "INFLUENCE"], ["Human Gut Microbiota", "Cancers", "IS LINKED TO"], ["Hua-Feng-Dan", "Lactobacteriaceae", "IMPACT"], ["Flavonifractor", "Gut microbiota", "PART OF"], ["Non-caloric artificial sweeteners", "glucose intolerance", "INFLUENCE"], ["anxiety", "Depressed mother rats", "TARGET"], ["cucurbitacin E", "impaired colonic morphology", "INFLUENCE"], ["multiple sclerosis", "humans", "TARGET"], ["Prebiotics", "human gut microbiota", "IMPACT"], ["piperine", "Human G-quadruplex DNA", "CHANGE EXPRESSION"], ["PD patients", "GC-MS", "USED BY"], ["Dietary sulforaphane glucosinolate", "depression-like behaviors", "INFLUENCE"], ["traumatic stress", "male and female rodents", "TARGET"], ["antibiotics", "neurodegenerative diseases", "CHANGE EFFECT"], ["postmenopausal osteoporosis", "ovariectomized (OVX) mice", "TARGET"], ["MPTP", "Parkinson's disease", "INFLUENCE"], ["GBM", "Ruminococcus 2", "CHANGE ABUNDANCE"], ["polyphenols", "polymers", "INTERACT"], ["probiotic", "GM", "IMPACT"], ["comorbid patients", "serum metabolomics profiling", "USED BY"], ["amyloid", "blood-brain barrier", "LOCATED IN"], ["intestine microbiota", "early PD", "IS LINKED TO"], ["AD", "Flavonifractor", "CHANGE ABUNDANCE"], ["body weight gain", "Sprague-Dawley (SD) rats", "TARGET"], ["Enterobacter kobei", "gut microbiota", "PART OF"], ["fecal microbiota", "healthy persons", "LOCATED IN"], ["Odoribacter", "faecal gut microbiota", "PART OF"], ["excess body weight during and after pregnancy", "offspring overweight", "AFFECT"], ["inflammatory bowel diseases", "Psychiatric disorders", "AFFECT"], ["ICH", "Vehicle group", "TARGET"], ["mental disorders", "Faecalibacterium", "CHANGE ABUNDANCE"], ["Parasutterella", "microbiota", "PART OF"], ["skin triglycerides", "acne mice", "LOCATED IN"], ["natural non-proteinogenic diamino acid", "dinoflagellates", "IMPACT"], ["Human gut microbiota", "human diseases", "IS LINKED TO"], ["fiber", "chronic disease", "INFLUENCE"], ["bacteria responsible for secondary bile acid synthesis", "microbial dysbiosis", "INFLUENCE"], ["melanin", "heart", "LOCATED IN"], ["Helicobacter_ganmani", "glycolipid metabolism disorders", "INFLUENCE"], ["chemical pollutant", "gut microbiota", "IMPACT"], ["mice", "bilateral intrahippocampal CA1 injection", "USED BY"], ["PD patients", "randomized controlled study", "USED BY"], ["Parkinson's disease", "men and women over 40 years old", "TARGET"], ["inactivated L. plantarum CCFM8661", "acne mice", "LOCATED IN"], ["gut microbiota", "Gut dysbiosis", "IS LINKED TO"], ["diabetes", "SD rats", "TARGET"], ["trehalose", "neuroprotective effects", "INFLUENCE"], ["maternal anxiety", "infant gastrointestinal complaints", "AFFECT"], ["GM", "sleep disturbance", "IS LINKED TO"], ["PD", "families Akkermansiaceae", "CHANGE ABUNDANCE"], ["Early-stage gut dysbiosis", "iRBD", "AFFECT"], ["GM dysbiosis", "mice", "TARGET"], ["Collinsella", "gut microbiota", "PART OF"], ["(R)-ketamine", "demyelination", "CHANGE EFFECT"], ["unhealthy diet", "neurodegenerative diseases", "INFLUENCE"], ["pharmacokinetic performance", "commonly employed formulations", "INTERACT"], ["significant improvements", "IBS patients", "TARGET"], ["mental health disorders", "child and adolescent population (0-18\u00a0years old)", "TARGET"], ["therapeutic benefits", "SCZ", "CHANGE EFFECT"], ["acetate", "amyotrophic lateral sclerosis", "INFLUENCE"], ["<i>Coprococcus</i> spp.", "neuropsychological and neurodegenerative disorders", "INFLUENCE"], ["pathogenic proteins", "gut microbiota", "PART OF"], ["microbiota", "early PD", "IS LINKED TO"], ["dysbiosis", "misfolded \u03b1-synuclein", "INTERACT"], ["mGlu8", "PD", "INFLUENCE"], ["probiotics", "Lactobacillus", "IMPACT"], ["Huntington's disease", "neurological disorders", "IS A"], ["Gut Microbiota", "non-tremor dominant", "IS LINKED TO"], ["chronic restraint stress", "mice", "TARGET"], ["gastrointestinal symptoms", "cancer patients", "TARGET"], ["Gut microbiota", "gastrointestinal tract", "LOCATED IN"], ["maternal vaginal microbes", "infant stool microbiota", "PART OF"], ["anxiety-like behaviour", "mice", "TARGET"], ["Gut microbiota", "A53T transgenic monkeys", "LOCATED IN"], ["MS group", "TST", "USED BY"], ["inflammatory bowel diseases", "psychiatric Disorders", "AFFECT"], ["intestine microbiota", "control monkeys", "LOCATED IN"], ["SIBO", "diverticular and celiac diseases", "AFFECT"], ["gut dysbiosis", "aging-associated neurodegenerative diseases", "AFFECT"], ["Mercury sulfide-containing Hua-Feng-Dan", "Clostridaceae species", "IMPACT"], ["cinnabar", "DA neuron loss", "INFLUENCE"], ["PTSD", "male", "TARGET"], ["Gut microbiota", "PD", "IS LINKED TO"], ["PD", "39 PD patients", "TARGET"], ["PD", "Bifidobacteriaceae", "CHANGE ABUNDANCE"], ["individuals", "multiomics study", "USED BY"], ["pramipexole", "gastrointestinal symptoms", "CHANGE EFFECT"], ["Fermented foods", "Bifidobacteria", "IMPACT"], ["chronic stress", "gut microbiota", "CHANGE ABUNDANCE"], ["Firmicutes", "GM", "PART OF"], ["Bacteroides pectinophilus", "bacterial taxa", "INTERACT"], ["diet", "neurological diseases", "INFLUENCE"], ["highly processed, poor quality foods", "mental disorder", "INFLUENCE"], ["MPTP", "norank_f_Muribaculaceae", "IMPACT"], ["gut microbial dysbiosis", "Parkinson's disease", "AFFECT"], ["CSDS", "mice", "TARGET"], ["insulin resistance", "host", "TARGET"], ["gut microbiota", "disturbances", "IS LINKED TO"], ["Gut Microbiota", "Rats", "LOCATED IN"], ["KRG", "Eubacterium", "IMPACT"], ["isoniazid", "tuberculosis", "CHANGE EFFECT"], ["anorexia nervosa", "eating disorders", "AFFECT"], ["<i>Desulfovibrio</i> bacteria", "gut microbiota", "PART OF"], ["mental disorders", "bacterial genera that produce short-chain fatty acids", "CHANGE ABUNDANCE"], ["BPD", "Actinobacteria", "CHANGE ABUNDANCE"], ["lipopolysaccharide", "Alzheimer's disease", "INFLUENCE"], ["neuroinflammation", "people", "TARGET"], ["obsessive-compulsive disorder", "mental health and neurocognitive disorders", "IS A"], ["Adiponectin", "immune diseases", "INFLUENCE"], ["gut microbiota", "psychosis", "IS LINKED TO"], ["nutraceuticals", "kidney disease", "INFLUENCE"], ["PD", "Parabacteroides", "CHANGE ABUNDANCE"], ["rifaximin", "neuroprotective effect", "CHANGE EFFECT"], ["microbial micro-environment", "ASD", "IS LINKED TO"], ["brain disorder", "brain", "STRIKE"], ["SGS", "gut microbiota", "IMPACT"], ["intestinal microbiota", "ALS", "IS LINKED TO"], ["probiotic bacteria", "neuroinflammation", "INFLUENCE"], ["Akkermansia", "microbial symbionts", "PART OF"], ["SCFAs", "vascular dementia", "INFLUENCE"], ["baseline gut microbiota", "remission and non-remission groups", "LOCATED IN"], ["psychobiotics", "mental health-related disorders", "INFLUENCE"], ["lactic-acid", "Bifidobacteria", "IMPACT"], ["Turicibacterales", "GLCA", "INTERACT"], ["dietary fiber intake", "mental health", "INFLUENCE"], ["patients with schizophrenia", "high-sensitivity C-reactive protein", "USED BY"], ["inactivated L. plantarum CCFM8661", "skin triglycerides", "INTERACT"], ["<i>Desulfovibrio</i> bacteria", "PD patients", "LOCATED IN"], ["microbial gut dysbiosis", "pathogenic microbial metabolites", "INTERACT"], ["Dorea", "gut microbiome", "PART OF"], ["distal colon", "mice", "LOCATED IN"], ["hydrogen sulfide", "<i>Desulfovibrio</i> bacteria", "IMPACT"], ["coeliac disease", "patients", "TARGET"], ["metabolites", "amyotrophic lateral sclerosis", "INFLUENCE"], ["Kineothrix alysoides", "high biodiversity treatment mice", "LOCATED IN"], ["SIBO", "short bowel syndrome", "AFFECT"], ["immune dysfunction", "inflammatory conditions", "AFFECT"], ["Eggerthella lenta", "Gut microbiota", "PART OF"], ["gut microbiome", "neurodegenerative disorders", "IS LINKED TO"], ["inflammation", "host", "TARGET"], ["ASD", "gut IgA levels", "INTERACT"], ["Temporal lobe epilepsy", "people", "TARGET"], ["obesity", "Prader-Willi syndrome", "AFFECT"], ["High-cholesterol diet", "neuroinflammation", "INFLUENCE"], ["PD", "genera Akkermansia and Catabacter", "CHANGE ABUNDANCE"], ["fecal gut microbiota", "overweight adults", "LOCATED IN"], ["MPTP", "PD-related injuries", "CHANGE EFFECT"], ["GI dysfunction", "PD", "AFFECT"], ["BCM-7", "obesity", "INFLUENCE"], ["MPTP", "neuroinflammation", "CHANGE EFFECT"], ["Piperine", "cerebral stroke", "INFLUENCE"], ["dysbiosis", "anxiety", "AFFECT"], ["gut microbiota", "human diseases", "IS LINKED TO"], ["glycan", "fatigue", "INFLUENCE"], ["overnutrition", "offspring", "TARGET"], ["Gut microbiota", "dementia", "IS LINKED TO"], ["W. somnifera", "neurodegenerative diseases", "INFLUENCE"], ["SHH", "Bacteroidota", "IMPACT"], ["HFD-original", "gut microbiota", "IMPACT"], ["hippuric acid", "Alcohol use-associated alterations", "INFLUENCE"], ["F. rodentium", "synaptic proteins", "INTERACT"], ["pathogenic proteins", "NDs", "INFLUENCE"], ["antibiotic cocktail", "ALI", "CHANGE EFFECT"], ["gut microbial metabolites", "Parkinson disease", "INFLUENCE"], ["AP-32 supplement", "motor function", "INFLUENCE"], ["\u03b3-aminobutyric acid", "probiotic groups", "IMPACT"], ["glial fibrillary acidic protein", "DEX and CUMS groups", "LOCATED IN"], ["chronic neuroinflammation", "MPTP neurotoxicity", "AFFECT"], ["choline", "age-related diseases", "INFLUENCE"], ["gastrointestinal (GI) dysfunction", "CS patients", "TARGET"], ["vitamin D", "maternal depression and anxiety", "INFLUENCE"], ["microbiota", "caecum", "LOCATED IN"], ["SHH", "Firmicutes", "IMPACT"], ["mental illness", "obesity", "AFFECT"], ["inactivated L. plantarum CCFM8661", "SREBP-1c", "CHANGE EXPRESSION"], ["Inflammation", "Patients", "TARGET"], ["damage to different tissues", "male rodents", "TARGET"], ["microbiome", "gut dysbiosis", "IS LINKED TO"], ["insulin resistance", "Parkinson disease", "AFFECT"], ["probiotics", "gut microbial system", "IMPACT"], ["gut microbiota", "stress-induced mental problems", "IS LINKED TO"], ["Gut Microbiota", "Adults", "LOCATED IN"], ["behavioral dysfunction", "Desulfovibrio", "CHANGE ABUNDANCE"], ["SARS-CoV-2", "PD", "AFFECT"], ["intestinal microflora", "16S RNA method", "USED BY"], ["gut microbiota", "control group (healthy controls)", "LOCATED IN"], ["SCFAs", "multiple sclerosis", "INFLUENCE"], ["oral medication", "PD", "CHANGE EFFECT"], ["adequate protein", "gut microbiome", "IMPACT"], ["Di-(2-ethylhexyl) phthalate", "damage to different tissues", "INFLUENCE"], ["cannabis", "psychosis", "INFLUENCE"], ["misfolded protein \u03b1-syn", "olfactory bulb", "LOCATED IN"], ["secondary metabolites", "gut microbiota", "PRODUCED BY"], ["controls", "16S rRNA-seq", "USED BY"], ["muscle mass", "PD rats", "TARGET"], ["cerebral toxoplasmosis", "chronic brain inflammation processes", "AFFECT"], ["walnut consumption", "mental health", "INFLUENCE"], ["(R)-ketamine", "lactic acid", "INTERACT"], ["low carbohydrate", "microbiota", "IMPACT"], ["LPS", "ALI", "INFLUENCE"], ["C21", "gut microbiota", "IMPACT"], ["Gut microbes", "stress", "IS LINKED TO"], ["Tourette syndrome", "patients", "TARGET"], ["Polycystic Ovary Syndrome", "women", "TARGET"], ["ASD", "children", "TARGET"], ["Vaginosis symptoms", "women", "TARGET"], ["Main gut microbiota alterations", "gut microbiota", "CHANGE ABUNDANCE"], ["striatum", "PD-model mice", "LOCATED IN"], ["Gut microbiota", "A53T monkeys", "LOCATED IN"], ["active AN", "gut microbiota", "CHANGE ABUNDANCE"], ["short-chain fatty acids", "neuromyelitis optica spectrum disorders", "INFLUENCE"], ["unidentified_Ruminococcaceae", "GM", "PART OF"], ["inhibitor", "gut microbiota", "IMPACT"], ["gut microbiota", "host anxiety levels", "IS LINKED TO"], ["small intestinal bacterial overgrowth", "Parkinson's subjects", "TARGET"], ["SCFAs", "stroke", "INFLUENCE"], ["glucose", "human body", "LOCATED IN"], ["PD-related injury", "PD mice", "TARGET"], ["L.brevis", "gut microbiota", "PART OF"], ["PWP herbal treatment", "gut microbiota", "IMPACT"], ["gut microbiota", "diabetes", "IS LINKED TO"], ["Gut Microbiota", "sleep disturbance", "IS LINKED TO"], ["6-OHDA", "tyrosine hydroxylase", "CHANGE EXPRESSION"], ["multiple sclerosis", "microbial communities", "CHANGE ABUNDANCE"], ["gastrointestinal symptoms", "Parkinson's disease (PD) symptomatology and pathophysiology", "AFFECT"], ["intestinal microbiota", "16S rRNA gene sequencing", "USED BY"], ["gut microbiota", "F1", "LOCATED IN"], ["GABA", "anxiety", "INFLUENCE"], ["BD", "Faecalibacterium", "CHANGE ABUNDANCE"], ["prebiotics", "mood disorders", "INFLUENCE"], ["extra-uterine growth restriction", "preterm babies", "TARGET"], ["Gut dysbiosis", "iRBD", "AFFECT"], ["Gastrointestinal tract dysfunction", "Parkinson's disease", "AFFECT"], ["gut microbiota", "PD and controls", "LOCATED IN"], ["butyrate", "Alzheimer's disease", "INFLUENCE"], ["gut microbiome", "people", "LOCATED IN"], ["sleep disorder (SD) patients", "WMT", "USED BY"], ["herpesvirus", "LBD", "INFLUENCE"], ["AGEs", "sugars", "PART OF"], ["realgar", "DA neuron loss", "INFLUENCE"], ["brain dysfunction", "humans", "TARGET"], ["behavioral alterations", "Transgenic mice", "TARGET"], ["DEHP", "obesity", "INFLUENCE"], ["Butyrivibrio", "Parkinson's disease", "INFLUENCE"], ["psychiatric symptom", "patients", "TARGET"], ["OCD", "mental health and neurocognitive disorders", "IS A"], ["Mediterranean diet", "PD", "INFLUENCE"], ["Kefir", "class Bacilli", "IMPACT"], ["microbiota", "disease", "IS LINKED TO"], ["Rannasangpei", "Methanobacteriaceae", "IMPACT"], ["fermented soy foods", "Alzheimer's", "INFLUENCE"], ["chronic pain", "patients", "TARGET"], ["infections", "gut microbiome", "CHANGE ABUNDANCE"], ["brain", "rats", "LOCATED IN"], ["dysbiosis", "SZ patients", "TARGET"], ["LPS plus rotenone-induced neurotoxicity", "rat", "TARGET"], ["stress", "Gut microbes", "CHANGE ABUNDANCE"], ["gut microbiota", "mood and anxiety disorders", "IS LINKED TO"], ["AGEs", "atherosclerosis", "INFLUENCE"], ["intestinal inflammation", "mice", "TARGET"], ["Prebiotics", "Gut Microbiota", "IMPACT"], ["dietary fiber intake", "weight management", "INFLUENCE"], ["Psychobiotics containing nutrients", "microbiota", "IMPACT"], ["depression", "gut microbiome", "CHANGE ABUNDANCE"], ["gut microbes", "complex and long-term psychiatric disorder", "IS LINKED TO"], ["<i>Negativibacillus</i> genus", "gut microbiome", "PART OF"], ["motor and non-motor manifestations", "gastrointestinal symptoms", "AFFECT"], ["calorie-controlled diets", "AD", "INFLUENCE"], ["abnormal composition", "mice", "TARGET"], ["Parkinson disease", "humans", "TARGET"], ["pro-inflammatory bacteria", "positive emotionality", "INFLUENCE"], ["Fusicatenibacter", "experiment group", "LOCATED IN"], ["dysbiosis", "type 2 diabetes mellitus", "AFFECT"], ["motor symptoms", "mice", "TARGET"], ["\u03b2-HgS-containing 70 Wei-Zhen-Zhu-Wan", "pathological lesions in the brain", "CHANGE EFFECT"], ["intestinal inflammation", "gastrointestinal tract", "STRIKE"], ["<i>Bifidobacteriaceae</i> family", "gut microbiome", "PART OF"], ["DEHP", "colorectal cancer", "INFLUENCE"], ["GBM", "patients", "TARGET"], ["H. suis", "patients", "LOCATED IN"], ["Peyer's patches", "mice", "LOCATED IN"], ["spasmolytics", "IBS", "CHANGE EFFECT"], ["BAs", "intestinal microbiota", "PRODUCED BY"], ["Mental Disorders", "Rats", "TARGET"], ["subjects", "16S rRNA sequence", "USED BY"], ["HFD-original", "disturbance of gut microbiota", "CHANGE EFFECT"], ["endogenous host proteins", "bacteria-derived protein aggregates", "INTERACT"], ["gut microbiota", "ADHD patients", "LOCATED IN"], ["Lachnostridium", "gut microbiota", "PART OF"], ["Mercury sulfide-containing Hua-Feng-Dan", "pathological lesions in the brain", "CHANGE EFFECT"], ["MPTP", "locomotor deficits", "CHANGE EFFECT"], ["psychiatric disorder", "patients", "TARGET"], ["berberine", "bacteroides", "IMPACT"], ["PD", "central nervous system", "STRIKE"], ["FWG", "depression-like behaviors", "INFLUENCE"], ["gut microbiota", "psychiatric disorder", "IS LINKED TO"], ["PD", "gut microbes", "CHANGE ABUNDANCE"], ["Parabacteroides", "children", "LOCATED IN"], ["gut microbiota", "neuroinflammation", "IS LINKED TO"], ["Gut Microbiota", "Alzheimer's Disease", "IS LINKED TO"], ["Bifidobacterium", "obesity", "INFLUENCE"], ["PD", "Lachnospira", "CHANGE ABUNDANCE"], ["dairy products", "PD incidence and progression", "INFLUENCE"], ["mood disorders", "men", "TARGET"], ["microbiota", "depression-related phenotypes", "IS LINKED TO"], ["gut microbiota", "CKD", "IS LINKED TO"], ["healthy controls", "16S and 18S ribosomal RNA amplicon sequencing", "USED BY"], ["TNF-\u03b1", "genus Blautia", "IMPACT"], ["IL-2", "depression", "INFLUENCE"], ["sugar regions", "gut microbiota", "PRODUCED BY"], ["SCI", "neuropathic pain", "AFFECT"], ["gut microbiome", "infancy", "LOCATED IN"], ["Gut microbiota", "organic ED", "IS LINKED TO"], ["Gut-microbiome-derived metabolites", "gut", "LOCATED IN"], ["Parkinson's disease", "Alistipes", "CHANGE ABUNDANCE"], ["Autoimmunity", "schizophrenia", "AFFECT"], ["Inulin", "mental health", "INFLUENCE"], ["microbial composition", "advanced PD patients", "LOCATED IN"], ["gut microbes", "neurodegeneration", "IS LINKED TO"], ["oxidants", "oxidative stress", "INFLUENCE"], ["organochlorines", "late onset neuropathologies", "INFLUENCE"], ["gut microbiota", "dopamine neuron loss", "IS LINKED TO"], ["Blautia", "Gut Microbiota", "PART OF"], ["AD", "gut bacterial species", "CHANGE ABUNDANCE"], ["microbiota", "metabolic syndrome", "IS LINKED TO"], ["Firmicutes", "gut microorganisms", "PART OF"], ["GMC", "toddler", "LOCATED IN"], ["human gut microbiota", "metabolic diseases", "IS LINKED TO"], ["flu", "women", "TARGET"], ["MP extract", "PD", "INFLUENCE"], ["intestinal microbiota", "Pink1</i><sup>-/-</sup> mice", "LOCATED IN"], ["chronic restrain stress", "male mice", "TARGET"], ["motor complications", "PD patients", "TARGET"], ["<i>Lachnospiraceae</i> family", "altered metabolism rates", "INFLUENCE"], ["delayed language development", "Coprococcus eutactus", "CHANGE ABUNDANCE"], ["gut microbiota", "SD", "IS LINKED TO"], ["HIV", "persons", "TARGET"], ["upregulated lipid metabolites", "gut microbiota", "PRODUCED BY"], ["alcohol overconsumption", "patients", "TARGET"], ["metabolite acetate", "cognitive decline", "INFLUENCE"], ["intestinal microbiota", "depression", "IS LINKED TO"], ["Lactobacillus", "beneficial gut bacteria", "INTERACT"], ["PD-related alterations", "Patients", "TARGET"], ["Gut Dysbiosis", "Primary Sj\u00f6gren's Syndrome-Mediated Dry Eye Patients", "TARGET"], ["microbiota-derived short-chain fatty acids", "human gut microbiota", "PRODUCED BY"], ["anti- or pro-inflammatory metabolites", "microbiota", "PRODUCED BY"], ["casein", "intestinal dysbacteriosis", "INFLUENCE"], ["taste receptors", "lower gastrointestinal tract", "LOCATED IN"], ["omega-3 fatty acids", "brain health", "INFLUENCE"], ["patients", "16S rRNA gene amplified sequencing", "USED BY"], ["chronic unpredictable mild stress", "Mice", "TARGET"], ["Parkinson's disease", "PD patients", "TARGET"], ["gut microbiota", "MS", "IS LINKED TO"], ["MGB", "neuropsychiatric disorders", "IS LINKED TO"], ["fermented foods", "neurological diseases", "INFLUENCE"], ["plasticizer", "type 2 diabetes", "INFLUENCE"], ["cinnabar", "gut microbiome", "IMPACT"], ["epigenetic inheritance", "F1", "TARGET"], ["PDX", "stress", "INFLUENCE"], ["fermentable carbohydrates", "microbial diversity", "IMPACT"], ["Polycystic Ovary Syndrome", "women of reproductive age", "TARGET"], ["patients", "16S ribosomal RNA sequencing", "USED BY"], ["dopamine", "gut microbiota", "IMPACT"], ["antidepressant treatment", "GM", "IMPACT"], ["Gut microbes", "individuals", "LOCATED IN"], ["nutraceutical supplementations", "chronic non-communicable degenerative diseases", "INFLUENCE"], ["aluminum", "Parkinson's disease", "INFLUENCE"], ["PD", "genera Roseburia, Faecalibacterium, and Lachnospiraceae ND3007 group", "CHANGE ABUNDANCE"], ["Gut Microbiome", "multiple sclerosis", "IS LINKED TO"], ["gut microbiota", "inflammation", "IS LINKED TO"], ["207-1", "probiotic groups", "IMPACT"], ["psychiatric symptoms", "SCH patients", "TARGET"], ["Gut Microbiota", "6-OHDA-Induced Parkinson's Disease", "IS LINKED TO"], ["Gut microbiota", "GC-MS", "USED BY"], ["5-hydroxytryptamine", "gut", "LOCATED IN"], ["gut flora", "Parkinson's and Alzheimer's disease", "IS LINKED TO"], ["BCAAs", "fecal microbiome", "PRODUCED BY"], ["synaptic proteins", "Chrna7 KO mice", "LOCATED IN"], ["lipid metabolites", "\u03b1-synuclein", "INTERACT"], ["probiotic", "\u03b1-synucleinopathies", "INFLUENCE"], ["low BMD", "depressed patients", "TARGET"], ["Migraine", "sensitivity to light, sound and smell", "AFFECT"], ["gut microbiota", "16S rRNA gene amplified sequencing", "USED BY"], ["systemic", "mice", "LOCATED IN"], ["major depression", "men", "TARGET"], ["NPs", "MDD", "INFLUENCE"], ["GI issues", "athletes", "TARGET"], ["anti-inflammatory bacteria", "reward-seeking", "INFLUENCE"], ["low carbohydrate", "Gut microbes", "IMPACT"], ["ROT", "Verrucomicrobiaceae", "IMPACT"], ["Dietary fiber", "gut microbiota", "IMPACT"], ["gastrointestinal tract", "animals", "LOCATED IN"], ["gut microbiota diversity", "extraversion", "IS LINKED TO"], ["Lachnospiraceae Lactobacillus", "gut microbiota", "PART OF"], ["New Actor Kefir", "Neurodegenerative Diseases", "INFLUENCE"], ["rasagiline", "gastrointestinal symptoms", "CHANGE EFFECT"], ["probiotics", "metabolic and inflammatory diseases", "INFLUENCE"], ["KD", "neurological disorders", "INFLUENCE"], ["Roseburia", "gut microbiota", "PART OF"], ["psychobiotics", "healthy populations", "LOCATED IN"], ["(R,S)-ketamine", "NMDAR", "INTERACT"], ["behavioral dysfunction", "Parabacteroides", "CHANGE ABUNDANCE"], ["PM", "SNpc", "LOCATED IN"], ["GM", "neurodegeneration", "IS LINKED TO"], ["vitamins", "microbiota", "IMPACT"], ["PD", "peripheral tissues", "STRIKE"], ["Bacteroides vulgatus", "ASD group", "LOCATED IN"], ["pathogenesis of PD", "PD", "AFFECT"], ["Human Gut Microbiota", "Graves' disease", "IS LINKED TO"], ["anti-inflammatory effects", "inflammation-related depression", "CHANGE EFFECT"], ["Injury to neurons", "Alzheimer's", "AFFECT"], ["L. helveticus NS8", "depression", "INFLUENCE"], ["Bifidobacterium", "beneficial gut bacteria", "INTERACT"], ["short chain fatty acids", "PD", "INFLUENCE"], ["probiotics", "psychiatric distress", "INFLUENCE"], ["Helicobacter pylori", "Alzheimer's disease", "INFLUENCE"], ["NLRP3 inflammasome", "ischemic and non-ischemic heart disease", "INFLUENCE"], ["prebiotics", "anxiety", "INFLUENCE"], ["saline", "gut microbiota", "IMPACT"], ["Human Microbiome", "Microbial Community Analysis", "USED BY"], ["intestinal microbiota", "schizophrenia", "IS LINKED TO"], ["Gut Microbiome", "Anxiety", "IS LINKED TO"], ["Rikenellaceae_RC9_gut_group", "fecal microbiome", "PART OF"], ["SIBO", "patients", "TARGET"], ["paraprobiotics", "age-associated neurodegenerative diseases", "INFLUENCE"], ["MDD", "patients", "TARGET"], ["adequate protein", "depression", "INFLUENCE"], ["polysaccharides", "MDD", "INFLUENCE"], ["Hyperglycemia", "TALLYHO/JngJ mice", "TARGET"], ["psychotropics", "GM", "IMPACT"], ["acetate", "PD", "INFLUENCE"], ["NPDs", "gut microbiota", "CHANGE ABUNDANCE"], ["Lachnoclostridium", "gut microbiota", "PART OF"], ["gut microbiota", "Drosophila", "LOCATED IN"], ["acetate", "autism", "INFLUENCE"], ["nicotinic acid", "Gut Microbiota", "PRODUCED BY"], ["sham group", "behavioral tests", "USED BY"], ["bile acids", "intestinal microbiota", "IMPACT"], ["vegetables", "neurological diseases", "INFLUENCE"], ["neurodegeneration", "brain", "STRIKE"], ["IBS/functional dyspepsia", "human participants", "TARGET"], ["Parkinson's Disease", "Blautia", "CHANGE ABUNDANCE"], ["sodium oligomannate", "cognition impairment", "CHANGE EFFECT"], ["gut microbiota", "neuropsychiatric disorders", "IS LINKED TO"], ["inflammation-associated gut microbiota", "gut", "LOCATED IN"], ["Probiotic and synbiotic, but not prebiotic, treatment", "MDD", "INFLUENCE"], ["gut microbes", "altered homeostasis", "IS LINKED TO"], ["inflammatory proteins", "COVID-19", "INFLUENCE"], ["rheumatoid arthritis", "gut microbiota", "CHANGE ABUNDANCE"], ["Honey", "Gut Microbiome", "IMPACT"], ["non-depressed general population", "targeted liquid chromatography mass spectrometry method", "USED BY"], ["cognitive impairments", "diverse symptoms", "AFFECT"], ["dexamethasone", "depression-like phenotypes", "CHANGE EFFECT"], ["disruption of the sentinel or housekeeping functions", "Injury to neurons", "AFFECT"], ["Escherichia-Shigella", "intestinal microbiota", "PART OF"], ["Parkinson's disease", "Constipation", "AFFECT"], ["L. brevis SG031 supplementation", "anxiety/depression-like behaviors", "INFLUENCE"], ["<i>L. plantarum</i> DP189", "gut microbiota", "PART OF"], ["SCH", "patients", "TARGET"], ["tumourigenesis", "AOM/DSS treated mice", "TARGET"], ["pro-inflammatory cytokines", "mice colon", "LOCATED IN"], ["Lachnospiraceae genus CAG-56", "MDD", "INFLUENCE"], ["<i>Clostridioides difficile</i> infections", "patients", "TARGET"], ["gut microbiota", "Bipolar disorder", "IS LINKED TO"], ["dysbiosis", "pro-inflammatory status", "AFFECT"], ["SCFA subtypes", "PD", "INFLUENCE"], ["abnormal composition of gut microbiota", "Chrna7 KO mice", "TARGET"], ["butyrate", "neurological disorders", "INFLUENCE"], ["GM", "children aged 3-4", "LOCATED IN"], ["Prevotellaceae", "Dcf1<sup>-/-</sup> (KO) mice", "LOCATED IN"], ["gut microbiota", "low-frequency transcranial magnetic stimulation", "USED BY"], ["Autism Spectrum Disorder", "Children", "TARGET"], ["food supplement", "irritable bowel syndrome", "INFLUENCE"], ["glutamate", "brain", "LOCATED IN"], ["Blautia", "SCFAs", "INTERACT"], ["psychiatric disorders", "Prevotella species", "CHANGE ABUNDANCE"], ["microbiome", "depression", "IS LINKED TO"], ["\u03b2-<i>N</i>-methylamino-L-alanine", "dinoflagellates", "IMPACT"], ["fecal microbiota", "FEP", "IS LINKED TO"], ["L. rhamnosus", "dysbiosis of mouse gut microbiota", "INFLUENCE"], ["submandibular gland", "NOD mice", "LOCATED IN"], ["microbial metabolites", "gut microbiota", "IMPACT"], ["mice", "Experimental Autoimmune Encephalomyelitis", "USED BY"], ["hippocampus", "depressed mice", "LOCATED IN"], ["PD", "family <i>Akkermansiaceae</i>", "CHANGE ABUNDANCE"], ["Nutraceuticals", "Psychiatric Disorders", "INFLUENCE"], ["asparagine", "GM", "PRODUCED BY"], ["CSDS", "betaine-treated mice", "TARGET"], ["KD", "Parkinson's disease", "INFLUENCE"], ["brain-derived neurotrophic factors", "gut microbiota", "IMPACT"], ["irritants", "Inflammation", "INFLUENCE"], ["liver toxicity", "SD rats", "TARGET"], ["A. muciniphila", "anxiety", "INFLUENCE"], ["Parkinson's disease", "olfactory impairment", "AFFECT"], ["levodopa", "neurodegenerative disorder", "CHANGE EFFECT"], ["Lactobacillus group bacteria", "first-episode psychosis", "INFLUENCE"], ["pathogens", "Inflammation", "INFLUENCE"], ["fish", "patients", "ADMINISTERED"], ["human microbiota", "microbial dysbiosis", "IS LINKED TO"], ["gut microbiota", "chronic alcohol overconsumption", "IS LINKED TO"], ["Proteobacteria", "dominated breast milk gut microbiota", "PART OF"], ["microbes", "autism spectrum disorders", "INFLUENCE"], ["telomere attrition", "neurodegeneration", "AFFECT"], ["gut microbiota", "mental and neurological disorders", "IS LINKED TO"], ["gut microbial dysbiosis", "PD mice", "TARGET"], ["casein", "intestinal pathologic injury", "INFLUENCE"], ["gut microbiota", "children", "LOCATED IN"], ["Changes", "maternal gut microbiota", "CHANGE ABUNDANCE"], ["gut microbiota", "gut microbiota dysbiosis", "IS LINKED TO"], ["P2Y12 receptor", "hippocampus", "LOCATED IN"], ["Eubacterium", "faecal gut microbiota", "PART OF"], ["high vagal tone", "valerate", "INTERACT"], ["GM", "intestinal epithelial surface", "LOCATED IN"], ["Anaerostipes", "MDD", "INFLUENCE"], ["antibiotic-treated animals", "forepaw stepping test", "USED BY"], ["Gram-negative bacteria", "progressive neurodegeneration", "INFLUENCE"], ["Inflammatory, neurodegenerative and psychiatric disorders", "people", "TARGET"], ["metabolites", "autism", "INFLUENCE"], ["plant foods", "gut bacteria", "IMPACT"], ["Animal and plant protein", "gut microbiota", "IMPACT"], ["Altered gut microbiota", "healthy spouses", "LOCATED IN"], ["Mitochondrial dysfunction", "cardiovascular and infectious diseases", "AFFECT"], ["commensal fungus Candida albicans", "dysregulation of endocannabinoid signaling", "INFLUENCE"], ["Gut Microbiota", "Neurologic Diseases and Injuries", "IS LINKED TO"], ["Rifaximin", "occludin", "INTERACT"], ["honey", "Lactobacillus", "IMPACT"], ["microbial gases", "intestine", "LOCATED IN"], ["gut microbiota", "MS and CUMS groups", "LOCATED IN"], ["aromatic amino acids", "Gut microbiota", "PRODUCED BY"], ["controls", "Illumina HiSeq 2500", "USED BY"], ["plants", "depressive symptoms", "INFLUENCE"], ["nutritional intervention", "Parkinson's disease", "INFLUENCE"], ["PD rats", "<i>in vivo</i> experiment-combined approach", "USED BY"], ["microbiota-based probiotic dietary supplementation", "Alzheimer's and Parkinson's diseases", "INFLUENCE"], ["parkinsonian symptoms", "Parkinson's disease", "AFFECT"], ["therapeutic agents", "neurodevelopmental and neurodegenerative disorders", "CHANGE EFFECT"], ["PD", "striatum", "STRIKE"], ["gut microbiome", "neuropsychiatric and neurodegenerative disorders", "IS LINKED TO"], ["Faecalobacterium", "gut microbiome", "PART OF"], ["gut microbes", "Parkinson's disease (PD) symptomatology and pathophysiology", "IS LINKED TO"], ["placebo tablets", "patients", "ADMINISTERED"], ["neurological diseases", "humans", "TARGET"], ["fecal microbiota", "transcriptome sequencing", "USED BY"], ["gut bacteria", "chronic disease", "INFLUENCE"], ["Prevotella", "gut microbiota", "PART OF"], ["gut microbiota", "Parasite infections", "IS LINKED TO"], ["Autism Spectrum Disorder", "persistent deficits in social communication and interaction", "AFFECT"], ["intestinal flora", "mice", "LOCATED IN"], ["dysregulation of systemic homeostasis", "CNS pathologies", "AFFECT"], ["LL1 + silymarin capsule supplementation", "mood disorders", "INFLUENCE"], ["healthy persons", "stool biobank", "USED BY"], ["Plant polysaccharides", "gut microbiota", "IMPACT"], ["iron", "Children", "LOCATED IN"], ["unmedicated patients with depressed bipolar disorder", "faecal metagenomic, serum metabolomics and neuroimaging studies", "USED BY"], ["methyltransferases", "epigenetic mechanisms", "INFLUENCE"], ["hUCB-derived plasma", "SNpc", "LOCATED IN"], ["SGS", "behavioral abnormalities", "INFLUENCE"], ["LPS plus ROT induced neurotoxicity", "rat", "TARGET"], ["PD", "Blautia", "CHANGE ABUNDANCE"], ["ASD", "gut microbiota", "CHANGE ABUNDANCE"], ["ketogenic diet", "neurologic disorders", "INFLUENCE"], ["Observed metabolic changes", "gut microbiota disruption", "AFFECT"], ["probiotic supplementation", "adolescents", "ADMINISTERED"], ["MS", "vagus nerve", "STRIKE"], ["butyrate", "Parkinson's disease", "INFLUENCE"], ["Christensenellaceae", "patients", "LOCATED IN"], ["low carbohydrate", "anxiety", "INFLUENCE"], ["BCAAs", "gut microbiota", "PRODUCED BY"], ["Gastrointestinal (GI) problems", "children", "TARGET"], ["Psychobiotics", "Lactobacillus", "IMPACT"], ["delayed language development", "children", "TARGET"], ["psychotropic medications", "gut microbiota", "IMPACT"], ["microbiota", "horizontal gene transfer", "IS LINKED TO"], ["Parkinson's disease", "Prevotellaceae", "CHANGE ABUNDANCE"], ["PD pathology", "rats", "TARGET"], ["gut microbiota", "ASD children", "LOCATED IN"], ["probiotics", "stress-related disorders", "INFLUENCE"], ["fecal microbiota", "Clostridium difficile infection", "IS LINKED TO"], ["Gut Microbiota", "Brain", "LOCATED IN"], ["Escherichia coli", "GM", "PART OF"], ["dysbiosis", "Cancers", "AFFECT"], ["IBS", "people", "TARGET"], ["KD", "Alzheimer's disease", "INFLUENCE"], ["Zn<sup>2+</sup>", "obesity", "INFLUENCE"], ["recombinant tissue inhibitors of metalloproteinase 3", "duodenum", "LOCATED IN"], ["<i>Lachnospiranaceae</i> genus", "gut microbiome", "PART OF"], ["functional dysbiosis", "patients", "TARGET"], ["Microbially derived toxic bile acids", "PD", "INFLUENCE"], ["gut microbiota", "high-throughput 16S rRNA gene sequencing", "USED BY"], ["CsgA", "Parkinson's disease", "INFLUENCE"], ["Turicibacteraceae", "taurodeoxycholic acid", "INTERACT"], ["BCM-7", "fractures", "INFLUENCE"], ["poorly soluble antipsychotic", "rate-limiting dissolution", "CHANGE EFFECT"], ["Zn<sup>2+</sup>", "neurodegeneration", "INFLUENCE"], ["body weight gain", "SD rats", "TARGET"], ["Mucosal Immunity", "Neuroimmune Disease", "AFFECT"], ["\u03b1-synuclein", "\u03b1-synuclein pathology", "INFLUENCE"], ["motor symptoms", "Patients", "TARGET"], ["microbes", "neurologic disorders", "INFLUENCE"], ["pleiotropic agents", "Parkinson's disease", "CHANGE EFFECT"], ["PD", "brain", "STRIKE"], ["PD", "Myristic acid", "INTERACT"], ["Affective disorders", "gut Christensenellaceae family", "CHANGE ABUNDANCE"], ["Parkinson's Disease", "Faecalibacterium", "CHANGE ABUNDANCE"], ["Helicobacter hepaticus", "Dopaminergic degeneration", "INFLUENCE"], ["olidextribacter", "gut microbiota", "PART OF"], ["abnormal T cells activation", "mice", "TARGET"], ["CBD", "Autism Spectrum Disorder", "CHANGE EFFECT"], ["micronutrient supplementation", "psychiatric symptoms", "INFLUENCE"], ["HgS", "LPS plus ROT induced neurotoxicity", "INFLUENCE"], ["MeDi", "genera", "IMPACT"], ["GABA", "children", "LOCATED IN"], ["rifaximin", "gut microbiota", "IMPACT"], ["lactic-acid", "gut microbiome", "PRODUCED BY"], ["gingerol", "IBS", "INFLUENCE"], ["gut Christensenellaceae family", "gut microbiota", "PART OF"], ["anxiety", "A53T transgenic monkeys", "TARGET"], ["human microbiome", "mouth", "LOCATED IN"], ["Levilactobacillus brevis SG031", "autonomic dysfunction", "INFLUENCE"], ["gut microbiota imbalance", "patients", "TARGET"], ["short chain fatty acids", "Gut microbiota", "PRODUCED BY"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "GM", "IMPACT"], ["intestinal microbiota", "anxiety symptoms", "IS LINKED TO"], ["Neurotoxins", "late onset neuropathologies", "INFLUENCE"], ["Firmicutes/Bacteroidetes ratio", "primary open-angle glaucoma", "INFLUENCE"], ["astin C", "TREM2", "CHANGE EXPRESSION"], ["Gram-negative sulfate-reducing bacteria", "genus <i>Desulfovibrio</i>", "INTERACT"], ["Ruminococcus torques", "Alzheimer's disease", "INFLUENCE"], ["Gracilibacter", "anxiety", "INFLUENCE"], ["cucurbitacin E", "colitis", "INFLUENCE"], ["increased depression-like", "Transgenic mice", "TARGET"], ["gut flora", "amyotrophic lateral sclerosis", "IS LINKED TO"], ["low FODMAP diet", "Irritable bowel syndrome", "INFLUENCE"], ["repurposed medications", "gut dysbiosis", "CHANGE EFFECT"], ["gut microbial", "schizophrenia", "IS LINKED TO"], ["healthy spouses", "16S ribosomal RNA sequencing", "USED BY"], ["Chicoric acid", "polyphenolic acid", "PART OF"], ["polyphenols", "diseases of the central nervous system", "INFLUENCE"], ["constipation", "individuals", "TARGET"], ["gut microbiota", "antipsychotic na\u00efve or quasi-na\u00efve people", "LOCATED IN"], ["disruption in bile acid control", "PD gut", "STRIKE"], ["Mediterranean Low Fodmap Diet", "Gut Microbiota", "IMPACT"], ["Gastrointestinal (GI) symptoms and pathology", "rats", "TARGET"], ["ketogenic diet", "amyotrophic lateral sclerosis", "INFLUENCE"], ["PD patients", "gas chromatography-mass spectrometer", "USED BY"], ["As<sub>4</sub>S<sub>4</sub>", "behavioral dysfunction", "INFLUENCE"], ["human microbiota", "skin", "LOCATED IN"], ["Faecalibaculum", "microbial symbionts", "PART OF"], ["early PD", "GAPDH", "INTERACT"], ["academic stress", "university students", "TARGET"], ["\u03b1-Lactalbumin", "polycystic ovary syndrome", "INFLUENCE"], ["Gut microbes", "EDs", "IS LINKED TO"], ["SIBO", "spondylarthropathy", "AFFECT"], ["small molecules", "gut", "LOCATED IN"], ["Major depressive disorder", "reduced activity", "AFFECT"], ["(S)-ketamine", "humans", "ADMINISTERED"], ["gut microbiota", "Major depression", "IS LINKED TO"], ["Bacterial dysbiosis", "patients", "TARGET"], ["rhesus monkeys", "metagenomic sequencing", "USED BY"], ["MPTP", "clinical motor symptoms", "INFLUENCE"], ["cholesterol", "hepatic tissues", "LOCATED IN"], ["medicinal herbs", "neurodegeneration", "INFLUENCE"], ["Proteobacteria", "PD patients", "LOCATED IN"], ["highly processed, poor quality foods", "gut microbiota", "IMPACT"], ["Inflammation", "late onset neuropathologies", "AFFECT"], ["Prebiotics", "gut microbiota", "IMPACT"], ["intestinal microbiota", "amyotrophic lateral sclerosis", "IS LINKED TO"], ["human gut microbiota", "depression", "IS LINKED TO"], ["enhanced cerebral blood flow (CBF) similarities", "CI", "AFFECT"], ["Gut microbiome changes", "Parkinson's disease", "AFFECT"], ["pollutants", "psychiatric or neurological disorders", "INFLUENCE"], ["antibiotics cocktail", "\u03b1-Synuclein pathology", "CHANGE EFFECT"], ["Coprococcus", "PTGS2", "CHANGE EXPRESSION"], ["major depression", "gut microbiome", "CHANGE ABUNDANCE"], ["TLR4", "gut inflammation", "INFLUENCE"], ["PD", "impaired sleep", "AFFECT"], ["Ruminiclostridium", "gut microbiota", "PART OF"], ["aluminum", "Alzheimer's disease", "INFLUENCE"], ["HgS", "behavioral dysfunction", "INFLUENCE"], ["LPS", "Neurodegenerative diseases", "INFLUENCE"], ["low-FODMAP diet", "intestinal bowel syndrome", "INFLUENCE"], ["gut microbiota", "type 2 diabetes patients", "LOCATED IN"], ["antidepressant", "MDD", "CHANGE EFFECT"], ["\"abnormal\" microbiota", "Parkinson's disease", "IS LINKED TO"], ["Parkinson's disease", "fatigue", "AFFECT"], ["kidney dysfunction", "autistic individuals", "TARGET"], ["colon", "mice", "LOCATED IN"], ["Polyphenols", "beneficial bacteria", "IMPACT"], ["Prevotellaceae", "PD patients", "LOCATED IN"], ["Gut Microbiota", "intestinal epithelial surface", "LOCATED IN"], ["LAC", "stress-induced learned helplessness", "INFLUENCE"], ["human gut microbiome", "human brain", "LOCATED IN"], ["Parabateroides Merdae", "gut microbiota", "PART OF"], ["Herpesvirus", "gut dysbiosis", "INFLUENCE"], ["GI issues", "GI-B", "TARGET"], ["gut microbiota", "CNS diseases", "IS LINKED TO"], ["microbiota", "NDDs", "IS LINKED TO"], ["fecal calprotectin", "pro-inflammatory gut microbial genera", "IMPACT"], ["mental disorders", "Actinobacteria", "CHANGE ABUNDANCE"], ["sphingolipid", "IBD", "INFLUENCE"], ["Gut microbiota", "age-related diseases", "IS LINKED TO"], ["intestinal epithelial barrier", "mice", "LOCATED IN"], ["gut", "adult human", "LOCATED IN"], ["Western diet", "dysregulation of the microbiota", "INFLUENCE"], ["psychiatric disorders", "youth", "TARGET"], ["microbial dysbiosis", "dementia", "AFFECT"], ["gut microbiome", "IBS", "IS LINKED TO"], ["microbial community", "host", "LOCATED IN"], ["disorder of neuroinflammation", "depression- and anxiety-like behaviors", "AFFECT"], ["Piperine", "Parkinson's disease", "INFLUENCE"], ["order Bifidobacteriales", "CCL2", "CHANGE EXPRESSION"], ["A53T transgenic monkeys", "targeted gas chromatography", "USED BY"], ["gastrointestinal tract", "host", "LOCATED IN"], ["depressive disorders", "infant gastrointestinal complaints", "AFFECT"], ["(R)-ketamine", "CSDS-susceptible mice", "ADMINISTERED"], ["gut microbiota", "healthy controls", "LOCATED IN"], ["depression", "mothers", "TARGET"], ["antioxidants", "oxidative stress", "INFLUENCE"], ["GM", "SCRD", "IS LINKED TO"], ["Probiotics", "psychiatric patients", "ADMINISTERED"], ["mild stress (CUMS) group", "sequencing 16S rDNAs", "USED BY"], ["PD", "Faecalibacterium", "CHANGE ABUNDANCE"], ["microbiota-derived metabolites", "Alzheimer's disease", "INFLUENCE"], ["PFC", "C57BL/6J mice", "LOCATED IN"], ["Prediabetes", "People", "TARGET"], ["medications", "PD", "CHANGE EFFECT"], ["Bifidobacterium pseudocatenulatum", "bacterial taxa", "INTERACT"], ["breast milk microbiota", "breastfeeding group", "LOCATED IN"], ["N-methyl-d-aspartate glutamate receptor (NMDAR)-enhancing agents", "cognition", "CHANGE EFFECT"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "Clostridaceae species", "IMPACT"], ["bacteria", "inflammation", "INFLUENCE"], ["metabolites", "Gut microbiota", "PRODUCED BY"], ["Kineothrix", "gut microbiota", "PART OF"], ["PD", "disruption to mitochondria", "AFFECT"], ["<i>Helicobacter pylori</i>-related hyperhomocysteinemia", "neurodegenerative disorders", "AFFECT"], ["Hua-Feng-Dan", "Verrucomicrobiaceae", "IMPACT"], ["BCM-7", "type 1 diabetes", "INFLUENCE"], ["Blautia", "gut microbiota", "PART OF"], ["KD", "inflammation", "INFLUENCE"], ["Faecalibacterium", "positive emotionality", "INFLUENCE"], ["gut microbiome", "Egyptian patients", "LOCATED IN"], ["lipopolysaccharide", "ionized calcium-binding adapter molecule 1", "CHANGE EXPRESSION"], ["low carbohydrate", "ALS", "INFLUENCE"], ["honey", "infection-causing bacteria", "IMPACT"], ["depression", "Streptococcaceae", "CHANGE ABUNDANCE"], ["Mediterranean diet", "IBS symptoms", "INFLUENCE"], ["mental health concerns", "emerging adult", "TARGET"], ["psychiatric diseases", "psychiatric patients", "TARGET"], ["microbiota-derived metabolites", "age-associated diseases", "INFLUENCE"], ["tight junction associated proteins", "mice colon", "LOCATED IN"], ["gut microbes", "Parkinson's disease", "IS LINKED TO"], ["probiotic", "mental health", "INFLUENCE"], ["increased enteric glial expression", "rats", "TARGET"], ["Verrucomicrobiaceae", "gut microbiome", "PART OF"], ["Lactobacillus", "intestinal microbiota", "PART OF"], ["gut microbial diversity", "patients", "LOCATED IN"], ["abnormal composition of gut microbiota", "Chrna7 knock-out (KO) mice", "TARGET"], ["probiotic", "depression", "INFLUENCE"], ["PD", "Genus <i>Akkermansia</i>", "CHANGE ABUNDANCE"], ["kynurenine", "Venous blood", "LOCATED IN"], ["Proteobacteria abundance in the fecal samples", "Sprague-Dawley (SD) rats", "TARGET"], ["Tianqi Pingchan Granule", "neurodegenerative disease", "CHANGE EFFECT"], ["Fusobacterium", "malnutrition", "INFLUENCE"], ["intestinal flora", "16S rRNA gene sequencing", "USED BY"], ["neurodegenerative diseases", "COVID-19 survivors", "TARGET"], ["controls", "next-generation sequencing approach", "USED BY"], ["\u03b1-synuclein protein", "nigral \u03b1-synuclein pathology", "INFLUENCE"], ["sleep disturbance", "AsA", "TARGET"], ["Probiotics", "PD", "INFLUENCE"], ["Alcohol use-associated alterations", "depression", "AFFECT"], ["patients", "real-time PCR", "USED BY"], ["Blautia", "PD patients", "LOCATED IN"], ["non-tremor dominant", "Lachnospira", "CHANGE ABUNDANCE"], ["attention deficit/hyperactivity disorder", "individuals", "TARGET"], ["Probiotics", "psychiatric diseases", "INFLUENCE"], ["constipation", "Gastrointestinal tract dysfunction", "IS A"], ["gut", "SZ patients", "LOCATED IN"], ["non-tremor dominant", "Coprococcus", "CHANGE ABUNDANCE"], ["TolC", "inner and outer membrane efflux pump factor proteins", "PART OF"], ["Protein synthesis", "metagenome", "CHANGE EXPRESSION"], ["DEHP", "diabetes", "INFLUENCE"], ["gut microbiota", "Metabolic Disease", "IS LINKED TO"], ["severe depression", "patients", "TARGET"], ["PD", "people", "TARGET"], ["Gut microbiome changes", "Alzheimer's disease", "AFFECT"], ["Antibiotics", "Parkinson's disease", "CHANGE EFFECT"], ["Gut microbiota composition", "16S rRNA sequencing", "USED BY"], ["Di-(2-ethylhexyl) phthalate", "glucose metabolism disorder", "INFLUENCE"], ["L. Planetarium 128", "ASD", "INFLUENCE"], ["d-form glutamate", "cognitive function", "INFLUENCE"], ["major depression disorder", "patients", "TARGET"], ["defensins", "neurodegenerative diseases", "INFLUENCE"], ["low carbohydrate", "Alzheimer's disease", "INFLUENCE"], ["NLRP3 inflammasome", "inflammatory bowel diseases", "INFLUENCE"], ["brain", "healthy controls", "LOCATED IN"], ["high and low vagal tone", "participants", "TARGET"], ["MDD", "GM", "CHANGE ABUNDANCE"], ["\u03b1-HgS-containing Hua-Feng-Dan", "pathological lesions in the brain", "CHANGE EFFECT"], ["neurological disorders", "rats", "TARGET"], ["genera", "PD", "INFLUENCE"], ["Alistipes", "Gut microbiota", "PART OF"], ["Stenotrophomonas", "neurodegenerative disorders", "INFLUENCE"], ["oral microbiota", "oral cavity", "LOCATED IN"], ["Cucurbitacin E", "Colonic Barrier Function Impairment", "INFLUENCE"], ["TH", "midbrain", "LOCATED IN"], ["Weeksellaceae", "AD oral microbiota", "PART OF"], ["altered bacterial metabolism", "reduced gut health", "AFFECT"], ["TMAO", "early stage PD", "INFLUENCE"], ["alterations", "PD patients", "TARGET"], ["flavonoids", "RA", "INFLUENCE"], ["depression", "FHWs", "TARGET"], ["NF-\u03baB", "gut inflammation", "INFLUENCE"], ["Piperine", "Alzheimer's disease", "INFLUENCE"], ["mPFC", "adult mice", "LOCATED IN"], ["KD", "CNS disorders", "INFLUENCE"], ["Probiotics", "Lactobacillus", "IMPACT"], ["GFLs", "heart", "LOCATED IN"], ["gut microbiota", "mental health-related illnesses", "IS LINKED TO"], ["DHA", "memory and cognition impairment", "INFLUENCE"], ["Adult specific pathogen free (SPF) Sprague-Dawley rats", "object recognition test", "USED BY"], ["specific neurotransmitters", "healthy adults", "LOCATED IN"], ["CsgA protein", "Parkinson's disease", "INFLUENCE"], ["demyelination", "subdiaphragmatic vagus nerve", "STRIKE"], ["live and inactivated L. plantarum CCFM8661", "Staphylococcus", "INTERACT"], ["Bifidobacterium", "gut flora", "PART OF"], ["Gut microbiota", "Alterations", "IS LINKED TO"], ["prebiotics", "MDD patients", "ADMINISTERED"], ["mercury", "late onset neuropathologies", "INFLUENCE"], ["phytic acid", "TREM2", "CHANGE EXPRESSION"], ["gamma-aminobutyric acid", "gut microbiota", "PRODUCED BY"], ["typically developing (TD) children", "blast shotgun metagenomic sequencing", "USED BY"], ["sex- and age-matched healthy controls", "16S rRNA sequencing", "USED BY"], ["GM", "OCD", "IS LINKED TO"], ["Cb", "PD", "INFLUENCE"], ["c_Actinobacteria", "IBS", "INFLUENCE"], ["individuals", "high-throughput sequencing", "USED BY"], ["increased intestinal permeability", "mice", "TARGET"], ["LDSD", "DCA", "INTERACT"], ["dietary fiber pectins", "gut health", "INFLUENCE"], ["increased CBF similarities", "sleep behaviors", "AFFECT"], ["succinate", "human gut microbiota", "PRODUCED BY"], ["neurotoxins", "late onset neuropathology", "INFLUENCE"], ["SGS", "depression-like behaviors", "INFLUENCE"], ["multidrug resistant bacteria", "GIP", "INTERACT"], ["A. muciniphila", "autism spectrum disorders", "INFLUENCE"], ["DA", "striatum", "LOCATED IN"], ["FD mice", "hippocampal proteomic analysis", "USED BY"], ["depression-Like behaviors", "mice", "TARGET"], ["saliva", "cisgender-heterosexuals", "LOCATED IN"], ["intestinal pathologic injury", "MPTP mice", "TARGET"], ["SNpc", "PD mice", "LOCATED IN"], ["Major Depressive Disorder", "Human Gut Microbiota", "CHANGE ABUNDANCE"], ["antibiotic-induced microbiome depletion", "adult mice", "TARGET"], ["typical development", "age-matched children", "TARGET"], ["rheumatoid arthritis", "patients", "TARGET"], ["lincosamides", "PD", "CHANGE EFFECT"], ["Adult specific pathogen free (SPF) Sprague-Dawley rats", "biochemical analysis", "USED BY"], ["NLRP3 activation", "CNS disorders", "AFFECT"], ["depressed/normal mother rats", "FMT", "USED BY"], ["remission group (patients with schizophrenia in remission)", "16S rRNA sequencing", "USED BY"], ["dietary polyphenols", "brain disorders", "INFLUENCE"], ["Neurocognitive dysfunction", "mood disorders", "AFFECT"], ["HFD-reduced", "LPS plus ROT induced neurotoxicity", "CHANGE EFFECT"], ["systemic inflammation", "adult mice", "TARGET"], ["Antibiotics", "Alzheimer's disease", "CHANGE EFFECT"], ["SND", "gut microbiota", "CHANGE ABUNDANCE"], ["F. rodentium", "depression- and anhedonia-like behaviors", "INFLUENCE"], ["esophageal cancer", "patients", "TARGET"], ["NLRP3 inflammasome", "neurologic disorders", "INFLUENCE"], ["GABA", "Children", "LOCATED IN"], ["fisetin", "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration", "CHANGE EFFECT"], ["unruptured IA", "patients", "TARGET"], ["glycan", "Depression", "INFLUENCE"], ["stress-induced injurious behaviors", "chickens", "TARGET"], ["ND", "hyperkinetic, and hypokinetic movements disorder", "AFFECT"], ["progressive parkinsonism", "non-human primates", "TARGET"], ["microbial dysbiosis", "OCD", "AFFECT"], ["Lachnospiraceae UCG-001", "SCZ", "INFLUENCE"], ["serum hormones", "gut microbiota composition", "IMPACT"], ["PD", "Bacteroides</i> phylum", "CHANGE ABUNDANCE"], ["gut microbiota", "central nervous system diseases", "IS LINKED TO"], ["bacterial genera", "gut microbiota richness", "PART OF"], ["immune response", "BBB", "STRIKE"], ["\u03b1-synuclein", "PD neuropathology", "INFLUENCE"], ["BD", "Lactobacillus", "CHANGE ABUNDANCE"], ["potentially pathogenic bacteria", "gut microbiota", "PART OF"], ["LPS", "Parkinson's disease", "INFLUENCE"], ["anxiety/depression", "depressed mothers", "TARGET"], ["intestinal milieu", "Parkinson's disease", "IS LINKED TO"], ["inulin supplementation", "mental health", "INFLUENCE"], ["hUCB-derived plasma", "substantia nigra pars compacta", "LOCATED IN"], ["polyphenols", "Parkinson's disease", "INFLUENCE"], ["Mitochondrial dysfunction", "neuronal diseases", "AFFECT"], ["groups", "UniFrac", "USED BY"], ["Bifidobacterium breve 207-1", "healthy adults", "LOCATED IN"], ["Helicobacter pylori", "gastrointestinal impairments", "INFLUENCE"], ["microbiota", "Alzheimer's", "IS LINKED TO"], ["gut microbiome", "neuropsychiatric disease", "IS LINKED TO"], ["low carbohydrate", "autism spectrum disorders", "INFLUENCE"], ["nutraceutical supplementations", "infant eczema", "INFLUENCE"], ["GM", "rats", "LOCATED IN"], ["Faecalibacterium", "Children", "LOCATED IN"], ["Peptostreptococcaceae", "gut microbiota", "PART OF"], ["Adiponectin", "adipose tissue", "LOCATED IN"], ["vaginal microbiome", "mental health parameters", "IS LINKED TO"], ["gut microbiota", "NS patients", "LOCATED IN"], ["restraint stress", "Adult specific pathogen free (SPF) Sprague-Dawley rats", "TARGET"], ["gut microbiota", "motor symptoms", "IS LINKED TO"], ["reproductive toxicity", "rodent", "TARGET"], ["multiple sclerosis", "SOD1 mice", "TARGET"], ["Adlercreutzia", "gut microbiome", "PART OF"], ["CKD", "Participants", "TARGET"], ["Gut microbiota", "midbrain", "LOCATED IN"], ["SR79", "Alzheimer's disease pathologies", "INFLUENCE"], ["Malnutrition", "geriatric populations", "TARGET"], ["subdiaphragmatic vagus nerve", "Chrna7 knock-out mice", "LOCATED IN"], ["manganese", "Alzheimer's disease", "INFLUENCE"], ["L. rhamnosus", "CUMS-induced depression-like behaviors", "INFLUENCE"], ["Roseburia hominis", "GM", "PART OF"], ["human microbiome", "PD patients", "LOCATED IN"], ["intestinal dysbacteriosis", "casein", "INTERACT"], ["interleukin (IL)-1\u03b2", "prefrontal cortex", "LOCATED IN"], ["sulforaphane glucosinolate", "gut microbiota", "IMPACT"], ["chemical pollutants", "microbiota", "IMPACT"], ["microbes", "epilepsy", "INFLUENCE"], ["<i>Lactobacillus plantarum</i> DP189", "Inflammation", "INFLUENCE"], ["common patterns", "Erysipelotrichaceae UCG-003", "CHANGE ABUNDANCE"], ["beneficial bacteria", "hormones", "INTERACT"], ["Actinobacteria phylum", "depressed mood", "INFLUENCE"], ["Zn", "Zn deficiency", "INFLUENCE"], ["human microbiome", "controls", "LOCATED IN"], ["GM", "GM disorders", "IS LINKED TO"], ["3-HBA", "intracellular \u03b1-syn seeding aggregation", "INFLUENCE"], ["PCOS", "women of childbearing age", "TARGET"], ["intestinal microbiota", "humans", "LOCATED IN"], ["Gut microbiota", "multiple sclerosis", "IS LINKED TO"], ["colonic microbiome", "MSA", "IS LINKED TO"], ["microbiota alterations", "psychotic illness", "AFFECT"], ["Cucurbitacin E", "Inflammation Response", "INFLUENCE"], ["dietary proteins and fats", "SCFAs", "INTERACT"], ["GM", "aging", "IS LINKED TO"], ["acupoints GB34", "PD mice", "LOCATED IN"], ["UC", "IBDs", "IS A"], ["proinflammatory cytokines", "colon", "LOCATED IN"], ["fecal microbiota", "healthy controls", "LOCATED IN"], ["gut microbiota", "Parkinson's", "IS LINKED TO"], ["Gut microbiota", "metagenomic sequencing", "USED BY"], ["social avoidance behaviors", "socially stressed mice", "TARGET"], ["inflammatory conditions", "brain", "STRIKE"], ["Gut microbes", "AD", "IS LINKED TO"], ["gut microbiota", "depressive symptoms", "IS LINKED TO"], ["neurodegenerative disease", "progressive impairment of motor and non-motor functions", "AFFECT"], ["microbiota-derived short-chain fatty acids", "depression", "INFLUENCE"], ["butyrate", "schizophrenia", "INFLUENCE"], ["Probiotics", "Viral Respiratory Infections", "INFLUENCE"], ["Parkinson's disease", "Lachinospiracea", "CHANGE ABUNDANCE"], ["Beclin-1", "hippocampus", "LOCATED IN"], ["synbiotic", "neuroprotection", "INFLUENCE"], ["stress", "gut microbes", "CHANGE ABUNDANCE"], ["BMAA", "SFB", "IMPACT"], ["human intestinal microbiota", "depression", "IS LINKED TO"], ["schizophrenia", "Patients", "TARGET"], ["intestinal flora", "mild metabolic disorders", "IS LINKED TO"], ["early PD", "Glyceraldehyde-3-phosphate dehydrogenase", "INTERACT"], ["Mediterranean Low Fodmap Diet", "Irritable Bowel Syndrome Symptoms", "INFLUENCE"], ["gut microbiome", "rRNA", "CHANGE EXPRESSION"], ["PD", "Lachnospiraceae", "CHANGE ABUNDANCE"], ["mild cognitive impairment", "patients", "TARGET"], ["microbiota", "gut dysbiosis", "IS LINKED TO"], ["coffee", "BBB tight junction protein occludin", "CHANGE EXPRESSION"], ["liver toxicity", "rodent", "TARGET"], ["psychobiotic strain", "hypnotic effects", "INFLUENCE"], ["5-HT", "GM", "IMPACT"], ["iRBD patients", "16S rRNA-seq", "USED BY"], ["Gut Microbiota", "Depression", "IS LINKED TO"], ["pollutants", "intestinal microbiota", "IMPACT"], ["altered gut microbiota", "inflammation and immune dysregulation", "IS LINKED TO"], ["MDD", "Roseburia hominis", "CHANGE ABUNDANCE"], ["Eggerthella", "positive emotionality", "INFLUENCE"], ["6-OHDA", "loss of dopaminergic neurons", "CHANGE EFFECT"], ["canine intestinal microbiota", "ulcerative histiocytic colitis", "IS LINKED TO"], ["Probiotics", "functional constipation", "INFLUENCE"], ["LPS", "Alzheimer's disease", "INFLUENCE"], ["Alzheimer's disease", "autoimmune diseases", "IS A"], ["GM", "BPSD", "IS LINKED TO"], ["metabolic conditions", "people", "TARGET"], ["Gut bacteria", "PD", "INFLUENCE"], ["polyphenols", "Alzheimer's disease", "INFLUENCE"], ["antibiotic treatments", "Parkinson's disease", "CHANGE EFFECT"], ["secondary bile acids", "gut microbiota", "IMPACT"], ["\u03b1-synuclein pathology", "patients", "TARGET"], ["bipolar disorder", "mental health and neurocognitive disorders", "IS A"], ["metabolite acetate", "long-term acetate deficiency", "INFLUENCE"], ["Phocea", "anxiety", "INFLUENCE"], ["depression", "obesity", "AFFECT"], ["gut microbiota metabolites", "gut", "LOCATED IN"], ["Selenomonadalesare", "insomnia", "INFLUENCE"], ["kynurenic acid", "gut microbiota", "PRODUCED BY"], ["leucine", "OSA", "INFLUENCE"], ["gut microbiome", "age-related diseases", "IS LINKED TO"], ["SR79", "6-OHDA-induced toxicity", "INFLUENCE"], ["gut microbiota diversity", "surgency", "IS LINKED TO"], ["Levodopa", "PD", "CHANGE EFFECT"], ["Bacteroidetes phylum", "gut microbiota", "PART OF"], ["zinc", "Zn deficiency", "INFLUENCE"], ["oral astilbin", "APAP-induced ALI", "INFLUENCE"], ["phylum Firmicutes", "gut microbiome", "PART OF"], ["Neurotensin", "brain", "LOCATED IN"], ["glaucoma", "patients", "TARGET"], ["gut microbiome", "assay techniques", "USED BY"], ["\u03b1-HgS-containing Hua-Feng-Dan", "Clostridaceae species", "IMPACT"], ["antibiotics", "microbiome", "IMPACT"], ["PD", "Flavonifractor", "CHANGE ABUNDANCE"], ["70W", "Verrucomicrobiaceae", "IMPACT"], ["gut microbiome", "pro-inflammatory variations", "IS LINKED TO"], ["Parkinson's Disease", "Gut Microbiome", "CHANGE ABUNDANCE"], ["microbiota-derived metabolites", "nervous system disorders", "INFLUENCE"], ["dysbiosis", "Graves' disease", "AFFECT"], ["Fe", "cancer-related bacteria", "IMPACT"], ["gut microbes", "disorders", "INFLUENCE"], ["Anthocyanins", "inflammation", "INFLUENCE"], ["Symprove\u2122", "PD", "INFLUENCE"], ["gut microbiota", "psychotic and affective disorders", "IS LINKED TO"], ["mice", "oral administration", "USED BY"], ["acetaminophen-induced acute liver injury", "mice", "TARGET"], ["NS8", "treatment-resistant depression", "INFLUENCE"], ["laxatives", "irritable bowel syndrome", "CHANGE EFFECT"], ["microbiota-derived short-chain fatty acids", "gut microbiota", "PRODUCED BY"], ["disturbance of gut microbiota", "mice", "TARGET"], ["Fusicatenibacter saccharivorans", "fecal metagenomes", "PART OF"], ["gut microbiome", "non-PD controls", "LOCATED IN"], ["short chain fatty acids", "striatum", "LOCATED IN"], ["Disruption of the intestinal microbiota", "neurodegenerative and behavioral disorders", "AFFECT"], ["Fe", "imbalance-inducing bacteria", "IMPACT"], ["microbial dysbiosis", "BPSD", "AFFECT"], ["C57BL/6J adult female mice", "open field and elevated plus test", "USED BY"], ["intestinal permeability", "CS patients", "TARGET"], ["IL-17", "gut dysbiosis", "INFLUENCE"], ["anxiety symptoms", "placebo group", "TARGET"], ["lipids", "PD", "INFLUENCE"], ["GBM", "Firmicutes", "CHANGE ABUNDANCE"], ["autism spectrum disorder", "individuals", "TARGET"], ["low carbohydrate", "ASDs", "INFLUENCE"], ["maternal fiber intake", "perinatal depression and anxiety", "INFLUENCE"], ["Collinsella", "DLB", "INFLUENCE"], ["Oral and gut dysbiosis", "Parkinson's disease", "AFFECT"], ["butyrate", "gut", "LOCATED IN"], ["gut microbiota", "synucleinopathies", "IS LINKED TO"], ["GI issues", "GI group", "TARGET"], ["Monkeys", "FEPPA PET scans", "USED BY"], ["gut neuropeptides", "Parkinson's disease", "INFLUENCE"], ["imbalance", "microbiota composition", "CHANGE ABUNDANCE"], ["MPTP", "PD", "INFLUENCE"], ["neurodegenerative diseases", "disease subpopulations", "TARGET"], ["Sodium butyrate", "autophagy", "INFLUENCE"], ["MDD", "Asian, Chinese group", "TARGET"], ["mental health depletion", "SCI patients", "TARGET"], ["Participants", "16S rRNA sequencing", "USED BY"], ["type 2 diabetes-like phenotype", "TALLYHO/JngJ mice", "TARGET"], ["Lactobacillus", "multiple sclerosis", "INFLUENCE"], ["AD", "MCI", "AFFECT"], ["Rikenellaceae_RC9_gut_group", "gut microbiota", "PART OF"], ["systemic inflammation", "CIA mice", "TARGET"], ["microbial disorders", "Parkinson's disease", "AFFECT"], ["Gut Microbiota", "Irritable Bowel Syndrome", "IS LINKED TO"], ["curcumin", "vacuolar degeneration", "INFLUENCE"], ["lipopolysaccharide", "amyotrophic lateral sclerosis", "INFLUENCE"], ["mental disorder", "Patients", "TARGET"], ["psychobiotics", "chronic stress", "INFLUENCE"], ["ketogenic diet", "PD", "INFLUENCE"], ["probiotics supplement", "migraine headache", "INFLUENCE"], ["patients", "FPI", "USED BY"], ["Parkinson's disease", "Coprococcus eutactus", "CHANGE ABUNDANCE"], ["Bifidobacterium breve 207-1", "specific neurotransmitters", "INTERACT"], ["reduced sensitivity to PROP", "bacteria", "CHANGE ABUNDANCE"], ["Colon cancer-related anemia", "colon cancer", "AFFECT"], ["microbiota-derived metabolites", "Parkinson's disease", "INFLUENCE"], ["CsgA", "gut", "LOCATED IN"], ["mental disorders", "children", "TARGET"], ["C. sporogenes", "levodopa", "INTERACT"], ["gut microbiome", "CFC patients", "LOCATED IN"], ["Polyphenols", "NND", "INFLUENCE"], ["Parkinson's disease", "misfolded alpha-synuclein", "INTERACT"], ["monozygotic twin", "Fecal samples", "USED BY"], ["Zn2+", "diabetes mellitus type 2", "INFLUENCE"], ["AGP treatments", "Birds", "ADMINISTERED"], ["Diet", "neurological diseases", "INFLUENCE"], ["depression", "microbiomes", "CHANGE ABUNDANCE"], ["changes in lipid metabolism", "cognitive impairment", "AFFECT"], ["calorie-controlled diets", "Alzheimer's disease", "INFLUENCE"], ["gut microbiota", "atherosclerosis", "IS LINKED TO"], ["apathy-like behavior", "Transgenic mice", "TARGET"], ["Faecalibacterium prausntizii", "GM", "PART OF"], ["chronic SD", "g_Cetobacterium", "CHANGE ABUNDANCE"], ["endocannabinoid palmitoylethanolamide", "anhedonia/amotivation", "INFLUENCE"], ["PFC", "NOD mice", "LOCATED IN"], ["vaccine", "psychiatric problems", "CHANGE EFFECT"], ["Probiotic Supplementation", "6-OHDA-Induced Motor Deficit", "INFLUENCE"], ["Dcf1<sup>-/-</sup>", "mice", "TARGET"], ["chronic insomnia disorder", "anxiety", "AFFECT"], ["dysbiosis of the gastrointestinal tract", "nonalcoholic fatty liver disease", "AFFECT"], ["host gut microbiome", "PD", "IS LINKED TO"], ["gut microbiota", "chronic health conditions", "IS LINKED TO"], ["piperine", "transient receptor potential vanilloid 1 proinflammatory cytokine", "INTERACT"], ["gut microbiome", "TLE", "IS LINKED TO"], ["amino acid", "central nervous system", "LOCATED IN"], ["gut microbiome", "posttraumatic stress disorder", "IS LINKED TO"], ["dietary and/or therapeutic interventions", "PD", "INFLUENCE"], ["Depression", "Bifidobacterium spp.", "CHANGE ABUNDANCE"], ["AGEs", "side-chain amino groups", "INTERACT"], ["human fear behavior", "infancy", "TARGET"], ["beneficial proteins", "microbiota", "IMPACT"], ["LBP", "systemic inflammation", "INFLUENCE"], ["low carbohydrate", "gut microbes", "IMPACT"], ["Gut Microbiota", "Aging Related Neurodegenerative Disorders", "IS LINKED TO"], ["gut microbiota", "central nervous system (CNS) disorders", "IS LINKED TO"], ["Roseburia", "PD-associated microbiota", "PART OF"], ["depression-prone mice", "swimming tests", "USED BY"], ["Vagal Tone", "Gut Microbiota", "CHANGE ABUNDANCE"], ["PD", "A53T transgenic monkeys", "TARGET"], ["CA", "MPTP-induced microbial dysbiosis", "INFLUENCE"], ["plasma cytokines", "gut microbiota", "IMPACT"], ["obesity", "people", "TARGET"], ["coffee", "Bax", "CHANGE EXPRESSION"], ["microbiota-derived short-chain fatty acids", "neuromyelitis optica spectrum disorders", "INFLUENCE"], ["gut microbial dysbiosis", "PD", "AFFECT"], ["neuroinflammation", "Injury to neurons", "AFFECT"], ["EGCG", "Parkinson's disease", "INFLUENCE"], ["Chronic Sleep Deprivation", "Rats", "TARGET"], ["gut microbiota", "MDD", "IS LINKED TO"], ["gut microbiota metabolites", "multiple sclerosis", "INFLUENCE"], ["Clostridium", "control", "LOCATED IN"], ["intestinal flora", "insomnia", "IS LINKED TO"], ["neurotransmitters", "essential metabolites", "INTERACT"], ["psychobiotics", "microbiota", "IMPACT"], ["controls", "Faecal microbiota analysis", "USED BY"], ["Pronicromonosporaceae", "gut microbiomes", "PART OF"], ["Dopamine", "neurological diseases", "INFLUENCE"], ["LPS", "inflammation", "INFLUENCE"], ["oral and gut microbiota", "gastrointestinal tract", "LOCATED IN"], ["\u03b2-HgS-containing 70W", "pathological lesions in the brain", "CHANGE EFFECT"], ["depression-like behaviors", "Chrna7 knock-out (KO) mice", "TARGET"], ["gut microbiota", "chickens", "LOCATED IN"], ["Kineothrix alysoides", "anxiety-like behaviour", "INFLUENCE"], ["gut microbiota", "immune function", "IS LINKED TO"], ["Helicobacter hepaticus", "gut microbiota", "PART OF"], ["nutritional deficiencies", "neurodevelopmental disorders", "AFFECT"], ["inflammation", "depression", "AFFECT"], ["Irritable bowel syndrome", "chronic debilitating issues", "IS A"], ["reduced synaptic plasticity", "mice", "TARGET"], ["MeDiet", "cognitive decline", "INFLUENCE"], ["oral and gut microbiome", "PD patients", "LOCATED IN"], ["probiotic", "energy metabolism", "INFLUENCE"], ["lipopolysaccharide", "Pronicromonosporaceae", "IMPACT"], ["symptoms and radiological signs suggestive of intestinal obstruction", "PIPO", "AFFECT"], ["protein synthesis", "intestinal microbiome", "IMPACT"], ["high vagal tone", "acetate", "INTERACT"], ["Human gut microbiota", "neurodegenerative diseases", "IS LINKED TO"], ["HFD-original", "neurodegenerative diseases", "CHANGE EFFECT"], ["functional microbiota", "controls", "LOCATED IN"], ["Prevotella copri", "Parkinson's disease", "INFLUENCE"], ["migraine", "gut microbiota", "CHANGE ABUNDANCE"], ["shrimp head hydrolysate", "gut microbiota", "IMPACT"], ["gut microbiota metabolites", "stroke", "INFLUENCE"], ["Malnutrition", "Parkinson disease", "AFFECT"], ["helminth infection", "children", "TARGET"], ["bacteria", "short-chain fatty acids", "INTERACT"], ["Antibiotics", "gut microbiota dysbiosis", "CHANGE EFFECT"], ["gut microbiome", "anxiety disorders", "IS LINKED TO"], ["Chronic Mild Stress", "Mice", "TARGET"], ["Zinc", "neurodegenerative and neurodevelopmental disorders", "INFLUENCE"], ["fecal short chain fatty acids", "colon", "LOCATED IN"], ["BAs", "depression", "INFLUENCE"], ["gastrointestinal (GI) disorders", "Autoimmunity", "AFFECT"], ["Long-chain <i>n</i>-3 fatty acids", "psychotic and mood disorders", "INFLUENCE"], ["gut microbiota", "FMT", "USED BY"], ["Parkinson's disease patients", "quantitative PCR", "USED BY"], ["PET tracers", "sterile or pathogen-mediated infection", "INFLUENCE"], ["LC-3B", "hippocampus", "LOCATED IN"], ["anti-inflammatory cytokines", "parkinsonian symptoms", "INFLUENCE"], ["gastrointestinal upset", "people", "TARGET"], ["GABA", "probiotic groups", "IMPACT"], ["butyrate", "nervous system disorders", "INFLUENCE"], ["elevated depressive symptoms", "women", "TARGET"], ["drugs", "exogenous depression", "CHANGE EFFECT"], ["Proteobacteria", "MPTP group", "INTERACT"], ["multiple sclerosis", "gut microbiota", "CHANGE ABUNDANCE"], ["DSS", "S24-7", "IMPACT"], ["high levels of stress and depressive symptoms", "women", "TARGET"], ["Escherichia", "Women with high perceived stress", "LOCATED IN"], ["prebiotics", "stress resistance", "INFLUENCE"], ["gut microbiome", "aged rats", "LOCATED IN"], ["Psychobiotics", "attention deficit hyperactivity disorder", "INFLUENCE"], ["rats", "oral pharmacokinetics", "USED BY"], ["gut microbes", "autism spectrum disorders", "IS LINKED TO"], ["gut flora", "physiologic response to traumatic injury", "IS LINKED TO"], ["Enterococcus faecalis", "PD therapy", "INFLUENCE"], ["dopaminergic neuronal loss", "SNpc", "STRIKE"], ["Parkinson's disease", "Parkinson's disease patients", "TARGET"], ["arginine", "PD patients", "LOCATED IN"], ["gut microbiota", "cognitive or brain function", "IS LINKED TO"], ["stress", "dysbiosis", "AFFECT"], ["short-chain fatty acid", "Blautia", "IMPACT"], ["PD", "Bacteroides", "CHANGE ABUNDANCE"], ["esophageal carcinoma patients", "gut microbiota", "CHANGE ABUNDANCE"], ["butyrate", "amyotrophic lateral sclerosis", "INFLUENCE"], ["short-chain fatty acids", "neurological disorders", "INFLUENCE"], ["Crohn's disease", "idiopathic disorders", "IS A"], ["gut microbiome", "16S rRNA analysis", "USED BY"], ["gut microbiome", "untargeted liquid chromatography-mass spectrometry-based metabolic profiling approach", "USED BY"], ["Altered Gut Microbiota Composition", "Difficulty in Explicit Emotion Regulation", "AFFECT"], ["Ruminococcus", "PD-MCI group", "LOCATED IN"], ["gut bacteria", "depressive behavior", "INFLUENCE"], ["probiotics", "dysbiosis", "INFLUENCE"], ["short-chain fatty acid", "gut microbiome", "PRODUCED BY"], ["PD", "rats", "TARGET"], ["lipid metabolites", "homeostatic protein components", "INTERACT"], ["Toll-like receptors", "Parkinson's disease", "INFLUENCE"], ["herpesvirus", "inflammation", "INFLUENCE"], ["PD", "elderly patients", "TARGET"], ["tetracyclines", "Alzheimer's and Parkinson's disease", "CHANGE EFFECT"], ["melanin", "ovaries", "LOCATED IN"], ["serotonin", "gut microbiota", "IMPACT"], ["antibiotic treated animals", "immunohistochemistry", "USED BY"], ["nitrites", "gut", "LOCATED IN"], ["gut microbiota composition", "neurodevelopmental disorders", "IS LINKED TO"], ["Multiple sclerosis", "disability", "AFFECT"], ["depression", "SCI patients", "TARGET"], ["PD and healthy controls", "GC-MS", "USED BY"], ["gut microbiota", "CIA mice", "LOCATED IN"], ["Gut dysbiosis biomarkers", "Parkinson's disease", "INFLUENCE"], ["gastrointestinal microbiota", "brain", "LOCATED IN"], ["gut microbiota", "psychiatrically unaffected individuals", "LOCATED IN"], ["trehalose", "mice", "LOCATED IN"], ["gamma-aminobutyric acid", "metabolites", "PART OF"], ["Dysregulation of gut microbiota-host bile acid (BA) co-metabolism", "diarrhea-predominant irritable bowel syndrome", "AFFECT"], ["stress", "neuropsychiatric disorders", "AFFECT"], ["prebiotics", "gut microbiota alterations", "INFLUENCE"], ["AD", "neurodegenerative disease", "IS A"], ["gut microbiota metrics", "groups", "TARGET"], ["psychoactive metabolites", "gut microbiota", "PRODUCED BY"], ["antidiarrheals", "irritable bowel syndrome", "CHANGE EFFECT"], ["gut microbiota", "AD-induced <i>Drosophila</i>", "LOCATED IN"], ["GABA", "mental health disorders", "INFLUENCE"], ["human gut microbiota", "nervous system disturbances", "IS LINKED TO"], ["Collinsella", "Alzheimer's disease", "INFLUENCE"], ["gut microbiota", "Parkinson's Disease", "IS LINKED TO"], ["succinate", "anxiety", "INFLUENCE"], ["therapeutic", "inflammation", "CHANGE EFFECT"], ["commensal bacteria", "Parkinson's disease", "INFLUENCE"], ["intestinal flora", "intestinal mucosal barrier condition", "IS LINKED TO"], ["trichloroethylene", "Parkinsonian pathology", "INFLUENCE"], ["gut microbiota", "adult mice", "LOCATED IN"], ["gut microbiota", "psychiatric and neurodegenerative disorders", "IS LINKED TO"], ["PD", "oxidative stress", "AFFECT"], ["gut microbiota", "Sprague-Dawley (SD) rats", "LOCATED IN"], ["substantia nigra", "C57BL/6 mice", "LOCATED IN"], ["microbial dysbiosis", "obsessive-compulsive disorder", "AFFECT"], ["SARS-CoV-2", "gut microbiota", "CHANGE ABUNDANCE"], ["personalized diet", "AD", "INFLUENCE"], ["lead", "late onset neuropathologies", "INFLUENCE"], ["demyelination", "MS patients", "TARGET"], ["Gut Microbiota", "Parkinson's disease", "IS LINKED TO"], ["\u03b1-synuclein pathology", "Parkinson's disease", "AFFECT"], ["Ketones bodies", "inflammation", "INFLUENCE"], ["gut microbiota", "women during pregnancy and postpartum", "LOCATED IN"], ["controls", "16S rRNA sequencing", "USED BY"], ["Gut microbiota", "PD and healthy controls", "LOCATED IN"], ["depression-like behaviors", "Chrna7 KO mice", "TARGET"], ["antibiotic", "gut microbiota", "IMPACT"], ["Bacteroides genus", "gut microbiota", "PART OF"], ["Agathobaculum butyriciproducens", "Parkinson's Disease", "INFLUENCE"], ["Bacteroides-dominant enterotype", "ET", "IS LINKED TO"], ["altered microbiota", "behavioral phenotypes", "IS LINKED TO"], ["Chronic Stress", "Growth-Period Mice", "TARGET"], ["anxiety", "men", "TARGET"], ["short-chain fatty acids", "Parkinson's disease", "INFLUENCE"], ["microbiota", "depression", "IS LINKED TO"], ["gut microbiome", "cancer", "IS LINKED TO"], ["Parkinson's disease", "pain", "AFFECT"], ["aberrant cognitive function, emotion regulation, and interoception", "unmedicated patients with depressed bipolar disorder", "TARGET"], ["patients", "16S RNA method", "USED BY"], ["gut microbiota", "offspring", "LOCATED IN"], ["Crohn's disease", "IBDs", "IS A"], ["CsgA protein", "gut", "LOCATED IN"], ["intestinal microbial metabolites", "Alzheimer's and Parkinson's diseases", "INFLUENCE"], ["human microbiota", "airways", "LOCATED IN"], ["bile acids", "stroke", "INFLUENCE"], ["Cb", "microglia activation", "INFLUENCE"], ["specific gut bacteria", "promising therapeutic option", "INFLUENCE"], ["microbiota", "bladder", "LOCATED IN"], ["depression", "socially stressed mice", "TARGET"], ["PD", "gut bacterial species", "CHANGE ABUNDANCE"], ["anxiety symptoms", "NVP-1704 group", "TARGET"], ["PMAD", "child", "TARGET"], ["gut microbiota", "rodents", "LOCATED IN"], ["KRG", "Ruminococcus", "IMPACT"], ["Secondary metabolic disturbances", "patients", "TARGET"], ["BDNF", "striatum", "LOCATED IN"], ["nicotinic acid", "gut microbiota", "PRODUCED BY"], ["affected brain regions", "PD patients", "LOCATED IN"], ["GABA", "metabolites", "PART OF"], ["gut microbiota", "V4 16S rRNA gene sequencing", "USED BY"], ["autism spectrum disorders", "ASD group", "TARGET"], ["CKD", "Lachnospira", "CHANGE ABUNDANCE"], ["realgar", "LPS plus rotenone-induced neurotoxicity", "INFLUENCE"], ["Short-Chain Fatty Acid-Producing Gut Microbiota", "Parkinson's Disease", "INFLUENCE"], ["Gram-negative bacteria", "Lipopolysaccharide", "INTERACT"], ["Actinobacteria", "depression", "INFLUENCE"], ["GP", "targeted liquid chromatography mass spectrometry method", "USED BY"], ["low carbohydrate", "epilepsy", "INFLUENCE"], ["HVA", "SNpc", "LOCATED IN"], ["medication", "PD", "CHANGE EFFECT"], ["fermented foods", "chronic diseases", "INFLUENCE"], ["colonic microbiome", "NMO", "IS LINKED TO"], ["environmental pollutants", "neurological and overall mental health", "INFLUENCE"], ["neuronal integrity", "brain regions", "STRIKE"], ["4EPS", "increased intestinal permeability", "INFLUENCE"], ["BCM-7", "cardiovascular diseases", "INFLUENCE"], ["KD", "epileptic encephalopathies", "INFLUENCE"], ["Prebiotic Nutraceutical Supplementations", "Non-communicable Disorders", "INFLUENCE"], ["70W", "pathological lesions in the brain", "CHANGE EFFECT"], ["ethanol exposure", "maternal gut microbiota", "CHANGE ABUNDANCE"], ["PD", "Corynebacteria", "CHANGE ABUNDANCE"], ["tryptophan", "brain", "LOCATED IN"], ["gut microbiome", "depression", "IS LINKED TO"], ["piperine", "multidrug resistance protein 1", "INTERACT"], ["antibiotics", "depression", "CHANGE EFFECT"], ["gut microbiome", "AI", "IS LINKED TO"], ["coronavirus disease 2019", "PD", "AFFECT"], ["intestinal microflora", "ELISA kit", "USED BY"], ["chronic SD", "p_Fusobacteria", "CHANGE ABUNDANCE"], ["systemic inflammation", "host", "TARGET"], ["autism-like behavior", "wild-type mice", "TARGET"], ["Intestinal Microbiota", "Psychopathologies", "IS LINKED TO"], ["microbiota", "ileum", "LOCATED IN"], ["anxiety", "non-depressed groups", "TARGET"], ["<i>L. plantarum</i> DP189", "TNF-\u03b1", "INTERACT"], ["Alzheimer's disease", "neurodegenerative central nervous system disorders", "IS A"], ["CD4", "ileum", "LOCATED IN"], ["NVP-1704", "Enterobacteriaceae", "IMPACT"], ["Breast Milk Microbiota", "Infant Gut Microbiota", "COMPARED TO"], ["motor deficits", "ASO mice", "TARGET"], ["Polyphenols", "Neurodegenerative Diseases", "INFLUENCE"], ["4-Ethylphenol", "gut", "LOCATED IN"], ["\u03b1-LA", "obesity", "INFLUENCE"], ["Di-(2-ethylhexyl) phthalate", "toxicity", "INFLUENCE"], ["lipopolysaccharide", "<i>Desulfovibrio</i> bacteria", "IMPACT"], ["Disturbances of circulating amino acids", "patients", "TARGET"], ["acetate", "stroke", "INFLUENCE"], ["SHH", "Muribaculaceae", "IMPACT"], ["gut microbiome", "healthy adults", "LOCATED IN"], ["gut flora", "neurodegenerative disease", "IS LINKED TO"], ["patients", "double-blind, randomized, placebo-controlled trial", "USED BY"], ["DBD high dosage", "Lachnospiraceae", "IMPACT"], ["idiopathic hypersomnia", "patients", "TARGET"], ["Parkinson's microbiota", "increased proteolytic fermentation", "IS LINKED TO"], ["altered microbiome", "immune dysregulation", "IS LINKED TO"], ["celiac disease", "people", "TARGET"], ["\u03b1-Lactalbumin", "Polycystic Ovary Syndrome", "INFLUENCE"], ["cinnabar", "LPS plus rotenone-induced neurotoxicity", "INFLUENCE"], ["prebiotics", "immune diseases", "INFLUENCE"], ["probiotics", "gut microbiome", "IMPACT"], ["CA", "polyphenolic acid", "PART OF"], ["H. pylori", "neurological disorders", "INFLUENCE"], ["antibiotic growth promotants", "poultry gut microbiome", "IMPACT"], ["microbiota", "brain disorders", "IS LINKED TO"], ["prebiotics", "obesity", "INFLUENCE"], ["plasma indoleamine-2,3-dioxygenase", "Venous blood", "LOCATED IN"], ["microbiota", "psychiatric disorders", "IS LINKED TO"], ["Lachnospiraceae NK4A136 group", "malnutrition", "INFLUENCE"], ["dysbiosis", "neurodegenerative disease", "AFFECT"], ["boron", "neurodegenerative diseases", "INFLUENCE"], ["schizophrenia", "UCG005", "CHANGE ABUNDANCE"], ["Di-(2-ethylhexyl) phthalate", "abundance of potential pathogens and microbial genes", "INFLUENCE"], ["sulforaphane glucosinolate", "behavioral abnormalities", "INFLUENCE"], ["severe organ damage", "SD rats", "TARGET"], ["PD", "Lactobacillus", "CHANGE ABUNDANCE"], ["cognitive impairment", "SCFA receptor knockout mice", "TARGET"], ["fecal microbiota", "FMT", "USED BY"], ["gut microbiota", "control monkeys", "LOCATED IN"], ["depression", "Korean population", "TARGET"], ["temperament", "preschool children", "TARGET"], ["oxidative stress", "maternal microbiota", "CHANGE ABUNDANCE"], ["gut microbiome", "gene set", "CHANGE EXPRESSION"], ["PM", "Fibrobacteres", "IMPACT"], ["Bacteroidescaecimyris", "gut microbiota", "PART OF"], ["Coffee", "MPTP-Induced Motor Deficits", "INFLUENCE"], ["acetate", "stress", "INFLUENCE"], ["MPTP", "intestinal pathology", "INFLUENCE"], ["Gut Microbiota Dysbiosis", "Alzheimer's disease", "AFFECT"], ["prebiotic PM", "GM", "IMPACT"], ["Eggerthella lenta", "gut microbiota", "PART OF"], ["dysbiosis", "CNS pathologies", "AFFECT"], ["bacteria", "infectious diseases", "INFLUENCE"], ["Bipolar disorder", "disability", "AFFECT"], ["PVD", "cardiovascular disease", "AFFECT"], ["dietary sources", "chronic low-grade gut inflammation", "INFLUENCE"], ["Piperine", "voltage-gated K+ current", "INTERACT"], ["DEHP", "severe organ damage", "INFLUENCE"], ["bacterial genera", "gut microbiota", "PART OF"], ["probiotics", "respiratory infections", "INFLUENCE"], ["healthy donor", "infusion of fecal matter", "USED BY"], ["prodromal and treatment-na\u00efve de novo PD subjects", "multi-omics assessments", "USED BY"], ["Gut dysbiosis", "Alzheimer's disease", "AFFECT"], ["gut microbiome", "antidepressant resistance", "IS LINKED TO"], ["Parkinson's disease", "LGG", "CHANGE ABUNDANCE"], ["asparagine endopeptidase", "\u03b1-Synuclein N103", "CHANGE EXPRESSION"], ["gut microbiota", "depression-like behaviors", "IS LINKED TO"], ["upward and downward 150 mT SMF groups", "behavioral tests", "USED BY"], ["cancer", "women", "TARGET"], ["depressive symptoms", "Chinese and Korean American immigrants", "TARGET"], ["bacteria", "metabolites", "INTERACT"], ["MDD", "Roseburia intestinalis", "CHANGE ABUNDANCE"], ["gut microbiota", "substance use disorder", "IS LINKED TO"], ["Gut microbiota composition", "psychiatric disorders", "IS LINKED TO"], ["sulfonamides", "PD", "CHANGE EFFECT"], ["K01667", "MDD group", "LOCATED IN"], ["inflammation", "plasma short-chain fatty acids", "INTERACT"], ["gut microbiota", "intestinal tract", "LOCATED IN"], ["ketogenic diet", "neurological diseases", "INFLUENCE"], ["Inulin", "anxiety", "INFLUENCE"], ["gut microbiome", "brain disorders", "IS LINKED TO"], ["dyskinesia", "patients", "TARGET"], ["five compositional different metabolites", "gut microbiota", "PRODUCED BY"], ["Gut Microbiota", "Neurological and Psychiatric Disorders", "IS LINKED TO"], ["dysbiosis", "patient", "TARGET"], ["LL1 + silymarin capsule supplementation", "overweight adults", "ADMINISTERED"], ["gut microbiota", "rheumatoid arthritis", "IS LINKED TO"], ["circadian rhythm disorders", "participants", "TARGET"], ["motor fluctuations", "patients", "TARGET"], ["gut metabolome", "gut microbiota", "PRODUCED BY"], ["Parkinson's disease", "classic motor symptoms", "AFFECT"], ["Acne vulgaris", "patients", "TARGET"], ["chronic SD", "gut microbiome", "CHANGE ABUNDANCE"], ["Gut microbiota", "microglia", "LOCATED IN"], ["epigenetic inheritance", "offspring", "TARGET"], ["medial prefrontal cortex", "adult mice", "LOCATED IN"], ["mental disorders", "gut microbiota", "CHANGE ABUNDANCE"], ["Ruminococcaceae", "controls", "LOCATED IN"], ["Symprove\u2122", "neuroinflammation", "INFLUENCE"], ["biliary abnormalities", "PD pathogenesis", "AFFECT"], ["dysbiosis of the gastrointestinal tract", "Gastric and esophageal cancer", "AFFECT"], ["mental health issues", "emerging adults", "TARGET"], ["26 healthy controls", "MRI scanning", "USED BY"], ["Multiple sclerosis", "central nervous system", "STRIKE"], ["gut microbial dysbiosis", "pathogenic microbial metabolites", "INTERACT"], ["succinate", "depression", "INFLUENCE"], ["MPTP", "dopaminergic (DAergic) neuron injury and inflammation", "CHANGE EFFECT"], ["phenylalanine", "PD patients", "LOCATED IN"], ["gut microbiota metabolite propionate", "intestinal epithelial barrier dysfunction-mediated Parkinson's disease", "INFLUENCE"], ["probiotic supplementation", "Fusicatenibacter saccharivorans", "IMPACT"], ["LPS plus ROT induced neurotoxicity", "rats", "TARGET"], ["host microbiome", "neuropsychiatric disorders", "IS LINKED TO"], ["gut microbiota", "Chronic intestinal pseudo-obstruction", "IS LINKED TO"], ["A53T monkeys", "targeted gas chromatography", "USED BY"], ["periodontitis", "neuropsychiatric disorders", "AFFECT"], ["human gut microbiota", "COVID-19", "IS LINKED TO"], ["Alistipes", "fecal microbiome", "PART OF"], ["iRBD", "mucin-layer-degrading genus <i>Akkermansia</i>", "CHANGE ABUNDANCE"], ["caecal microbiota", "T-cell-depleted group", "LOCATED IN"], ["PD appendix", "PD patients", "LOCATED IN"], ["gut microbiome", "men and women over 40 years old", "LOCATED IN"], ["Gastric <i>Helicobacter suis</i> Infection", "Neurotoxicity", "AFFECT"], ["healthy volunteers", "Comparative taxonomic analysis", "USED BY"], ["depressive symptoms", "placebo group", "TARGET"], ["\u03b1-Synuclein pathology", "SNCA mice", "TARGET"], ["gut microbiota diversity", "temperament", "IS LINKED TO"], ["food bioactive compounds", "depression", "INFLUENCE"], ["gut microbiota", "severe mental illness", "IS LINKED TO"], ["anti-inflammatory metabolites", "gut microbial ecologies", "PRODUCED BY"], ["IL-6", "chronic social defeat", "INFLUENCE"], ["4EPS", "anxiety phenotype", "INFLUENCE"], ["age-associated diseases", "older individuals", "TARGET"], ["melanin", "arteries", "LOCATED IN"], ["healthy controls", "16S rRNA gene amplicon sequencing", "USED BY"], ["Gut microbiota", "shotgun metagenomic sequencing", "USED BY"], ["<i>L. plantarum</i> DP189", "Nrf2", "CHANGE EXPRESSION"], ["triphala polyphenols", "cognitive impairment", "INFLUENCE"], ["metabolites", "stress", "INFLUENCE"], ["probiotic formulation", "depressive symptoms", "INFLUENCE"], ["Kefir", "genus <i>Holdemania</i>", "IMPACT"], ["\u03b2-HgS-containing 70 Wei-Zhen-Zhu-Wan", "Parkinson's disease", "CHANGE EFFECT"], ["Mitochondrial dysfunction", "chronic fatigue syndrome", "AFFECT"], ["gastric disturbances", "PD patients", "TARGET"], ["QUR", "Insulin resistance", "INFLUENCE"], ["mitochondrial function", "brain", "STRIKE"], ["gut microbiome", "neurological conditions", "IS LINKED TO"], ["metformin", "A. muciniphila", "IMPACT"], ["gut microbiota", "people", "LOCATED IN"], ["legumes", "neurological diseases", "INFLUENCE"], ["abnormal aggregation", "intestine", "STRIKE"], ["Veillonella atypica", "SDS or BDI-II scores", "INFLUENCE"], ["Dietary AGEs", "gut microbiota", "IMPACT"], ["gut microbiota", "migraine headache", "IS LINKED TO"], ["myenteric plexus", "rats", "LOCATED IN"], ["MCC950", "CST injury", "CHANGE EFFECT"], ["maternal vaginal microbiota", "microbiota of neonatal gut and nose", "COMPARED TO"], ["realgar", "neurological disorders", "INFLUENCE"], ["population's diet", "mental disorders", "INFLUENCE"], ["constipation symptoms", "PD patients", "TARGET"], ["Psychobiotics", "depression", "INFLUENCE"], ["Piperine", "kidney diseases", "INFLUENCE"], ["Perinatal mood and anxiety disorders", "mother", "TARGET"], ["Flavonifractor", "patients", "LOCATED IN"], ["adequate protein", "ALS", "INFLUENCE"], ["PD pathology", "gut microbiota", "CHANGE ABUNDANCE"], ["Enterobacteriaceae", "Gut Microbiota", "PART OF"], ["Rifaximin", "Lachnospiraceae UCG-001", "IMPACT"], ["HFD", "gut microbiota", "IMPACT"], ["sham group", "open field and elevated plus test", "USED BY"], ["glucose", "liver", "LOCATED IN"], ["oral medication", "GM", "IMPACT"], ["vascular system dysfunction", "neurodegeneration", "AFFECT"], ["LPS", "amyotrophic lateral sclerosis", "INFLUENCE"], ["dopaminergic neuronal loss", "substantia nigra pars compacta", "STRIKE"], ["CI", "patients", "TARGET"], ["matched controls", "16S rRNA gene sequencing", "USED BY"], ["PDX", "stress-induced learned helplessness", "INFLUENCE"], ["microbial diversity", "oral cavity", "LOCATED IN"], ["Medications", "PD", "CHANGE EFFECT"], ["curli amyloid fibril", "host neurodegeneration", "INFLUENCE"], ["gut microbiota", "AsA", "LOCATED IN"], ["anthocyanins", "chronic disorders", "INFLUENCE"], ["antibiotics", "motor deficits", "CHANGE EFFECT"], ["gut bacterial dysbiosis", "succinate", "INTERACT"], ["microbial composition", "patients", "LOCATED IN"], ["typical development", "TD group", "TARGET"], ["Rifaximin", "interleukin-6", "INTERACT"], ["\u03b1-SYN Aggravation", "MPTP-Induced Parkinson's Disease Mice", "TARGET"], ["commensal gut microbiota", "Multiple sclerosis", "IS LINKED TO"], ["succinate", "schizophrenia", "INFLUENCE"], ["Th1 inflammatory response", "SD rats", "TARGET"], ["microbiota-derived metabolites", "gut", "LOCATED IN"], ["gut microbiome", "PTSD", "IS LINKED TO"], ["gastrointestinal disorders", "ET", "AFFECT"], ["obesity", "Sprague-Dawley (SD) rats", "TARGET"], ["gastrointestinal dysfunction", "Parkinson's disease", "AFFECT"], ["gut microbiota", "nervous system diseases", "IS LINKED TO"], ["Adiponectin", "gut microbiota", "IMPACT"], ["adequate protein", "Alzheimer's disease", "INFLUENCE"], ["Coprococcus", "Gut Microbiota", "PART OF"], ["fibre", "microbiota", "IMPACT"], ["Probiotics", "Neurological Diseases", "INFLUENCE"], ["T2DM", "participants", "TARGET"], ["PD", "motor and non-motor manifestations", "AFFECT"], ["Parkinson's disease", "39 PD patients", "TARGET"], ["Drosophila", "RNAi-mediated knockdown", "USED BY"], ["gut microbiota", "PD symptoms", "IS LINKED TO"], ["food bioactive compounds", "psychiatric disorders", "INFLUENCE"], ["terpenoids", "GM", "IMPACT"], ["Parkinson's disease", "Bifidobacteriaceae", "CHANGE ABUNDANCE"], ["LPS plus rotenone-induced neurotoxicity", "rats", "TARGET"], ["inhibited mitogen-activated protein kinases", "mice colon", "LOCATED IN"], ["obesity", "patients", "TARGET"], ["depression", "Asian Americans", "TARGET"], ["phytochemicals", "STING", "CHANGE EXPRESSION"], ["PD gut", "PD patients", "LOCATED IN"], ["Akkermansia muciniphila", "gut microbiota", "PART OF"], ["gut microbiota dysbiosis", "PD patients", "TARGET"], ["Vancomycin Pretreatment", "Inflammation", "CHANGE EFFECT"], ["fibres", "patients", "ADMINISTERED"], ["menthol", "IBS/FD", "INFLUENCE"], ["PD/parkinsonism", "viral infection", "AFFECT"], ["Parabacteroide", "gut microbiota", "PART OF"], ["CSDS", "acetic acid", "INTERACT"], ["Rifaximin", "Muribaculum", "IMPACT"], ["Coriobacteriia", "GM", "PART OF"], ["prebiotics", "ASD", "INFLUENCE"], ["subdiaphragmatic vagus nerve", "Chrna7 KO mice", "LOCATED IN"], ["opioid-induced gut dysbiosis", "cancer patients", "TARGET"], ["Alzheimer's disease", "neurological disorders", "IS A"], ["Gut microbes", "ASDs", "IS LINKED TO"], ["dysregulation of microglia genes", "neurodegeneration", "AFFECT"], ["antibiotic treatments", "gut microbiota dysbiosis", "CHANGE EFFECT"], ["short-chain fatty acids", "nervous system", "LOCATED IN"], ["gut microbiome", "Alzheimer's", "IS LINKED TO"], ["mucosa associated microbiota", "DNA extraction", "USED BY"], ["butyrate", "PD", "INFLUENCE"], ["gut microbes", "epilepsy", "IS LINKED TO"], ["KO mice", "Open field test", "USED BY"], ["207-1", "gut microbiota", "IMPACT"], ["gut microbiota", "psychiatric diseases", "IS LINKED TO"], ["butyrate", "autism", "INFLUENCE"], ["Probiotic NVP-1704", "Healthy Adults", "ADMINISTERED"], ["AP-32 supplement", "muscle mass", "INFLUENCE"], ["SIBO", "chronic intestinal pseudo-obstruction", "AFFECT"], ["non-absorbable antibiotic vancomycin", "gut microbiota", "IMPACT"], ["Chronic gut inflammation", "human PD patients", "TARGET"], ["Co-morbid GI inflammation", "humoral immunity", "AFFECT"], ["chronic insomnia disorder", "impaired intestinal barrier function", "AFFECT"], ["antifungal medications", "PD", "CHANGE EFFECT"], ["Parkinson's disease", "neurodegenerative central nervous system disorders", "IS A"], ["dietary fiber", "microbiota-driven modification of gene expression", "INFLUENCE"], ["GABA", "major depression", "INFLUENCE"], ["5-hydroxytryptamine", "brain", "LOCATED IN"], ["gut-associated microbes", "Parkinson's disease", "INFLUENCE"], ["Adolescent female mice", "western blot", "USED BY"], ["gut dysbiosis", "major depressive disorder", "AFFECT"], ["I-FABP", "IL-18BPa", "INTERACT"], ["prebiotics", "neurodegeneration", "INFLUENCE"], ["Major depressive disorder", "Roseburia hominis", "CHANGE ABUNDANCE"], ["established illness", "patients", "TARGET"], ["gut microbiota", "intestinal, systemic and brain inflammation", "IS LINKED TO"], ["demyelination", "cuprizone-treated mouse brain", "STRIKE"], ["altered gut microbiota", "nutritional deficits", "IS LINKED TO"], ["PEA", "anhedonia/amotivation", "INFLUENCE"], ["dietary sources", "Parkinson's disease", "INFLUENCE"], ["Parkinson's disease", "neurological disorders", "IS A"], ["microbiota", "neurodegeneration", "IS LINKED TO"], ["commensal gut microbiota", "chronic non-communicable degenerative diseases", "IS LINKED TO"], ["coffee", "MPTP-induced gut microbiota dysbiosis", "INFLUENCE"], ["posttraumatic stress disorder", "Spanish cohort", "TARGET"], ["HFD", "disturbance of gut microbiota", "CHANGE EFFECT"], ["females", "preclinical studies", "USED BY"], ["BD", "gut microbiota", "CHANGE ABUNDANCE"], ["CMS", "anxiety- and depressive-like behaviors", "AFFECT"], ["Clostridaceae species", "gut microbiomes", "PART OF"], ["Probiotics", "Psychiatric Symptoms", "INFLUENCE"], ["prebiotics", "neurological illnesses", "INFLUENCE"], ["inflammation", "patients", "TARGET"], ["SCFAs", "human gut microbiota", "PRODUCED BY"], ["Gut Microbiota", "Chinese and Korean American immigrants", "LOCATED IN"], ["WIN55,212-2", "psychosis", "INFLUENCE"], ["neuroinflammation", "PD patients", "TARGET"], ["antibiotics", "iatrogenic psychiatric disorder", "CHANGE EFFECT"], ["gut microbiome", "constipation", "IS LINKED TO"], ["gut microbiota", "perinatal mood and anxiety disorders", "IS LINKED TO"], ["phytochemicals", "gut bacteria", "IMPACT"], ["HVA", "substantia nigra pars compacta", "LOCATED IN"], ["Erythrocytic \u03b1-Synuclein", "Parkinson's Disease", "INFLUENCE"], ["human microbiota", "NDDs", "IS LINKED TO"], ["reactive oxygen species", "cell danger response", "INFLUENCE"], ["6-OHDA", "6-OHDA-induced dopaminergic neuron loss", "INFLUENCE"], ["migraine medication", "chronic migraine", "CHANGE EFFECT"], ["CRP", "controls", "LOCATED IN"], ["4EP", "gut", "LOCATED IN"], ["butyrate producing bacteria", "butyrate producing gut microbiota", "PART OF"], ["low carbohydrate", "neurologic disorders", "INFLUENCE"], ["PD", "colonic FMT group", "TARGET"], ["short-chain fatty acids", "nervous system disorders", "INFLUENCE"], ["fecal calprotectin", "gut dysbiosis", "INFLUENCE"], ["healthy controls", "shotgun metagenomic sequencing", "USED BY"], ["GM", "midbrain", "LOCATED IN"], ["first-episode psychosis", "antipsychotic na\u00efve or quasi-na\u00efve people", "TARGET"], ["P. gingivalis", "A\u03b2", "INTERACT"], ["vagus nerve", "rodents", "LOCATED IN"], ["medication option", "PD", "CHANGE EFFECT"], ["gut microbiome", "affective disorders", "IS LINKED TO"], ["anxiety/depression", "cohabited offspring", "TARGET"], ["controls", "mass spectrometry", "USED BY"], ["depression", "bacterial taxa", "CHANGE ABUNDANCE"], ["HFD-reduced", "gut microbiota", "IMPACT"], ["adequate protein", "MS", "INFLUENCE"], ["gut flora dysbiosis", "neurodegenerative disease", "AFFECT"], ["brain diseases", "patients", "TARGET"], ["microbiota", "intestines", "LOCATED IN"], ["L. brevis SG031", "anxiety", "INFLUENCE"], ["PFC", "LPS-treated mice", "LOCATED IN"], ["gut microbiota", "dementia", "IS LINKED TO"], ["vitamins", "depressive behavior", "INFLUENCE"], ["Eggerthella", "stress response", "INFLUENCE"], ["maternal-infant microbiota", "C-section infants", "LOCATED IN"], ["SCZ", "Patients", "TARGET"], ["gut microbiota", "antibiotic resistance genes", "CHANGE EXPRESSION"], ["Bacteroides", "gut flora", "PART OF"], ["human gut microbiota", "human host", "LOCATED IN"], ["Fusobacterium spp.", "gut microbiota", "PART OF"], ["microbes", "neurological diseases", "INFLUENCE"], ["disrupted microbiome", "multiple sclerosis", "IS LINKED TO"], ["Human Gut Microbiota", "dysbiosis", "IS LINKED TO"], ["microbiota-derived metabolites", "amyotrophic lateral sclerosis", "INFLUENCE"], ["Lactobacillaceae", "GM", "PART OF"], ["impairment", "short-chain fatty acids", "INTERACT"], ["Yersinia frederiksenii", "gut microbiota", "PART OF"], ["probiotics", "AD", "INFLUENCE"], ["microbial by-products", "gut flora", "PRODUCED BY"], ["d-glutamate", "cognitive function", "INFLUENCE"], ["faecal microbiota", "Phylogenetic Investigation of Communities by Reconstruction of Unobserved States (PICRUSt) analysis", "USED BY"], ["obesity", "SD rats", "TARGET"], ["brain-derived neurotrophic factor", "striatum", "LOCATED IN"], ["differential metabolites", "gut microbiome", "PRODUCED BY"], ["NAS", "dysbiosis", "INFLUENCE"], ["PD patients", "Faecal microbiota analysis", "USED BY"], ["JianpiJiedu decoction", "colorectal cancer", "CHANGE EFFECT"], ["multiple sclerosis", "individuals", "TARGET"], ["gut microbiome", "motor and GI symptoms", "IS LINKED TO"], ["probiotics", "psycho-related diseases", "INFLUENCE"], ["Low-dose PHP", "Elovl6", "CHANGE EXPRESSION"], ["bacteria", "SCFA", "INTERACT"], ["neurological diseases", "gut microbiota", "CHANGE ABUNDANCE"], ["Guillain-Barr\u00e9 syndrome", "patients", "TARGET"], ["dysbiosis", "multiple sclerosis", "AFFECT"], ["carbohydrate", "fatigue", "INFLUENCE"], ["<i>Helicobacter pylori</i>-related inflammatory mediators", "neurodegenerative diseases", "INFLUENCE"], ["gut microbiota", "social avoidance effects", "IS LINKED TO"], ["gut dysbiosis", "SCI patients", "TARGET"], ["Lactobacillus", "ARGs", "CHANGE EXPRESSION"], ["probiotics", "brain disorders", "INFLUENCE"], ["loss of dopaminergic neurons", "human PD cases", "TARGET"], ["duodenum", "age-/sex-matched healthy controls", "LOCATED IN"], ["glial pathology", "rats", "TARGET"], ["foods", "microbiota", "IMPACT"], ["Gut microbes", "ALS", "IS LINKED TO"], ["mitochondrial function", "muscles", "STRIKE"], ["chemokines", "neuroinflammation", "INFLUENCE"], ["intestinal microbiota", "multiple sclerosis", "IS LINKED TO"], ["anhedonic behaviors", "intestinal microbial community disturbance", "AFFECT"], ["Male C57BL/6 mice", "pole test", "USED BY"], ["depressive symptoms", "NVP-1704 group", "TARGET"], ["motor deficits", "MPTP-induced mice", "TARGET"], ["Turicibacter", "TLCA", "INTERACT"], ["<i>L. plantarum</i> DP189", "ROS", "INTERACT"], ["depression", "IBS-D", "AFFECT"], ["PPD", "CMUS group", "TARGET"], ["Gut Microbiota Dysbiosis", "Parkinson's disease", "AFFECT"], ["gut microbiota", "neuropsychiatric illnesses", "IS LINKED TO"], ["enteric inflammation", "Parkinson's disease patients", "TARGET"], ["maternal anxiety", "early infant diseases", "AFFECT"], ["depression", "RA", "AFFECT"], ["MS", "disability", "AFFECT"], ["Prevotella ruminicola", "MCI", "INFLUENCE"], ["depression-like phenotype", "adult mice", "TARGET"], ["Gut dysbiosis", "Parkinson's disease", "AFFECT"], ["social stress-induced injurious behaviors", "chickens", "TARGET"], ["gut microbiota dysbiosis", "Proteobacteria", "CHANGE ABUNDANCE"], ["gut microbiota", "major depressive disorder (MDD) patients", "LOCATED IN"], ["psychotropic medications", "GM", "IMPACT"], ["microbial metabolites", "molecular signals", "LOCATED IN"], ["ICH", "Helicobacter", "CHANGE ABUNDANCE"], ["neurologic disease", "SOD1 mice", "TARGET"], ["GM", "Chinese population", "LOCATED IN"], ["L. rhamnosus", "intestinal inflammation", "INFLUENCE"], ["neuronal loss", "rats", "TARGET"], ["Altered gut microbiota", "Parkinson's disease patients", "LOCATED IN"], ["anhedonia", "MDD", "AFFECT"], ["biomarker", "AD", "INFLUENCE"], ["brain", "IBD patients", "LOCATED IN"], ["short-chain fatty acids", "gut", "LOCATED IN"], ["gut microbiome", "mental health", "IS LINKED TO"], ["gut dysbiosis", "ET", "AFFECT"], ["3-Methylindole", "gut microbiota", "PRODUCED BY"], ["Parkinson's disease", "Firmicutes", "CHANGE ABUNDANCE"], ["Bacilli", "CUMS group", "LOCATED IN"], ["Gut microbiota", "mental illnesses", "IS LINKED TO"], ["brain-derived neurotrophic factor", "genetic and epigenetic mechanisms", "INFLUENCE"], ["DBD high dosage", "Odoribacter", "IMPACT"], ["PFC", "CIA mice", "LOCATED IN"], ["adequate protein", "CNS disorders", "INFLUENCE"], ["transient gut dysbiosis", "late onset neuropathology", "AFFECT"], ["probiotic", "Parkinson's disease", "INFLUENCE"], ["Baicalin", "obesity", "INFLUENCE"], ["depression", "Actinobacteria", "CHANGE ABUNDANCE"], ["CT-26", "butyrate-producing bacteria", "IMPACT"], ["Parkinson's disease", "Fusicatenibacter", "CHANGE ABUNDANCE"], ["gut microbiome", "PD patients", "LOCATED IN"], ["MP extract", "motor deficit", "INFLUENCE"], ["gut microbiota", "mood", "IS LINKED TO"], ["high vagal tone", "butyrate", "INTERACT"], ["human gut microbiota", "Alzheimer's disease", "IS LINKED TO"], ["gut-brain axis diseases", "patients", "TARGET"], ["gut dysbiosis", "mental disorders", "AFFECT"], ["oxaliplatin", "Lactococcus", "IMPACT"], ["probiotic formulation", "Levilactobacillus brevis P30021", "IMPACT"], ["phytochemicals", "type 2 diabetes", "INFLUENCE"], ["PD", "neurodegenerative disease", "IS A"], ["HFD-original", "gut microbiome", "IMPACT"], ["piperine", "anti-apoptotic proteins", "INTERACT"], ["HFD-reduced", "disturbance of gut microbiota", "CHANGE EFFECT"], ["adequate protein", "ASDs", "INFLUENCE"], ["HFD microbiota", "toll-like receptor 4", "CHANGE EXPRESSION"], ["gut microbiota", "FMT via nasal-jejunal tube", "USED BY"], ["serum metabolites", "gut microbiota", "PRODUCED BY"], ["Rannasangpei", "Clostridaceae species", "IMPACT"], ["SHH", "gut microbiota", "IMPACT"], ["novel therapeutic strategies", "psychological stress", "CHANGE EFFECT"], ["ADHD", "Ruminococcus_torques_group", "CHANGE ABUNDANCE"], ["dexamethasone", "gut microbiota", "IMPACT"], ["gut microbiota", "Mn exposure rats", "LOCATED IN"], ["gut metabolite SCFAs", "controls", "LOCATED IN"], ["new antidepressant (R)-ketamine", "depression", "CHANGE EFFECT"], ["multi-ingredient supplements", "GI complaints", "INFLUENCE"], ["late onset neuropathologies", "Gut dysbiosis", "AFFECT"], ["aromatic amino acids", "gut microbiota", "PRODUCED BY"], ["therapeutic drug", "osteoporosis", "CHANGE EFFECT"], ["fecal short-chain fatty acids", "Parkinson's disease", "INFLUENCE"], ["Psychobiotics", "neurodegenerative and neurodevelopmental disorders", "INFLUENCE"], ["NSSI", "adolescents", "TARGET"], ["gut microbiome", "neurocognitive and mental health-related conditions", "IS LINKED TO"], ["fatty acids", "depressive symptoms", "INFLUENCE"], ["gut bacteria", "CSDS-induced anhedonia", "INFLUENCE"], ["organochlorines", "late onset neuropathology", "INFLUENCE"], ["Altered gut microbiota-host bile acid metabolism", "IBS-D patients", "TARGET"], ["food bioactive compounds", "Autism spectrum disorder", "INFLUENCE"], ["NLRP3 inflammasome", "metabolic pathologies", "INFLUENCE"], ["acetoacetate", "symptomatic and LVT groups", "LOCATED IN"], ["microbiota-detrimental food", "microbiota", "IMPACT"], ["betaine", "gut microbiome", "IMPACT"], ["dysregulation of the defense function", "Injury to neurons", "AFFECT"], ["Gut Microbiome", "mental health and neurocognitive disorders", "IS LINKED TO"], ["Depressive symptoms", "bariatric patients", "TARGET"], ["dementia", "obesity", "AFFECT"], ["disrupted microbiome", "central nervous system diseases", "IS LINKED TO"], ["human microbiota", "Alzheimer's", "IS LINKED TO"], ["depression-like behaviors", "knock-out mice", "TARGET"], ["tight junction protein expression", "inflammation", "INFLUENCE"], ["PD", "behavioral changes", "AFFECT"], ["depression", "Escherichia coli", "CHANGE ABUNDANCE"], ["live L. plantarum CCFM8661", "triglycerides", "INTERACT"], ["Human Gut Microbiota", "cancer", "IS LINKED TO"], ["commensal bacteria", "multiple sclerosis", "INFLUENCE"], ["dietary sources", "mitochondrial dysfunction", "INFLUENCE"], ["microbiota", "nervous system disturbances", "IS LINKED TO"], ["Adult specific pathogen free (SPF) Sprague-Dawley rats", "OFT", "USED BY"], ["healthy controls", "fecal metagenome-wide sequencing", "USED BY"], ["Prevotellaceae", "GM", "PART OF"], ["different microbiota dynamics", "treated mice", "TARGET"], ["resveratrol", "TREM2", "CHANGE EXPRESSION"], ["early PD", "Prevotella", "CHANGE ABUNDANCE"], ["microbial agents", "PD", "IS LINKED TO"], ["enteric bacteria", "CNS diseases", "INFLUENCE"], ["Breast cancer", "women", "TARGET"], ["LPS", "ionized calcium-binding adapter molecule 1", "CHANGE EXPRESSION"], ["Gut microbiota", "Parkinson disease", "IS LINKED TO"], ["abusive consumption of refined, simple, and low-quality carbohydrates", "main Western diseases of the 21st century", "INFLUENCE"], ["Parkinson disease", "heterogeneous pathology", "IS A"], ["PD mice", "16S rRNA sequence analysis", "USED BY"], ["indoxyl sulfate", "RIA", "INFLUENCE"], ["clinically heterogenic disorder", "PD patients", "TARGET"], ["Lactobacillus sp. BL302", "KO\u00a0+\u00a0SDV group", "LOCATED IN"], ["dopaminergic, survival, and behavioral deficits", "mutant PINK1<sup>B9</sup> flies", "TARGET"], ["infants' inflammatory diseases", "offspring", "TARGET"], ["inflammation-associated microbial genera", "PD", "INFLUENCE"], ["adequate protein", "gut microbes", "IMPACT"], ["gut microbiota", "Chrna7", "CHANGE EXPRESSION"], ["SD patients", "WMT", "USED BY"], ["fecal microbiota", "first-episode psychosis", "IS LINKED TO"], ["ESCC", "Proteobacteria", "CHANGE ABUNDANCE"], ["fermented wheat germs", "stress-induced depression", "INFLUENCE"], ["fiber intake", "anxiety", "INFLUENCE"], ["human microbiome", "schizophrenia", "IS LINKED TO"], ["short-chain fatty acids", "adult mice", "LOCATED IN"], ["plasticizer", "Th1 inflammatory response", "INFLUENCE"], ["H<sub>2</sub>", "butyrate-producing bacteria", "IMPACT"], ["IBS", "human participants", "TARGET"], ["physical (PHQ) and mental wellbeing", "athletes", "TARGET"], ["Clostridaceae species", "gut microbiota", "PART OF"], ["Lachnospira", "ET", "INFLUENCE"], ["TCE", "gut microbiome", "IMPACT"], ["microbiota-derived short-chain fatty acids", "neurological disorders", "INFLUENCE"], ["Faecalibacterium", "Gut microbiota", "PART OF"], ["Parkinson's disease", "gut microbiota dysbiosis", "AFFECT"], ["DEHP", "gut microbiota", "IMPACT"], ["microbiota", "Neurodegenerative diseases", "IS LINKED TO"], ["Probiotics", "Major Depression", "INFLUENCE"], ["Gut microbiota", "gastrointestinal (GI) tract", "LOCATED IN"], ["risk for earlier death", "patients", "TARGET"], ["SCFAs", "Gut Microbiota", "PRODUCED BY"], ["imbalance in the gut microbiota", "mental health disorders", "AFFECT"], ["Chronic and Unpredictable Mild Stress", "Rats", "TARGET"], ["misfolded protein alpha-synuclein", "gut", "LOCATED IN"], ["GI peptides", "PD", "CHANGE EFFECT"], ["<i>Periplaneta Americana</i> oligosaccharides", "P. Americana", "LOCATED IN"], ["antibiotic-treated animals", "cylinder test", "USED BY"], ["<i>genus</i>_<i>Eubacterium</i>", "gut microbiota", "PART OF"], ["Neurocognitive dysfunction", "social dysfunction", "AFFECT"], ["CFX", "mice", "ADMINISTERED"], ["posttraumatic stress disorder", "Anaerostipes", "CHANGE ABUNDANCE"], ["brain", "young, healthy adults", "LOCATED IN"], ["hippocampus", "sham-operated mice", "LOCATED IN"], ["AD", "disease subpopulations", "TARGET"], ["HCs", "MRI scanning", "USED BY"], ["Turicibacter", "taurodeoxycholic acid", "INTERACT"], ["Chicoric acid", "viruses", "INFLUENCE"], ["Stenotrophomonas", "gut microbiota", "PART OF"], ["prediabetes", "individuals", "TARGET"], ["GM", "depressive symptoms", "IS LINKED TO"], ["LPHP", "Fasn", "CHANGE EXPRESSION"], ["gut microbiota dysbiosis", "anxiety-like disorder", "AFFECT"], ["Levilactobacillus brevis", "mood disorders", "INFLUENCE"], ["PD", "Patients", "TARGET"], ["mitochondrial dysfunction", "rhesus monkeys", "TARGET"], ["microbiota-gut-brain", "neuropsychiatric disorders", "IS LINKED TO"], ["microbiota", "Neurodegenerative Diseases", "IS LINKED TO"], ["IL-1\u03b2", "colon", "LOCATED IN"], ["bacterial taxa", "energy metabolism", "INTERACT"], ["AP-induced", "metabolic alterations", "CHANGE EFFECT"], ["BAs", "brain disorders", "INFLUENCE"], ["nicotinamide", "gut microbiota", "PRODUCED BY"], ["ND", "Cognitive decline", "AFFECT"], ["Parkinson's disease", "peripheral tissues", "STRIKE"], ["taste receptors", "bacterial molecules", "IMPACT"], ["modified gut microbiome composition", "Gastrointestinal (GI) symptoms and pathology", "AFFECT"], ["Adiponectin", "neurodegenerative diseases", "INFLUENCE"], ["motor symptoms", "human case-control studies", "TARGET"], ["<i>genus</i>_<i>Coprococcus2</i>", "gut microbiota", "PART OF"], ["psychotropic medication", "schizophrenia-spectrum disorders", "CHANGE EFFECT"], ["gut dysbiosis", "human case-control studies", "TARGET"], ["Eggerthella", "negative emotionality", "INFLUENCE"], ["Anxiety Disorders", "Primary Sj\u00f6gren's Syndrome-Mediated Dry Eye Patients", "TARGET"], ["reproductive toxicity", "male rodents", "TARGET"], ["short-chain fatty acids", "amyotrophic lateral sclerosis", "INFLUENCE"], ["<i>L. plantarum</i> DP189", "malondialdehyde", "INTERACT"], ["sexual or gender minority", "cisgender heterosexuals", "TARGET"], ["Enhanced cerebral blood flow similarity", "chronic insomnia", "AFFECT"], ["dysbiotic gut microbiota", "PTSD", "IS LINKED TO"], ["stress-related psychiatric disorders", "offspring", "TARGET"], ["impairment of the intestinal barrier", "gut microbiota", "CHANGE ABUNDANCE"], ["gut microbiota", "human", "LOCATED IN"], ["Gut Microbiota", "Anxiety", "IS LINKED TO"], ["DEHP", "glucose metabolism disorder", "INFLUENCE"], ["Psychobiotics", "mental health", "INFLUENCE"], ["gut microbiota", "16\u2009S rRNA gene sequencing", "USED BY"], ["ketogenic diet", "multiple sclerosis", "INFLUENCE"], ["gut microbiota metabolites", "human gut microbiota", "PRODUCED BY"], ["inflammation", "PD-like degeneration", "AFFECT"], ["microglia activation", "human PD cases", "TARGET"], ["antibiotic-induced microbiome depletion", "anhedonia", "AFFECT"], ["gut microbes", "central nervous system (CNS) disorders", "IS LINKED TO"], ["Enterobacteriaceae", "gut microbiota", "PART OF"], ["Gut microbiota", "controls", "LOCATED IN"], ["gut microbiota", "irritable bowel disease", "IS LINKED TO"], ["human intestinal microbiota", "Stress", "IS LINKED TO"], ["gut microbiota", "ND patients", "LOCATED IN"], ["specific gut bacteria", "gastrointestinal symptoms", "INFLUENCE"], ["Subdoligranulum", "MMP9", "CHANGE EXPRESSION"], ["healthy spouses", "shotgun metagenomic sequencing", "USED BY"], ["food bioactive compounds", "brain diseases", "INFLUENCE"], ["gut microbiota", "MCI", "IS LINKED TO"], ["levodopa", "PD", "CHANGE EFFECT"], ["lipid", "gut microbiota", "PRODUCED BY"], ["gut microbiota", "findings", "IS LINKED TO"], ["gut", "patient", "LOCATED IN"], ["human depression", "chronic inflammatory disorders", "AFFECT"], ["plasma metabolites", "several microbiome", "IMPACT"], ["\"abnormal\" microbiota", "ASD", "IS LINKED TO"], ["Piperine", "kinase-activated NLR family pyrin domain containing-3 inflammasome", "INTERACT"], ["mother-infant pairs", "qPCR", "USED BY"], ["probiotics", "irritable bowel syndrome", "INFLUENCE"], ["mitochondrial dysfunction", "A53T monkeys", "TARGET"], ["PS128", "abnormal behaviors", "INFLUENCE"], ["KD", "PD", "INFLUENCE"], ["gut microbiota", "Neurological Diseases", "IS LINKED TO"], ["Lactobacillus plantarum PS128", "neurodegenerative progression", "INFLUENCE"], ["gut microbiota communities", "neuropathy", "IS LINKED TO"], ["Gut microbes", "depression", "IS LINKED TO"], ["Lactobacillus spp.", "gut microbiota", "PART OF"], ["dopamine", "brain", "LOCATED IN"], ["\u03b1-synuclein protein", "brain", "LOCATED IN"], ["coronavirus disease 2019", "Depression", "AFFECT"], ["gut microbiota", "IBS", "IS LINKED TO"], ["W. somnifera", "gut-dysbiosis", "INFLUENCE"], ["mental disorders", "individuals", "TARGET"], ["Blautia", "Women with high perceived stress", "LOCATED IN"], ["liver toxicity", "male rodents", "TARGET"], ["healthy diet", "brain aging", "INFLUENCE"], ["novel microbial ligands", "chronic pain management", "INFLUENCE"], ["Coprococcus", "gut microbiota", "PART OF"], ["microbiomes", "individuals", "LOCATED IN"], ["microbes", "multiple sclerosis", "INFLUENCE"], ["gut microbiota", "weight gain", "IS LINKED TO"], ["SIBO", "acromegaly", "AFFECT"], ["Influenza infections", "Parkinson's disease", "AFFECT"], ["Akkermansia", "microbiota", "PART OF"], ["gut microbes", "neurodegenerative disorders", "IS LINKED TO"], ["Butyrate", "gut", "LOCATED IN"], ["sleep disturbance", "Chinese and Korean immigrants", "TARGET"], ["GM", "neurodegenerative diseases", "IS LINKED TO"], ["pubertal neuroinflammatory insults", "brain disorders", "AFFECT"], ["Parkinson's disease", "Faecalibacterium", "CHANGE ABUNDANCE"], ["SGM", "young adults", "TARGET"], ["<i>Family</i>_<i>Ruminococcaceae</i>", "gut microbiota", "PART OF"], ["olanzapine", "mild metabolic disturbances", "CHANGE EFFECT"], ["Oscillibacter", "microbial genera", "PART OF"], ["Aging", "Systemic Chronic Inflammation", "AFFECT"], ["Inflammation", "nonmotor symptoms", "AFFECT"], ["fiber", "chronic metabolic diseases", "INFLUENCE"], ["probiotic supplementation", "Prader-Willi syndrome", "INFLUENCE"], ["gut microbiota", "early PD", "IS LINKED TO"], ["healthy controls", "16S rRNA sequencing", "USED BY"], ["gut microbiota", "clinical assessment", "USED BY"], ["PD", "men and women over 40 years old", "TARGET"], ["anxiety/depression", "children", "TARGET"], ["\u03b1-HgS-containing Hua-Feng-Dan", "Parkinson's disease", "CHANGE EFFECT"], ["brain aging", "gut microbiota-induced systemic chronic inflammation", "AFFECT"], ["gut metabolite SCFAs", "patients", "LOCATED IN"], ["Megasphaera", "patients", "LOCATED IN"], ["impaired glycemic control", "fathers", "TARGET"], ["animal studies", "probiotic administration", "USED BY"], ["trace elements", "healthy controls", "LOCATED IN"], ["Probiotics", "Alzheimer's", "INFLUENCE"], ["gut bacteria", "VVS", "INFLUENCE"], ["gut bacterial dysbiosis", "gut microbiota metabolites", "INTERACT"], ["ketogenic diet", "stress", "INFLUENCE"], ["metabolite features", "bacterial taxa", "CHANGE ABUNDANCE"], ["SGS", "depression", "INFLUENCE"], ["gut microbiota alterations", "essential tremor", "AFFECT"], ["abundance of potential pathogens and microbial genes", "Sprague-Dawley (SD) rats", "TARGET"], ["polymannuronic acid", "brain-derived neurotrophic factor", "INTERACT"], ["acetate", "neuromyelitis optica spectrum disorders", "INFLUENCE"], ["substantia nigra", "PD mice", "LOCATED IN"], ["RA", "patients", "TARGET"], ["EGCG", "neuronal and behavioral defects", "INFLUENCE"], ["Probiotic Supplementation", "Energy Metabolism", "INFLUENCE"], ["Piperine", "Akt/mTOR/MMP-9", "INTERACT"], ["PD", "Enterobacteriales", "CHANGE ABUNDANCE"], ["Klebsiella", "anxiety", "INFLUENCE"], ["gut microbiota", "transgenic mice", "LOCATED IN"], ["schizophrenia", "patients", "TARGET"], ["Parkinson's Disease", "Patients", "TARGET"], ["flavonoids", "GM", "IMPACT"], ["secondary and tertiary metabolites", "gut bacteria", "IMPACT"], ["gastrointestinal (GI) dysfunction", "Parkinson's disease", "AFFECT"], ["trace elements", "children", "LOCATED IN"], ["psychotropics", "neurocognitive and mental health disorders", "CHANGE EFFECT"], ["mental disorders", "people", "TARGET"], ["NADPH oxidase 2", "Parkinson's disease", "INFLUENCE"], ["MPTP", "intestinal pathology", "CHANGE EFFECT"], ["intestine", "host", "LOCATED IN"], ["prion-like \u03b1-synuclein fibrils", "intestine", "LOCATED IN"], ["LDSD", "lithocholic acid", "INTERACT"], ["mental disorders", "lactic acid-producing bacteria", "CHANGE ABUNDANCE"], ["clinical variables", "AD population", "TARGET"], ["Manganese", "Parkinson's disease", "INFLUENCE"], ["PM", "brain-derived neurotrophic factor", "INTERACT"], ["Cognitive and Behavioural Effects", "Maternal Obesity", "AFFECT"], ["Psychotic symptoms", "criteria-acute group (patients with acute schizophrenia)", "TARGET"], ["antidepressant treatments", "MDD", "CHANGE EFFECT"], ["Lipopolysaccharide", "Lactobacteriaceae", "IMPACT"], ["Cognitive Impairment", "Gut Microbiota", "CHANGE ABUNDANCE"], ["BDNF", "GM", "IMPACT"], ["fruits", "neurological diseases", "INFLUENCE"], ["levodopa", "tyrosine decarboxylase gene", "CHANGE EXPRESSION"], ["Engineered Probiotic", "Non-communicable Disorders", "INFLUENCE"], ["Protein synthesis", "aminoacyl-tRNA transferases", "CHANGE EXPRESSION"], ["Bifidobacterium", "controls", "LOCATED IN"], ["CKD", "older populations", "TARGET"], ["GMB", "mental illnesses", "IS LINKED TO"], ["MPTP", "gut microbiomes", "IMPACT"], ["Affective disorders", "gut Flavonifractor genus", "CHANGE ABUNDANCE"], ["distinct microbial patterns", "group", "LOCATED IN"], ["\u03b1-synuclein", "gut", "LOCATED IN"], ["gut microbiome", "AD", "IS LINKED TO"], ["SR79", "d-AMPH", "INTERACT"], ["Bifidobacterium longum", "ASD", "INFLUENCE"], ["PD patients", "mass spectrometry", "USED BY"], ["malnutrition", "Parkinson disease", "AFFECT"], ["constipation", "probiotics group", "TARGET"], ["depression-like phenotype", "sham-operated mice", "TARGET"], ["spleen", "mice", "LOCATED IN"], ["Gram-negative bacteria", "gut microbiota", "PART OF"], ["Salvia rosmarinus", "gut microbiota", "IMPACT"], ["Helicobacter pylori", "<i>Helicobacter pylori</i> infection", "INFLUENCE"], ["microbiota-derived short-chain fatty acids", "Alzheimer's disease", "INFLUENCE"], ["Bifidobacterium", "depressed mood", "INFLUENCE"], ["6-n-propylthiouracil", "PD patients", "LOCATED IN"], ["anxiety", "cohabited rat pups", "TARGET"], ["vancomycin pretreatment", "motor dysfunction", "CHANGE EFFECT"], ["iRBD patients", "16S rRNA sequencing", "USED BY"], ["GM", "MDD", "IS LINKED TO"], ["GABA-producing bacteria", "depression", "INFLUENCE"], ["neurological and neuropsychiatric disorders", "gut microbiota", "CHANGE ABUNDANCE"], ["particulate matter", "neurological and overall mental health", "INFLUENCE"], ["KD", "mental disorders", "INFLUENCE"], ["Celiac Disease", "Inactive Adults", "TARGET"], ["TMAO", "early Parkinson's disease", "INFLUENCE"], ["cerebral malaria", "chronic brain inflammation processes", "AFFECT"], ["controls", "16S ribosomal RNA (16S rRNA) gene sequencing", "USED BY"], ["Gut Microbiome-Modified Polyphenolic Compounds", "\u03b1-Synucleinopathies", "INFLUENCE"], ["Parkinson's disease", "Sybergistetes", "CHANGE ABUNDANCE"], ["gut neuropeptides", "PD", "INFLUENCE"], ["calorie-dense foods", "disease susceptibility", "INFLUENCE"], ["lipopolysaccharide", "altered gut microbiota", "INFLUENCE"], ["Crohn's disease", "IBD", "IS A"], ["gut microbiota", "neurocognitive and mental disorders", "IS LINKED TO"], ["microbiota", "Iba1", "CHANGE EXPRESSION"], ["anxiety", "healthy adults", "TARGET"], ["Gut Microbiota", "depressive symptoms", "IS LINKED TO"], ["Parkinson's disease", "Glyceric acid", "INTERACT"], ["peptides", "autoimmune disease", "INFLUENCE"], ["ASD", "restricted and repetitive patterns of behavior", "AFFECT"], ["gut microbiota", "water\u00a0+\u00a0LPS group", "LOCATED IN"], ["Constipation", "PD patients", "TARGET"], ["short chain fatty acids", "colon", "LOCATED IN"], ["childhood anxiety", "children", "TARGET"], ["GM", "emerging adults", "LOCATED IN"], ["metabolites", "neuromyelitis optica spectrum disorders", "INFLUENCE"], ["Neurotransmitters", "gut microbiota composition", "IMPACT"], ["Zn<sup>2+</sup>", "diabetes mellitus type 2", "INFLUENCE"], ["propionic acid", "PD patient group", "LOCATED IN"], ["gut microbiome", "populations", "LOCATED IN"], ["dysbiosis", "gut inflammation", "AFFECT"], ["oxaliplatin", "cancer-related bacteria", "IMPACT"], ["gut microbiota", "increased CBF similarities", "IS LINKED TO"], ["FCR", "cancer survivors", "TARGET"], ["PD", "tremor at rest", "AFFECT"], ["P. gingivalis", "AD", "INFLUENCE"], ["fecal microbiota dysbiosis", "patients", "TARGET"], ["microbiota-derived metabolites", "autism", "INFLUENCE"], ["oxaliplatin", "imbalance-inducing bacteria", "IMPACT"], ["\u03b1-synuclein", "gut microbiota", "IMPACT"], ["Alpha-Synuclein", "Human and Non-Human Amyloidogenic Proteins", "PART OF"], ["wellbeing", "athletes", "TARGET"], ["polyphenols", "metabolic and inflammatory diseases", "INFLUENCE"], ["glycolipid metabolism disorders", "KO mice", "TARGET"], ["70W", "Parkinson's disease", "CHANGE EFFECT"], ["PCOS", "depressed women", "TARGET"], ["altered gut microbiota", "Parkinson's Disease", "IS LINKED TO"], ["animal studies", "microbiota restoration", "USED BY"], ["mercury", "late onset neuropathology", "INFLUENCE"], ["microbiota", "host health", "IS LINKED TO"], ["Negativicutes", "increased CBF similarities", "INFLUENCE"], ["Gut Microbiota", "Trained Recreative and Competitive Athletes", "LOCATED IN"], ["Diet", "mental health", "INFLUENCE"], ["\u03b2-<i>N</i>-methylamino-L-alanine", "diatoms", "IMPACT"], ["Diarrhea", "Collinsella", "CHANGE ABUNDANCE"], ["LPS", "progressive neurodegeneration", "INFLUENCE"], ["intestinal microbiota", "gut", "LOCATED IN"], ["Fisetin", "brain dysfunction", "INFLUENCE"], ["depression", "children", "TARGET"], ["severe GI complaints", "GI-S", "TARGET"], ["dopaminergic treatments", "Parkinson's disease", "INFLUENCE"], ["HFD-original", "LPS plus rotenone-induced neurotoxicity", "CHANGE EFFECT"], ["Roseburia faecis", "fecal metagenomes", "PART OF"], ["Gut microbiota", "patients", "LOCATED IN"], ["Anthocyanins", "neuropeptides", "INTERACT"], ["arsenic", "late onset neuropathology", "INFLUENCE"], ["PD", "gut microbiota", "CHANGE ABUNDANCE"], ["gut microbiota", "colonic FMT group", "LOCATED IN"], ["microbiota", "lungs", "LOCATED IN"], ["Lactobacillus", "gut microbiota", "PART OF"], ["heat-killed PS150", "hypnotic effects", "INFLUENCE"], ["prebiotics", "human gut microbiota", "IMPACT"], ["central monoamine neurotransmitters", "gut microbiota", "IMPACT"], ["ropinirole", "gastrointestinal symptoms", "CHANGE EFFECT"], ["alcohol intake", "PD incidence and progression", "INFLUENCE"], ["gut microbiota", "PTGS2", "CHANGE EXPRESSION"], ["gastrointestinal disorders", "headaches", "AFFECT"], ["PROP", "39 PD patients", "LOCATED IN"], ["DEHP", "body weight gain", "INFLUENCE"], ["gut microbiota", "painful gastrointestinal disorders", "IS LINKED TO"], ["Parabacteroides", "fecal microbiome", "PART OF"], ["Ruminococcaceae", "VVS children", "LOCATED IN"], ["microbes", "adipose tissue", "LOCATED IN"], ["4EPS", "kidneys", "LOCATED IN"], ["Fusobacteria", "gut microorganisms", "PART OF"], ["CAD", "patients", "TARGET"], ["commensal gut microbiota", "infant eczema", "IS LINKED TO"], ["s_Desulfovibrio_piger", "gut microbiota", "PART OF"], ["gut microbiomes", "PD pathogenesis", "IS LINKED TO"], ["Zn", "COVID-19", "INFLUENCE"], ["NADPH oxidase 2", "neuroinflammation", "INFLUENCE"], ["Bacteroidetes", "altered gut microbiota", "PART OF"], ["Psychobiotics", "insomnia", "INFLUENCE"], ["E. coli TG1", "multidrug resistant bacteria", "INTERACT"], ["\u03b1-syn", "multiple system atrophy", "INFLUENCE"], ["midbrain", "PD mice", "LOCATED IN"], ["SD", "SD groups", "TARGET"], ["Gut microbes", "neurocognitive and mental health disorders", "IS LINKED TO"], ["Western diet", "stress reactivity", "INFLUENCE"], ["acute mania", "patients", "TARGET"], ["Parkinson's disease", "impaired sleep", "AFFECT"], ["Gut microbiota", "bipolar disorder", "IS LINKED TO"], ["gut microbiome", "responder and non-responder groups", "LOCATED IN"], ["Anthocyanins", "insulin-like growth factor-1", "INTERACT"], ["<i>L. plantarum</i> DP189", "IL-1\u03b2", "INTERACT"], ["Piperine", "metabolic syndrome", "INFLUENCE"], ["colonic microbiome", "Alzheimer's disease", "IS LINKED TO"], ["<i>Helicobacter pylori</i> infection", "world's population", "TARGET"], ["4EPS", "human brains", "LOCATED IN"], ["Cucurbitacin E", "inflammatory response", "INFLUENCE"], ["bacteria", "OCD", "INFLUENCE"], ["Inflammation", "late onset neuropathology", "AFFECT"], ["AD", "patients", "TARGET"], ["IL-6", "Social avoidance behaviors", "INFLUENCE"], ["Mn-induced neurotoxicity", "brain", "STRIKE"], ["GOS", "depressive symptoms", "INFLUENCE"], ["patients", "16S rRNA gene sequencing", "USED BY"], ["ICH", "Faecalibaculum", "CHANGE ABUNDANCE"], ["inhibition", "NLRP3 inflammasome", "CHANGE EXPRESSION"], ["differentially abundant taxa", "influential features", "AFFECT"], ["differentially expressed proteins", "substantia nigra", "LOCATED IN"], ["Injury to neurons", "Huntington's", "AFFECT"], ["non-photosynthetic cyanobacteria", "human gut microbiota", "PART OF"], ["MPTP", "Methanobacteriaceae", "IMPACT"], ["gut microbiome", "idiopathic Parkinson's disease", "IS LINKED TO"], ["<i>L. plantarum</i> DP189", "interleukin-6", "INTERACT"], ["ileal submucosal plexus", "rats", "LOCATED IN"], ["human gut microbiome", "diabetes", "IS LINKED TO"], ["NVP-1704", "Bifidobacteriaceae", "IMPACT"], ["microorganisms", "host", "LOCATED IN"], ["microbiota", "neurological disorders", "IS LINKED TO"], ["gut microbiota", "radiation", "USED BY"], ["necrotizing enterocolitis", "preterm babies", "TARGET"], ["rhEPO", "CCRA", "INFLUENCE"], ["IL-1\u03b2", "DEX and CUMS groups", "LOCATED IN"], ["oral medication", "gut microbiome", "IMPACT"], ["cognitive impairment", "rhesus monkeys", "TARGET"], ["tetracycline compounds", "AD/PD patients", "LOCATED IN"], ["<i>L. plantarum</i> DP189", "neurodegeneration", "INFLUENCE"], ["gut microbiota", "metabolic diseases", "IS LINKED TO"], ["Rats", "Absolute Bacterial Quantification-Combined Approach", "USED BY"], ["probiotic NVP-1704", "depression", "INFLUENCE"], ["Gut Microbiome", "depression", "IS LINKED TO"], ["cholesterol accumulation", "rats", "TARGET"], ["(R)-ketamine", "gut-microbiota", "IMPACT"], ["PD cases", "Full-length bacterial 16S rRNA gene sequencing", "USED BY"], ["IL-17", "arthropathy", "INFLUENCE"], ["probiotics", "gastrointestinal tract problems", "INFLUENCE"], ["probiotics", "Neurodegenerative diseases", "INFLUENCE"], ["gut microbiota", "NDDs", "IS LINKED TO"], ["patients", "ELISA kit", "USED BY"], ["anxiety", "gut microbiome", "CHANGE ABUNDANCE"], ["bacterial antigen", "gut epithelium", "LOCATED IN"], ["Gut microbiota", "16S rRNA sequencing", "USED BY"], ["NLRP3 inflammasome", "multiple sclerosis", "INFLUENCE"], ["psychiatric symptoms", "SZ patients", "TARGET"], ["Gut Microbiota", "Parkinson'sDisease", "IS LINKED TO"], ["controls", "metatranscriptomic analysis", "USED BY"], ["Parkinson's disease", "dopaminergic neuron loss", "AFFECT"], ["Multiple sclerosis", "young adults", "TARGET"], ["SCFAs", "depression", "INFLUENCE"], ["BAs", "intestinal lumen", "LOCATED IN"], ["ND", "ND patients", "TARGET"], ["microbiota", "translocation", "IS LINKED TO"], ["gut microbiota", "age-related diseases", "IS LINKED TO"], ["live L. plantarum CCFM8661", "skin lipids", "INTERACT"], ["ALI", "mice", "TARGET"], ["neuroplastic changes", "Parkinson's disease (PD) patients", "TARGET"], ["gut microbiota", "Disease-associated metagenomics studies", "USED BY"], ["harmful substances", "blood-brain barrier", "LOCATED IN"], ["faecal gut microbiota", "Patients", "LOCATED IN"], ["clinically available antidepressants", "depressive symptoms", "CHANGE EFFECT"], ["microbiota", "autoimmune diseases", "IS LINKED TO"], ["Parkinson's disease", "people", "TARGET"], ["Lung cancer", "gut microbiota", "CHANGE ABUNDANCE"], ["oxidative stress", "chronic neuroinflammatory diseases", "AFFECT"], ["constipation", "healthy adults", "TARGET"], ["lipopolysaccharide", "gut microbiota", "IMPACT"], ["APs", "SCZ", "CHANGE EFFECT"], ["Bifidobacterium", "PD-associated microbiota", "PART OF"], ["bipolar disorder", "Actinobacteria", "CHANGE ABUNDANCE"], ["pathogens", "gut microbiota", "PART OF"], ["\u03b1-synucleinopathy", "mucin-layer-degrading genus <i>Akkermansia</i>", "CHANGE ABUNDANCE"], ["men and women over 40 years old", "OMM-sequence", "USED BY"], ["gut microbiota", "AR", "IS LINKED TO"], ["probiotics", "Clostridium difficile colitis", "INFLUENCE"], ["Actinobacteria spp.", "gut microbiota", "PART OF"], ["Herpesvirus", "inflammation", "INFLUENCE"], ["PD", "intestinal flora", "CHANGE ABUNDANCE"], ["LPS-induced splenomegaly", "mice", "TARGET"], ["gut microbiome", "Veterans", "LOCATED IN"], ["gut microbes", "Multiple sclerosis", "IS LINKED TO"], ["Gut microbiota disturbance", "children", "TARGET"], ["berberine", "coliform", "IMPACT"], ["acetate-producing bacteria", "learning and memory impairments", "INFLUENCE"], ["pro-inflammatory cytokines", "chronic neuroinflammatory diseases", "INFLUENCE"], ["genus <i>Coprococcus</i>", "neuropsychological and neurodegenerative disorders", "INFLUENCE"], ["breast milk microbiota", "infant gut microbiota", "COMPARED TO"], ["first-episode psychosis", "patients", "TARGET"], ["PD", "dopaminergic neuron degeneration", "AFFECT"], ["anhedonia-like behavior", "ABX-treated WT and Ephx2 KO mice", "TARGET"], ["individuals", "task-based fMRI studies", "USED BY"], ["mucosal immunity", "gut microbiota", "CHANGE ABUNDANCE"], ["\u03b1-LA", "intestinal inflammation", "INFLUENCE"], ["intestinal inflammation", "gut mucosal layer", "STRIKE"], ["HT", "APAP-induced ALI", "INFLUENCE"], ["gut dysbiosis", "Parkinson's disease patients", "TARGET"], ["gut", "healthy controls", "LOCATED IN"], ["microbiota", "Parkinson's disease", "IS LINKED TO"], ["probiotics", "psychiatric symptoms", "INFLUENCE"], ["IBD", "prospectively enrolled patients", "TARGET"], ["Prebiotics", "Major Depression", "INFLUENCE"], ["synbiotic", "Gut microbiota", "IMPACT"], ["plasticizer", "colorectal cancer", "INFLUENCE"], ["Adolescent female mice", "ELISA", "USED BY"], ["Gut microbes", "amyotrophic lateral sclerosis", "IS LINKED TO"], ["patients", "amplicon sequencing", "USED BY"], ["A. muciniphila", "multiple sclerosis", "INFLUENCE"], ["loss of neurons", "impaired movement", "AFFECT"], ["Paenibacillus", "gut flora", "PART OF"], ["chronic and selective process of neuron cell death", "Neurodegenerative diseases", "AFFECT"], ["gut microbiome", "irritable bowel syndrome", "IS LINKED TO"], ["nutraceutical supplementations", "necrotizing enterocolitis", "INFLUENCE"], ["As<sub>4</sub>S<sub>4</sub>", "DA neuron loss", "INFLUENCE"], ["mood disturbances", "diverse symptoms", "AFFECT"], ["HFD microbiota", "mice", "LOCATED IN"], ["gut microbiota", "psychiatric comorbidity", "IS LINKED TO"], ["nutraceutical supplementations", "metabolic disorders", "INFLUENCE"], ["Dietary fiber", "depression", "INFLUENCE"], ["beneficial metabolites", "microbiota", "PRODUCED BY"], ["gut microbiota", "human PD cases", "LOCATED IN"], ["Malnutrition", "gut-microbiota-brain axis dysfunction", "AFFECT"], ["colonic microbiome", "MS", "IS LINKED TO"], ["Autism spectrum disorder", "children", "TARGET"], ["Rifaximin", "Gut Microbiota", "IMPACT"], ["schizophrenia patients", "PICRUSt analysis", "USED BY"], ["Gut Microbiome", "schizophrenia", "IS LINKED TO"], ["MedDiet", "neurological diseases", "INFLUENCE"], ["amino acids", "Gut microbiota", "PRODUCED BY"], ["microbes", "dysbiosis", "INFLUENCE"], ["gut", "children", "LOCATED IN"], ["Opioids", "well-known pharmacological effects", "CHANGE EFFECT"], ["mGlu8", "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "INTERACT"], ["Parkinson's disease", "Eggerthella lenta", "CHANGE ABUNDANCE"], ["phytochemicals", "chronic disease", "INFLUENCE"], ["diabetes mellitus", "Patients", "TARGET"], ["vancomycin pretreatment", "neuroinflammation", "CHANGE EFFECT"], ["prebiotic/probiotic formulations", "metabolic alterations", "INFLUENCE"], ["HgS", "DA neuron loss", "INFLUENCE"], ["PDX", "stress-evoked decreases in mRNA", "INFLUENCE"], ["imbalance in the gut microbiota", "psychiatric illnesses", "AFFECT"], ["inflammation", "prodromal/pre-motor features", "AFFECT"], ["esophageal cancer", "gut microbiome", "CHANGE ABUNDANCE"], ["SMI", "CCL25", "INTERACT"], ["phytochemicals", "NF-kb", "CHANGE EXPRESSION"], ["Clostridium sensu stricto 1", "microbial genera", "PART OF"], ["dysregulations", "gut microbiota", "CHANGE ABUNDANCE"], ["local immune disorders of the intestine", "PD mice", "TARGET"], ["Bacteroidetes", "HCs", "LOCATED IN"], ["AD", "mild cognitive impairment", "AFFECT"], ["microbiota-driven modification of gene expression", "depression", "AFFECT"], ["polydextrose", "stress", "INFLUENCE"], ["PD", "Selenomonadales", "CHANGE ABUNDANCE"], ["vitamins", "Depression", "INFLUENCE"], ["altered gut microbiota", "oral LPS", "USED BY"], ["Neurodegenerative Disease", "patients", "TARGET"], ["insulin resistance", "cognitive decline", "AFFECT"], ["migraine headache", "gastrointestinal diseases", "AFFECT"], ["CMS", "mice", "TARGET"], ["CUMS", "mice", "TARGET"], ["GM", "individuals", "LOCATED IN"], ["Fisetin", "neurological disorders", "INFLUENCE"], ["Gut Microbiota", "Parkinson's Disease", "IS LINKED TO"], ["Low-Caloric Diet", "Dementia", "INFLUENCE"], ["NLRP3 inflammasome", "liver diseases", "INFLUENCE"], ["GM", "Macaca mulatta", "LOCATED IN"], ["mildly impaired cognition", "community-dwelling older adults", "TARGET"], ["plasticizer", "diabetes", "INFLUENCE"], ["Cinnabar", "neurological disorders", "INFLUENCE"], ["anti-PD medication", "bacterial TDC", "INTERACT"], ["gut microbiota", "weight disorders", "IS LINKED TO"], ["stress", "pro-inflammatory cytokines", "INTERACT"], ["prefrontal cortex", "NOD mice", "LOCATED IN"], ["pSS", "psychological disorders", "IS A"], ["serum metabolites", "HC", "LOCATED IN"], ["enterotype-P", "controls", "LOCATED IN"], ["microbiota", "Alzheimer's disease", "IS LINKED TO"], ["prebiotics", "Gut Microbiota", "IMPACT"], ["LP299v", "long-chain acylcarnitines", "INTERACT"], ["COVID-19", "gut microbiota", "CHANGE ABUNDANCE"], ["oxytocin", "children", "LOCATED IN"], ["microbiota-derived short-chain fatty acids", "Parkinson's disease", "INFLUENCE"], ["mucin homeostasis", "RSDS mice", "TARGET"], ["ST36", "PD mice", "LOCATED IN"], ["specific MAM associated to underlying pathology", "PIPO patients", "LOCATED IN"], ["Obesity", "cardiovascular diseases", "AFFECT"], ["LAC", "gut bacteria", "IMPACT"], ["plasma BCAA and AAA", "PD patients", "LOCATED IN"], ["intestinal <i>Bacteroides</i>", "GABA", "INTERACT"], ["stress-induced mental health problems", "at-risk groups", "TARGET"], ["increased intestinal epithelial barrier permeability", "Parkinson's disease patients", "TARGET"], ["K01667", "gut microbiota", "PRODUCED BY"], ["plasma proinflammatory cytokine", "baseline plasma interleukin-1\u03b1", "INTERACT"], ["anti-inflammatory bacteria", "positive emotionality", "INFLUENCE"], ["KD", "spinal cord injury", "INFLUENCE"], ["microbial community", "human gut", "LOCATED IN"], ["enterotype-P", "patients' group", "LOCATED IN"], ["adequate protein", "neurologic disorders", "INFLUENCE"], ["gut microbiota", "16S rDNA gene sequencing method", "USED BY"], ["harmful substances", "peripheral circulation", "LOCATED IN"], ["remarkable olfactory deficits", "patients", "TARGET"], ["Low FODMAP diet", "Depression", "INFLUENCE"], ["rotenone-induced toxicity", "SCFAs", "INTERACT"], ["psychobiotics", "PD", "INFLUENCE"], ["Actinomyces", "GM", "PART OF"], ["(S)-ketamine", "Deltaproteobacteria", "IMPACT"], ["GM", "mammals", "LOCATED IN"], ["Helicobacter pylori (HP) infection", "worse motor function", "AFFECT"], ["Prevotella copri", "rheumatoid arthritis", "INFLUENCE"], ["dietary fiber intake", "digestive health", "INFLUENCE"], ["Turicibacteraceae", "glycodeoxycholic acid", "INTERACT"], ["dysbiosis", "cancer", "AFFECT"], ["depression", "people", "TARGET"], ["Low-dose PHP", "Abhd5", "CHANGE EXPRESSION"], ["gut microbiome", "Asian, Chinese people", "LOCATED IN"], ["gut microbiota", "non-TD", "IS LINKED TO"], ["neuropsychiatric disorders", "Women", "TARGET"], ["MDD", "Faecalibacterium prausnitzii", "CHANGE ABUNDANCE"], ["SMG", "NOD mice", "LOCATED IN"], ["LPHP", "fatty acid transport genes", "CHANGE EXPRESSION"], ["gut microbiota", "gastrointestinal dysfunction", "IS LINKED TO"], ["uncultured_bacterium_g_Bacillus", "fisetin intervented MPTP group gut microbiota", "PART OF"], ["lead", "bacteria", "IMPACT"], ["NS8", "depression", "INFLUENCE"], ["ultra-processed foods", "NDs", "INFLUENCE"], ["gastrointestinal microbiota", "Parkinson's disease", "IS LINKED TO"], ["gut bacterial community composition", "PD", "IS LINKED TO"], ["Parkinson's disease", "Lachnospiraceae", "CHANGE ABUNDANCE"], ["Microbiota", "Irritable Bowel Syndrome", "IS LINKED TO"], ["(R,S)-ketamine", "humans", "ADMINISTERED"], ["synaptic dysfunction", "MPTP-induced mice", "TARGET"], ["lipopolysaccharide", "gut microbiomes", "IMPACT"], ["unhealthy nutrition", "gut microbiota", "CHANGE ABUNDANCE"], ["Citrobacter werkmanii", "gut microbiota", "PART OF"], ["cinnabar", "LPS plus ROT induced neurotoxicity", "INFLUENCE"], ["Parkinson's disease", "striatum", "STRIKE"], ["IBS-D", "Enterobacter cloacae", "CHANGE ABUNDANCE"], ["chronic unpredictable mild stress", "mice", "TARGET"], ["Fisetin", "Parkinson's disease", "INFLUENCE"], ["ayurvedic herbs", "neurological diseases", "INFLUENCE"], ["Clostridiuminnocuumgroup", "insomnia", "INFLUENCE"], ["cerebral NLRP3 inflammasome", "gut microbiota", "IMPACT"], ["altered gut microbiota", "PD", "IS LINKED TO"], ["tremor dominant", "PD patients", "TARGET"], ["carbohydrates", "Colon microbiota", "IMPACT"], ["rigidity of respiratory muscles", "elderly population", "TARGET"], ["bile acid pool", "dysbiotic microbial communities", "PRODUCED BY"], ["H<sub>2</sub>S", "Parkinson's disease", "INFLUENCE"], ["ketamine", "major depressive disorder", "CHANGE EFFECT"], ["piperine", "c-Fos", "INTERACT"], ["PD", "control group", "TARGET"], ["Parkinson disease", "patients", "TARGET"], ["gastrointestinal disturbances", "patients", "TARGET"], ["AR", "PD patients", "TARGET"], ["LD", "inflammatory intestinal microenvironment", "CHANGE EFFECT"], ["Gut microbiota", "Metabolomics analysis", "USED BY"], ["Gut Microbial Metabolites", "Parkinson's Disease", "INFLUENCE"], ["insulin", "peripheral nervous system", "LOCATED IN"], ["MDD", "persistent depression", "AFFECT"], ["bacterial endotoxin", "Gram-negative bacteria", "IMPACT"], ["participants", "16S rRNA sequencing", "USED BY"], ["Flavonifractor", "reward-seeking", "INFLUENCE"], ["IS", "RIA", "INFLUENCE"], ["control monkeys", "targeted gas chromatography", "USED BY"], ["Scardovia_wiggsiae", "PD", "INFLUENCE"], ["Piperine", "gastrointestinal disorders", "INFLUENCE"], ["Small intestinal bacterial overgrowth", "small intestine", "STRIKE"], ["microbial composition", "psychiatric disorders", "IS LINKED TO"], ["gut microbiota", "healthy subjects", "LOCATED IN"], ["irritable bowel syndrome", "anxiety disorders", "AFFECT"], ["fisetin", "neurodegeneration", "CHANGE EFFECT"], ["genera <i>Adlercreutzia</i> and <i>Christensenellaceae R7 group</i>", "gut microbiota", "PART OF"], ["Oral and gut dysbiosis", "PD", "AFFECT"], ["anti-PD medications", "gastrointestinal symptoms", "CHANGE EFFECT"], ["DEHP", "toxicity", "INFLUENCE"], ["control patients", "gastric biopsies", "USED BY"], ["PD", "Proteobacteria", "CHANGE ABUNDANCE"], ["brain", "participants", "LOCATED IN"], ["Social avoidance behaviors", "pro-inflammatory cytokines", "INTERACT"], ["misfolded protein \u03b1-syn", "vagus nerve", "LOCATED IN"], ["minerals", "microbiota", "IMPACT"], ["L. helveticus NS8", "chronic restraint stress depression", "INFLUENCE"], ["gut disorders", "central nervous system (CNS) disorders", "AFFECT"], ["gut microbiota-associated epitopes", "children", "LOCATED IN"], ["Chicoric acid", "inflammation", "INFLUENCE"], ["MeDi", "gut microbiota", "IMPACT"], ["microbiota", "subjects", "LOCATED IN"], ["probiotics", "Alzheimer's disease", "INFLUENCE"], ["SIBO", "hyperlipidemia", "AFFECT"], ["vitamin D", "neurodegenerative diseases", "INFLUENCE"], ["adequate protein", "amyotrophic lateral sclerosis", "INFLUENCE"], ["altered gut microbiota", "patients", "TARGET"], ["neuroinflammation", "human case-control studies", "TARGET"], ["Staphylococcus", "gut microbiota", "PART OF"], ["Human microbiota", "mice", "LOCATED IN"], ["fermented foods", "Alzheimer's disease", "INFLUENCE"], ["microbiota", "MS", "IS LINKED TO"], ["Elderly patients", "inflammatory markers", "USED BY"], ["gut microbiota", "Colonic FMT group", "LOCATED IN"], ["Diarrhea", "Bifidobacterium", "CHANGE ABUNDANCE"], ["high-fiber diet", "Akkermansias", "IMPACT"], ["NVP-1704", "Lactobacillacea", "IMPACT"], ["probiotics", "anxiety", "INFLUENCE"], ["Piperine", "diabetes", "INFLUENCE"], ["altered gut microbiota", "Neurological impairments", "IS LINKED TO"], ["microbiota", "Participants", "LOCATED IN"], ["gingerol", "FD", "INFLUENCE"], ["couples", "quantitative PCR", "USED BY"], ["gut microbiota", "rodent", "LOCATED IN"], ["curcumin", "C3", "CHANGE EXPRESSION"], ["L-Aspartic acid", "microbiota", "PRODUCED BY"], ["Faecalibacterium", "Parkinson's disease pathophysiology", "INFLUENCE"], ["gut microbiota", "cancer", "IS LINKED TO"], ["PIPO patients", "DNA extraction", "USED BY"], ["five compositional different metabolites", "microbiota", "PRODUCED BY"], ["Prenatal Stress", "Psychiatric Risks", "AFFECT"], ["neurological disorders", "patients", "TARGET"], ["<i>Helicobacter pylori</i> infection", "substantiated local gastric pathologies", "AFFECT"], ["gut microbiota", "HCs", "LOCATED IN"], ["probiotics", "mood disorders", "INFLUENCE"], ["PD", "Lachnospiraceae NK4A136", "CHANGE ABUNDANCE"], ["butyrate", "stress", "INFLUENCE"], ["Gut Bacteria", "Parkinson's Disease", "INFLUENCE"], ["Flavonifractor", "systemic low-grade inflammation", "INFLUENCE"], ["nutritional deficits", "inflammation and immune dysregulation", "AFFECT"], ["dysregulation of the microbiota", "cognitive decline", "AFFECT"], ["neuropeptides", "Parkinson's disease", "INFLUENCE"], ["short-chain fatty acids", "patients", "LOCATED IN"], ["Fisetin", "Alzheimer's disease", "INFLUENCE"], ["Flavobacterium spp.", "chronic social defeat", "INFLUENCE"], ["Faecalibacterium", "short-chain fatty acids", "INTERACT"], ["senescence", "Alzheimer's and Parkinson's diseases", "AFFECT"], ["NTS", "gut microbiota", "PRODUCED BY"], ["gastrointestinal disorders", "gut microbiota", "CHANGE ABUNDANCE"], ["nutraceutical supplementations", "non-communicable diseases", "INFLUENCE"], ["psychobiotic strain", "sleep disturbances", "INFLUENCE"], ["AD", "patient", "TARGET"], ["gut microenvironment", "stress-related psychiatric disorders", "IS LINKED TO"], ["Ruminococcus", "ET", "INFLUENCE"], ["Fisetin", "Gut Microbiota", "IMPACT"], ["mice", "MPTP injection", "USED BY"], ["fecal gut microbiota", "16S rRNA sequences", "CHANGE EXPRESSION"], ["GOS", "stress-induced learned helplessness", "INFLUENCE"], ["healthy controls", "LC-MS/MS", "USED BY"], ["metabotropic glutamate receptor 8", "MPTP", "INTERACT"], ["human diseases", "patients", "TARGET"], ["functional dysbiosis", "human case-control studies", "TARGET"], ["food bioactive compounds", "Alzheimer's disease", "INFLUENCE"], ["Coprobacter", "NS group and GP group", "LOCATED IN"], ["LDSD", "serum BA precursor 7\u03b1-hydroxy-4-cholesten-3-one", "INTERACT"], ["microbiota-enhancing", "microbiota", "IMPACT"], ["Coriobacteriales", "GM", "PART OF"], ["antidepressants", "Depression", "CHANGE EFFECT"], ["silibinin", "TREM2", "CHANGE EXPRESSION"], ["gastrointestinal microbiota", "traumatic brain injury", "IS LINKED TO"], ["gut microbiota", "depression", "IS LINKED TO"], ["murine gut microbiota", "radiation", "USED BY"], ["gut microbiome-dependent metabolites", "neurodegenerative diseases", "INFLUENCE"], ["antibiotic", "PD-like phenotype", "CHANGE EXPRESSION"], ["ProSAP/Shank scaffold", "gut microbiota", "IMPACT"], ["gastrointestinal (GI) symptoms", "well-trained athletes", "TARGET"], ["neurodegenerative diseases", "humans", "TARGET"], ["multiple system atrophy", "patients", "TARGET"], ["Prebiotics", "depression", "INFLUENCE"], ["peripheral dysregulations", "gut microbiota", "CHANGE ABUNDANCE"], ["<i>genus</i>_<i>Ruminococcaceae</i>", "OSA onset", "INFLUENCE"], ["Fisetin", "traumatic brain injury", "INFLUENCE"], ["Gut microbiota", "anxiety", "IS LINKED TO"], ["GM", "dyslipidemia", "IS LINKED TO"], ["Parkinson's disease", "A53T transgenic monkeys", "TARGET"], ["SARS-CoV-2", "Parkinson's disease", "AFFECT"], ["Depression-like Behaviour", "Growth-Period Mice", "TARGET"], ["manganese", "late onset neuropathology", "INFLUENCE"], ["<i>genus</i>_<i>Ruminococcaceae</i>", "gut microbiota", "PART OF"], ["small intestinal microbiome", "older subjects", "LOCATED IN"], ["depression", "individuals", "TARGET"], ["amyloidogenesis", "gut", "STRIKE"], ["brain", "human PD cases", "LOCATED IN"], ["HFD-original", "Verrucomicrobiaceae", "IMPACT"], ["Pelomonas", "PD mice", "LOCATED IN"], ["male rhesus monkeys", "16S rRNA sequencing", "USED BY"], ["Dietary AGEs", "endothelial dysfunction", "INFLUENCE"], ["gut microbiota", "Patients", "LOCATED IN"], ["3-HPPA", "intracellular \u03b1-syn seeding aggregation", "INFLUENCE"], ["antianaerobics", "PD", "CHANGE EFFECT"], ["hyposalivation", "PD patients", "TARGET"], ["BMAA", "PD pathology", "INFLUENCE"], ["microbiota", "CNS disorders", "IS LINKED TO"], ["disrupted microbiome", "Parkinson disease", "IS LINKED TO"], ["SD", "Bacteroidetes", "CHANGE ABUNDANCE"], ["stress", "adults", "TARGET"], ["PD", "tremor", "AFFECT"], ["Sodium butyrate", "rotenone-induced toxicity", "INFLUENCE"], ["polycystic ovary syndrome", "women of reproductive age", "TARGET"], ["Parkinson's Disease", "Occidental Patients", "TARGET"], ["gut microbiota", "healthy humans", "LOCATED IN"], ["IL-6", "Flavobacterium spp.", "IMPACT"], ["group", "16S rRNA (V3 and V4 regions) sequencing", "USED BY"], ["Schizophrenia", "individuals", "TARGET"], ["Erysipelotrichaceae UCG-003", "SCZ", "INFLUENCE"], ["lipopolysaccharide", "Methanobacteriaceae", "IMPACT"], ["Myristic acid", "intestine microbiota", "PRODUCED BY"], ["early PD", "Glyceric acid", "INTERACT"], ["gut microbiota", "breast cancer", "IS LINKED TO"], ["male", "enzyme-linked immunosorbent assay", "USED BY"], ["microglia activation", "patients", "TARGET"], ["gut microbiota", "EA", "USED BY"], ["Gut microbes", "neurologic disorders", "IS LINKED TO"], ["cancer", "age-associated diseases", "IS A"], ["SCZ", "mice", "TARGET"], ["alterations in the gut microbial composition", "patients with BD", "TARGET"], ["dopaminergic treatments", "short-chain fatty acid-producing bacteria", "IMPACT"], ["PD", "periphery of the body", "STRIKE"], ["Wolbachia", "Huntington's", "INFLUENCE"], ["Rifaximin", "interleukin-1\u03b2", "INTERACT"], ["fecal calprotectin", "short-chain fatty acid producing genera", "IMPACT"], ["prosaic foods", "neurodegenerative diseases", "INFLUENCE"], ["chronic SD", "p_Firmicutes", "CHANGE ABUNDANCE"], ["gut microbiota", "Wistar rats", "LOCATED IN"], ["tryptophan metabolites", "RIA", "INFLUENCE"], ["loss of dopaminergic neurons", "patients", "TARGET"], ["gut-associated microbes", "autism", "INFLUENCE"], ["Piperine", "Wnt/\u03b2-catenin", "INTERACT"], ["JPJDF", "CAC", "CHANGE EFFECT"], ["Gut Dysbiosis", "Cryptogenic Stroke", "AFFECT"], ["tizanidine", "propionic acid", "INTERACT"], ["established schizophrenia", "people", "TARGET"], ["therapeutic agents", "hemato-oncological conditions", "CHANGE EFFECT"], ["herpesvirus", "PD", "INFLUENCE"], ["Fecal calprotectin", "IBD", "INFLUENCE"], ["WIN55,212-2", "ionized calcium-binding adapter molecule 1", "CHANGE EXPRESSION"], ["gut bacteria", "Constipation", "INFLUENCE"], ["synbiotics", "neurological illnesses", "INFLUENCE"], ["NADPH oxidase 2", "amyotrophic lateral sclerosis", "INFLUENCE"], ["gut microbiota", "acne pathogenesis", "IS LINKED TO"], ["MS", "microbial communities", "CHANGE ABUNDANCE"], ["autophagy", "SCFAs", "INTERACT"], ["patients", "<sup>13</sup>C-D-xylose breath testing", "USED BY"], ["indole-producing microbiota", "gut microbiome", "PART OF"], ["leaky gut", "PD patients", "TARGET"], ["Parkinson's Disease", "Prevotellaceae", "CHANGE ABUNDANCE"], ["Bifidobacterium breve 207-1", "hormones", "INTERACT"], ["opportunistic pathogens", "PD", "INFLUENCE"], ["gut microbiota", "major depression disorder", "IS LINKED TO"], ["Lactobacteriaceae", "gut microbiome", "PART OF"], ["nucleotide-binding oligomerization domain", "duodenum", "LOCATED IN"], ["AD progression", "phenylalanine", "INTERACT"], ["Cuprizone", "demyelination", "CHANGE EFFECT"], ["Actinomyces", "gut microorganisms", "PART OF"], ["\u03b1-synuclein protein", "gut microbiome", "IMPACT"], ["PD medications", "gut-microbiota", "IMPACT"], ["CUR", "gut flora", "IMPACT"], ["HFD-reduced", "neurodegenerative diseases", "CHANGE EFFECT"], ["CT-26", "Lactococcus", "IMPACT"], ["GMB", "metabolic adverse effects", "IS LINKED TO"], ["polycystic ovary syndrome", "women", "TARGET"], ["Alzheimer's disease", "ND patients", "TARGET"], ["gastrointestinal disorders", "patients with PD", "TARGET"], ["Anthocyanins", "oxidative stress", "INFLUENCE"], ["anxiety", "(expectant) mothers", "TARGET"], ["A. muciniphila", "neuropsychiatric disorders", "INFLUENCE"], ["KRG", "Verrucomicrobia", "IMPACT"], ["Adolescent female mice", "Enzyme-linked immunosorbent assay", "USED BY"], ["(S)-ketamine", "rodents", "ADMINISTERED"], ["caecum", "host", "LOCATED IN"], ["tumor necrosis factor-\u03b1", "systemic inflammation", "INFLUENCE"], ["Depression", "patients", "TARGET"], ["patient's gastrointestinal tract", "FMT recipients", "LOCATED IN"], ["PD", "Lacticaseibacillus rhamnosus GG", "CHANGE ABUNDANCE"], ["amyloidogenic proteins", "human diseases", "INFLUENCE"], ["gut microbiota", "MMP9", "CHANGE EXPRESSION"], ["anxiety", "KO mice", "TARGET"], ["constipation", "PD patients", "TARGET"]]